data_2cpq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2cpq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.794 0.331 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.31 71.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.077 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.576 ' CD2' ' CB ' ' A' ' 269' ' ' ALA . 45.0 m-85 -114.55 139.63 49.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.851 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -138.97 137.31 36.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -113.43 127.39 56.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.409 ' CD ' ' O ' ' A' ' 222' ' ' GLU . 4.9 tm-20 -135.21 111.97 10.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.516 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 14.9 p90 -139.87 158.17 44.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 42.9 t -103.5 128.5 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.139 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 36.4 t -110.2 138.46 37.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 17.0 mtm-85 -56.85 128.49 37.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -55.6 -18.12 7.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -84.98 -31.85 23.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 59.8 mt -90.76 -23.32 20.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 25.3 mtp -45.99 -57.13 4.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.76 -61.81 1.53 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.492 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 60.1 mt -60.89 -43.68 98.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.881 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -52.0 -40.57 61.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.121 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 58.1 mt -78.63 -36.41 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 89.94 -155.16 24.36 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.521 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 237' ' ' HIS . 15.0 m -91.88 142.93 27.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.853 0.359 . . . . 0.0 111.156 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.437 ' C ' ' O ' ' A' ' 236' ' ' THR . 9.5 m170 35.2 48.28 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.48 ' O ' ' NE2' ' A' ' 242' ' ' GLN . . . 55.67 59.19 10.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.463 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.0 t -80.83 -63.54 1.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.846 0.355 . . . . 0.0 110.862 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 4.9 m120 -46.84 -61.02 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 31.7 mt -44.1 -61.45 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.087 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' A' ' 242' ' ' GLN . 0.0 OUTLIER -43.8 -44.58 6.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.926 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -63.92 -52.38 60.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -49.57 -38.75 32.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 17.2 ttt-85 -72.19 -21.96 61.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.84 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -81.22 7.36 11.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.464 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 99.4 t -91.93 138.94 24.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.628 0.728 . . . . 0.0 111.136 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.464 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 54.3 Cg_endo -69.72 154.25 68.13 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.264 . . . . 0.0 112.407 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.43 -11.68 43.58 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.472 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 95.8 t -90.03 109.85 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.892 0.377 . . . . 0.0 111.136 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 68.5 p -67.92 -50.97 52.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.132 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -156.56 171.01 21.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 82.4 mt -143.89 110.77 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -111.21 151.96 27.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.54 HD21 ' CZ ' ' A' ' 262' ' ' PHE . 10.9 tp -131.0 134.98 47.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 260' ' ' GLY . 1.3 m-20 -105.35 110.4 22.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -78.79 -37.14 41.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -43.07 -40.98 3.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 77.2 p -122.78 -22.67 5.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 256' ' ' ASP . . . 86.99 45.44 5.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.483 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 85.3 m -112.74 119.13 37.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 111.116 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.54 ' CZ ' HD21 ' A' ' 255' ' ' LEU . 10.8 m-85 -81.76 120.87 25.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -110.47 111.78 23.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 8.6 mt -105.16 145.11 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -125.74 120.35 30.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . 0.422 ' N ' HG12 ' A' ' 272' ' ' VAL . . . -145.29 144.06 12.61 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.486 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.1 -30.19 67.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 0.0 110.868 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 57.9 m -134.37 136.36 43.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.576 ' CB ' ' CD2' ' A' ' 219' ' ' PHE . . . -49.34 -33.85 14.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.079 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.81 -38.23 69.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.78 -67.47 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.073 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 266' ' ' GLY . 1.3 m -48.51 -30.34 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.184 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -68.98 -52.72 25.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -57.09 -40.03 76.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -74.06 -37.17 64.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.115 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.516 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 27.0 ttt180 -52.45 -42.12 63.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -51.18 -30.85 25.32 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -74.16 -38.94 63.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.84 -23.51 41.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.965 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.796 0.331 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.71 -47.73 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.079 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.498 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 61.0 m-85 -103.87 137.02 42.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.425 ' CD2' ' O ' ' A' ' 220' ' ' HIS . 7.7 p-80 -136.22 137.43 40.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -114.47 130.25 56.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.441 ' CD ' ' C ' ' A' ' 222' ' ' GLU . 1.8 tm-20 -133.21 118.63 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.409 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 16.0 p90 -141.86 149.1 39.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 40.4 t -98.9 124.43 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 226' ' ' ARG . 80.4 t -111.44 137.07 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.105 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.45 ' N ' HG12 ' A' ' 225' ' ' VAL . 28.0 mtp180 -55.63 126.82 27.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -49.44 -22.68 1.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -77.08 -46.57 23.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 53.7 mt -73.02 -31.69 64.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 19.5 mtp -37.08 -64.38 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.899 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -38.17 -48.08 2.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.62 -50.84 32.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.857 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -50.04 -40.47 45.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.101 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 240' ' ' ASN . 54.4 mt -78.25 -36.17 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 99.63 -147.93 18.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 12.0 t -109.06 119.09 38.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 111.127 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 64.26 38.26 8.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 64.31 59.34 8.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.47 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.4 t -87.67 -69.76 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 3.6 m120 -43.71 -55.39 4.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . 0.45 HG12 ' CD2' ' A' ' 279' ' ' LEU . 21.7 mt -49.27 -52.11 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -50.24 -53.18 30.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.482 ' NE2' ' N ' ' A' ' 243' ' ' GLN . 0.3 OUTLIER -55.54 -39.62 70.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.955 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.36 94.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.063 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -69.47 -17.96 63.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -85.75 12.72 8.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.471 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 98.9 t -93.16 138.89 22.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 0.0 111.16 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.471 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.2 Cg_endo -69.83 131.68 21.65 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.705 2.27 . . . . 0.0 112.305 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 98.29 -9.42 63.02 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.517 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 74.2 t -88.65 108.05 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 43.8 p -64.92 -53.1 51.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -158.98 161.47 36.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.106 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 38.8 mt -134.09 96.43 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -94.44 157.35 16.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 4.0 tp -141.38 129.02 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.941 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -83.81 96.7 8.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.67 3.09 6.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -93.3 -48.19 6.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.1 p -108.28 -22.51 12.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 89.91 52.64 2.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 31.6 m -122.64 122.73 39.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 0.0 111.093 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -89.57 116.85 28.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -109.08 116.0 31.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.9 mt -104.25 146.72 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.139 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -128.88 127.07 41.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -150.19 147.99 18.75 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.508 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.24 -21.72 66.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.917 0.389 . . . . 0.0 110.892 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 2.1 m -145.34 140.22 27.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.858 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.498 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.21 -30.92 3.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.052 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.27 -38.86 81.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.838 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -68.96 -65.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.083 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -50.4 -38.65 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -60.87 -53.13 61.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -56.35 -40.98 75.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.94 -33.34 70.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.146 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.409 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 36.7 ttp180 -59.7 -43.94 93.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.848 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -52.42 -15.57 2.94 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.445 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -92.78 -33.73 14.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 0.0 110.876 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.45 ' CD2' HG12 ' A' ' 241' ' ' ILE . 88.3 mt -87.08 7.29 28.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.756 0.312 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.24 93.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.099 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.515 ' CD2' ' HB3' ' A' ' 269' ' ' ALA . 88.3 m-85 -110.96 133.72 53.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.864 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -132.41 132.43 42.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -112.67 151.49 30.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.856 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -152.39 123.99 7.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 18.5 p90 -142.79 140.68 31.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 24.3 t -93.4 122.68 45.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 226' ' ' ARG . 82.7 t -111.23 137.77 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.137 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.463 ' N ' HG13 ' A' ' 225' ' ' VAL . 62.0 mtt180 -54.81 127.59 29.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -41.85 -45.27 3.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.848 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -62.78 -37.72 87.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 60.6 mt -72.94 -37.84 67.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' MET . . . . . 0.432 ' CE ' HD13 ' A' ' 255' ' ' LEU . 27.0 mtp -37.52 -60.62 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -36.13 -61.41 0.8 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 54.0 mt -60.92 -47.07 88.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.938 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -50.17 -41.65 49.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.058 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 59.4 mt -79.41 -27.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 88.81 -137.63 14.35 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.482 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 4.5 t -112.59 136.63 51.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.804 0.335 . . . . 0.0 111.125 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 27.4 m80 42.13 45.18 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 60.19 65.04 3.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.5 t -91.58 -69.3 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.874 0.369 . . . . 0.0 110.85 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -42.88 -55.26 3.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 52.4 mt -47.94 -55.45 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.104 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -47.64 -55.8 8.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -50.39 -58.63 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -45.6 -48.57 14.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -64.59 -24.13 67.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -82.83 17.05 1.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.475 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 99.5 t -100.44 138.89 20.28 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.616 0.722 . . . . 0.0 111.097 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.475 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.71 137.95 36.82 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.723 2.282 . . . . 0.0 112.358 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 95.67 -12.6 67.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 81.8 t -89.45 104.87 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.898 0.38 . . . . 0.0 111.139 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 71.1 p -60.1 -50.5 73.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.15 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.17 169.84 22.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.07 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 81.4 mt -141.84 113.96 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -113.21 160.67 18.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.511 HD11 ' CE2' ' A' ' 262' ' ' PHE . 12.1 tp -141.84 108.84 5.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.13 112.89 13.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -80.86 -37.63 29.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -38.96 -42.36 0.85 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 32.0 p -120.34 -21.59 6.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 88.82 51.72 2.97 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.482 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 96.2 m -119.44 136.34 54.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 111.124 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.554 ' CE1' HD23 ' A' ' 279' ' ' LEU . 12.3 m-85 -95.15 125.02 39.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 -114.13 111.05 20.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.7 mt -105.02 135.48 42.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.138 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -116.27 126.55 53.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . 0.453 ' N ' HG13 ' A' ' 272' ' ' VAL . . . -148.42 141.12 8.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.505 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -59.71 -33.63 71.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 110.856 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.1 m -128.8 136.79 50.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.515 ' HB3' ' CD2' ' A' ' 219' ' ' PHE . . . -47.32 -29.33 2.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.079 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.04 -39.88 93.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -68.46 -62.62 1.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . 0.453 HG13 ' N ' ' A' ' 266' ' ' GLY . 0.1 OUTLIER -52.18 -31.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.171 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -70.85 -50.44 35.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.934 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -59.75 -44.59 93.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.64 80.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -59.44 -37.57 78.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -56.83 -13.11 7.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.438 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -95.1 -25.49 16.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.883 0.373 . . . . 0.0 110.839 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.554 HD23 ' CE1' ' A' ' 262' ' ' PHE . 76.8 mt -98.74 0.96 45.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.877 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.767 0.318 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.67 83.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.072 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -104.82 140.78 37.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -130.52 153.38 48.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -132.68 136.72 46.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.83 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.467 ' CG ' ' HG2' ' A' ' 263' ' ' ARG . 3.5 mt-10 -145.74 116.41 7.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.894 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -139.2 147.3 41.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 15.2 t -94.81 116.92 37.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.172 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 73.5 t -98.25 147.42 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -58.74 124.97 21.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -53.89 -16.23 1.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.931 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.8 -38.75 15.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 230' ' ' MET . 69.9 mt -79.64 -29.03 40.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' MET . . . . . 0.413 ' C ' ' O ' ' A' ' 229' ' ' LEU . 19.8 mtp -37.42 -66.62 0.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -38.34 -46.74 2.02 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.51 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 56.8 mt -69.84 -57.05 5.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -45.06 -38.47 4.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 71.4 mt -77.27 -35.45 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 92.64 -145.98 17.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.487 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' HIS . 24.9 p -100.56 143.65 30.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 236' ' ' THR . 6.6 m80 34.77 41.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 61.89 61.35 6.81 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.432 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.6 m -86.83 -59.9 2.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.84 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -49.3 -54.68 15.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 18.2 mt -48.02 -52.85 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -52.29 -44.59 65.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -60.45 -50.88 71.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -53.86 -36.2 62.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.058 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -74.61 -11.94 60.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -93.97 15.11 17.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.467 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 99.5 t -96.98 138.91 21.29 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.614 0.721 . . . . 0.0 111.126 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.467 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.5 Cg_endo -69.83 144.94 55.21 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.641 2.227 . . . . 0.0 112.323 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 91.37 -19.65 45.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 91.4 t -84.46 112.59 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.957 0.408 . . . . 0.0 111.155 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.8 p -68.86 -46.78 67.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -162.12 166.09 26.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.098 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 91.4 mt -140.5 115.65 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.121 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -117.76 154.39 31.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 11.5 tp -130.77 147.13 52.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.465 ' OD2' ' CZ ' ' A' ' 263' ' ' ARG . 5.7 m-20 -107.85 136.07 48.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -101.34 -18.25 16.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -58.03 -49.17 77.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 63.3 p -123.68 -25.63 4.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.108 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 99.95 54.68 1.03 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.485 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 27.2 m -114.14 121.84 45.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.884 0.373 . . . . 0.0 111.127 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -86.29 113.99 22.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . 0.467 ' HG2' ' CG ' ' A' ' 222' ' ' GLU . 48.6 mtm180 -98.83 114.59 27.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 17.9 mt -111.08 133.07 57.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -113.91 122.95 48.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -146.12 143.82 12.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.5 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.35 -23.6 67.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 0.0 110.927 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 24.5 m -141.74 131.33 23.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.797 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -42.57 -34.27 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.122 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -55.72 -43.48 76.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.29 -68.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -48.1 -31.82 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -67.2 -50.9 59.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -59.42 -40.12 85.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.56 -38.5 65.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -49.28 -46.88 46.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.41 -32.94 10.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.504 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -71.83 -42.03 67.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.871 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 97.1 mt -78.75 -13.27 59.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.92 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.934 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.723 0.297 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.76 73.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.97 134.32 54.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 220' ' ' HIS . 7.6 p-80 -136.01 133.3 37.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -112.64 138.57 49.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.438 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 20.4 tt0 -141.6 125.3 16.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.501 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 11.8 p90 -142.4 149.66 39.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.847 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.62 115.5 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.16 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.41 HG11 ' N ' ' A' ' 226' ' ' ARG . 41.4 t -104.94 136.57 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.109 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.41 ' N ' HG11 ' A' ' 225' ' ' VAL . 51.5 mtp180 -54.4 133.94 45.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -50.91 -28.8 10.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -74.82 -39.69 61.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.857 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 53.4 mt -74.01 -27.11 60.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 8.5 mmm -41.5 -55.68 2.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -52.22 -40.24 52.13 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 44.1 mt -71.71 -58.62 3.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -52.02 -37.33 53.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.064 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 37.6 mt -77.03 -33.4 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.145 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 88.9 -150.93 21.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.429 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 9.9 t -103.03 123.92 47.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 0.0 111.139 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 18.7 m80 55.32 46.41 23.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 56.83 58.32 15.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.509 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.5 t -84.45 -57.67 3.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.361 . . . . 0.0 110.862 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 2.5 m120 -54.37 -57.62 10.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 70.7 mt -45.22 -49.58 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -51.92 -68.47 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -44.01 -35.3 2.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.78 -51.67 66.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -66.96 -11.85 57.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -86.91 3.36 45.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.474 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 97.7 t -89.74 138.85 27.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 111.091 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.474 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.8 144.76 54.83 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.93 -14.75 62.51 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.462 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 93.8 t -88.97 103.1 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 0.0 111.153 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 64.9 p -56.9 -50.85 71.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -161.15 171.41 18.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 49.4 mt -143.52 113.17 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.144 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -116.11 156.98 25.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.509 HD23 ' CZ ' ' A' ' 262' ' ' PHE . 7.8 tp -142.09 147.21 36.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -103.97 135.57 45.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -100.22 -23.03 14.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -82.58 -22.03 35.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 68.1 p -120.74 -23.23 6.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 71.79 47.31 33.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.438 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 90.2 m -122.62 124.08 42.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.353 . . . . 0.0 111.174 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.509 ' CZ ' HD23 ' A' ' 255' ' ' LEU . 10.7 m-85 -87.14 123.07 31.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -113.39 115.95 28.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 7.1 mt -108.42 139.26 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.137 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -119.22 121.42 39.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . 0.455 ' N ' HG12 ' A' ' 272' ' ' VAL . . . -144.73 145.12 14.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.518 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.09 -33.34 74.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.891 0.377 . . . . 0.0 110.946 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.8 m -132.93 135.23 45.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.864 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.447 ' HA ' ' CG2' ' A' ' 272' ' ' VAL . . . -46.11 -26.94 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.118 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -60.87 -40.94 94.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.53 -64.36 0.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.137 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 266' ' ' GLY . 0.2 OUTLIER -50.07 -31.08 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 269' ' ' ALA . 19.5 mtpp -68.99 -53.18 21.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.874 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -42.99 94.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.84 -33.89 76.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -61.37 -41.43 97.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.879 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.419 ' HA2' ' CG ' ' A' ' 280' ' ' GLU . . . -51.54 -20.02 5.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.478 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -85.32 -39.89 17.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.913 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.484 HD23 ' CE1' ' A' ' 262' ' ' PHE . 72.3 mt -87.24 6.16 34.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.419 ' CG ' ' HA2' ' A' ' 277' ' ' GLY . 7.6 mm-40 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.817 0.341 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -73.92 -30.12 62.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.09 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 68.1 m-85 -118.22 137.94 52.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.88 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -144.02 148.68 35.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -117.67 136.23 53.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -132.98 113.36 12.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 15.7 p90 -137.61 141.3 41.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 59.2 t -92.62 120.17 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 53.5 t -103.47 136.07 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.418 ' HA ' ' NE ' ' A' ' 226' ' ' ARG . 2.9 mmp_? -53.38 130.94 36.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -52.78 -16.72 1.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -92.9 -36.34 12.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 88.4 mt -74.38 -23.52 59.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' MET . . . . . 0.438 ' O ' ' C ' ' A' ' 231' ' ' GLY . 4.6 mtt -41.14 -65.2 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.895 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -35.44 -56.3 0.96 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.468 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 235' ' ' GLY . 41.6 mt -63.95 -64.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -41.32 -28.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.152 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 60.1 mt -89.95 -34.43 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 232' ' ' LEU . . . 89.94 -149.97 20.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 237' ' ' HIS . 4.9 t -98.9 143.58 29.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 111.192 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.44 ' C ' ' O ' ' A' ' 236' ' ' THR . 27.3 m-70 34.85 45.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.841 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 60.31 60.08 9.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.49 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.4 t -84.43 -61.46 1.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.876 0.37 . . . . 0.0 110.852 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -48.51 -59.84 3.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 30.9 mt -42.62 -53.37 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -50.05 -67.9 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -39.92 -52.8 2.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -50.69 -48.16 58.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -69.28 -13.55 62.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.841 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -86.27 6.82 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.473 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 99.4 t -92.71 138.88 23.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.628 0.728 . . . . 0.0 111.119 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.473 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.76 149.95 67.6 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.709 2.273 . . . . 0.0 112.309 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.05 -19.24 31.48 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.505 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.9 t -83.54 107.11 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.398 . . . . 0.0 111.129 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 59.1 p -60.2 -56.04 26.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.167 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -156.34 162.11 40.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.125 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 76.4 mt -135.14 107.05 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -107.13 163.27 13.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.548 HD22 ' CZ ' ' A' ' 262' ' ' PHE . 7.9 tp -141.06 141.98 34.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.933 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -100.33 129.7 46.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -100.31 -14.9 18.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -63.69 -38.72 92.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 54.5 p -128.81 -29.46 2.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.091 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.16 58.69 0.78 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.495 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.2 m -125.35 122.38 36.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 111.107 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.548 ' CZ ' HD22 ' A' ' 255' ' ' LEU . 11.1 m-85 -86.5 123.99 32.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -110.84 111.89 23.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 9.5 mt -104.44 141.02 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -121.63 131.28 54.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -154.29 143.63 10.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.481 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -58.22 -32.53 68.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 0.0 110.938 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.1 t -134.67 137.07 43.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.877 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.43 -28.87 2.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.134 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -42.53 84.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.74 -66.89 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.112 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -48.76 -34.84 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 36.2 mttm -64.23 -50.75 66.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -63.32 -39.75 95.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.8 -29.62 62.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.466 ' CZ ' ' OE1' ' A' ' 280' ' ' GLU . 21.2 ttt-85 -60.7 -42.79 97.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.841 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.41 ' HA2' ' CG ' ' A' ' 280' ' ' GLU . . . -51.09 -24.93 9.64 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.491 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -80.36 -25.82 38.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 110.866 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.52 HD23 ' CE1' ' A' ' 262' ' ' PHE . 68.3 mt -102.16 11.39 38.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.466 ' OE1' ' CZ ' ' A' ' 276' ' ' ARG . 8.9 mm-40 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.047 0 CA-C-O 120.802 0.334 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.81 86.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.127 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.506 ' CD2' ' HB3' ' A' ' 269' ' ' ALA . 83.4 m-85 -108.02 142.29 38.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -133.06 140.46 47.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -111.55 141.85 44.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.418 ' CD ' ' C ' ' A' ' 222' ' ' GLU . 0.6 OUTLIER -148.94 111.31 4.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.837 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.53 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 34.0 p90 -140.9 151.42 44.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 20.0 t -96.52 134.34 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.123 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 69.0 t -118.61 137.38 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -57.02 130.07 44.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -57.7 -22.53 46.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -83.72 -19.54 35.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 30.9 mt -100.42 -18.07 16.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 4.8 mmt -45.02 -66.96 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -40.45 -40.59 2.03 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.511 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 40.9 mt -69.94 -55.99 8.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.834 0.35 . . . . 0.0 110.945 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -52.9 -38.43 61.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.045 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 25.7 mt -77.5 -37.8 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 95.16 -158.5 22.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.471 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 22.1 m -95.77 128.59 42.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 111.189 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 67.4 t60 52.67 46.34 26.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.831 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 53.76 67.95 1.89 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.511 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.8 t -92.8 -61.51 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 110.912 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -50.02 -60.58 2.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 19.2 mt -41.61 -49.06 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -54.53 -51.2 65.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -58.02 -37.63 74.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.94 96.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 5.9 mtp-105 -70.7 -0.91 9.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -104.98 12.88 31.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.467 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 84.9 t -95.16 138.63 21.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 111.142 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.467 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.7 Cg_endo -69.77 133.4 25.46 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.683 2.255 . . . . 0.0 112.331 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 96.74 -0.43 61.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 74.5 t -102.17 106.57 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 111.147 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 265' ' ' TYR . 35.9 p -63.0 -58.25 7.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -151.47 157.59 42.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 66.0 mt -130.37 114.17 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.148 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -118.38 149.12 41.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 8.9 tp -127.56 147.7 50.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.944 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.84 118.92 36.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -84.74 -27.82 26.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -49.72 -40.5 40.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 62.0 p -125.25 -27.76 3.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.139 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 97.68 39.01 4.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 35.1 m -103.97 130.28 51.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 0.0 111.146 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.515 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.9 m-85 -93.58 116.6 29.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 53.5 mtt-85 -104.28 119.23 38.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 10.9 mt -115.49 143.32 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 251' ' ' THR . 88.9 m-85 -122.9 117.16 24.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . 0.418 ' N ' HG12 ' A' ' 272' ' ' VAL . . . -141.07 151.35 22.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.506 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -69.74 -26.51 64.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.2 p -132.71 132.79 42.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.506 ' HB3' ' CD2' ' A' ' 219' ' ' PHE . . . -47.21 -29.89 2.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.103 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.31 -35.71 81.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -69.79 -53.96 15.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.08 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 266' ' ' GLY . 0.4 OUTLIER -63.11 -29.54 47.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -72.22 -51.32 21.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -55.53 -48.94 73.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.97 -34.36 76.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.53 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 45.9 ttt180 -53.88 -47.06 71.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -46.44 -26.12 2.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -79.53 -33.71 41.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.905 0.383 . . . . 0.0 110.884 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.515 HD22 ' CE1' ' A' ' 262' ' ' PHE . 92.9 mt -85.27 -17.23 37.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.765 0.317 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -66.83 -36.29 82.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.074 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.445 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 88.2 m-85 -112.56 141.01 46.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.912 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -140.89 138.73 34.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.853 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -113.93 138.62 50.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -139.12 121.36 15.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 12.9 p90 -142.33 143.14 32.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.94 119.73 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 226' ' ' ARG . 93.8 t -109.31 134.73 50.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 229' ' ' LEU . 46.9 mtm180 -54.26 120.9 7.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -38.15 -28.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 226' ' ' ARG . 15.9 t0 -72.42 -44.36 62.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 226' ' ' ARG . 86.4 mt -74.14 -26.15 60.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' MET . . . . . 0.413 ' O ' ' C ' ' A' ' 231' ' ' GLY . 30.3 mtp -49.22 -58.91 4.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -36.47 -56.62 1.22 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.464 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 50.4 mt -67.78 -52.17 40.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -46.24 -34.59 4.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.087 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 56.4 mt -85.94 -32.44 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.128 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 93.78 -150.57 19.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.485 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 85.2 m -111.34 112.67 24.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 111.129 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 73.73 35.03 0.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.82 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 63.05 62.8 5.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 27.6 t -92.21 -53.62 4.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.835 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 7.1 m120 -58.01 -50.53 73.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 52.7 mt -52.06 -45.74 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.124 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -53.95 -67.31 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -42.79 -43.45 3.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.82 81.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -69.8 -21.69 63.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -76.33 -5.01 45.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.476 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 84.0 t -77.78 138.65 62.06 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.63 0.729 . . . . 0.0 111.104 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.476 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 54.0 Cg_endo -69.77 143.31 50.4 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.662 2.241 . . . . 0.0 112.388 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 91.41 -19.92 44.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.0 t -80.49 106.05 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.921 0.391 . . . . 0.0 111.129 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 265' ' ' TYR . 32.6 p -60.09 -58.76 7.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.159 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -154.46 159.13 40.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 50.9 mt -132.57 103.85 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.158 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -104.05 155.63 18.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 8.5 tp -140.17 157.11 46.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -116.93 134.5 54.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -100.88 -16.97 17.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.37 -34.37 28.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.83 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 59.7 p -114.77 -21.76 10.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.186 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 74.02 53.03 7.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.516 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.8 m -122.4 129.47 52.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.319 . . . . 0.0 111.142 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.556 ' HB2' ' CE2' ' A' ' 223' ' ' PHE . 10.9 m-85 -93.11 121.85 34.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.871 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.7 mtm-85 -113.02 114.17 26.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.834 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.2 mt -107.1 138.59 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.112 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 251' ' ' THR . 93.7 m-85 -122.82 117.47 25.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . 0.418 ' N ' HG11 ' A' ' 272' ' ' VAL . . . -139.88 144.81 15.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -58.06 -33.4 69.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.899 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.2 t -134.57 137.29 43.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.878 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.454 ' HA ' ' CG2' ' A' ' 272' ' ' VAL . . . -45.2 -26.8 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.061 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.25 -44.83 94.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.47 -65.09 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.139 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . 0.454 ' CG2' ' HA ' ' A' ' 269' ' ' ALA . 0.9 OUTLIER -48.46 -31.1 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -71.54 -54.14 11.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -58.17 -35.5 71.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -76.46 -37.34 57.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -54.8 -36.61 65.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -58.65 -12.22 13.16 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -94.61 -28.08 15.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 110.891 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.485 HD23 ' CE1' ' A' ' 262' ' ' PHE . 82.2 mt -92.95 -2.68 55.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 179.904 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.777 0.322 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -73.23 -41.22 63.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -107.98 132.29 53.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -126.17 145.72 50.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -119.22 137.65 53.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -143.53 111.96 6.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.449 ' CE2' ' HG3' ' A' ' 276' ' ' ARG . 30.2 p90 -141.21 150.08 42.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.869 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.47 132.25 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 226' ' ' ARG . 97.5 t -113.77 137.43 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.098 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.459 ' N ' HG12 ' A' ' 225' ' ' VAL . 36.9 mtp180 -53.54 122.06 9.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -49.7 -20.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -86.16 -38.49 17.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 34.6 mt -79.8 -25.24 40.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 25.7 mtp -45.98 -58.84 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.87 -52.24 3.25 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.463 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 26.1 mt -67.8 -50.71 55.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.838 0.352 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.426 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -47.51 -45.78 26.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 52.8 mt -69.68 -40.7 79.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 101.84 -143.87 16.16 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.489 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 8.8 t -115.29 114.26 24.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.774 0.321 . . . . 0.0 111.13 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 69.19 39.25 1.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 60.11 59.54 10.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 2.5 t -89.29 -60.11 2.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.907 0.384 . . . . 0.0 110.858 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 3.7 m120 -50.6 -56.89 9.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 48.9 mt -44.94 -51.35 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -56.24 -44.43 79.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -60.73 -35.38 76.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -64.48 -53.63 45.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -60.84 -30.29 70.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -64.81 -6.66 8.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.473 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 85.7 t -77.15 138.7 64.69 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.614 0.721 . . . . 0.0 111.136 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.473 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.9 Cg_endo -69.75 128.55 16.2 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.686 2.257 . . . . 0.0 112.368 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 104.12 -12.27 52.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.9 t -87.1 102.2 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 111.137 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 53.0 p -57.1 -48.96 77.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.168 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -162.35 166.86 24.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.096 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 58.6 mt -139.05 113.11 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.121 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -111.94 152.58 27.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 8.3 tp -129.19 110.72 12.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.91 99.4 6.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -73.75 -30.92 63.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.882 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -42.81 -39.52 2.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 3.0 p -127.06 -28.53 2.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.126 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 101.89 40.39 2.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.512 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.8 m -110.15 116.79 32.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.846 0.355 . . . . 0.0 111.13 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.468 ' CE1' HD23 ' A' ' 279' ' ' LEU . 10.8 m-85 -79.87 118.36 21.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -108.37 113.73 27.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 40.7 mt -107.25 139.79 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -117.9 121.92 41.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . 0.508 ' N ' ' CG1' ' A' ' 272' ' ' VAL . . . -144.79 140.45 9.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.504 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -61.99 -33.11 73.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.851 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 271' ' ' ALA . 23.8 p -127.37 123.83 37.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.872 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -38.5 -33.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.081 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -57.7 -46.05 84.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.834 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 268' ' ' SER . . . -61.27 -68.15 0.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.071 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 266' ' ' GLY . 3.5 m -47.86 -34.21 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -66.6 -52.23 47.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 39.8 tttt -54.5 -49.04 71.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.16 84.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.113 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.449 ' HG3' ' CE2' ' A' ' 223' ' ' PHE . 24.9 ttp85 -47.1 -44.47 21.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -49.27 -35.32 19.99 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -69.43 -42.7 74.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.468 HD23 ' CE1' ' A' ' 262' ' ' PHE . 81.1 mt -75.05 -27.03 59.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.983 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.916 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.737 0.303 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.84 76.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.103 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.553 ' CD2' ' HB3' ' A' ' 269' ' ' ALA . 70.5 m-85 -122.08 125.46 46.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -122.76 138.62 54.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -115.08 146.16 41.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.433 ' HG3' ' CG2' ' A' ' 261' ' ' THR . 19.5 tt0 -149.28 124.6 10.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.483 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 4.8 p90 -141.42 146.0 36.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.0 t -97.83 110.48 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 226' ' ' ARG . 31.5 t -95.66 146.03 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.441 ' N ' HG13 ' A' ' 225' ' ' VAL . 12.4 mmm-85 -61.6 148.59 41.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.14 -22.58 66.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -94.47 -12.91 26.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 91.5 mt -98.36 -8.93 26.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' MET . . . . . 0.438 ' O ' ' C ' ' A' ' 231' ' ' GLY . 2.9 mmt -56.38 -68.63 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -34.74 -57.09 0.78 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.466 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 62.7 mt -61.99 -51.16 69.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.922 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.75 -22.61 47.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.15 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 37.8 mt -100.44 -10.75 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.14 -157.68 53.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.529 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 238' ' ' GLY . 15.2 t -89.33 147.4 24.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.125 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.436 ' C ' ' O ' ' A' ' 236' ' ' THR . 96.1 m-70 35.37 33.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 236' ' ' THR . . . 65.13 48.91 65.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.476 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 236' ' ' THR . 3.0 t -77.25 -48.84 16.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 110.837 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -53.54 -54.71 33.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 55.7 mt -48.57 -45.46 14.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -55.03 -62.0 1.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -43.75 -49.03 8.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.935 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.19 -43.9 92.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -73.43 -18.07 61.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -90.64 15.24 11.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.448 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 98.0 t -93.95 138.38 22.71 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.616 0.722 . . . . 0.0 111.142 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.448 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 54.5 Cg_endo -69.7 128.89 16.73 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.702 2.268 . . . . 0.0 112.397 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.72 -7.88 50.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.537 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 84.0 t -96.75 103.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 111.137 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 68.3 p -54.11 -57.41 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.149 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.07 174.62 14.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.128 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 79.1 mt -143.19 108.54 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -105.43 155.34 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.556 HD22 ' CZ ' ' A' ' 262' ' ' PHE . 9.8 tp -141.01 133.43 28.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.7 120.49 40.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.809 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -85.36 -26.96 26.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.76 -40.03 27.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 35.0 p -127.16 -27.97 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 98.45 54.99 1.12 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.477 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.433 ' CG2' ' HG3' ' A' ' 222' ' ' GLU . 3.5 m -116.3 123.93 48.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.341 . . . . 0.0 111.154 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.556 ' CZ ' HD22 ' A' ' 255' ' ' LEU . 11.0 m-85 -92.52 112.74 24.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.883 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 38.4 mtp85 -103.21 120.37 40.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 7.4 mt -110.89 136.93 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.182 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -116.88 119.59 35.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . 0.416 ' N ' HG12 ' A' ' 272' ' ' VAL . . . -141.51 146.62 17.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.468 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -68.22 -28.28 67.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 p -130.21 130.8 45.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.553 ' HB3' ' CD2' ' A' ' 219' ' ' PHE . . . -43.82 -30.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.072 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.21 -40.79 98.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.47 -65.9 0.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.093 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 266' ' ' GLY . 0.3 OUTLIER -47.92 -41.25 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -67.13 -47.0 72.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.936 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -59.85 -39.21 84.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -75.57 -30.35 59.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.139 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -62.84 -39.92 95.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -54.64 -13.38 4.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.514 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -93.91 -26.06 17.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 83.0 mt -94.85 6.2 49.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.803 0.335 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -70.94 -29.17 65.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.069 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.412 ' CD2' ' CB ' ' A' ' 269' ' ' ALA . 86.6 m-85 -123.37 114.5 20.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -118.03 145.6 44.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -114.33 133.22 55.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.465 ' CD ' ' C ' ' A' ' 222' ' ' GLU . 0.3 OUTLIER -135.87 117.04 14.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 12.0 p90 -142.57 151.77 41.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.851 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 18.4 t -102.26 121.99 53.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.082 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 93.2 t -109.24 144.98 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 229' ' ' LEU . 70.8 mtt180 -60.9 122.06 13.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -40.48 -32.37 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.95 -43.08 56.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 226' ' ' ARG . 80.2 mt -71.23 -25.39 62.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' MET . . . . . 0.42 ' O ' ' C ' ' A' ' 231' ' ' GLY . 26.5 mtp -47.22 -64.46 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -36.32 -51.69 1.31 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.48 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 63.1 mt -67.03 -44.6 79.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 110.947 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -55.56 -37.9 68.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 41.8 mt -83.7 -27.61 7.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.147 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 90.18 -153.94 23.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.524 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 91.2 m -108.66 117.13 33.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.8 0.333 . . . . 0.0 111.182 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 9.1 t60 72.93 30.64 1.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.857 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 65.31 56.76 13.82 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.522 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 30.8 t -86.49 -58.15 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 0.0 110.856 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 4.6 m120 -51.17 -59.39 4.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.906 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 44.3 mt -42.83 -48.34 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -54.93 -55.36 31.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -48.74 -54.76 13.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -52.62 -40.6 62.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.075 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -71.31 -19.45 62.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -85.09 15.75 3.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.43 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 95.6 t -98.6 138.05 20.71 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.634 0.731 . . . . 0.0 111.092 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.43 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 54.3 Cg_endo -69.73 133.07 24.74 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.698 2.265 . . . . 0.0 112.391 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 101.41 -17.65 55.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.521 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.31 101.78 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.851 0.358 . . . . 0.0 111.164 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 66.7 p -56.28 -47.91 77.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -163.76 170.88 16.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.081 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.8 mt -140.1 116.22 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.101 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -113.65 160.45 18.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.542 HD12 ' CE2' ' A' ' 262' ' ' PHE . 4.1 tp -142.13 144.0 33.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -104.61 126.64 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.828 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -97.25 -19.17 18.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -58.6 -44.28 89.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 67.6 p -124.1 -31.01 3.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.173 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.67 57.35 0.7 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 90.7 m -122.65 119.17 29.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 111.189 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.569 ' CE1' HD21 ' A' ' 279' ' ' LEU . 12.4 m-85 -85.7 130.97 34.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -119.49 119.2 33.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.2 mt -109.47 139.94 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.148 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -120.0 115.53 23.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . 0.453 ' N ' HG13 ' A' ' 272' ' ' VAL . . . -140.16 138.05 8.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.453 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -56.86 -29.48 62.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.861 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.1 t -134.91 138.95 44.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.412 ' CB ' ' CD2' ' A' ' 219' ' ' PHE . . . -47.78 -30.19 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.071 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -59.56 -40.68 88.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -68.09 -67.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . 0.453 HG13 ' N ' ' A' ' 266' ' ' GLY . 0.3 OUTLIER -47.32 -38.46 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -64.03 -54.59 31.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -39.82 78.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.906 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.18 -35.75 71.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.054 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -59.17 -35.59 73.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -60.05 -8.87 9.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.493 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -98.72 -24.65 14.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 110.911 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.569 HD21 ' CE1' ' A' ' 262' ' ' PHE . 82.4 mt -99.28 1.94 45.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.887 179.921 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.835 0.35 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -65.42 -38.55 90.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.517 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 77.7 m-85 -109.01 130.86 55.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -127.68 141.32 51.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -113.62 142.82 45.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.43 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 0.1 OUTLIER -147.13 105.55 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.419 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 15.5 p90 -130.12 156.38 44.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 62.1 t -106.91 126.69 62.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.081 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.0 t -110.0 143.29 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.088 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -55.69 123.08 12.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -45.5 -25.08 0.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.26 -39.29 17.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 45.3 mt -71.81 -30.23 65.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 24.1 mtp -39.7 -57.94 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -41.55 -49.02 4.87 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.502 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 30.0 mt -70.67 -58.02 4.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 110.905 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -42.26 -42.75 3.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.064 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 22.9 mt -74.81 -36.08 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 99.51 -158.09 19.86 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 22.0 m -105.19 113.27 26.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.806 0.336 . . . . 0.0 111.137 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 74.4 31.34 1.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.858 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 64.11 61.52 6.01 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.461 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 29.3 t -90.96 -55.17 3.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.901 0.381 . . . . 0.0 110.851 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -55.84 -47.94 76.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 26.5 mt -54.55 -47.74 71.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -57.23 -46.72 82.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -60.25 -54.51 44.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -48.8 -40.1 27.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.082 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 18.4 ttt85 -72.87 -22.33 60.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -86.65 21.72 2.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.447 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 86.3 t -100.89 138.07 19.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.619 0.724 . . . . 0.0 111.104 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.447 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.77 127.26 14.33 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.711 2.274 . . . . 0.0 112.359 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 104.1 -4.53 45.1 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.538 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 82.9 t -100.89 104.96 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 0.0 111.141 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 69.9 p -59.19 -54.03 51.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.02 166.41 33.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.107 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 77.0 mt -137.57 105.94 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.163 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -110.79 148.59 32.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.523 HD23 ' CZ ' ' A' ' 262' ' ' PHE . 8.0 tp -128.15 154.57 45.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.929 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -112.07 130.15 55.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -100.13 -14.74 18.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.21 -45.18 95.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.9 p -126.0 -28.65 3.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.131 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.58 61.62 0.66 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.481 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.43 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 91.9 m -124.67 122.21 36.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 0.0 111.124 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.523 ' CZ ' HD23 ' A' ' 255' ' ' LEU . 13.6 m-85 -89.2 113.14 24.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -102.2 110.63 22.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 7.2 mt -104.59 144.78 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -123.0 124.11 42.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . 0.42 ' N ' HG11 ' A' ' 272' ' ' VAL . . . -149.46 136.3 5.71 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.533 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -56.58 -29.73 62.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.833 0.349 . . . . 0.0 110.866 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 13.2 p -129.08 135.23 48.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.517 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -49.29 -28.83 5.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.141 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.62 -36.86 84.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.854 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.6 -59.82 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.075 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . 0.42 HG11 ' N ' ' A' ' 266' ' ' GLY . 0.3 OUTLIER -58.85 -29.98 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -68.07 -50.45 55.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -58.21 -48.01 81.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.61 76.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.419 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 74.1 ttt180 -53.89 -50.12 67.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -44.14 -27.73 1.17 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.495 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -80.54 -39.07 28.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.924 0.392 . . . . 0.0 110.953 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.504 HD22 ' CE1' ' A' ' 262' ' ' PHE . 30.7 mt -88.08 -2.54 58.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.863 179.948 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.784 0.326 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.56 -43.75 89.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.125 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.569 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 83.5 m-85 -110.05 143.66 39.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -137.06 143.79 42.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -115.01 134.26 55.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.891 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.1 108.09 5.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.53 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 32.0 p90 -139.31 163.37 32.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.65 132.34 56.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.15 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 79.2 t -113.39 142.62 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 -55.16 125.04 18.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -53.76 -18.16 2.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.54 -38.53 17.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 51.4 mt -80.24 -27.54 38.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 22.4 mtp -40.23 -59.26 1.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.849 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -41.21 -54.13 3.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.467 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.04 -54.75 33.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.882 0.372 . . . . 0.0 110.936 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -45.92 -44.11 14.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.105 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 11.0 mt -71.6 -38.5 67.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 94.84 -134.25 11.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.454 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 237' ' ' HIS . 60.2 m -113.01 138.66 49.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.833 0.349 . . . . 0.0 111.141 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 236' ' ' THR . 5.5 m-70 35.91 48.8 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 59.29 57.73 18.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.493 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.7 t -84.57 -68.14 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.877 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 4.7 m120 -41.64 -62.32 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 60.2 mt -39.9 -52.52 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -54.76 -48.93 72.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.944 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.452 ' N ' ' OE1' ' A' ' 243' ' ' GLN . 0.3 OUTLIER -60.97 -30.83 70.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -68.54 -53.39 23.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -57.72 -23.91 54.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -72.51 1.89 7.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.474 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 99.4 t -82.67 138.9 43.75 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.654 0.74 . . . . 0.0 111.105 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.474 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.4 Cg_endo -69.75 133.28 25.22 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.728 2.286 . . . . 0.0 112.316 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 96.83 -3.45 62.68 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.511 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 70.6 t -96.59 113.46 31.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 111.095 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 20.6 p -70.87 -57.83 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -148.41 168.24 23.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.074 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 65.6 mt -143.84 109.17 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.126 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -113.13 154.45 26.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 8.0 tp -131.47 138.78 49.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -104.51 113.28 26.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -82.38 -33.19 28.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.849 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -45.46 -35.68 3.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 63.6 p -128.07 -31.33 2.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 99.15 47.05 1.93 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.49 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 223' ' ' PHE . 97.7 m -115.17 128.84 56.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 111.132 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -91.12 123.0 34.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -111.78 114.67 27.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 19.2 mt -109.1 139.84 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -120.25 117.05 26.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . 0.44 ' N ' HG11 ' A' ' 272' ' ' VAL . . . -139.67 151.88 22.24 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.506 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -67.74 -31.52 71.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 110.917 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.3 p -129.84 134.99 47.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.569 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -46.46 -32.42 3.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.099 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -62.06 -41.84 98.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.73 -65.54 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.085 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . 0.44 HG11 ' N ' ' A' ' 266' ' ' GLY . 0.3 OUTLIER -51.22 -34.57 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.153 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -65.59 -53.05 47.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -53.63 -48.25 69.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.36 -35.25 77.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.113 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.53 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 56.5 ttt180 -51.92 -42.81 63.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -49.46 -33.83 18.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.97 -43.81 67.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.381 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 69.8 mt -72.79 -28.94 62.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.904 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.796 0.332 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -51.84 -33.56 36.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.123 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -119.02 122.77 42.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -121.28 152.19 39.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.822 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -129.87 153.11 48.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -157.49 117.53 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.403 ' CE2' ' HG3' ' A' ' 276' ' ' ARG . 27.9 p90 -142.79 144.96 32.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.3 t -91.73 129.19 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.44 HG11 ' N ' ' A' ' 226' ' ' ARG . 55.3 t -109.83 139.03 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.12 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.44 ' N ' HG11 ' A' ' 225' ' ' VAL . 58.3 mtt180 -53.82 131.08 39.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.17 -11.69 6.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -96.82 -21.29 17.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.827 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 74.4 mt -97.58 -9.03 27.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 5.4 mmt -49.97 -66.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -40.27 -51.41 3.62 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.503 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 68.1 mt -59.42 -63.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -45.97 -39.53 9.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 45.6 mt -75.74 -30.38 21.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 88.85 -147.35 19.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.483 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 237' ' ' HIS . 9.6 t -101.58 140.69 35.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.765 0.317 . . . . 0.0 111.185 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 236' ' ' THR . 14.4 p80 34.63 49.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 56.46 66.27 2.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.486 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.7 t -93.74 -61.24 1.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 110.86 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -48.42 -63.46 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 45.4 mt -39.59 -52.75 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -50.68 -45.5 58.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -61.98 -50.24 72.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.934 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -56.7 -35.59 68.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.09 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -75.99 -18.37 59.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -89.29 12.86 14.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.409 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 93.7 t -91.76 137.4 25.54 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.646 0.736 . . . . 0.0 111.16 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.409 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 54.0 Cg_endo -69.69 139.69 41.08 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.657 2.238 . . . . 0.0 112.385 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 95.97 -18.99 56.42 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.541 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 86.9 t -81.01 116.79 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 111.104 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 265' ' ' TYR . 37.2 p -71.24 -49.17 46.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.108 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -161.45 169.44 21.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 90.6 mt -144.6 113.56 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.088 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -114.01 153.51 29.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 1.8 tp -135.31 125.52 26.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.889 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -84.87 107.81 17.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 29.7 mp0 -83.15 -3.93 57.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -91.33 -36.23 13.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 40.1 p -115.36 -17.02 11.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 76.88 51.79 6.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.475 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 96.8 m -124.97 126.62 45.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 111.161 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -88.02 114.16 24.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 27.4 mtt-85 -104.24 117.09 33.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.44 HG21 ' N ' ' A' ' 265' ' ' TYR . 10.2 mt -110.02 148.43 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.44 ' N ' HG21 ' A' ' 264' ' ' ILE . 60.2 m-85 -131.65 112.43 12.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . 0.437 ' N ' HG12 ' A' ' 272' ' ' VAL . . . -133.34 148.81 19.49 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.524 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -67.4 -25.71 66.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.888 0.375 . . . . 0.0 110.9 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 270' ' ' ASP . 6.3 m -141.08 131.26 24.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.833 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -36.8 -34.11 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 268' ' ' SER . 2.6 m-20 -57.74 -50.73 72.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.87 -66.98 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 266' ' ' GLY . 2.4 m -50.66 -41.7 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -56.28 -52.79 63.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -57.79 -49.23 77.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.56 -31.53 72.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.403 ' HG3' ' CE2' ' A' ' 223' ' ' PHE . 37.8 ttp85 -60.41 -45.99 91.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.06 -22.52 2.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.469 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -85.55 -50.63 7.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 0.0 110.851 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 78.2 mt -68.75 -8.66 45.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.938 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 179.962 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.784 0.326 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -74.84 -43.11 56.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.519 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 96.7 m-85 -114.41 122.72 47.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -118.46 141.79 48.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -119.13 135.97 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.05 122.93 18.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.479 ' N ' ' CD1' ' A' ' 223' ' ' PHE . 1.7 p90 -140.57 151.79 44.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.9 t -104.42 114.03 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 19.5 t -97.91 143.6 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.155 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -53.9 172.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -91.42 -17.57 25.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -102.28 -8.89 20.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 65.7 mt -100.69 -4.08 28.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 2.8 mmt -58.21 -66.8 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -42.85 -39.21 3.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 68.1 mt -66.34 -59.86 3.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 0.0 110.889 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.422 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -53.76 -49.68 67.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 8.0 mt -65.76 -31.66 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.158 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 92.92 -153.12 21.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.463 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 70.1 p -108.72 118.13 35.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.349 . . . . 0.0 111.169 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 69.25 35.44 2.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.857 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 58.84 61.07 7.79 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.485 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.3 t -92.42 -54.25 3.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.882 0.372 . . . . 0.0 110.876 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 5.5 m120 -52.88 -56.2 17.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.885 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 39.4 mt -46.54 -45.59 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -55.21 -62.53 1.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -45.91 -41.41 11.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.69 -57.21 13.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -60.3 -11.62 6.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -98.21 14.1 28.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.448 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 98.1 t -94.36 138.29 22.48 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.581 0.705 . . . . 0.0 111.153 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.448 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.8 Cg_endo -69.77 128.41 15.97 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.649 2.233 . . . . 0.0 112.355 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.423 ' HA3' ' CB ' ' A' ' 271' ' ' ALA . . . 103.75 -6.26 48.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 78.3 t -98.14 108.55 22.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 0.0 111.122 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 43.5 p -64.89 -46.29 82.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.152 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -162.02 165.79 26.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.065 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 58.3 mt -139.37 106.37 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.089 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -109.37 151.98 25.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.561 HD22 ' CZ ' ' A' ' 262' ' ' PHE . 7.8 tp -138.07 151.37 47.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.916 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -112.89 124.37 52.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -89.49 -19.57 24.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.95 -27.39 39.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.836 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 60.3 p -121.69 -14.15 8.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 66.67 44.08 90.46 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.51 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 71.1 m -115.25 123.48 48.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 111.137 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.561 ' CZ ' HD22 ' A' ' 255' ' ' LEU . 11.3 m-85 -91.25 113.99 26.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -104.65 115.52 30.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 265' ' ' TYR . 55.8 mt -108.32 140.36 27.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.183 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.454 ' N ' HG23 ' A' ' 264' ' ' ILE . 95.3 m-85 -121.25 122.16 39.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.941 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -143.46 152.73 24.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -71.77 -34.4 69.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.341 . . . . 0.0 110.858 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 21.5 p -125.76 132.08 52.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -43.0 -31.28 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.39 -43.7 98.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.423 ' CB ' ' HA3' ' A' ' 249' ' ' GLY . . . -60.3 -64.41 0.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.091 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -52.77 -40.52 35.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.118 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -59.63 -55.81 29.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -58.49 -41.96 86.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.881 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.83 -24.14 61.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 18.3 ttt-85 -68.35 -45.11 73.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.67 -27.64 6.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.477 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -78.58 -36.82 43.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.37 . . . . 0.0 110.868 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 86.0 mt -88.33 -13.75 39.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.931 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 179.95 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.818 0.342 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.25 -39.54 75.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.04 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -111.6 135.33 52.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -133.32 138.01 46.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -115.34 127.17 55.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.554 ' CD ' ' CG2' ' A' ' 261' ' ' THR . 3.0 tp10 -132.73 119.62 20.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.931 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -140.52 153.16 46.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.47 122.62 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 19.1 t -104.59 146.23 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -53.52 173.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -89.79 -27.54 19.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -90.92 -30.98 16.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 64.2 mt -73.09 -18.74 61.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 2.3 mtt -47.13 -59.03 3.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -46.22 -43.22 13.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.497 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 36.7 mt -68.29 -63.27 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 110.889 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.444 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -45.08 -43.47 9.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.162 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 61.2 mt -73.91 -35.52 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.1 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 89.95 -158.06 26.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.511 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 237' ' ' HIS . 5.4 m -92.12 145.25 24.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.35 . . . . 0.0 111.132 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.43 ' C ' ' O ' ' A' ' 236' ' ' THR . 89.4 m-70 35.2 51.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 50.19 66.93 2.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 17.1 t -92.06 -68.95 0.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.862 0.363 . . . . 0.0 110.849 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.444 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 5.0 m120 -40.33 -67.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 240' ' ' ASN . 45.4 mt -36.5 -54.99 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -55.21 -48.63 73.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -58.45 -52.54 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -50.67 -39.14 50.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -71.91 -25.04 61.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -81.3 11.05 4.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.472 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 98.7 t -91.38 138.94 25.26 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.612 0.72 . . . . 0.0 111.128 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.472 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.8 Cg_endo -69.72 137.4 35.47 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.704 2.27 . . . . 0.0 112.34 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 97.93 -21.46 45.97 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.514 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 88.5 t -82.15 115.72 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.918 0.389 . . . . 0.0 111.086 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 265' ' ' TYR . 79.4 p -71.35 -48.39 50.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -158.85 169.43 24.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 73.3 mt -145.42 109.72 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -110.97 163.22 14.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.56 ' HB2' ' CE1' ' A' ' 262' ' ' PHE . 10.3 tp -140.88 153.98 45.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -121.03 119.28 32.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.831 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -86.12 -13.93 45.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -58.29 -52.85 63.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 37.3 p -119.18 -19.36 8.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 95.28 48.28 2.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.514 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.554 ' CG2' ' CD ' ' A' ' 222' ' ' GLU . 20.7 m -110.97 136.79 49.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 111.117 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' ' 255' ' ' LEU . 11.6 m-85 -107.39 127.02 53.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . 0.406 ' CG ' ' CD ' ' A' ' 222' ' ' GLU . 17.4 mtp180 -113.99 115.23 27.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 265' ' ' TYR . 34.0 mt -107.18 142.64 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 251' ' ' THR . 79.1 m-85 -124.5 124.02 41.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -147.73 136.27 5.96 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.461 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -54.96 -41.75 71.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.87 0.367 . . . . 0.0 110.869 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 38.3 m -122.24 136.26 54.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 271' ' ' ALA . . . -43.04 -59.65 1.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.139 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 269' ' ' ALA . 3.1 m-20 -36.51 -30.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 269' ' ' ALA . . . -75.07 -68.94 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.116 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -51.8 -28.71 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.087 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.09 -51.17 22.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -60.35 -33.96 73.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -82.5 -30.69 29.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -58.56 -44.4 89.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.07 -27.39 5.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.504 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -79.04 -54.95 5.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.866 0.365 . . . . 0.0 110.829 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.511 HD21 ' CD1' ' A' ' 262' ' ' PHE . 67.4 mt -63.48 -22.14 66.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 179.942 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.802 0.334 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -48.2 -39.05 19.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.489 ' CD2' ' HB1' ' A' ' 269' ' ' ALA . 75.9 m-85 -110.39 146.45 35.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.896 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -145.03 140.33 28.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -113.46 138.26 50.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.413 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 8.6 tt0 -143.0 116.94 9.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.52 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 29.6 p90 -142.23 139.22 31.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.02 123.6 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 226' ' ' ARG . 56.0 t -111.72 136.35 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.46 ' HB2' ' CD1' ' A' ' 229' ' ' LEU . 23.6 mmt180 -54.05 142.96 23.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -58.5 -25.85 62.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.51 -43.53 22.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.46 ' CD1' ' HB2' ' A' ' 226' ' ' ARG . 23.6 mt -66.59 -32.02 73.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' MET . . . . . 0.451 ' O ' ' C ' ' A' ' 231' ' ' GLY . 3.2 mtt -36.83 -66.81 0.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -34.47 -61.8 0.54 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.496 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 235' ' ' GLY . 60.2 mt -60.11 -65.32 0.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' LEU . . . -37.62 -36.85 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.102 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 64.7 mt -83.02 -36.2 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 232' ' ' LEU . . . 96.58 -151.2 19.81 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 86.0 m -100.99 136.28 41.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.768 0.318 . . . . 0.0 111.16 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 2.7 m80 43.99 49.49 7.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 52.45 65.74 3.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 3.5 t -92.68 -65.65 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.861 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -43.64 -63.35 0.86 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 33.7 mt -39.71 -52.11 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.096 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -54.05 -51.17 64.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -54.59 -48.13 72.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -54.69 -48.05 72.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.092 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -65.91 -29.66 70.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -72.17 -1.33 14.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.475 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 99.2 t -82.39 138.88 44.71 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.657 0.741 . . . . 0.0 111.142 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.475 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.7 Cg_endo -69.76 148.43 65.09 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.671 2.247 . . . . 0.0 112.355 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 89.26 -26.8 8.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 87.6 t -74.4 105.5 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.931 0.396 . . . . 0.0 111.11 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 34.7 p -60.52 -49.41 77.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.25 162.92 33.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.089 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 24.4 mt -134.05 106.42 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -107.74 155.7 19.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 6.1 tp -141.64 150.54 42.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -108.16 141.53 39.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -103.57 -20.15 14.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -76.76 -36.46 57.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.7 p -115.02 -22.76 9.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.154 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 77.58 47.0 9.19 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.413 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 48.6 m -112.89 135.54 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 111.191 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.52 ' HB2' ' CE2' ' A' ' 223' ' ' PHE . 12.9 m-85 -98.73 115.68 29.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -105.89 114.48 28.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.917 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 34.5 mt -108.91 132.0 58.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.141 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -111.22 126.4 54.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -147.24 143.61 11.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.453 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.34 -34.8 74.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.925 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 14.2 m -133.24 131.43 40.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.489 ' HB1' ' CD2' ' A' ' 219' ' ' PHE . . . -40.73 -38.56 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.112 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.49 -43.16 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.873 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.09 -68.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 1.2 m -49.38 -30.54 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.1 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -67.94 -52.46 35.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -56.72 -41.23 77.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.64 -41.77 62.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.081 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -50.34 -39.92 47.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.835 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -53.79 -23.36 21.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.535 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -82.14 -36.84 27.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.362 . . . . 0.0 110.898 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.516 HD21 ' CE1' ' A' ' 262' ' ' PHE . 69.0 mt -91.08 16.92 8.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 179.883 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.796 0.331 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.44 -30.71 61.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.579 ' CD2' ' CB ' ' A' ' 269' ' ' ALA . 58.9 m-85 -117.62 138.36 52.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -139.17 147.71 42.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -121.84 144.88 48.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -147.27 112.21 5.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -136.17 147.62 47.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 37.4 t -101.18 122.95 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.157 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.408 HG11 ' N ' ' A' ' 226' ' ' ARG . 99.6 t -108.21 136.34 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.46 ' O ' ' N ' ' A' ' 229' ' ' LEU . 37.7 mtt-85 -54.15 122.44 10.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -42.1 -32.04 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -74.94 -37.5 61.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 226' ' ' ARG . 51.5 mt -74.87 -30.01 61.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' MET . . . . . 0.405 ' C ' ' O ' ' A' ' 229' ' ' LEU . 4.0 mmt -37.26 -61.51 0.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.0 -53.48 2.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 35.6 mt -67.04 -54.61 19.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.815 0.34 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.443 ' O ' ' ND2' ' A' ' 240' ' ' ASN . . . -43.06 -48.85 6.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 38.8 mt -71.49 -34.6 53.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.095 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 94.21 -145.97 17.93 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.474 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 237' ' ' HIS . 0.0 OUTLIER -99.84 140.26 34.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.86 0.362 . . . . 0.0 111.104 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 236' ' ' THR . 8.1 m170 36.76 42.59 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 59.72 65.6 3.31 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.493 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 27.2 t -93.54 -59.58 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.82 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 233' ' ' ALA . 2.4 m120 -47.16 -57.86 4.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.904 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 27.2 mt -45.01 -53.46 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.159 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -46.97 -64.77 0.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -42.36 -45.34 4.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.56 98.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.077 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -72.32 -12.71 61.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.902 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -95.99 8.46 43.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.407 HG11 ' N ' ' A' ' 248' ' ' PRO . 84.2 t -86.93 136.69 33.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.597 0.713 . . . . 0.0 111.159 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.407 ' N ' HG11 ' A' ' 247' ' ' VAL . 53.1 Cg_endo -69.86 130.06 18.58 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.66 2.24 . . . . 0.0 112.319 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 102.21 -9.13 56.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.452 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 45.9 t -91.62 99.3 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.886 0.374 . . . . 0.0 111.137 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.7 p -55.34 -49.46 72.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -159.36 170.02 22.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 56.8 mt -144.2 106.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -101.89 155.42 18.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.538 HD23 ' CZ ' ' A' ' 262' ' ' PHE . 2.5 tp -138.76 122.44 17.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 260' ' ' GLY . 19.1 m-20 -93.42 102.32 14.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.49 -33.06 68.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -43.35 -46.72 6.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.857 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 11.1 p -122.75 -9.89 8.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 256' ' ' ASP . . . 79.2 56.61 3.4 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.52 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 25.2 m -117.95 112.84 20.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.849 0.357 . . . . 0.0 111.153 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.538 ' CZ ' HD23 ' A' ' 255' ' ' LEU . 9.9 m-85 -85.01 114.25 22.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -106.58 123.32 47.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.417 HG21 ' N ' ' A' ' 265' ' ' TYR . 6.3 mt -109.53 146.46 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.417 ' N ' HG21 ' A' ' 264' ' ' ILE . 98.9 m-85 -128.12 118.5 23.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -142.23 155.73 25.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -71.95 -25.22 61.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.873 0.368 . . . . 0.0 110.874 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 270' ' ' ASP . 2.3 m -141.75 132.23 25.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.579 ' CB ' ' CD2' ' A' ' 219' ' ' PHE . . . -40.12 -27.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.096 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 268' ' ' SER . 0.8 OUTLIER -62.13 -46.65 88.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -61.38 -64.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.115 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -51.29 -35.45 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.111 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 269' ' ' ALA . 19.0 mtpp -63.06 -53.55 51.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -56.81 -39.57 74.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.933 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.37 -41.93 69.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -59.06 -27.55 65.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -67.84 -6.9 46.66 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.459 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -101.37 -32.52 10.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 0.0 110.891 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 40.8 mt -86.29 0.94 52.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 179.945 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.803 0.335 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.04 -38.78 68.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.07 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.493 ' CD2' ' HB1' ' A' ' 269' ' ' ALA . 39.2 m-85 -111.08 139.38 46.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -135.4 151.84 50.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -132.88 146.29 51.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.447 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 7.3 tm-20 -152.3 116.7 5.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -137.95 153.62 49.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.06 121.5 53.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.89 140.98 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.137 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -56.51 127.08 29.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -50.8 -21.86 1.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.64 -42.25 18.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.831 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 65.9 mt -77.86 -16.17 58.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 5.3 mmt -45.25 -67.73 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.844 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.13 -58.29 1.97 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.501 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 235' ' ' GLY . 50.5 mt -55.31 -62.88 1.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.806 0.336 . . . . 0.0 110.931 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -42.33 -45.69 4.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 54.9 mt -73.39 -29.28 27.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.137 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 232' ' ' LEU . . . 93.75 -162.35 25.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.513 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 67.9 p -96.68 123.82 40.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.155 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 60.25 37.66 20.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 61.54 63.21 5.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.435 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 5.5 t -92.55 -58.29 2.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.907 0.384 . . . . 0.0 110.843 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -50.06 -53.23 28.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 14.4 mt -49.76 -49.12 20.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -50.31 -63.46 1.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -48.31 -41.59 28.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.39 -52.94 63.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -62.65 -12.12 21.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -96.02 11.8 32.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.468 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 99.0 t -91.3 138.91 25.39 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.617 0.722 . . . . 0.0 111.127 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.468 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.76 139.4 40.12 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.677 2.251 . . . . 0.0 112.381 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 96.2 -24.19 31.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.454 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 86.0 t -77.88 109.89 12.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 30.0 p -67.47 -49.8 61.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.154 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.14 153.6 22.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 22.4 mt -128.81 112.38 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -112.35 153.67 26.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.562 HD22 ' CE1' ' A' ' 262' ' ' PHE . 11.1 tp -137.79 109.42 7.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.959 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.44 92.29 3.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.93 -25.43 68.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.874 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -43.8 -49.57 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 2.3 p -116.83 -29.28 6.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.127 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 107.78 43.86 1.28 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.434 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.447 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 6.5 m -110.79 133.42 53.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 111.117 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.562 ' CE1' HD22 ' A' ' 255' ' ' LEU . 10.5 m-85 -99.59 113.97 26.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.5 mtt-85 -103.69 113.93 27.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 9.3 mt -109.25 136.54 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.096 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -120.58 123.57 43.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -142.7 151.13 22.84 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.515 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.95 -27.39 66.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 12.1 m -138.14 132.68 32.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.861 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.493 ' HB1' ' CD2' ' A' ' 219' ' ' PHE . . . -41.24 -35.24 0.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -55.55 -46.88 77.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -59.05 -67.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 1.5 m -51.61 -34.22 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -65.05 -49.6 69.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -66.0 -36.34 83.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -75.54 -30.86 59.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -60.37 -47.67 85.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -45.53 -27.8 2.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -78.85 -41.7 29.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.873 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.21 -13.8 58.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.923 179.926 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.798 0.332 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.52 -42.6 98.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.1 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -109.31 143.46 38.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -140.49 137.09 33.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -111.59 143.2 42.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -148.45 112.46 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.914 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -137.77 149.51 46.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 20.0 t -95.37 120.98 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.17 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.2 t -103.46 137.14 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -54.94 126.99 26.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -53.95 -22.0 9.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -86.59 -23.66 25.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 37.7 mt -95.33 -12.68 25.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 4.8 mmt -47.1 -60.48 2.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -47.53 -50.83 17.84 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.513 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 49.5 mt -57.56 -55.96 28.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.814 0.34 . . . . 0.0 110.919 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.42 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -52.59 -52.31 55.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.114 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 70.9 mt -61.02 -24.33 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.6 -154.89 34.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.461 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 237' ' ' HIS . 23.9 m -92.93 138.13 31.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 111.153 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 236' ' ' THR . 9.5 m170 37.07 54.46 1.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 50.83 56.73 12.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.484 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 30.2 t -84.96 -60.7 1.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.855 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.42 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 4.4 m120 -49.39 -62.57 1.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 48.2 mt -39.48 -46.44 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.166 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -59.06 -52.92 63.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -54.66 -43.0 72.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.968 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.26 -45.17 95.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -68.0 -16.38 64.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -91.03 19.82 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.473 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 86.4 t -98.28 138.75 20.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.666 0.746 . . . . 0.0 111.125 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.473 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.3 Cg_endo -69.75 131.97 22.38 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.271 . . . . 0.0 112.338 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.12 -22.59 36.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 79.6 t -79.63 108.45 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.373 . . . . 0.0 111.124 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 63.3 p -64.64 -50.91 65.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.09 165.46 36.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.2 mt -139.65 111.95 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -112.87 159.51 18.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.48 HD12 ' CZ ' ' A' ' 262' ' ' PHE . 15.4 tp -135.83 138.32 42.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -108.69 112.19 24.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -80.15 -35.38 36.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -42.18 -40.58 2.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 78.0 p -124.58 -25.97 3.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 93.68 37.26 5.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.4 m -106.81 118.37 36.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 111.169 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.48 ' CZ ' HD12 ' A' ' 255' ' ' LEU . 11.1 m-85 -81.15 132.36 35.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -116.57 118.31 32.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 7.1 mt -112.66 139.44 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -120.9 130.37 53.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . 0.408 ' N ' HG13 ' A' ' 272' ' ' VAL . . . -154.87 146.77 15.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.443 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -62.35 -33.63 75.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 110.882 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 47.4 m -128.91 132.09 47.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -44.91 -37.95 4.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.115 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -53.59 -37.76 63.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.853 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -68.01 -65.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 266' ' ' GLY . 1.0 OUTLIER -55.15 -29.95 23.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.141 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -66.25 -53.52 35.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.934 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -57.81 -43.65 85.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.56 -32.86 70.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 34.9 ttp85 -55.04 -48.47 73.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -45.92 -32.06 4.45 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.428 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -73.01 -49.24 30.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.841 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.439 HD21 ' CE1' ' A' ' 262' ' ' PHE . 94.1 mt -71.15 -9.33 57.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.918 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 41.3 t -45.09 153.12 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.394 . . . . 0.0 110.871 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 66.3 m -97.04 152.92 18.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.862 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 154.84 47.19 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.512 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 17.2 t -81.16 164.46 22.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.882 0.372 . . . . 0.0 110.83 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 75.7 m -126.38 -45.79 1.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.849 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 163.45 -159.53 32.14 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.478 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 81.8 p -120.74 125.43 47.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 111.174 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -62.35 -44.95 95.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -116.78 138.02 51.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 23.9 mt -48.17 -58.66 4.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.22 177.66 8.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -106.76 122.93 47.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.084 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.31 71.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.077 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.576 ' CD2' ' CB ' ' A' ' 269' ' ' ALA . 45.0 m-85 -114.55 139.63 49.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.851 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -138.97 137.31 36.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -113.43 127.39 56.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.409 ' CD ' ' O ' ' A' ' 222' ' ' GLU . 4.9 tm-20 -135.21 111.97 10.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.516 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 14.9 p90 -139.87 158.17 44.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 42.9 t -103.5 128.5 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.139 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 36.4 t -110.2 138.46 37.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 17.0 mtm-85 -56.85 128.49 37.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -55.6 -18.12 7.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -84.98 -31.85 23.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.442 ' CD1' ' HB2' ' A' ' 281' ' ' PHE . 59.8 mt -90.76 -23.32 20.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 25.3 mtp -45.99 -57.13 4.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.76 -61.81 1.53 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.492 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 60.1 mt -60.89 -43.68 98.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.881 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -52.0 -40.57 61.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.121 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 58.1 mt -78.63 -36.41 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 89.94 -155.16 24.36 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.521 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 237' ' ' HIS . 15.0 m -91.88 142.93 27.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.853 0.359 . . . . 0.0 111.156 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.437 ' C ' ' O ' ' A' ' 236' ' ' THR . 9.5 m170 35.2 48.28 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.48 ' O ' ' NE2' ' A' ' 242' ' ' GLN . . . 55.67 59.19 10.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.463 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.0 t -80.83 -63.54 1.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.846 0.355 . . . . 0.0 110.862 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 4.9 m120 -46.84 -61.02 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 31.7 mt -44.1 -61.45 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.087 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' A' ' 242' ' ' GLN . 0.0 OUTLIER -43.8 -44.58 6.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.926 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -63.92 -52.38 60.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -49.57 -38.75 32.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 17.2 ttt-85 -72.19 -21.96 61.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.84 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -81.22 7.36 11.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.464 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 99.4 t -91.93 138.94 24.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.628 0.728 . . . . 0.0 111.136 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.464 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 54.3 Cg_endo -69.72 154.25 68.13 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.264 . . . . 0.0 112.407 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.43 -11.68 43.58 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.472 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 95.8 t -90.03 109.85 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.892 0.377 . . . . 0.0 111.136 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 68.5 p -67.92 -50.97 52.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.132 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -156.56 171.01 21.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 82.4 mt -143.89 110.77 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -111.21 151.96 27.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.54 HD21 ' CZ ' ' A' ' 262' ' ' PHE . 10.9 tp -131.0 134.98 47.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 260' ' ' GLY . 1.3 m-20 -105.35 110.4 22.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -78.79 -37.14 41.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -43.07 -40.98 3.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 77.2 p -122.78 -22.67 5.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 256' ' ' ASP . . . 86.99 45.44 5.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.483 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 85.3 m -112.74 119.13 37.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 111.116 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.54 ' CZ ' HD21 ' A' ' 255' ' ' LEU . 10.8 m-85 -81.76 120.87 25.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -110.47 111.78 23.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 8.6 mt -105.16 145.11 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -125.74 120.35 30.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . 0.422 ' N ' HG12 ' A' ' 272' ' ' VAL . . . -145.29 144.06 12.61 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.486 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.1 -30.19 67.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 0.0 110.868 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 57.9 m -134.37 136.36 43.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.576 ' CB ' ' CD2' ' A' ' 219' ' ' PHE . . . -49.34 -33.85 14.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.079 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.81 -38.23 69.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.78 -67.47 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.073 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 266' ' ' GLY . 1.3 m -48.51 -30.34 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.184 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -68.98 -52.72 25.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -57.09 -40.03 76.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -74.06 -37.17 64.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.115 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.516 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 27.0 ttt180 -52.45 -42.12 63.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -51.18 -30.85 25.32 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -74.16 -38.94 63.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.84 -23.51 41.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.965 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -50.04 148.83 3.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.442 ' HB2' ' CD1' ' A' ' 229' ' ' LEU . 8.3 p90 -68.22 149.53 49.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.841 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.5 134.54 64.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -63.65 148.64 48.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.96 111.6 0.87 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -109.37 141.83 41.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 48.6 mm -123.39 99.45 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -110.12 112.27 24.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 30.7 m -87.06 144.28 36.16 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 0.0 111.148 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -5.98 17.52 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.656 2.237 . . . . 0.0 112.314 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 86.1 p 40.67 51.59 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.863 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 133.02 81.02 0.18 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.52 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 97.77 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.682 2.255 . . . . 0.0 112.36 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 17.2 m -75.71 118.24 18.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 86.7 p -78.4 -46.33 20.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.855 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.47 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 55.6 m -159.89 176.63 11.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 0.0 110.838 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.4 m -156.83 140.12 15.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.842 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 138.46 -168.36 24.7 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.502 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.7 t -85.96 161.11 19.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 110.848 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 79.1 p -93.77 168.52 10.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.828 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -174.0 140.08 5.31 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.508 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 14.7 t -91.81 134.02 35.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.371 . . . . 0.0 111.096 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -132.18 168.28 18.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -126.9 40.13 3.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.919 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 216' ' ' ALA . 4.5 mm? -77.76 105.88 9.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 215' ' ' LEU . . . -34.81 144.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -85.14 117.56 24.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.101 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.71 -47.73 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.079 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.498 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 61.0 m-85 -103.87 137.02 42.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.425 ' CD2' ' O ' ' A' ' 220' ' ' HIS . 7.7 p-80 -136.22 137.43 40.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -114.47 130.25 56.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.441 ' CD ' ' C ' ' A' ' 222' ' ' GLU . 1.8 tm-20 -133.21 118.63 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.409 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 16.0 p90 -141.86 149.1 39.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 40.4 t -98.9 124.43 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 226' ' ' ARG . 80.4 t -111.44 137.07 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.105 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.45 ' N ' HG12 ' A' ' 225' ' ' VAL . 28.0 mtp180 -55.63 126.82 27.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -49.44 -22.68 1.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -77.08 -46.57 23.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 53.7 mt -73.02 -31.69 64.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 19.5 mtp -37.08 -64.38 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.899 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -38.17 -48.08 2.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.62 -50.84 32.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.857 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -50.04 -40.47 45.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.101 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 240' ' ' ASN . 54.4 mt -78.25 -36.17 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 99.63 -147.93 18.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 12.0 t -109.06 119.09 38.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 111.127 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 64.26 38.26 8.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 64.31 59.34 8.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.47 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.4 t -87.67 -69.76 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 3.6 m120 -43.71 -55.39 4.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . 0.45 HG12 ' CD2' ' A' ' 279' ' ' LEU . 21.7 mt -49.27 -52.11 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -50.24 -53.18 30.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.482 ' NE2' ' N ' ' A' ' 243' ' ' GLN . 0.3 OUTLIER -55.54 -39.62 70.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.955 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.36 94.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.063 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -69.47 -17.96 63.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -85.75 12.72 8.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.471 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 98.9 t -93.16 138.89 22.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 0.0 111.16 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.471 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.2 Cg_endo -69.83 131.68 21.65 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.705 2.27 . . . . 0.0 112.305 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 98.29 -9.42 63.02 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.517 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 74.2 t -88.65 108.05 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 43.8 p -64.92 -53.1 51.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -158.98 161.47 36.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.106 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 38.8 mt -134.09 96.43 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -94.44 157.35 16.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 4.0 tp -141.38 129.02 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.941 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -83.81 96.7 8.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.67 3.09 6.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -93.3 -48.19 6.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.1 p -108.28 -22.51 12.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 89.91 52.64 2.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 31.6 m -122.64 122.73 39.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 0.0 111.093 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -89.57 116.85 28.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -109.08 116.0 31.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.9 mt -104.25 146.72 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.139 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -128.88 127.07 41.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -150.19 147.99 18.75 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.508 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.24 -21.72 66.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.917 0.389 . . . . 0.0 110.892 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 2.1 m -145.34 140.22 27.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.858 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.498 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.21 -30.92 3.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.052 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.27 -38.86 81.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.838 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -68.96 -65.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.083 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -50.4 -38.65 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -60.87 -53.13 61.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -56.35 -40.98 75.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.94 -33.34 70.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.146 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.409 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 36.7 ttp180 -59.7 -43.94 93.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.848 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -52.42 -15.57 2.94 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.445 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -92.78 -33.73 14.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 0.0 110.876 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.45 ' CD2' HG12 ' A' ' 241' ' ' ILE . 88.3 mt -87.08 7.29 28.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -58.34 155.14 12.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.506 ' O ' ' CD1' ' A' ' 281' ' ' PHE . 26.8 p90 -84.33 129.67 34.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.41 130.39 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.132 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -64.59 158.6 23.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.42 106.0 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.848 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -88.47 142.23 27.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 5.4 mp -106.75 98.6 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.123 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -89.78 154.02 20.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 24.0 m -74.27 144.35 81.38 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.625 0.726 . . . . 0.0 111.136 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 87.14 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.683 2.256 . . . . 0.0 112.34 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 18.6 m -146.0 120.61 9.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 145.86 147.16 4.54 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.452 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -18.04 37.05 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.662 2.241 . . . . 0.0 112.314 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 77.1 p -44.09 145.3 0.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.882 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 43.8 t -146.75 133.13 19.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.471 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.4 t -111.65 159.3 18.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 0.0 110.833 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 25.5 t -103.7 119.28 38.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.08 106.11 0.19 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.507 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.4 m -146.65 175.16 10.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 0.0 110.845 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 30.5 p -112.11 140.49 46.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.906 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -111.29 53.79 0.57 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.477 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 24.8 p -137.74 155.71 48.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.92 0.39 . . . . 0.0 111.136 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 22.8 mmtm -103.14 142.65 33.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -118.44 -178.44 3.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.494 ' CD2' ' O ' ' A' ' 215' ' ' LEU . 0.0 OUTLIER -130.5 8.85 5.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -137.76 165.71 25.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -92.39 114.01 26.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.24 93.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.099 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.515 ' CD2' ' HB3' ' A' ' 269' ' ' ALA . 88.3 m-85 -110.96 133.72 53.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.864 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -132.41 132.43 42.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -112.67 151.49 30.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.856 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -152.39 123.99 7.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 18.5 p90 -142.79 140.68 31.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 24.3 t -93.4 122.68 45.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 226' ' ' ARG . 82.7 t -111.23 137.77 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.137 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.463 ' N ' HG13 ' A' ' 225' ' ' VAL . 62.0 mtt180 -54.81 127.59 29.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -41.85 -45.27 3.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.848 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -62.78 -37.72 87.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.458 ' CD2' ' HA ' ' A' ' 283' ' ' GLU . 60.6 mt -72.94 -37.84 67.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' MET . . . . . 0.432 ' CE ' HD13 ' A' ' 255' ' ' LEU . 27.0 mtp -37.52 -60.62 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -36.13 -61.41 0.8 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 54.0 mt -60.92 -47.07 88.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.938 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -50.17 -41.65 49.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.058 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 59.4 mt -79.41 -27.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 88.81 -137.63 14.35 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.482 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 4.5 t -112.59 136.63 51.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.804 0.335 . . . . 0.0 111.125 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 27.4 m80 42.13 45.18 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 60.19 65.04 3.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.5 t -91.58 -69.3 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.874 0.369 . . . . 0.0 110.85 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -42.88 -55.26 3.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 52.4 mt -47.94 -55.45 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.104 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -47.64 -55.8 8.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -50.39 -58.63 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -45.6 -48.57 14.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -64.59 -24.13 67.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -82.83 17.05 1.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.475 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 99.5 t -100.44 138.89 20.28 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.616 0.722 . . . . 0.0 111.097 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.475 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.71 137.95 36.82 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.723 2.282 . . . . 0.0 112.358 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 95.67 -12.6 67.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 81.8 t -89.45 104.87 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.898 0.38 . . . . 0.0 111.139 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 71.1 p -60.1 -50.5 73.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.15 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.17 169.84 22.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.07 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 81.4 mt -141.84 113.96 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -113.21 160.67 18.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.511 HD11 ' CE2' ' A' ' 262' ' ' PHE . 12.1 tp -141.84 108.84 5.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.13 112.89 13.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -80.86 -37.63 29.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -38.96 -42.36 0.85 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 32.0 p -120.34 -21.59 6.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 88.82 51.72 2.97 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.482 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 96.2 m -119.44 136.34 54.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 111.124 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.554 ' CE1' HD23 ' A' ' 279' ' ' LEU . 12.3 m-85 -95.15 125.02 39.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 -114.13 111.05 20.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.7 mt -105.02 135.48 42.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.138 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -116.27 126.55 53.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . 0.453 ' N ' HG13 ' A' ' 272' ' ' VAL . . . -148.42 141.12 8.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.505 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -59.71 -33.63 71.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 110.856 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.1 m -128.8 136.79 50.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.515 ' HB3' ' CD2' ' A' ' 219' ' ' PHE . . . -47.32 -29.33 2.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.079 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.04 -39.88 93.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -68.46 -62.62 1.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.453 HG13 ' N ' ' A' ' 266' ' ' GLY . 0.1 OUTLIER -52.18 -31.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.171 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -70.85 -50.44 35.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.934 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -59.75 -44.59 93.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.64 80.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -59.44 -37.57 78.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -56.83 -13.11 7.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.438 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -95.1 -25.49 16.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.883 0.373 . . . . 0.0 110.839 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.554 HD23 ' CE1' ' A' ' 262' ' ' PHE . 76.8 mt -98.74 0.96 45.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -50.88 139.75 16.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.877 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.441 ' CD2' ' O ' ' A' ' 281' ' ' PHE . 30.2 p90 -68.35 118.62 11.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 84.7 t -121.2 127.26 75.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.174 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.458 ' HA ' ' CD2' ' A' ' 229' ' ' LEU . 2.3 pp20? -95.09 154.35 17.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 283' ' ' GLU . 1.3 p30 -36.15 97.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 283' ' ' GLU . 12.8 p90 -84.4 141.53 30.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 47.0 mt -125.2 96.46 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.114 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -114.45 136.86 52.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 16.0 m -115.58 144.42 32.44 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.608 0.718 . . . . 0.0 111.126 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -32.32 18.95 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.271 . . . . 0.0 112.374 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 53.9 m -94.54 89.11 5.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -130.79 -95.07 0.69 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.524 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 293' ' ' SER . 53.8 Cg_endo -69.78 94.51 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.683 2.255 . . . . 0.0 112.337 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 292' ' ' PRO . 1.9 m 37.26 37.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.1 t -84.15 148.4 26.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.839 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.496 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 34.1 p -147.28 108.09 4.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 110.836 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.5 t -72.93 -60.31 2.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -72.64 -150.8 1.27 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.467 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 8.2 t -144.58 175.87 9.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.833 0.349 . . . . 0.0 110.886 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 24.8 p -166.97 172.64 10.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 152.61 77.64 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 75.8 p -136.03 126.49 26.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.845 0.355 . . . . 0.0 111.14 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.6 ptpt -155.02 157.18 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -172.19 161.41 5.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.977 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 78.4 mt -51.5 -45.43 62.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.86 174.39 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.058 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -107.01 114.54 28.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.67 83.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.072 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -104.82 140.78 37.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -130.52 153.38 48.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -132.68 136.72 46.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.83 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.467 ' CG ' ' HG2' ' A' ' 263' ' ' ARG . 3.5 mt-10 -145.74 116.41 7.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.894 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -139.2 147.3 41.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 15.2 t -94.81 116.92 37.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.172 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 73.5 t -98.25 147.42 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -58.74 124.97 21.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -53.89 -16.23 1.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.931 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.8 -38.75 15.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.467 ' CD1' ' HB2' ' A' ' 281' ' ' PHE . 69.9 mt -79.64 -29.03 40.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' MET . . . . . 0.413 ' C ' ' O ' ' A' ' 229' ' ' LEU . 19.8 mtp -37.42 -66.62 0.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -38.34 -46.74 2.02 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.51 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 56.8 mt -69.84 -57.05 5.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -45.06 -38.47 4.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 71.4 mt -77.27 -35.45 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 92.64 -145.98 17.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.487 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' HIS . 24.9 p -100.56 143.65 30.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 236' ' ' THR . 6.6 m80 34.77 41.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 61.89 61.35 6.81 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.432 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.6 m -86.83 -59.9 2.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.84 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -49.3 -54.68 15.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 18.2 mt -48.02 -52.85 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -52.29 -44.59 65.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -60.45 -50.88 71.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -53.86 -36.2 62.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.058 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -74.61 -11.94 60.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -93.97 15.11 17.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.467 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 99.5 t -96.98 138.91 21.29 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.614 0.721 . . . . 0.0 111.126 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.467 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.5 Cg_endo -69.83 144.94 55.21 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.641 2.227 . . . . 0.0 112.323 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 91.37 -19.65 45.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 91.4 t -84.46 112.59 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.957 0.408 . . . . 0.0 111.155 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.8 p -68.86 -46.78 67.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -162.12 166.09 26.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.098 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 91.4 mt -140.5 115.65 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.121 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -117.76 154.39 31.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 11.5 tp -130.77 147.13 52.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.465 ' OD2' ' CZ ' ' A' ' 263' ' ' ARG . 5.7 m-20 -107.85 136.07 48.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -101.34 -18.25 16.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -58.03 -49.17 77.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 63.3 p -123.68 -25.63 4.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.108 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 99.95 54.68 1.03 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.485 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 27.2 m -114.14 121.84 45.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.884 0.373 . . . . 0.0 111.127 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -86.29 113.99 22.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . 0.467 ' HG2' ' CG ' ' A' ' 222' ' ' GLU . 48.6 mtm180 -98.83 114.59 27.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 17.9 mt -111.08 133.07 57.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -113.91 122.95 48.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -146.12 143.82 12.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.5 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.35 -23.6 67.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 0.0 110.927 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 24.5 m -141.74 131.33 23.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.797 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -42.57 -34.27 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.122 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -55.72 -43.48 76.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.29 -68.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -48.1 -31.82 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -67.2 -50.9 59.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -59.42 -40.12 85.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.56 -38.5 65.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -49.28 -46.88 46.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.41 -32.94 10.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.504 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -71.83 -42.03 67.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.871 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 97.1 mt -78.75 -13.27 59.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.92 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -59.97 142.96 52.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.467 ' HB2' ' CD1' ' A' ' 229' ' ' LEU . 7.4 p90 -67.56 142.17 56.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 89.8 t -121.8 132.23 71.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.146 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -59.56 140.33 56.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -50.07 126.44 14.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -105.12 141.58 36.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 72.9 mt -127.21 103.05 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.168 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -95.22 141.29 29.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.75 144.42 29.9 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.636 0.732 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 290' ' ' SER . 53.2 Cg_endo -69.78 2.83 3.2 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.653 2.235 . . . . 0.0 112.331 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 289' ' ' PRO . 40.1 t -34.58 -56.32 0.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.86 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 170.13 146.53 5.16 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -8.61 24.03 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.66 2.24 . . . . 0.0 112.338 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 2.0 m -60.06 -62.14 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.814 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 23.1 t -58.29 102.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.815 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.474 179.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 2.6 m -148.93 153.71 38.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.894 0.378 . . . . 0.0 110.858 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.8 m -123.12 170.33 10.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 134.9 91.38 0.37 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.45 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 11.7 m -132.56 97.35 4.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.904 0.383 . . . . 0.0 110.871 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 97.9 p -108.64 155.95 20.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 149.72 169.81 16.47 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.5 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.422 ' O ' ' NE2' ' A' ' 214' ' ' GLN . 20.2 m -141.13 125.25 17.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 111.158 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.0 tptt -58.9 116.81 4.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.422 ' NE2' ' O ' ' A' ' 212' ' ' THR . 1.6 mp0 -122.21 177.46 5.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.71 58.05 1.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -164.57 -175.74 4.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -120.81 118.09 29.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.76 73.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.97 134.32 54.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 220' ' ' HIS . 7.6 p-80 -136.01 133.3 37.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -112.64 138.57 49.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.438 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 20.4 tt0 -141.6 125.3 16.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.501 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 11.8 p90 -142.4 149.66 39.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.847 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.62 115.5 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.16 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.41 HG11 ' N ' ' A' ' 226' ' ' ARG . 41.4 t -104.94 136.57 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.109 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.41 ' N ' HG11 ' A' ' 225' ' ' VAL . 51.5 mtp180 -54.4 133.94 45.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -50.91 -28.8 10.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -74.82 -39.69 61.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.857 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.4 ' CD2' ' HA ' ' A' ' 283' ' ' GLU . 53.4 mt -74.01 -27.11 60.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 8.5 mmm -41.5 -55.68 2.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -52.22 -40.24 52.13 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.45 HD23 ' CE2' ' A' ' 285' ' ' PHE . 44.1 mt -71.71 -58.62 3.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -52.02 -37.33 53.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.064 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 37.6 mt -77.03 -33.4 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.145 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 88.9 -150.93 21.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.429 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 9.9 t -103.03 123.92 47.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 0.0 111.139 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 18.7 m80 55.32 46.41 23.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 56.83 58.32 15.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.509 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.5 t -84.45 -57.67 3.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.361 . . . . 0.0 110.862 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 2.5 m120 -54.37 -57.62 10.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 70.7 mt -45.22 -49.58 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -51.92 -68.47 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -44.01 -35.3 2.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.78 -51.67 66.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -66.96 -11.85 57.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -86.91 3.36 45.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.474 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 97.7 t -89.74 138.85 27.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 111.091 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.474 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.8 144.76 54.83 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.93 -14.75 62.51 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.462 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 93.8 t -88.97 103.1 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 0.0 111.153 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 64.9 p -56.9 -50.85 71.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -161.15 171.41 18.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 49.4 mt -143.52 113.17 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.144 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -116.11 156.98 25.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.509 HD23 ' CZ ' ' A' ' 262' ' ' PHE . 7.8 tp -142.09 147.21 36.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -103.97 135.57 45.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -100.22 -23.03 14.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -82.58 -22.03 35.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 68.1 p -120.74 -23.23 6.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 71.79 47.31 33.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.438 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 90.2 m -122.62 124.08 42.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.353 . . . . 0.0 111.174 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.509 ' CZ ' HD23 ' A' ' 255' ' ' LEU . 10.7 m-85 -87.14 123.07 31.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -113.39 115.95 28.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 7.1 mt -108.42 139.26 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.137 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -119.22 121.42 39.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . 0.455 ' N ' HG12 ' A' ' 272' ' ' VAL . . . -144.73 145.12 14.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.518 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.09 -33.34 74.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.891 0.377 . . . . 0.0 110.946 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.8 m -132.93 135.23 45.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.864 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.447 ' HA ' ' CG2' ' A' ' 272' ' ' VAL . . . -46.11 -26.94 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.118 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -60.87 -40.94 94.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.53 -64.36 0.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.137 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 266' ' ' GLY . 0.2 OUTLIER -50.07 -31.08 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 269' ' ' ALA . 19.5 mtpp -68.99 -53.18 21.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.874 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -42.99 94.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.84 -33.89 76.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -61.37 -41.43 97.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.879 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.419 ' HA2' ' CG ' ' A' ' 280' ' ' GLU . . . -51.54 -20.02 5.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.478 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -85.32 -39.89 17.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.913 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.484 HD23 ' CE1' ' A' ' 262' ' ' PHE . 72.3 mt -87.24 6.16 34.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.419 ' CG ' ' HA2' ' A' ' 277' ' ' GLY . 7.6 mm-40 -53.25 149.62 7.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.45 ' CD2' ' O ' ' A' ' 281' ' ' PHE . 39.0 p90 -75.28 119.94 20.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 73.0 t -119.96 126.91 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.4 ' HA ' ' CD2' ' A' ' 229' ' ' LEU . 35.3 mt-10 -82.53 160.02 22.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -38.74 107.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . 0.45 ' CE2' HD23 ' A' ' 232' ' ' LEU . 37.7 p90 -99.97 136.92 39.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 4.8 mp -119.75 101.4 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -116.95 142.16 47.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.895 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 16.8 m -114.57 145.61 34.21 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.624 0.726 . . . . 0.0 111.149 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 161.0 47.64 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.658 2.239 . . . . 0.0 112.363 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 2.0 t -148.22 133.24 18.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.838 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 84.52 -157.9 33.4 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.458 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.86 -31.76 19.44 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.637 2.225 . . . . 0.0 112.316 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 38.9 t -38.5 150.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 52.2 m -82.29 170.27 15.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.823 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.488 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 89.4 p -149.46 155.92 41.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 0.0 110.824 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 93.6 p -168.87 148.04 4.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.892 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.29 162.75 32.53 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.507 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -124.6 115.89 21.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.917 0.389 . . . . 0.0 110.848 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.5 m -136.1 172.9 12.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -80.88 113.1 3.57 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.47 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 7.7 t -131.79 154.96 48.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 0.0 111.147 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.08 136.05 55.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -131.23 163.76 27.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.956 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.22 -63.0 1.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -148.94 135.22 19.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.058 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -76.64 127.11 32.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.088 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -73.92 -30.12 62.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.09 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 68.1 m-85 -118.22 137.94 52.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.88 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -144.02 148.68 35.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -117.67 136.23 53.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -132.98 113.36 12.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 15.7 p90 -137.61 141.3 41.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 59.2 t -92.62 120.17 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 53.5 t -103.47 136.07 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.418 ' HA ' ' NE ' ' A' ' 226' ' ' ARG . 2.9 mmp_? -53.38 130.94 36.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -52.78 -16.72 1.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -92.9 -36.34 12.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 88.4 mt -74.38 -23.52 59.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' MET . . . . . 0.438 ' O ' ' C ' ' A' ' 231' ' ' GLY . 4.6 mtt -41.14 -65.2 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.895 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -35.44 -56.3 0.96 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.468 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 235' ' ' GLY . 41.6 mt -63.95 -64.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -41.32 -28.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.152 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 60.1 mt -89.95 -34.43 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 232' ' ' LEU . . . 89.94 -149.97 20.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 237' ' ' HIS . 4.9 t -98.9 143.58 29.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 111.192 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.44 ' C ' ' O ' ' A' ' 236' ' ' THR . 27.3 m-70 34.85 45.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.841 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 60.31 60.08 9.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.49 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.4 t -84.43 -61.46 1.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.876 0.37 . . . . 0.0 110.852 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -48.51 -59.84 3.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 30.9 mt -42.62 -53.37 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -50.05 -67.9 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -39.92 -52.8 2.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -50.69 -48.16 58.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -69.28 -13.55 62.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.841 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -86.27 6.82 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.473 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 99.4 t -92.71 138.88 23.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.628 0.728 . . . . 0.0 111.119 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.473 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.76 149.95 67.6 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.709 2.273 . . . . 0.0 112.309 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.05 -19.24 31.48 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.505 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.9 t -83.54 107.11 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.398 . . . . 0.0 111.129 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 59.1 p -60.2 -56.04 26.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.167 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -156.34 162.11 40.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.125 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 76.4 mt -135.14 107.05 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -107.13 163.27 13.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.548 HD22 ' CZ ' ' A' ' 262' ' ' PHE . 7.9 tp -141.06 141.98 34.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.933 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -100.33 129.7 46.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -100.31 -14.9 18.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -63.69 -38.72 92.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 54.5 p -128.81 -29.46 2.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.091 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.16 58.69 0.78 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.495 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.2 m -125.35 122.38 36.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 111.107 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.548 ' CZ ' HD22 ' A' ' 255' ' ' LEU . 11.1 m-85 -86.5 123.99 32.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -110.84 111.89 23.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 9.5 mt -104.44 141.02 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -121.63 131.28 54.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -154.29 143.63 10.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.481 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -58.22 -32.53 68.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 0.0 110.938 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.1 t -134.67 137.07 43.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.877 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.43 -28.87 2.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.134 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -42.53 84.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.74 -66.89 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.112 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -48.76 -34.84 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 36.2 mttm -64.23 -50.75 66.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -63.32 -39.75 95.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.8 -29.62 62.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.466 ' CZ ' ' OE1' ' A' ' 280' ' ' GLU . 21.2 ttt-85 -60.7 -42.79 97.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.841 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.41 ' HA2' ' CG ' ' A' ' 280' ' ' GLU . . . -51.09 -24.93 9.64 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.491 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -80.36 -25.82 38.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 110.866 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.52 HD23 ' CE1' ' A' ' 262' ' ' PHE . 68.3 mt -102.16 11.39 38.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.466 ' OE1' ' CZ ' ' A' ' 276' ' ' ARG . 8.9 mm-40 -63.61 144.09 57.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.487 ' O ' ' CD1' ' A' ' 281' ' ' PHE . 46.8 p90 -69.86 120.22 15.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 94.1 t -119.89 126.78 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -74.0 166.71 22.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -63.77 122.96 17.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -108.25 119.95 40.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 27.7 mm -122.76 103.28 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -91.7 129.23 37.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.913 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 22.1 m -101.04 144.24 28.17 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.565 0.698 . . . . 0.0 111.123 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 110.61 2.6 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.626 2.218 . . . . 0.0 112.356 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 91.4 p -79.86 -44.3 20.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -78.59 150.9 35.32 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.501 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 138.21 37.37 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.669 2.246 . . . . 0.0 112.337 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 89.6 p -118.57 154.05 33.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 71.5 p -169.22 111.45 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.475 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 3.6 m -126.19 147.36 49.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.883 0.373 . . . . 0.0 110.892 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 89.2 p -132.98 118.99 19.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -109.34 -160.16 18.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.449 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.6 t -126.02 102.43 7.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.877 0.37 . . . . 0.0 110.831 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.3 m -84.09 162.55 20.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 155.73 -70.04 0.28 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 46.4 m -129.99 137.27 50.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.371 . . . . 0.0 111.143 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.48 150.46 8.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -109.57 177.13 4.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 43.5 mt -116.38 90.48 3.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -171.47 133.53 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.069 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -106.76 111.62 24.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.077 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.81 86.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.127 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.506 ' CD2' ' HB3' ' A' ' 269' ' ' ALA . 83.4 m-85 -108.02 142.29 38.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -133.06 140.46 47.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -111.55 141.85 44.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.418 ' CD ' ' C ' ' A' ' 222' ' ' GLU . 0.6 OUTLIER -148.94 111.31 4.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.837 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.53 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 34.0 p90 -140.9 151.42 44.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 20.0 t -96.52 134.34 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.123 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 69.0 t -118.61 137.38 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -57.02 130.07 44.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -57.7 -22.53 46.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -83.72 -19.54 35.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.402 ' CD1' ' HB2' ' A' ' 281' ' ' PHE . 30.9 mt -100.42 -18.07 16.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 4.8 mmt -45.02 -66.96 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -40.45 -40.59 2.03 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.511 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 40.9 mt -69.94 -55.99 8.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.834 0.35 . . . . 0.0 110.945 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -52.9 -38.43 61.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.045 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 25.7 mt -77.5 -37.8 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 95.16 -158.5 22.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.471 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 22.1 m -95.77 128.59 42.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 111.189 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 67.4 t60 52.67 46.34 26.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.831 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 53.76 67.95 1.89 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.511 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.8 t -92.8 -61.51 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 110.912 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -50.02 -60.58 2.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 19.2 mt -41.61 -49.06 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -54.53 -51.2 65.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -58.02 -37.63 74.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.94 96.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 5.9 mtp-105 -70.7 -0.91 9.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -104.98 12.88 31.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.467 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 84.9 t -95.16 138.63 21.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 111.142 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.467 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.7 Cg_endo -69.77 133.4 25.46 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.683 2.255 . . . . 0.0 112.331 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 96.74 -0.43 61.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 74.5 t -102.17 106.57 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 111.147 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 265' ' ' TYR . 35.9 p -63.0 -58.25 7.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -151.47 157.59 42.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 66.0 mt -130.37 114.17 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.148 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -118.38 149.12 41.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 8.9 tp -127.56 147.7 50.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.944 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.84 118.92 36.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -84.74 -27.82 26.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -49.72 -40.5 40.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 62.0 p -125.25 -27.76 3.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.139 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 97.68 39.01 4.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 35.1 m -103.97 130.28 51.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 0.0 111.146 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.515 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.9 m-85 -93.58 116.6 29.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 53.5 mtt-85 -104.28 119.23 38.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 10.9 mt -115.49 143.32 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 251' ' ' THR . 88.9 m-85 -122.9 117.16 24.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . 0.418 ' N ' HG12 ' A' ' 272' ' ' VAL . . . -141.07 151.35 22.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.506 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -69.74 -26.51 64.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.2 p -132.71 132.79 42.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.506 ' HB3' ' CD2' ' A' ' 219' ' ' PHE . . . -47.21 -29.89 2.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.103 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.31 -35.71 81.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -69.79 -53.96 15.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.08 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 266' ' ' GLY . 0.4 OUTLIER -63.11 -29.54 47.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -72.22 -51.32 21.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -55.53 -48.94 73.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.97 -34.36 76.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.53 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 45.9 ttt180 -53.88 -47.06 71.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -46.44 -26.12 2.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -79.53 -33.71 41.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.905 0.383 . . . . 0.0 110.884 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.515 HD22 ' CE1' ' A' ' 262' ' ' PHE . 92.9 mt -85.27 -17.23 37.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -62.78 141.33 58.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.402 ' HB2' ' CD1' ' A' ' 229' ' ' LEU . 8.4 p90 -62.34 144.59 55.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.881 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 62.9 t -127.23 127.69 69.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.114 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 284' ' ' ASP . 22.7 mp0 -54.51 145.83 17.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 283' ' ' GLU . 10.5 t0 -35.63 134.84 0.31 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -81.28 134.79 35.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 39.1 mt -108.12 98.34 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 43.9 tp60 -69.05 141.13 54.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.937 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 32.8 m -94.93 146.71 31.83 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.606 0.717 . . . . 0.0 111.142 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 109.91 2.43 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.673 2.249 . . . . 0.0 112.301 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 72.7 m -48.98 170.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -142.93 146.11 16.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -34.58 14.35 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.7 2.266 . . . . 0.0 112.295 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 96.9 p -54.01 136.21 41.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.832 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 12.0 t -75.05 -42.72 56.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.521 -179.964 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 6.3 t -161.97 144.51 11.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.89 0.376 . . . . 0.0 110.905 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.6 t -87.4 115.08 24.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 113.27 124.06 4.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.461 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.1 m -152.51 137.27 17.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.921 0.391 . . . . 0.0 110.857 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 211' ' ' GLY . 3.3 t -51.35 127.88 20.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 210' ' ' SER . . . -34.85 108.67 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.457 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 34.4 p -123.99 170.02 11.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.171 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -124.24 94.62 4.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.9 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -108.12 131.19 54.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 12.9 tp -127.65 38.56 4.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -158.42 157.45 32.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.103 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -110.99 132.07 54.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.091 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -66.83 -36.29 82.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.074 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.445 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 88.2 m-85 -112.56 141.01 46.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.912 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -140.89 138.73 34.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.853 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -113.93 138.62 50.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -139.12 121.36 15.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 12.9 p90 -142.33 143.14 32.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.94 119.73 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 226' ' ' ARG . 93.8 t -109.31 134.73 50.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 229' ' ' LEU . 46.9 mtm180 -54.26 120.9 7.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -38.15 -28.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 226' ' ' ARG . 15.9 t0 -72.42 -44.36 62.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 226' ' ' ARG . 86.4 mt -74.14 -26.15 60.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' MET . . . . . 0.413 ' O ' ' C ' ' A' ' 231' ' ' GLY . 30.3 mtp -49.22 -58.91 4.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -36.47 -56.62 1.22 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.464 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 50.4 mt -67.78 -52.17 40.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -46.24 -34.59 4.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.087 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 56.4 mt -85.94 -32.44 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.128 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 93.78 -150.57 19.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.485 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 85.2 m -111.34 112.67 24.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 111.129 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 73.73 35.03 0.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.82 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 63.05 62.8 5.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 27.6 t -92.21 -53.62 4.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.835 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 7.1 m120 -58.01 -50.53 73.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 52.7 mt -52.06 -45.74 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.124 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -53.95 -67.31 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -42.79 -43.45 3.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.82 81.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -69.8 -21.69 63.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -76.33 -5.01 45.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.476 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 84.0 t -77.78 138.65 62.06 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.63 0.729 . . . . 0.0 111.104 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.476 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 54.0 Cg_endo -69.77 143.31 50.4 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.662 2.241 . . . . 0.0 112.388 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 91.41 -19.92 44.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.0 t -80.49 106.05 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.921 0.391 . . . . 0.0 111.129 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 265' ' ' TYR . 32.6 p -60.09 -58.76 7.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.159 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -154.46 159.13 40.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 50.9 mt -132.57 103.85 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.158 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -104.05 155.63 18.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 8.5 tp -140.17 157.11 46.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -116.93 134.5 54.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -100.88 -16.97 17.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.37 -34.37 28.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.83 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 59.7 p -114.77 -21.76 10.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.186 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 74.02 53.03 7.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.516 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.8 m -122.4 129.47 52.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.319 . . . . 0.0 111.142 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.556 ' HB2' ' CE2' ' A' ' 223' ' ' PHE . 10.9 m-85 -93.11 121.85 34.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.871 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.7 mtm-85 -113.02 114.17 26.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.834 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.2 mt -107.1 138.59 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.112 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 251' ' ' THR . 93.7 m-85 -122.82 117.47 25.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . 0.418 ' N ' HG11 ' A' ' 272' ' ' VAL . . . -139.88 144.81 15.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -58.06 -33.4 69.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.899 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.2 t -134.57 137.29 43.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.878 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.454 ' HA ' ' CG2' ' A' ' 272' ' ' VAL . . . -45.2 -26.8 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.061 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.25 -44.83 94.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.47 -65.09 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.139 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.454 ' CG2' ' HA ' ' A' ' 269' ' ' ALA . 0.9 OUTLIER -48.46 -31.1 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -71.54 -54.14 11.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -58.17 -35.5 71.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -76.46 -37.34 57.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -54.8 -36.61 65.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -58.65 -12.22 13.16 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -94.61 -28.08 15.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 110.891 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.485 HD23 ' CE1' ' A' ' 262' ' ' PHE . 82.2 mt -92.95 -2.68 55.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -47.92 153.1 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -82.07 135.87 35.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.893 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 80.1 t -128.14 133.64 66.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -77.36 162.5 27.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.81 143.54 57.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -81.8 139.59 34.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 52.3 mt -103.0 95.86 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 13.5 tp60 -80.19 105.0 11.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 16.6 m -91.93 144.4 29.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.612 0.72 . . . . 0.0 111.142 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -5.75 16.96 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.689 2.259 . . . . 0.0 112.341 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.3 m -95.51 161.73 13.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -141.93 153.85 24.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.523 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 171.68 14.0 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.716 2.278 . . . . 0.0 112.355 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 73.9 m -143.1 145.56 32.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.804 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 54.7 p -58.28 125.63 24.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.868 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.545 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 35.3 p -137.11 152.2 49.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.918 0.39 . . . . 0.0 110.825 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.0 t -48.63 -61.02 2.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 209' ' ' SER . . . 132.04 -54.35 0.78 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.51 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 208' ' ' GLY . 34.0 t -36.86 145.52 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.879 0.371 . . . . 0.0 110.842 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 80.1 p -134.13 164.89 26.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 99.57 94.19 2.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.505 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 23.3 m -127.57 149.49 50.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 111.126 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -86.82 168.83 13.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -94.12 46.71 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 216' ' ' ALA . 28.2 tp -78.05 157.64 29.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.451 ' N ' ' HG ' ' A' ' 215' ' ' LEU . . . -69.65 159.75 32.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.108 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -111.94 137.12 50.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.099 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -73.23 -41.22 63.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -107.98 132.29 53.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -126.17 145.72 50.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -119.22 137.65 53.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -143.53 111.96 6.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.449 ' CE2' ' HG3' ' A' ' 276' ' ' ARG . 30.2 p90 -141.21 150.08 42.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.869 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.47 132.25 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 226' ' ' ARG . 97.5 t -113.77 137.43 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.098 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.459 ' N ' HG12 ' A' ' 225' ' ' VAL . 36.9 mtp180 -53.54 122.06 9.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -49.7 -20.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -86.16 -38.49 17.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 281' ' ' PHE . 34.6 mt -79.8 -25.24 40.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 25.7 mtp -45.98 -58.84 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.87 -52.24 3.25 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.463 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 26.1 mt -67.8 -50.71 55.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.838 0.352 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.426 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -47.51 -45.78 26.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 52.8 mt -69.68 -40.7 79.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 101.84 -143.87 16.16 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.489 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 8.8 t -115.29 114.26 24.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.774 0.321 . . . . 0.0 111.13 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 69.19 39.25 1.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 60.11 59.54 10.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 2.5 t -89.29 -60.11 2.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.907 0.384 . . . . 0.0 110.858 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 3.7 m120 -50.6 -56.89 9.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 48.9 mt -44.94 -51.35 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -56.24 -44.43 79.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -60.73 -35.38 76.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -64.48 -53.63 45.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -60.84 -30.29 70.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -64.81 -6.66 8.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.473 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 85.7 t -77.15 138.7 64.69 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.614 0.721 . . . . 0.0 111.136 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.473 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.9 Cg_endo -69.75 128.55 16.2 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.686 2.257 . . . . 0.0 112.368 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 104.12 -12.27 52.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.9 t -87.1 102.2 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 111.137 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 53.0 p -57.1 -48.96 77.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.168 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -162.35 166.86 24.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.096 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 58.6 mt -139.05 113.11 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.121 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -111.94 152.58 27.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 8.3 tp -129.19 110.72 12.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.91 99.4 6.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -73.75 -30.92 63.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.882 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -42.81 -39.52 2.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 3.0 p -127.06 -28.53 2.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.126 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 101.89 40.39 2.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.512 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 93.8 m -110.15 116.79 32.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.846 0.355 . . . . 0.0 111.13 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.468 ' CE1' HD23 ' A' ' 279' ' ' LEU . 10.8 m-85 -79.87 118.36 21.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -108.37 113.73 27.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 40.7 mt -107.25 139.79 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -117.9 121.92 41.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . 0.508 ' N ' ' CG1' ' A' ' 272' ' ' VAL . . . -144.79 140.45 9.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.504 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -61.99 -33.11 73.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.851 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 271' ' ' ALA . 23.8 p -127.37 123.83 37.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.872 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -38.5 -33.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.081 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -57.7 -46.05 84.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.834 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 268' ' ' SER . . . -61.27 -68.15 0.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.071 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 266' ' ' GLY . 3.5 m -47.86 -34.21 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -66.6 -52.23 47.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 39.8 tttt -54.5 -49.04 71.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.16 84.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.113 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.449 ' HG3' ' CE2' ' A' ' 223' ' ' PHE . 24.9 ttp85 -47.1 -44.47 21.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -49.27 -35.32 19.99 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -69.43 -42.7 74.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.468 HD23 ' CE1' ' A' ' 262' ' ' PHE . 81.1 mt -75.05 -27.03 59.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.983 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -49.79 148.02 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.444 ' HB2' ' CD1' ' A' ' 229' ' ' LEU . 9.7 p90 -66.87 144.29 56.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 85.8 t -127.18 131.54 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.153 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 284' ' ' ASP . 5.7 mm-40 -58.14 133.01 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 283' ' ' GLU . 6.9 p-10 -34.93 112.25 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -100.24 125.04 46.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 70.6 mt -104.02 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.087 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -108.31 145.3 34.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 35.6 m -108.51 144.3 29.24 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.588 0.708 . . . . 0.0 111.115 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 93.07 0.52 Allowed 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.7 2.267 . . . . 0.0 112.364 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.9 m -89.03 -62.16 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -162.95 83.38 0.11 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.456 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 140.17 42.03 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.7 2.266 . . . . 0.0 112.362 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 24.3 m -107.99 171.22 7.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.3 t 40.91 41.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.889 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.484 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 53.0 p -121.54 138.11 54.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.918 0.389 . . . . 0.0 110.814 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 59.2 m -69.9 152.91 43.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.888 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -88.07 -103.89 0.94 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.531 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.4 p -94.62 147.9 22.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 110.825 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.4 t -76.05 121.87 23.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -107.69 -85.89 1.79 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.486 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 52.4 p -86.84 134.19 33.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 0.0 111.183 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.5 161.13 9.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.895 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -138.89 142.06 38.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.11 82.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -148.24 135.43 20.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.051 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -103.49 110.69 22.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.84 76.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.103 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.553 ' CD2' ' HB3' ' A' ' 269' ' ' ALA . 70.5 m-85 -122.08 125.46 46.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -122.76 138.62 54.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -115.08 146.16 41.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.433 ' HG3' ' CG2' ' A' ' 261' ' ' THR . 19.5 tt0 -149.28 124.6 10.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.483 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 4.8 p90 -141.42 146.0 36.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.0 t -97.83 110.48 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 226' ' ' ARG . 31.5 t -95.66 146.03 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.441 ' N ' HG13 ' A' ' 225' ' ' VAL . 12.4 mmm-85 -61.6 148.59 41.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.14 -22.58 66.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -94.47 -12.91 26.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 91.5 mt -98.36 -8.93 26.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' MET . . . . . 0.438 ' O ' ' C ' ' A' ' 231' ' ' GLY . 2.9 mmt -56.38 -68.63 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -34.74 -57.09 0.78 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.466 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 62.7 mt -61.99 -51.16 69.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.922 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.75 -22.61 47.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.15 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 37.8 mt -100.44 -10.75 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.14 -157.68 53.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.529 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 238' ' ' GLY . 15.2 t -89.33 147.4 24.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.125 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.436 ' C ' ' O ' ' A' ' 236' ' ' THR . 96.1 m-70 35.37 33.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 236' ' ' THR . . . 65.13 48.91 65.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.476 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 236' ' ' THR . 3.0 t -77.25 -48.84 16.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 110.837 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -53.54 -54.71 33.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 55.7 mt -48.57 -45.46 14.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -55.03 -62.0 1.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -43.75 -49.03 8.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.935 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.19 -43.9 92.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -73.43 -18.07 61.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -90.64 15.24 11.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.448 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 98.0 t -93.95 138.38 22.71 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.616 0.722 . . . . 0.0 111.142 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.448 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 54.5 Cg_endo -69.7 128.89 16.73 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.702 2.268 . . . . 0.0 112.397 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.72 -7.88 50.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.537 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 84.0 t -96.75 103.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 111.137 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 68.3 p -54.11 -57.41 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.149 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.07 174.62 14.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.128 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 79.1 mt -143.19 108.54 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -105.43 155.34 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.556 HD22 ' CZ ' ' A' ' 262' ' ' PHE . 9.8 tp -141.01 133.43 28.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.7 120.49 40.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.809 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -85.36 -26.96 26.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.76 -40.03 27.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 35.0 p -127.16 -27.97 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 98.45 54.99 1.12 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.477 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.433 ' CG2' ' HG3' ' A' ' 222' ' ' GLU . 3.5 m -116.3 123.93 48.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.341 . . . . 0.0 111.154 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.556 ' CZ ' HD22 ' A' ' 255' ' ' LEU . 11.0 m-85 -92.52 112.74 24.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.883 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 38.4 mtp85 -103.21 120.37 40.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 7.4 mt -110.89 136.93 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.182 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -116.88 119.59 35.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . 0.416 ' N ' HG12 ' A' ' 272' ' ' VAL . . . -141.51 146.62 17.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.468 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -68.22 -28.28 67.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 p -130.21 130.8 45.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.553 ' HB3' ' CD2' ' A' ' 219' ' ' PHE . . . -43.82 -30.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.072 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.21 -40.79 98.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.47 -65.9 0.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.093 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 266' ' ' GLY . 0.3 OUTLIER -47.92 -41.25 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -67.13 -47.0 72.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.936 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -59.85 -39.21 84.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -75.57 -30.35 59.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.139 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -62.84 -39.92 95.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -54.64 -13.38 4.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.514 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -93.91 -26.06 17.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 83.0 mt -94.85 6.2 49.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -56.16 138.12 50.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -66.3 135.06 53.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 63.8 t -126.09 127.12 70.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -77.15 155.02 32.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.892 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -61.59 112.96 2.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.83 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -107.28 144.99 33.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 4.6 mp -95.92 95.68 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.18 107.08 14.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 33.9 m -110.44 146.41 34.25 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.622 0.725 . . . . 0.0 111.12 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 128.05 15.45 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.739 2.293 . . . . 0.0 112.319 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 47.0 t -94.3 93.2 7.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 95.9 150.96 27.69 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 123.81 10.47 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.711 2.274 . . . . 0.0 112.355 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 80.0 p 37.31 43.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.4 p -131.56 -53.3 1.01 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 46.9 t -39.51 150.09 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 110.853 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.7 t -149.87 128.63 12.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.839 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -125.04 89.24 0.39 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.496 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 30.4 m -70.89 114.15 8.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.865 0.364 . . . . 0.0 110.841 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 81.0 p -124.75 175.98 6.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.892 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.52 -137.79 2.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 53.2 p -121.88 129.97 52.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.83 0.348 . . . . 0.0 111.154 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm -90.84 89.23 7.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.897 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -82.42 -179.17 7.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.945 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.34 13.79 12.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.952 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -139.28 171.87 13.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -84.15 114.23 21.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.073 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -70.94 -29.17 65.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.069 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.412 ' CD2' ' CB ' ' A' ' 269' ' ' ALA . 86.6 m-85 -123.37 114.5 20.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -118.03 145.6 44.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -114.33 133.22 55.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.465 ' CD ' ' C ' ' A' ' 222' ' ' GLU . 0.3 OUTLIER -135.87 117.04 14.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 12.0 p90 -142.57 151.77 41.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.851 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 18.4 t -102.26 121.99 53.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.082 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 93.2 t -109.24 144.98 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 229' ' ' LEU . 70.8 mtt180 -60.9 122.06 13.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -40.48 -32.37 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.95 -43.08 56.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 226' ' ' ARG . 80.2 mt -71.23 -25.39 62.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' MET . . . . . 0.42 ' O ' ' C ' ' A' ' 231' ' ' GLY . 26.5 mtp -47.22 -64.46 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -36.32 -51.69 1.31 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.48 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 63.1 mt -67.03 -44.6 79.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 110.947 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -55.56 -37.9 68.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 41.8 mt -83.7 -27.61 7.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.147 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 90.18 -153.94 23.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.524 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 91.2 m -108.66 117.13 33.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.8 0.333 . . . . 0.0 111.182 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 9.1 t60 72.93 30.64 1.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.857 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 65.31 56.76 13.82 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.522 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 30.8 t -86.49 -58.15 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 0.0 110.856 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 4.6 m120 -51.17 -59.39 4.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.906 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 44.3 mt -42.83 -48.34 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -54.93 -55.36 31.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -48.74 -54.76 13.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -52.62 -40.6 62.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.075 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -71.31 -19.45 62.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -85.09 15.75 3.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.43 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 95.6 t -98.6 138.05 20.71 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.634 0.731 . . . . 0.0 111.092 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.43 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 54.3 Cg_endo -69.73 133.07 24.74 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.698 2.265 . . . . 0.0 112.391 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 101.41 -17.65 55.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.521 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.31 101.78 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.851 0.358 . . . . 0.0 111.164 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 66.7 p -56.28 -47.91 77.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -163.76 170.88 16.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.081 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.8 mt -140.1 116.22 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.101 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -113.65 160.45 18.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.542 HD12 ' CE2' ' A' ' 262' ' ' PHE . 4.1 tp -142.13 144.0 33.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -104.61 126.64 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.828 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -97.25 -19.17 18.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -58.6 -44.28 89.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 67.6 p -124.1 -31.01 3.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.173 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.67 57.35 0.7 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 90.7 m -122.65 119.17 29.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 111.189 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.569 ' CE1' HD21 ' A' ' 279' ' ' LEU . 12.4 m-85 -85.7 130.97 34.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -119.49 119.2 33.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.2 mt -109.47 139.94 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.148 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -120.0 115.53 23.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . 0.453 ' N ' HG13 ' A' ' 272' ' ' VAL . . . -140.16 138.05 8.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.453 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -56.86 -29.48 62.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.861 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.1 t -134.91 138.95 44.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.412 ' CB ' ' CD2' ' A' ' 219' ' ' PHE . . . -47.78 -30.19 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.071 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -59.56 -40.68 88.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -68.09 -67.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.453 HG13 ' N ' ' A' ' 266' ' ' GLY . 0.3 OUTLIER -47.32 -38.46 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -64.03 -54.59 31.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -39.82 78.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.906 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.18 -35.75 71.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.054 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -59.17 -35.59 73.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -60.05 -8.87 9.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.493 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -98.72 -24.65 14.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 110.911 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.569 HD21 ' CE1' ' A' ' 262' ' ' PHE . 82.4 mt -99.28 1.94 45.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -54.53 145.24 19.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.887 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -67.52 127.59 33.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 87.5 t -126.55 126.94 69.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.09 164.34 26.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.04 133.08 38.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -70.24 121.45 17.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 85.6 mt -107.12 98.76 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.106 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -115.45 153.29 31.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.6 m -132.31 146.22 60.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.629 0.728 . . . . 0.0 111.116 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 116.25 4.47 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.702 2.268 . . . . 0.0 112.322 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 38.7 m -167.14 154.41 8.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -127.2 171.33 18.76 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.526 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 166.96 25.82 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.702 2.268 . . . . 0.0 112.367 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 19.4 m -65.76 163.45 16.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 29.0 t -98.96 117.67 34.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.878 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.458 -179.926 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 7.8 t -171.0 163.51 7.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.858 0.361 . . . . 0.0 110.834 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 69.4 m -58.27 164.35 2.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.9 147.01 18.37 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 25.0 t -134.26 96.04 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.899 0.381 . . . . 0.0 110.841 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 80.2 p -146.24 150.19 35.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 148.72 -81.64 0.19 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.489 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 26.9 m -117.49 124.84 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 0.0 111.167 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -84.78 172.64 11.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -170.94 159.34 6.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.932 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.488 ' CD1' ' O ' ' A' ' 215' ' ' LEU . 3.9 pp -84.9 45.44 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -143.34 136.66 28.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.088 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -98.97 113.54 25.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -65.42 -38.55 90.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.517 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 77.7 m-85 -109.01 130.86 55.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -127.68 141.32 51.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -113.62 142.82 45.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.43 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 0.1 OUTLIER -147.13 105.55 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.419 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 15.5 p90 -130.12 156.38 44.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 62.1 t -106.91 126.69 62.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.081 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.0 t -110.0 143.29 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.088 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -55.69 123.08 12.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -45.5 -25.08 0.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.26 -39.29 17.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 45.3 mt -71.81 -30.23 65.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 24.1 mtp -39.7 -57.94 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -41.55 -49.02 4.87 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.502 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 30.0 mt -70.67 -58.02 4.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 110.905 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -42.26 -42.75 3.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.064 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 22.9 mt -74.81 -36.08 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 99.51 -158.09 19.86 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 22.0 m -105.19 113.27 26.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.806 0.336 . . . . 0.0 111.137 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 74.4 31.34 1.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.858 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 64.11 61.52 6.01 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.461 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 29.3 t -90.96 -55.17 3.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.901 0.381 . . . . 0.0 110.851 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -55.84 -47.94 76.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 26.5 mt -54.55 -47.74 71.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -57.23 -46.72 82.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -60.25 -54.51 44.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -48.8 -40.1 27.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.082 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 18.4 ttt85 -72.87 -22.33 60.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -86.65 21.72 2.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.447 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 86.3 t -100.89 138.07 19.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.619 0.724 . . . . 0.0 111.104 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.447 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.77 127.26 14.33 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.711 2.274 . . . . 0.0 112.359 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 104.1 -4.53 45.1 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.538 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 82.9 t -100.89 104.96 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 0.0 111.141 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 69.9 p -59.19 -54.03 51.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.02 166.41 33.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.107 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 77.0 mt -137.57 105.94 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.163 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -110.79 148.59 32.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.523 HD23 ' CZ ' ' A' ' 262' ' ' PHE . 8.0 tp -128.15 154.57 45.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.929 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -112.07 130.15 55.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -100.13 -14.74 18.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.21 -45.18 95.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.9 p -126.0 -28.65 3.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.131 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.58 61.62 0.66 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.481 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.43 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 91.9 m -124.67 122.21 36.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 0.0 111.124 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.523 ' CZ ' HD23 ' A' ' 255' ' ' LEU . 13.6 m-85 -89.2 113.14 24.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -102.2 110.63 22.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 7.2 mt -104.59 144.78 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -123.0 124.11 42.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . 0.42 ' N ' HG11 ' A' ' 272' ' ' VAL . . . -149.46 136.3 5.71 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.533 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -56.58 -29.73 62.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.833 0.349 . . . . 0.0 110.866 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 13.2 p -129.08 135.23 48.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.517 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -49.29 -28.83 5.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.141 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.62 -36.86 84.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.854 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.6 -59.82 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.075 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.42 HG11 ' N ' ' A' ' 266' ' ' GLY . 0.3 OUTLIER -58.85 -29.98 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -68.07 -50.45 55.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -58.21 -48.01 81.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.61 76.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.419 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 74.1 ttt180 -53.89 -50.12 67.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -44.14 -27.73 1.17 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.495 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -80.54 -39.07 28.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.924 0.392 . . . . 0.0 110.953 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.504 HD22 ' CE1' ' A' ' 262' ' ' PHE . 30.7 mt -88.08 -2.54 58.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -66.35 142.81 57.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.863 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -64.85 132.96 50.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.12 125.32 66.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.118 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -55.77 160.33 2.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.22 115.42 2.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -105.72 148.18 27.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 30.4 mt -116.32 103.33 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -107.21 151.65 25.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.58 146.28 42.86 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.639 0.733 . . . . 0.0 111.121 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 138.73 38.53 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.731 2.287 . . . . 0.0 112.357 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 7.7 t -82.02 135.98 35.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -64.64 -158.42 0.31 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -31.73 19.92 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.677 2.252 . . . . 0.0 112.38 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 1.5 t -85.38 155.8 21.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.866 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 295' ' ' GLY . 96.5 p -136.87 174.84 10.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.84 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 294' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.486 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 8.6 m -121.18 99.99 6.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 0.0 110.875 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 51.0 p -99.46 159.55 14.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.68 -115.41 0.64 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.474 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 44.6 m 47.57 42.44 14.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.9 0.381 . . . . 0.0 110.883 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.2 m -139.93 144.6 37.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.867 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -72.56 -110.06 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.437 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 23.5 m -128.11 126.71 41.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.826 0.346 . . . . 0.0 111.115 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -152.26 150.55 29.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -112.25 92.96 4.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.974 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 15.3 tp -131.8 147.27 52.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -38.72 145.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.107 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -78.68 116.15 18.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.083 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.56 -43.75 89.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.125 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.569 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 83.5 m-85 -110.05 143.66 39.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -137.06 143.79 42.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -115.01 134.26 55.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.891 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.1 108.09 5.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.53 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 32.0 p90 -139.31 163.37 32.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.65 132.34 56.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.15 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 79.2 t -113.39 142.62 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 -55.16 125.04 18.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -53.76 -18.16 2.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.54 -38.53 17.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 281' ' ' PHE . 51.4 mt -80.24 -27.54 38.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 22.4 mtp -40.23 -59.26 1.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.849 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -41.21 -54.13 3.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.467 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.04 -54.75 33.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.882 0.372 . . . . 0.0 110.936 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -45.92 -44.11 14.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.105 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 11.0 mt -71.6 -38.5 67.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 94.84 -134.25 11.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.454 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 237' ' ' HIS . 60.2 m -113.01 138.66 49.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.833 0.349 . . . . 0.0 111.141 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 236' ' ' THR . 5.5 m-70 35.91 48.8 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 59.29 57.73 18.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.493 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.7 t -84.57 -68.14 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.877 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 4.7 m120 -41.64 -62.32 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 60.2 mt -39.9 -52.52 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -54.76 -48.93 72.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.944 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.452 ' N ' ' OE1' ' A' ' 243' ' ' GLN . 0.3 OUTLIER -60.97 -30.83 70.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -68.54 -53.39 23.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -57.72 -23.91 54.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -72.51 1.89 7.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.474 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 99.4 t -82.67 138.9 43.75 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.654 0.74 . . . . 0.0 111.105 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.474 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.4 Cg_endo -69.75 133.28 25.22 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.728 2.286 . . . . 0.0 112.316 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 96.83 -3.45 62.68 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.511 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 70.6 t -96.59 113.46 31.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 111.095 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 20.6 p -70.87 -57.83 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -148.41 168.24 23.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.074 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 65.6 mt -143.84 109.17 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.126 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -113.13 154.45 26.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 8.0 tp -131.47 138.78 49.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -104.51 113.28 26.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -82.38 -33.19 28.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.849 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -45.46 -35.68 3.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 63.6 p -128.07 -31.33 2.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 99.15 47.05 1.93 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.49 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 223' ' ' PHE . 97.7 m -115.17 128.84 56.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 111.132 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -91.12 123.0 34.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -111.78 114.67 27.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 19.2 mt -109.1 139.84 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -120.25 117.05 26.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . 0.44 ' N ' HG11 ' A' ' 272' ' ' VAL . . . -139.67 151.88 22.24 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.506 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -67.74 -31.52 71.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 110.917 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.3 p -129.84 134.99 47.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.569 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -46.46 -32.42 3.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.099 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -62.06 -41.84 98.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.73 -65.54 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.085 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.44 HG11 ' N ' ' A' ' 266' ' ' GLY . 0.3 OUTLIER -51.22 -34.57 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.153 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -65.59 -53.05 47.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -53.63 -48.25 69.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.36 -35.25 77.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.113 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.53 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 56.5 ttt180 -51.92 -42.81 63.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -49.46 -33.83 18.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.97 -43.81 67.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.381 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 69.8 mt -72.79 -28.94 62.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -49.02 145.76 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.404 ' HB2' ' CD1' ' A' ' 229' ' ' LEU . 14.8 p90 -66.25 142.91 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 86.4 t -127.51 137.17 58.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.139 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 284' ' ' ASP . 2.9 mp0 -68.85 139.73 55.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 283' ' ' GLU . 6.0 m-20 -35.56 113.27 0.2 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -112.88 122.88 48.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.886 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 4.7 mp -109.32 100.95 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -88.49 147.93 24.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 11.9 m -85.37 144.43 40.61 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.641 0.734 . . . . 0.0 111.123 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 176.19 7.13 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.683 2.255 . . . . 0.0 112.306 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 49.7 m -157.33 158.25 35.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -128.74 146.2 16.76 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.491 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 177.9 5.11 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.657 2.238 . . . . 0.0 112.358 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 20.0 t -131.78 114.1 14.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.828 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 30.8 m -40.51 161.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.827 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.506 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 8.7 t 69.61 40.39 1.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.874 0.369 . . . . 0.0 110.899 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 31.3 t -49.73 100.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.832 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -142.03 110.59 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.495 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 30.6 p -79.4 138.65 37.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.87 0.367 . . . . 0.0 110.852 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 82.5 p -166.08 148.66 7.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.876 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -91.68 111.51 4.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.497 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 80.7 p -124.46 151.82 44.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.35 . . . . 0.0 111.138 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -141.33 120.73 13.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -122.12 38.4 4.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 18.0 mt -44.68 -49.27 10.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -89.21 158.75 17.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -79.52 115.22 19.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.104 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -51.84 -33.56 36.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.123 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -119.02 122.77 42.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -121.28 152.19 39.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.822 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -129.87 153.11 48.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -157.49 117.53 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.403 ' CE2' ' HG3' ' A' ' 276' ' ' ARG . 27.9 p90 -142.79 144.96 32.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.3 t -91.73 129.19 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.44 HG11 ' N ' ' A' ' 226' ' ' ARG . 55.3 t -109.83 139.03 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.12 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.44 ' N ' HG11 ' A' ' 225' ' ' VAL . 58.3 mtt180 -53.82 131.08 39.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.17 -11.69 6.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -96.82 -21.29 17.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.827 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 74.4 mt -97.58 -9.03 27.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 5.4 mmt -49.97 -66.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -40.27 -51.41 3.62 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.503 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 68.1 mt -59.42 -63.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -45.97 -39.53 9.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 45.6 mt -75.74 -30.38 21.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 88.85 -147.35 19.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.483 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 237' ' ' HIS . 9.6 t -101.58 140.69 35.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.765 0.317 . . . . 0.0 111.185 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 236' ' ' THR . 14.4 p80 34.63 49.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 56.46 66.27 2.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.486 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.7 t -93.74 -61.24 1.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 110.86 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -48.42 -63.46 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 45.4 mt -39.59 -52.75 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -50.68 -45.5 58.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -61.98 -50.24 72.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.934 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -56.7 -35.59 68.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.09 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -75.99 -18.37 59.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -89.29 12.86 14.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.409 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 93.7 t -91.76 137.4 25.54 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.646 0.736 . . . . 0.0 111.16 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.409 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 54.0 Cg_endo -69.69 139.69 41.08 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.657 2.238 . . . . 0.0 112.385 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 95.97 -18.99 56.42 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.541 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 86.9 t -81.01 116.79 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 111.104 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 265' ' ' TYR . 37.2 p -71.24 -49.17 46.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.108 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -161.45 169.44 21.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 90.6 mt -144.6 113.56 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.088 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -114.01 153.51 29.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 1.8 tp -135.31 125.52 26.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.889 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -84.87 107.81 17.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 29.7 mp0 -83.15 -3.93 57.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -91.33 -36.23 13.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 40.1 p -115.36 -17.02 11.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 76.88 51.79 6.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.475 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 96.8 m -124.97 126.62 45.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 111.161 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -88.02 114.16 24.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 27.4 mtt-85 -104.24 117.09 33.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.44 HG21 ' N ' ' A' ' 265' ' ' TYR . 10.2 mt -110.02 148.43 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.44 ' N ' HG21 ' A' ' 264' ' ' ILE . 60.2 m-85 -131.65 112.43 12.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . 0.437 ' N ' HG12 ' A' ' 272' ' ' VAL . . . -133.34 148.81 19.49 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.524 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -67.4 -25.71 66.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.888 0.375 . . . . 0.0 110.9 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 270' ' ' ASP . 6.3 m -141.08 131.26 24.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.833 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -36.8 -34.11 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 268' ' ' SER . 2.6 m-20 -57.74 -50.73 72.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.87 -66.98 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 266' ' ' GLY . 2.4 m -50.66 -41.7 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -56.28 -52.79 63.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -57.79 -49.23 77.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.56 -31.53 72.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.403 ' HG3' ' CE2' ' A' ' 223' ' ' PHE . 37.8 ttp85 -60.41 -45.99 91.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.06 -22.52 2.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.469 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -85.55 -50.63 7.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 0.0 110.851 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 78.2 mt -68.75 -8.66 45.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.938 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -64.63 139.75 58.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.442 ' O ' ' CD1' ' A' ' 281' ' ' PHE . 8.1 p90 -64.1 142.97 58.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 90.9 t -126.72 134.7 65.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -67.2 152.15 46.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.15 130.44 30.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -107.2 123.82 48.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 85.0 mt -116.85 101.55 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.135 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -121.6 121.77 38.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.932 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.8 m -96.1 144.35 27.67 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 111.138 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -50.54 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.662 2.241 . . . . 0.0 112.355 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 41.1 t -150.99 118.21 5.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -102.03 162.61 17.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.512 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -25.81 28.5 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.705 2.27 . . . . 0.0 112.348 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.6 m -83.73 94.03 8.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.87 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.1 t -96.43 136.3 37.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.486 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 98.4 p -129.12 125.25 36.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.87 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.4 t -142.23 136.83 30.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.75 98.3 1.99 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.475 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 89.1 p -171.09 166.31 7.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 0.0 110.892 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.2 m -63.44 82.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -83.49 129.59 9.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 38.3 p -137.66 148.24 45.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.84 0.352 . . . . 0.0 111.172 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -62.63 165.83 6.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -82.89 163.61 21.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.958 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 73.8 mt -86.41 -58.11 2.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.954 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.94 -178.9 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.129 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -123.58 137.11 54.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.104 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -74.84 -43.11 56.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.519 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 96.7 m-85 -114.41 122.72 47.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -118.46 141.79 48.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -119.13 135.97 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.05 122.93 18.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.479 ' N ' ' CD1' ' A' ' 223' ' ' PHE . 1.7 p90 -140.57 151.79 44.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.9 t -104.42 114.03 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 19.5 t -97.91 143.6 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.155 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -53.9 172.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -91.42 -17.57 25.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -102.28 -8.89 20.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 65.7 mt -100.69 -4.08 28.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 2.8 mmt -58.21 -66.8 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -42.85 -39.21 3.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 68.1 mt -66.34 -59.86 3.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 0.0 110.889 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.422 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -53.76 -49.68 67.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 8.0 mt -65.76 -31.66 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.158 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 92.92 -153.12 21.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.463 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 70.1 p -108.72 118.13 35.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.349 . . . . 0.0 111.169 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 69.25 35.44 2.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.857 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 58.84 61.07 7.79 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.485 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.3 t -92.42 -54.25 3.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.882 0.372 . . . . 0.0 110.876 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 5.5 m120 -52.88 -56.2 17.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.885 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 39.4 mt -46.54 -45.59 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -55.21 -62.53 1.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -45.91 -41.41 11.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.69 -57.21 13.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -60.3 -11.62 6.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -98.21 14.1 28.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.448 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 98.1 t -94.36 138.29 22.48 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.581 0.705 . . . . 0.0 111.153 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.448 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.8 Cg_endo -69.77 128.41 15.97 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.649 2.233 . . . . 0.0 112.355 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.423 ' HA3' ' CB ' ' A' ' 271' ' ' ALA . . . 103.75 -6.26 48.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 78.3 t -98.14 108.55 22.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 0.0 111.122 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 43.5 p -64.89 -46.29 82.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.152 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -162.02 165.79 26.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.065 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 58.3 mt -139.37 106.37 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.089 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -109.37 151.98 25.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.561 HD22 ' CZ ' ' A' ' 262' ' ' PHE . 7.8 tp -138.07 151.37 47.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.916 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -112.89 124.37 52.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -89.49 -19.57 24.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.95 -27.39 39.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.836 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 60.3 p -121.69 -14.15 8.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 66.67 44.08 90.46 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.51 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 71.1 m -115.25 123.48 48.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 111.137 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.561 ' CZ ' HD22 ' A' ' 255' ' ' LEU . 11.3 m-85 -91.25 113.99 26.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -104.65 115.52 30.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 265' ' ' TYR . 55.8 mt -108.32 140.36 27.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.183 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.454 ' N ' HG23 ' A' ' 264' ' ' ILE . 95.3 m-85 -121.25 122.16 39.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.941 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -143.46 152.73 24.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -71.77 -34.4 69.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.341 . . . . 0.0 110.858 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 21.5 p -125.76 132.08 52.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -43.0 -31.28 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.39 -43.7 98.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.423 ' CB ' ' HA3' ' A' ' 249' ' ' GLY . . . -60.3 -64.41 0.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.091 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -52.77 -40.52 35.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.118 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -59.63 -55.81 29.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -58.49 -41.96 86.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.881 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.83 -24.14 61.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 18.3 ttt-85 -68.35 -45.11 73.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.67 -27.64 6.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.477 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -78.58 -36.82 43.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.37 . . . . 0.0 110.868 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 86.0 mt -88.33 -13.75 39.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.931 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -55.15 138.04 45.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -63.82 140.81 58.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.95 133.52 68.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.087 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.92 135.46 54.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.78 161.56 4.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -111.03 145.82 37.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 3.8 mm -114.94 102.13 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -94.03 121.21 35.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.92 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 26.2 m -99.53 144.35 28.14 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.652 0.739 . . . . 0.0 111.108 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 92.83 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.637 2.225 . . . . 0.0 112.35 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 16.1 p -125.78 130.34 51.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.866 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 95.28 -155.12 21.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 150.11 67.78 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.728 2.285 . . . . 0.0 112.351 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 3.1 m -77.82 162.46 26.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.84 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 62.7 p -164.87 132.8 3.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.444 -179.96 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 5.2 t -142.21 157.78 44.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.86 0.362 . . . . 0.0 110.834 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 53.1 p -77.68 169.82 17.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.879 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -103.0 -129.26 6.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.465 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 28.9 t -67.48 130.04 41.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.826 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.8 p -142.65 124.55 15.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.896 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -160.83 97.39 0.16 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.491 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 9.0 t -127.76 151.15 49.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.894 0.378 . . . . 0.0 111.108 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -118.68 157.49 27.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -64.39 96.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 22.1 tp -138.71 146.13 41.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.911 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.06 161.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -102.03 117.59 35.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.102 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.25 -39.54 75.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.04 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -111.6 135.33 52.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -133.32 138.01 46.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -115.34 127.17 55.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.554 ' CD ' ' CG2' ' A' ' 261' ' ' THR . 3.0 tp10 -132.73 119.62 20.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.931 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -140.52 153.16 46.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.47 122.62 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 19.1 t -104.59 146.23 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -53.52 173.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -89.79 -27.54 19.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -90.92 -30.98 16.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.417 ' CD1' ' HB2' ' A' ' 281' ' ' PHE . 64.2 mt -73.09 -18.74 61.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 2.3 mtt -47.13 -59.03 3.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -46.22 -43.22 13.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.497 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 36.7 mt -68.29 -63.27 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 110.889 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.444 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -45.08 -43.47 9.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.162 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 61.2 mt -73.91 -35.52 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.1 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 89.95 -158.06 26.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.511 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 237' ' ' HIS . 5.4 m -92.12 145.25 24.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.35 . . . . 0.0 111.132 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.43 ' C ' ' O ' ' A' ' 236' ' ' THR . 89.4 m-70 35.2 51.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 50.19 66.93 2.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 17.1 t -92.06 -68.95 0.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.862 0.363 . . . . 0.0 110.849 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.444 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 5.0 m120 -40.33 -67.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 240' ' ' ASN . 45.4 mt -36.5 -54.99 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -55.21 -48.63 73.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -58.45 -52.54 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -50.67 -39.14 50.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -71.91 -25.04 61.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -81.3 11.05 4.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.472 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 98.7 t -91.38 138.94 25.26 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.612 0.72 . . . . 0.0 111.128 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.472 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.8 Cg_endo -69.72 137.4 35.47 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.704 2.27 . . . . 0.0 112.34 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 97.93 -21.46 45.97 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.514 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 88.5 t -82.15 115.72 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.918 0.389 . . . . 0.0 111.086 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 265' ' ' TYR . 79.4 p -71.35 -48.39 50.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -158.85 169.43 24.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 73.3 mt -145.42 109.72 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -110.97 163.22 14.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.56 ' HB2' ' CE1' ' A' ' 262' ' ' PHE . 10.3 tp -140.88 153.98 45.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -121.03 119.28 32.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.831 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -86.12 -13.93 45.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -58.29 -52.85 63.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 37.3 p -119.18 -19.36 8.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 95.28 48.28 2.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.514 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.554 ' CG2' ' CD ' ' A' ' 222' ' ' GLU . 20.7 m -110.97 136.79 49.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 111.117 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' ' 255' ' ' LEU . 11.6 m-85 -107.39 127.02 53.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . 0.406 ' CG ' ' CD ' ' A' ' 222' ' ' GLU . 17.4 mtp180 -113.99 115.23 27.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 265' ' ' TYR . 34.0 mt -107.18 142.64 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 251' ' ' THR . 79.1 m-85 -124.5 124.02 41.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -147.73 136.27 5.96 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.461 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -54.96 -41.75 71.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.87 0.367 . . . . 0.0 110.869 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 38.3 m -122.24 136.26 54.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 271' ' ' ALA . . . -43.04 -59.65 1.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.139 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 269' ' ' ALA . 3.1 m-20 -36.51 -30.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 269' ' ' ALA . . . -75.07 -68.94 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.116 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -51.8 -28.71 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.087 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.09 -51.17 22.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -60.35 -33.96 73.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -82.5 -30.69 29.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -58.56 -44.4 89.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.07 -27.39 5.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.504 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -79.04 -54.95 5.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.866 0.365 . . . . 0.0 110.829 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.511 HD21 ' CD1' ' A' ' 262' ' ' PHE . 67.4 mt -63.48 -22.14 66.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -58.35 141.5 51.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.417 ' HB2' ' CD1' ' A' ' 229' ' ' LEU . 10.1 p90 -62.07 152.08 33.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 81.6 t -128.14 128.87 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.168 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -51.64 158.67 0.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.925 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.84 76.89 4.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -84.99 127.03 34.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 5.3 mp -108.78 99.09 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.183 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.7 149.36 21.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.7 m -103.93 142.23 24.16 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.672 0.749 . . . . 0.0 111.108 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 112.32 3.05 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.691 2.26 . . . . 0.0 112.332 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 7.9 t -94.05 150.51 20.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.826 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 61.93 -170.02 11.7 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.52 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -12.79 33.46 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 2.262 . . . . 0.0 112.301 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 74.8 m -86.71 97.04 10.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.8 t -106.35 90.14 3.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.492 -179.973 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 48.0 t -164.2 111.61 1.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.8 m -122.5 173.42 7.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.896 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -120.7 173.81 15.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.437 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 71.1 m -100.05 80.55 2.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.953 0.406 . . . . 0.0 110.851 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.6 t -56.82 156.24 6.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.836 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -90.87 47.19 2.95 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.46 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 8.9 t -124.01 133.23 53.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.869 0.366 . . . . 0.0 111.164 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -134.45 91.62 2.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -132.18 170.13 15.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 15.7 tp -113.08 94.21 4.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -152.43 155.96 38.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.08 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -111.19 110.41 20.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.053 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -48.2 -39.05 19.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.489 ' CD2' ' HB1' ' A' ' 269' ' ' ALA . 75.9 m-85 -110.39 146.45 35.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.896 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -145.03 140.33 28.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -113.46 138.26 50.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.413 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 8.6 tt0 -143.0 116.94 9.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.52 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 29.6 p90 -142.23 139.22 31.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.02 123.6 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 226' ' ' ARG . 56.0 t -111.72 136.35 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.46 ' HB2' ' CD1' ' A' ' 229' ' ' LEU . 23.6 mmt180 -54.05 142.96 23.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -58.5 -25.85 62.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.51 -43.53 22.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.46 ' CD1' ' HB2' ' A' ' 226' ' ' ARG . 23.6 mt -66.59 -32.02 73.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' MET . . . . . 0.451 ' O ' ' C ' ' A' ' 231' ' ' GLY . 3.2 mtt -36.83 -66.81 0.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -34.47 -61.8 0.54 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.496 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 235' ' ' GLY . 60.2 mt -60.11 -65.32 0.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' LEU . . . -37.62 -36.85 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.102 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 64.7 mt -83.02 -36.2 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 232' ' ' LEU . . . 96.58 -151.2 19.81 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 86.0 m -100.99 136.28 41.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.768 0.318 . . . . 0.0 111.16 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 2.7 m80 43.99 49.49 7.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 52.45 65.74 3.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 3.5 t -92.68 -65.65 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.861 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -43.64 -63.35 0.86 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 33.7 mt -39.71 -52.11 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.096 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -54.05 -51.17 64.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -54.59 -48.13 72.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -54.69 -48.05 72.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.092 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -65.91 -29.66 70.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -72.17 -1.33 14.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.475 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 99.2 t -82.39 138.88 44.71 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.657 0.741 . . . . 0.0 111.142 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.475 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.7 Cg_endo -69.76 148.43 65.09 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.671 2.247 . . . . 0.0 112.355 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 89.26 -26.8 8.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 87.6 t -74.4 105.5 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.931 0.396 . . . . 0.0 111.11 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 34.7 p -60.52 -49.41 77.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.25 162.92 33.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.089 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 24.4 mt -134.05 106.42 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -107.74 155.7 19.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 6.1 tp -141.64 150.54 42.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -108.16 141.53 39.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -103.57 -20.15 14.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -76.76 -36.46 57.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.7 p -115.02 -22.76 9.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.154 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 77.58 47.0 9.19 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.413 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 48.6 m -112.89 135.54 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 111.191 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.52 ' HB2' ' CE2' ' A' ' 223' ' ' PHE . 12.9 m-85 -98.73 115.68 29.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -105.89 114.48 28.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.917 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 34.5 mt -108.91 132.0 58.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.141 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -111.22 126.4 54.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -147.24 143.61 11.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.453 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.34 -34.8 74.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.925 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 14.2 m -133.24 131.43 40.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.489 ' HB1' ' CD2' ' A' ' 219' ' ' PHE . . . -40.73 -38.56 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.112 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.49 -43.16 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.873 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.09 -68.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 1.2 m -49.38 -30.54 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.1 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -67.94 -52.46 35.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -56.72 -41.23 77.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.64 -41.77 62.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.081 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -50.34 -39.92 47.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.835 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -53.79 -23.36 21.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.535 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -82.14 -36.84 27.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.362 . . . . 0.0 110.898 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.516 HD21 ' CE1' ' A' ' 262' ' ' PHE . 69.0 mt -91.08 16.92 8.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -64.88 145.44 56.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.414 ' O ' ' CD1' ' A' ' 281' ' ' PHE . 52.0 p90 -72.35 124.77 25.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.409 ' O ' ' CD2' ' A' ' 229' ' ' LEU . 91.5 t -123.04 127.61 74.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.11 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.452 ' HA ' ' CD2' ' A' ' 229' ' ' LEU . 70.1 mt-10 -58.51 161.78 4.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.02 123.41 25.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -96.49 138.2 34.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 45.8 mt -120.38 104.07 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -100.77 143.11 31.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 30.8 m -125.3 144.34 47.28 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.64 0.734 . . . . 0.0 111.115 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 148.85 65.81 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.667 2.244 . . . . 0.0 112.341 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.4 t -93.5 -55.92 3.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 163.29 -158.2 30.52 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.47 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 86.68 0.58 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.669 2.246 . . . . 0.0 112.342 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 4.4 m -52.85 113.86 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 2.6 m 56.39 52.72 9.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.859 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.445 -179.988 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 3.6 m -132.36 145.55 51.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.881 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 27.8 t -160.93 137.37 8.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.842 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.52 -137.54 3.72 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.541 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.0 t -84.69 106.92 16.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.933 0.397 . . . . 0.0 110.88 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.3 p -82.44 100.87 10.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 60.92 -93.5 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.524 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 52.4 p -85.75 144.79 27.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.922 0.392 . . . . 0.0 111.142 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -48.3 -49.26 34.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -68.82 166.64 17.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.1 pp -138.88 155.68 47.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -109.96 155.76 21.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.075 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -88.5 112.59 23.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.064 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.44 -30.71 61.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.579 ' CD2' ' CB ' ' A' ' 269' ' ' ALA . 58.9 m-85 -117.62 138.36 52.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -139.17 147.71 42.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -121.84 144.88 48.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -147.27 112.21 5.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -136.17 147.62 47.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 37.4 t -101.18 122.95 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.157 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.408 HG11 ' N ' ' A' ' 226' ' ' ARG . 99.6 t -108.21 136.34 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.46 ' O ' ' N ' ' A' ' 229' ' ' LEU . 37.7 mtt-85 -54.15 122.44 10.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -42.1 -32.04 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -74.94 -37.5 61.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 226' ' ' ARG . 51.5 mt -74.87 -30.01 61.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' MET . . . . . 0.405 ' C ' ' O ' ' A' ' 229' ' ' LEU . 4.0 mmt -37.26 -61.51 0.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.0 -53.48 2.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 35.6 mt -67.04 -54.61 19.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.815 0.34 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.443 ' O ' ' ND2' ' A' ' 240' ' ' ASN . . . -43.06 -48.85 6.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 38.8 mt -71.49 -34.6 53.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.095 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 94.21 -145.97 17.93 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.474 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 237' ' ' HIS . 0.0 OUTLIER -99.84 140.26 34.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.86 0.362 . . . . 0.0 111.104 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 236' ' ' THR . 8.1 m170 36.76 42.59 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 59.72 65.6 3.31 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.493 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 27.2 t -93.54 -59.58 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.82 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 233' ' ' ALA . 2.4 m120 -47.16 -57.86 4.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.904 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 27.2 mt -45.01 -53.46 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.159 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -46.97 -64.77 0.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -42.36 -45.34 4.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.56 98.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.077 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -72.32 -12.71 61.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.902 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -95.99 8.46 43.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.407 HG11 ' N ' ' A' ' 248' ' ' PRO . 84.2 t -86.93 136.69 33.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.597 0.713 . . . . 0.0 111.159 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.407 ' N ' HG11 ' A' ' 247' ' ' VAL . 53.1 Cg_endo -69.86 130.06 18.58 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.66 2.24 . . . . 0.0 112.319 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 102.21 -9.13 56.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.452 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 45.9 t -91.62 99.3 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.886 0.374 . . . . 0.0 111.137 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.7 p -55.34 -49.46 72.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -159.36 170.02 22.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 56.8 mt -144.2 106.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -101.89 155.42 18.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.538 HD23 ' CZ ' ' A' ' 262' ' ' PHE . 2.5 tp -138.76 122.44 17.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 260' ' ' GLY . 19.1 m-20 -93.42 102.32 14.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.49 -33.06 68.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -43.35 -46.72 6.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.857 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 11.1 p -122.75 -9.89 8.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 256' ' ' ASP . . . 79.2 56.61 3.4 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.52 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 25.2 m -117.95 112.84 20.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.849 0.357 . . . . 0.0 111.153 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.538 ' CZ ' HD23 ' A' ' 255' ' ' LEU . 9.9 m-85 -85.01 114.25 22.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -106.58 123.32 47.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.417 HG21 ' N ' ' A' ' 265' ' ' TYR . 6.3 mt -109.53 146.46 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.417 ' N ' HG21 ' A' ' 264' ' ' ILE . 98.9 m-85 -128.12 118.5 23.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -142.23 155.73 25.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -71.95 -25.22 61.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.873 0.368 . . . . 0.0 110.874 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 270' ' ' ASP . 2.3 m -141.75 132.23 25.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.579 ' CB ' ' CD2' ' A' ' 219' ' ' PHE . . . -40.12 -27.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.096 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 268' ' ' SER . 0.8 OUTLIER -62.13 -46.65 88.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -61.38 -64.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.115 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -51.29 -35.45 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.111 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 269' ' ' ALA . 19.0 mtpp -63.06 -53.55 51.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -56.81 -39.57 74.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.933 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.37 -41.93 69.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -59.06 -27.55 65.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -67.84 -6.9 46.66 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.459 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -101.37 -32.52 10.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 0.0 110.891 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 40.8 mt -86.29 0.94 52.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -47.07 155.31 0.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -82.67 127.71 33.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.852 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 87.0 t -123.74 131.44 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.152 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -89.7 162.71 15.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -40.6 103.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -100.85 138.12 38.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 50.6 mt -106.77 98.79 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.85 136.35 34.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.07 146.27 71.09 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.658 0.742 . . . . 0.0 111.116 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 -40.85 4.9 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.648 2.232 . . . . 0.0 112.381 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.2 t -53.13 114.0 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.829 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -115.35 150.68 18.65 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.532 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -11.69 31.4 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.71 2.273 . . . . 0.0 112.339 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 42.0 t -119.06 143.95 46.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.835 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.5 t -108.72 -62.82 1.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.497 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 27.4 t -100.73 159.92 14.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.83 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 93.7 p -94.23 123.97 37.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 124.57 -177.59 16.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.471 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 14.8 p -113.41 134.89 54.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 0.0 110.865 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.5 p -81.17 135.78 35.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.861 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -147.99 164.32 28.89 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.499 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 9.3 t -98.09 138.05 35.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.36 . . . . 0.0 111.15 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -102.74 -55.92 2.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -90.14 132.91 35.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.928 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.1 mp -66.3 -35.73 81.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.08 146.35 54.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -119.44 116.49 26.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.114 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.04 -38.78 68.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.07 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.493 ' CD2' ' HB1' ' A' ' 269' ' ' ALA . 39.2 m-85 -111.08 139.38 46.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -135.4 151.84 50.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -132.88 146.29 51.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.447 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 7.3 tm-20 -152.3 116.7 5.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -137.95 153.62 49.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.06 121.5 53.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.89 140.98 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.137 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -56.51 127.08 29.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -50.8 -21.86 1.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.64 -42.25 18.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.831 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 65.9 mt -77.86 -16.17 58.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 5.3 mmt -45.25 -67.73 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.844 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.13 -58.29 1.97 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.501 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 235' ' ' GLY . 50.5 mt -55.31 -62.88 1.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.806 0.336 . . . . 0.0 110.931 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -42.33 -45.69 4.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 54.9 mt -73.39 -29.28 27.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.137 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 232' ' ' LEU . . . 93.75 -162.35 25.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.513 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 67.9 p -96.68 123.82 40.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.155 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 60.25 37.66 20.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 61.54 63.21 5.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.435 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 5.5 t -92.55 -58.29 2.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.907 0.384 . . . . 0.0 110.843 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -50.06 -53.23 28.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 14.4 mt -49.76 -49.12 20.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -50.31 -63.46 1.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -48.31 -41.59 28.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.39 -52.94 63.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -62.65 -12.12 21.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -96.02 11.8 32.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.468 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 99.0 t -91.3 138.91 25.39 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.617 0.722 . . . . 0.0 111.127 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.468 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.76 139.4 40.12 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.677 2.251 . . . . 0.0 112.381 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 96.2 -24.19 31.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.454 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 86.0 t -77.88 109.89 12.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 30.0 p -67.47 -49.8 61.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.154 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.14 153.6 22.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 22.4 mt -128.81 112.38 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -112.35 153.67 26.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.562 HD22 ' CE1' ' A' ' 262' ' ' PHE . 11.1 tp -137.79 109.42 7.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.959 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.44 92.29 3.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.93 -25.43 68.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.874 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -43.8 -49.57 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 2.3 p -116.83 -29.28 6.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.127 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 107.78 43.86 1.28 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.434 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.447 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 6.5 m -110.79 133.42 53.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 111.117 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.562 ' CE1' HD22 ' A' ' 255' ' ' LEU . 10.5 m-85 -99.59 113.97 26.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.5 mtt-85 -103.69 113.93 27.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 9.3 mt -109.25 136.54 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.096 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -120.58 123.57 43.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -142.7 151.13 22.84 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.515 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.95 -27.39 66.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 12.1 m -138.14 132.68 32.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.861 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.493 ' HB1' ' CD2' ' A' ' 219' ' ' PHE . . . -41.24 -35.24 0.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -55.55 -46.88 77.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -59.05 -67.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 1.5 m -51.61 -34.22 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -65.05 -49.6 69.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -66.0 -36.34 83.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -75.54 -30.86 59.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -60.37 -47.67 85.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -45.53 -27.8 2.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -78.85 -41.7 29.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.873 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.21 -13.8 58.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -57.11 138.51 54.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.923 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -65.78 143.99 57.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.917 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.423 HG11 ' CE1' ' A' ' 285' ' ' PHE . 45.6 t -128.23 126.63 66.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.143 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -58.88 166.82 1.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.8 141.55 38.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.848 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . 0.423 ' CE1' HG11 ' A' ' 282' ' ' VAL . 53.3 m-85 -88.33 144.22 26.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 63.4 mt -127.68 109.32 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -110.63 119.05 37.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.475 ' CG2' ' HD2' ' A' ' 289' ' ' PRO . 4.4 p -113.04 138.84 22.41 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.647 0.737 . . . . 0.0 111.168 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.475 ' HD2' ' CG2' ' A' ' 288' ' ' VAL . 53.6 Cg_endo -69.73 118.71 5.84 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.71 2.273 . . . . 0.0 112.319 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 t -116.2 -56.15 2.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.897 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 151.45 82.14 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.523 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 151.52 69.01 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.647 2.231 . . . . 0.0 112.366 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 4.8 m -109.62 164.51 12.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.82 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 60.6 p -105.32 178.92 4.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.838 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.518 -179.931 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 30.4 t -150.58 106.42 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.875 0.369 . . . . 0.0 110.841 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 60.3 p -160.78 134.8 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.35 152.02 23.88 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.5 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 62.7 m -72.33 166.63 22.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.887 0.375 . . . . 0.0 110.867 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 98.7 p -104.24 129.27 52.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 65.81 -164.9 38.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.488 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 71.2 p -111.09 138.04 48.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 0.0 111.174 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -100.74 113.51 26.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -70.47 82.84 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.961 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 25.2 tp -168.36 116.93 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -45.25 160.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -86.18 132.32 34.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.52 -42.6 98.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.1 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -109.31 143.46 38.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -140.49 137.09 33.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -111.59 143.2 42.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -148.45 112.46 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.914 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -137.77 149.51 46.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 20.0 t -95.37 120.98 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.17 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.2 t -103.46 137.14 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -54.94 126.99 26.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -53.95 -22.0 9.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -86.59 -23.66 25.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 281' ' ' PHE . 37.7 mt -95.33 -12.68 25.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 4.8 mmt -47.1 -60.48 2.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -47.53 -50.83 17.84 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.513 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 49.5 mt -57.56 -55.96 28.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.814 0.34 . . . . 0.0 110.919 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.42 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -52.59 -52.31 55.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.114 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 70.9 mt -61.02 -24.33 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.6 -154.89 34.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.461 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 237' ' ' HIS . 23.9 m -92.93 138.13 31.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 111.153 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 236' ' ' THR . 9.5 m170 37.07 54.46 1.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 50.83 56.73 12.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.484 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 30.2 t -84.96 -60.7 1.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.855 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.42 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 4.4 m120 -49.39 -62.57 1.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 48.2 mt -39.48 -46.44 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.166 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -59.06 -52.92 63.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -54.66 -43.0 72.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.968 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.26 -45.17 95.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -68.0 -16.38 64.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -91.03 19.82 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.473 ' CG1' ' HD2' ' A' ' 248' ' ' PRO . 86.4 t -98.28 138.75 20.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.666 0.746 . . . . 0.0 111.125 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.473 ' HD2' ' CG1' ' A' ' 247' ' ' VAL . 53.3 Cg_endo -69.75 131.97 22.38 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.271 . . . . 0.0 112.338 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.12 -22.59 36.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 79.6 t -79.63 108.45 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.373 . . . . 0.0 111.124 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 63.3 p -64.64 -50.91 65.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.09 165.46 36.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.2 mt -139.65 111.95 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -112.87 159.51 18.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.48 HD12 ' CZ ' ' A' ' 262' ' ' PHE . 15.4 tp -135.83 138.32 42.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -108.69 112.19 24.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -80.15 -35.38 36.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -42.18 -40.58 2.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 78.0 p -124.58 -25.97 3.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 93.68 37.26 5.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.4 m -106.81 118.37 36.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 111.169 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.48 ' CZ ' HD12 ' A' ' 255' ' ' LEU . 11.1 m-85 -81.15 132.36 35.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -116.57 118.31 32.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 7.1 mt -112.66 139.44 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -120.9 130.37 53.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . 0.408 ' N ' HG13 ' A' ' 272' ' ' VAL . . . -154.87 146.77 15.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.443 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -62.35 -33.63 75.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 110.882 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 47.4 m -128.91 132.09 47.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -44.91 -37.95 4.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.115 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -53.59 -37.76 63.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.853 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -68.01 -65.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 266' ' ' GLY . 1.0 OUTLIER -55.15 -29.95 23.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.141 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -66.25 -53.52 35.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.934 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -57.81 -43.65 85.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.56 -32.86 70.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 34.9 ttp85 -55.04 -48.47 73.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -45.92 -32.06 4.45 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.428 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -73.01 -49.24 30.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.841 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.439 HD21 ' CE1' ' A' ' 262' ' ' PHE . 94.1 mt -71.15 -9.33 57.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -68.12 142.44 55.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.436 ' HB2' ' CD1' ' A' ' 229' ' ' LEU . 15.5 p90 -63.88 143.49 57.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.24 132.74 69.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.1 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -70.54 133.74 47.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -39.66 138.02 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -110.49 106.37 15.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 49.8 mm -108.61 96.92 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.082 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -121.08 142.56 49.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.476 ' CG2' ' HD2' ' A' ' 289' ' ' PRO . 5.4 p -89.05 138.63 29.01 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.656 0.741 . . . . 0.0 111.132 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.476 ' HD2' ' CG2' ' A' ' 288' ' ' VAL . 54.1 Cg_endo -69.72 -44.75 1.92 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.675 2.25 . . . . 0.0 112.388 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 53.2 p 46.49 41.45 9.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -149.31 63.14 0.41 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.477 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 165.11 32.02 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.651 2.234 . . . . 0.0 112.411 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 2.7 m -169.0 121.5 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.7 p -38.5 -32.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.454 -179.996 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.794 0.331 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -57.16 -37.31 71.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.077 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 1.084 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 45.0 m-85 -114.55 139.63 49.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.851 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -138.97 137.31 36.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -113.43 127.39 56.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.409 ' CD ' ' O ' ' A' ' 222' ' ' GLU . 4.9 tm-20 -135.21 111.97 10.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.522 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 14.9 p90 -139.87 158.17 44.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.584 HG22 ' OG1' ' A' ' 261' ' ' THR . 42.9 t -103.5 128.5 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 36.4 t -110.2 138.46 37.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 17.0 mtm-85 -56.85 128.49 37.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -55.6 -18.12 7.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -84.98 -31.85 23.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 59.8 mt -90.76 -23.32 20.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 25.3 mtp -45.99 -57.13 4.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.76 -61.81 1.53 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.492 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 60.1 mt -60.89 -43.68 98.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.881 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -52.0 -40.57 61.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.121 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 58.1 mt -78.63 -36.41 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 89.94 -155.16 24.36 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.521 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 237' ' ' HIS . 15.0 m -91.88 142.93 27.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.853 0.359 . . . . 0.0 111.156 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.437 ' C ' ' O ' ' A' ' 236' ' ' THR . 9.5 m170 35.2 48.28 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.48 ' O ' ' NE2' ' A' ' 242' ' ' GLN . . . 55.67 59.19 10.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.463 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.0 t -80.83 -63.54 1.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.846 0.355 . . . . 0.0 110.862 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 4.9 m120 -46.84 -61.02 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 31.7 mt -44.1 -61.45 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.087 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLN . . . . . 0.49 ' OE1' ' N ' ' A' ' 242' ' ' GLN . 0.0 OUTLIER -43.8 -44.58 6.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.926 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -63.92 -52.38 60.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -49.57 -38.75 32.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 17.2 ttt-85 -72.19 -21.96 61.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.84 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -81.22 7.36 11.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.682 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.4 t -91.93 138.94 24.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.628 0.728 . . . . 0.0 111.136 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.682 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.3 Cg_endo -69.72 154.25 68.13 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.264 . . . . 0.0 112.407 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.43 -11.68 43.58 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.472 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 95.8 t -90.03 109.85 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.892 0.377 . . . . 0.0 111.136 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 68.5 p -67.92 -50.97 52.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.132 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -156.56 171.01 21.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.593 HG12 HG23 ' A' ' 264' ' ' ILE . 82.4 mt -143.89 110.77 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -111.21 151.96 27.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 256' ' ' ASP . 10.9 tp -131.0 134.98 47.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.579 ' N ' HD12 ' A' ' 255' ' ' LEU . 1.3 m-20 -105.35 110.4 22.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -78.79 -37.14 41.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -43.07 -40.98 3.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 77.2 p -122.78 -22.67 5.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 256' ' ' ASP . . . 86.99 45.44 5.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.483 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.584 ' OG1' HG22 ' A' ' 224' ' ' VAL . 85.3 m -112.74 119.13 37.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 111.116 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.644 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.8 m-85 -81.76 120.87 25.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -110.47 111.78 23.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.823 HG22 HG12 ' A' ' 272' ' ' VAL . 8.6 mt -105.16 145.11 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -125.74 120.35 30.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.598 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -145.29 144.06 12.61 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.486 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 86.4 mt-10 -59.1 -30.19 67.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 0.0 110.868 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 57.9 m -134.37 136.36 43.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 1.084 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -49.34 -33.85 14.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.079 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.81 -38.23 69.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.78 -67.47 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.073 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.823 HG12 HG22 ' A' ' 264' ' ' ILE . 1.3 m -48.51 -30.34 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.184 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -68.98 -52.72 25.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -57.09 -40.03 76.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -74.06 -37.17 64.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.115 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.522 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 27.0 ttt180 -52.45 -42.12 63.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -51.18 -30.85 25.32 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -74.16 -38.94 63.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.644 HD22 ' CE1' ' A' ' 262' ' ' PHE . 96.3 mt -79.84 -23.51 41.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.965 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.483 ' HB1' ' N ' ' A' ' 266' ' ' GLY . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.796 0.331 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.71 -47.73 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.079 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.846 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 61.0 m-85 -103.87 137.02 42.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -136.22 137.43 40.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -114.47 130.25 56.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.441 ' C ' ' CD ' ' A' ' 222' ' ' GLU . 1.8 tm-20 -133.21 118.63 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.418 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 16.0 p90 -141.86 149.1 39.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 40.4 t -98.9 124.43 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 80.4 t -111.44 137.07 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.105 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 28.0 mtp180 -55.63 126.82 27.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -49.44 -22.68 1.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -77.08 -46.57 23.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 53.7 mt -73.02 -31.69 64.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.611 ' HE1' HD11 ' A' ' 255' ' ' LEU . 19.5 mtp -37.08 -64.38 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.899 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -38.17 -48.08 2.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.62 -50.84 32.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.857 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -50.04 -40.47 45.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.101 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.567 HG23 HG13 ' A' ' 241' ' ' ILE . 54.4 mt -78.25 -36.17 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 99.63 -147.93 18.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 236' ' ' THR . 12.0 t -109.06 119.09 38.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 111.127 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 64.26 38.26 8.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.464 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 64.31 59.34 8.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.47 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.4 t -87.67 -69.76 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 3.6 m120 -43.71 -55.39 4.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.658 HG12 HD21 ' A' ' 279' ' ' LEU . 21.7 mt -49.27 -52.11 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -50.24 -53.18 30.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.482 ' NE2' ' N ' ' A' ' 243' ' ' GLN . 0.3 OUTLIER -55.54 -39.62 70.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.955 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.36 94.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.063 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.623 ' HG3' HD12 ' A' ' 253' ' ' ILE . 44.0 mtp180 -69.47 -17.96 63.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -85.75 12.72 8.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.678 HG13 ' HD2' ' A' ' 248' ' ' PRO . 98.9 t -93.16 138.89 22.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 0.0 111.16 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.678 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.2 Cg_endo -69.83 131.68 21.65 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.705 2.27 . . . . 0.0 112.305 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 98.29 -9.42 63.02 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.517 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 74.2 t -88.65 108.05 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 43.8 p -64.92 -53.1 51.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -158.98 161.47 36.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.106 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.623 HD12 ' HG3' ' A' ' 245' ' ' ARG . 38.8 mt -134.09 96.43 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -94.44 157.35 16.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.611 HD11 ' HE1' ' A' ' 230' ' ' MET . 4.0 tp -141.38 129.02 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.941 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -83.81 96.7 8.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.67 3.09 6.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -93.3 -48.19 6.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.1 p -108.28 -22.51 12.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 89.91 52.64 2.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 31.6 m -122.64 122.73 39.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 0.0 111.093 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.462 ' CE1' HD22 ' A' ' 255' ' ' LEU . 18.4 m-85 -89.57 116.85 28.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -109.08 116.0 31.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.768 HG22 HG12 ' A' ' 272' ' ' VAL . 5.9 mt -104.25 146.72 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.139 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -128.88 127.07 41.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.483 ' N ' ' HB1' ' A' ' 217' ' ' ALA . . . -150.19 147.99 18.75 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.508 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.24 -21.72 66.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.917 0.389 . . . . 0.0 110.892 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 2.1 m -145.34 140.22 27.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.858 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.846 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.21 -30.92 3.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.052 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.27 -38.86 81.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.838 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.472 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -68.96 -65.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.083 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.768 HG12 HG22 ' A' ' 264' ' ' ILE . 0.2 OUTLIER -50.4 -38.65 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -60.87 -53.13 61.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.504 ' HB3' HG11 ' A' ' 247' ' ' VAL . 19.4 tttt -56.35 -40.98 75.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.94 -33.34 70.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.146 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.418 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 36.7 ttp180 -59.7 -43.94 93.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.848 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -52.42 -15.57 2.94 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.445 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -92.78 -33.73 14.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 0.0 110.876 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.658 HD21 HG12 ' A' ' 241' ' ' ILE . 88.3 mt -87.08 7.29 28.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.756 0.312 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -65.56 -41.24 93.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.099 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.631 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 88.3 m-85 -110.96 133.72 53.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.864 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -132.41 132.43 42.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -112.67 151.49 30.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.856 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -152.39 123.99 7.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.449 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 18.5 p90 -142.79 140.68 31.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.592 HG22 ' OG1' ' A' ' 261' ' ' THR . 24.3 t -93.4 122.68 45.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 82.7 t -111.23 137.77 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.137 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.445 ' HB2' HD12 ' A' ' 229' ' ' LEU . 62.0 mtt180 -54.81 127.59 29.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -41.85 -45.27 3.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.848 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -62.78 -37.72 87.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 226' ' ' ARG . 60.6 mt -72.94 -37.84 67.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.888 ' CE ' HD11 ' A' ' 255' ' ' LEU . 27.0 mtp -37.52 -60.62 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -36.13 -61.41 0.8 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 54.0 mt -60.92 -47.07 88.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.938 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -50.17 -41.65 49.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.058 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.407 HG23 HG13 ' A' ' 241' ' ' ILE . 59.4 mt -79.41 -27.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 88.81 -137.63 14.35 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.482 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 4.5 t -112.59 136.63 51.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.804 0.335 . . . . 0.0 111.125 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 27.4 m80 42.13 45.18 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 60.19 65.04 3.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.5 t -91.58 -69.3 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.874 0.369 . . . . 0.0 110.85 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -42.88 -55.26 3.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.407 HG13 HG23 ' A' ' 234' ' ' ILE . 52.4 mt -47.94 -55.45 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.104 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -47.64 -55.8 8.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -50.39 -58.63 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.42 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -45.6 -48.57 14.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -64.59 -24.13 67.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -82.83 17.05 1.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.684 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.5 t -100.44 138.89 20.28 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.616 0.722 . . . . 0.0 111.097 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.684 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.71 137.95 36.82 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.723 2.282 . . . . 0.0 112.358 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 95.67 -12.6 67.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 81.8 t -89.45 104.87 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.898 0.38 . . . . 0.0 111.139 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 71.1 p -60.1 -50.5 73.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.15 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.17 169.84 22.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.07 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.572 HG12 HG23 ' A' ' 264' ' ' ILE . 81.4 mt -141.84 113.96 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.149 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -113.21 160.67 18.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.888 HD11 ' CE ' ' A' ' 230' ' ' MET . 12.1 tp -141.84 108.84 5.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.13 112.89 13.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -80.86 -37.63 29.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -38.96 -42.36 0.85 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 32.0 p -120.34 -21.59 6.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 88.82 51.72 2.97 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.482 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.592 ' OG1' HG22 ' A' ' 224' ' ' VAL . 96.2 m -119.44 136.34 54.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 111.124 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.696 ' CE1' HD22 ' A' ' 279' ' ' LEU . 12.3 m-85 -95.15 125.02 39.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 -114.13 111.05 20.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.572 HG23 HG12 ' A' ' 253' ' ' ILE . 6.7 mt -105.02 135.48 42.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.138 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -116.27 126.55 53.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.541 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -148.42 141.12 8.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.505 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 65.2 mt-10 -59.71 -33.63 71.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 110.856 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.1 m -128.8 136.79 50.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.631 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.32 -29.33 2.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.079 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.04 -39.88 93.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -68.46 -62.62 1.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.541 HG13 ' HA3' ' A' ' 266' ' ' GLY . 0.1 OUTLIER -52.18 -31.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.171 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -70.85 -50.44 35.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.934 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -59.75 -44.59 93.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.42 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -66.64 -35.64 80.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -59.44 -37.57 78.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -56.83 -13.11 7.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.438 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -95.1 -25.49 16.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.883 0.373 . . . . 0.0 110.839 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.696 HD22 ' CE1' ' A' ' 262' ' ' PHE . 76.8 mt -98.74 0.96 45.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.877 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.425 ' HB1' ' N ' ' A' ' 266' ' ' GLY . . . . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.767 0.318 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.67 83.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.072 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -104.82 140.78 37.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -130.52 153.38 48.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -132.68 136.72 46.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.83 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.495 ' CG ' ' HG2' ' A' ' 263' ' ' ARG . 3.5 mt-10 -145.74 116.41 7.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.894 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -139.2 147.3 41.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.423 HG22 ' OG1' ' A' ' 261' ' ' THR . 15.2 t -94.81 116.92 37.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.172 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 73.5 t -98.25 147.42 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -58.74 124.97 21.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -53.89 -16.23 1.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.931 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.8 -38.75 15.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 230' ' ' MET . 69.9 mt -79.64 -29.03 40.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.417 ' CE ' HD11 ' A' ' 255' ' ' LEU . 19.8 mtp -37.42 -66.62 0.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -38.34 -46.74 2.02 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.51 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 56.8 mt -69.84 -57.05 5.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -45.06 -38.47 4.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.412 HG23 HG13 ' A' ' 241' ' ' ILE . 71.4 mt -77.27 -35.45 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 92.64 -145.98 17.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.487 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' HIS . 24.9 p -100.56 143.65 30.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 236' ' ' THR . 6.6 m80 34.77 41.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 61.89 61.35 6.81 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.432 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.6 m -86.83 -59.9 2.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.84 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -49.3 -54.68 15.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.412 HG13 HG23 ' A' ' 234' ' ' ILE . 18.2 mt -48.02 -52.85 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -52.29 -44.59 65.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -60.45 -50.88 71.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -53.86 -36.2 62.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.058 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -74.61 -11.94 60.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -93.97 15.11 17.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.676 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.5 t -96.98 138.91 21.29 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.614 0.721 . . . . 0.0 111.126 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.676 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.5 Cg_endo -69.83 144.94 55.21 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.641 2.227 . . . . 0.0 112.323 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 91.37 -19.65 45.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 91.4 t -84.46 112.59 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.957 0.408 . . . . 0.0 111.155 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 217' ' ' ALA . 41.8 p -68.86 -46.78 67.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -162.12 166.09 26.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.098 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.549 HG12 HG23 ' A' ' 264' ' ' ILE . 91.4 mt -140.5 115.65 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.121 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -117.76 154.39 31.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.469 HD12 ' H ' ' A' ' 256' ' ' ASP . 11.5 tp -130.77 147.13 52.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.469 ' H ' HD12 ' A' ' 255' ' ' LEU . 5.7 m-20 -107.85 136.07 48.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -101.34 -18.25 16.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -58.03 -49.17 77.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 63.3 p -123.68 -25.63 4.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.108 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 99.95 54.68 1.03 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.485 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.423 ' OG1' HG22 ' A' ' 224' ' ' VAL . 27.2 m -114.14 121.84 45.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.884 0.373 . . . . 0.0 111.127 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.708 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.9 m-85 -86.29 113.99 22.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ARG . . . . . 0.495 ' HG2' ' CG ' ' A' ' 222' ' ' GLU . 48.6 mtm180 -98.83 114.59 27.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 1.002 HG22 HG12 ' A' ' 272' ' ' VAL . 17.9 mt -111.08 133.07 57.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -113.91 122.95 48.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.634 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -146.12 143.82 12.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.5 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.35 -23.6 67.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 0.0 110.927 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 24.5 m -141.74 131.33 23.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.797 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -42.57 -34.27 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.122 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -55.72 -43.48 76.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.411 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -65.29 -68.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 1.002 HG12 HG22 ' A' ' 264' ' ' ILE . 1.0 OUTLIER -48.1 -31.82 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -67.2 -50.9 59.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -59.42 -40.12 85.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.56 -38.5 65.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -49.28 -46.88 46.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.41 -32.94 10.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.504 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -71.83 -42.03 67.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.871 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.708 HD22 ' CE1' ' A' ' 262' ' ' PHE . 97.1 mt -78.75 -13.27 59.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.92 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.934 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.723 0.297 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -60.55 -33.76 73.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.82 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 79.8 m-85 -121.97 134.32 54.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.915 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -136.01 133.3 37.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -112.64 138.57 49.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.458 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 20.4 tt0 -141.6 125.3 16.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.515 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 11.8 p90 -142.4 149.66 39.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.847 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.62 115.5 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.16 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 41.4 t -104.94 136.57 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.109 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.411 ' HB2' HD12 ' A' ' 229' ' ' LEU . 51.5 mtp180 -54.4 133.94 45.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -50.91 -28.8 10.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -74.82 -39.69 61.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.857 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 226' ' ' ARG . 53.4 mt -74.01 -27.11 60.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.796 ' CE ' HD11 ' A' ' 255' ' ' LEU . 8.5 mmm -41.5 -55.68 2.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -52.22 -40.24 52.13 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 44.1 mt -71.71 -58.62 3.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -52.02 -37.33 53.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.064 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 37.6 mt -77.03 -33.4 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.145 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 88.9 -150.93 21.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.429 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 236' ' ' THR . 9.9 t -103.03 123.92 47.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 0.0 111.139 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 18.7 m80 55.32 46.41 23.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 56.83 58.32 15.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.509 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.5 t -84.45 -57.67 3.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.361 . . . . 0.0 110.862 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 2.5 m120 -54.37 -57.62 10.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.728 HG12 HD21 ' A' ' 279' ' ' LEU . 70.7 mt -45.22 -49.58 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -51.92 -68.47 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -44.01 -35.3 2.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 241' ' ' ILE . . . -62.78 -51.67 66.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -66.96 -11.85 57.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -86.91 3.36 45.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.68 HG13 ' HD2' ' A' ' 248' ' ' PRO . 97.7 t -89.74 138.85 27.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 111.091 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.68 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.8 144.76 54.83 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.93 -14.75 62.51 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.462 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 93.8 t -88.97 103.1 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 0.0 111.153 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 64.9 p -56.9 -50.85 71.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -161.15 171.41 18.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 264' ' ' ILE . 49.4 mt -143.52 113.17 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.144 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -116.11 156.98 25.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.796 HD11 ' CE ' ' A' ' 230' ' ' MET . 7.8 tp -142.09 147.21 36.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.43 ' H ' HD12 ' A' ' 255' ' ' LEU . 5.2 t0 -103.97 135.57 45.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -100.22 -23.03 14.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -82.58 -22.03 35.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 68.1 p -120.74 -23.23 6.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 71.79 47.31 33.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.458 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 90.2 m -122.62 124.08 42.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.353 . . . . 0.0 111.174 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.677 ' CZ ' HD22 ' A' ' 255' ' ' LEU . 10.7 m-85 -87.14 123.07 31.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -113.39 115.95 28.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.691 HG22 HG12 ' A' ' 272' ' ' VAL . 7.1 mt -108.42 139.26 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.137 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -119.22 121.42 39.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.578 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -144.73 145.12 14.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.518 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 38.0 mt-10 -62.09 -33.34 74.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.891 0.377 . . . . 0.0 110.946 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.8 m -132.93 135.23 45.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.864 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.82 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -46.11 -26.94 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.118 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -60.87 -40.94 94.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.53 -64.36 0.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.137 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.691 HG12 HG22 ' A' ' 264' ' ' ILE . 0.2 OUTLIER -50.07 -31.08 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 269' ' ' ALA . 19.5 mtpp -68.99 -53.18 21.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.874 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -42.99 94.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.84 -33.89 76.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -61.37 -41.43 97.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.879 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.418 ' HA2' ' CG ' ' A' ' 280' ' ' GLU . . . -51.54 -20.02 5.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.478 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -85.32 -39.89 17.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.913 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.728 HD21 HG12 ' A' ' 241' ' ' ILE . 72.3 mt -87.24 6.16 34.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.418 ' CG ' ' HA2' ' A' ' 277' ' ' GLY . 7.6 mm-40 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.817 0.341 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -73.92 -30.12 62.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.09 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.876 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 68.1 m-85 -118.22 137.94 52.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.88 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -144.02 148.68 35.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -117.67 136.23 53.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -132.98 113.36 12.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 15.7 p90 -137.61 141.3 41.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.613 HG22 ' OG1' ' A' ' 261' ' ' THR . 59.2 t -92.62 120.17 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 53.5 t -103.47 136.07 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.456 ' HB2' HD12 ' A' ' 229' ' ' LEU . 2.9 mmp_? -53.38 130.94 36.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -52.78 -16.72 1.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -92.9 -36.34 12.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.456 HD12 ' HB2' ' A' ' 226' ' ' ARG . 88.4 mt -74.38 -23.52 59.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.655 ' CE ' HD11 ' A' ' 255' ' ' LEU . 4.6 mtt -41.14 -65.2 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.895 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -35.44 -56.3 0.96 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.468 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 235' ' ' GLY . 41.6 mt -63.95 -64.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -41.32 -28.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.152 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 60.1 mt -89.95 -34.43 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 232' ' ' LEU . . . 89.94 -149.97 20.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 237' ' ' HIS . 4.9 t -98.9 143.58 29.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 111.192 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.44 ' C ' ' O ' ' A' ' 236' ' ' THR . 27.3 m-70 34.85 45.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.841 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 60.31 60.08 9.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.49 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.4 t -84.43 -61.46 1.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.876 0.37 . . . . 0.0 110.852 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -48.51 -59.84 3.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 30.9 mt -42.62 -53.37 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -50.05 -67.9 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -39.92 -52.8 2.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -50.69 -48.16 58.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -69.28 -13.55 62.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.841 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -86.27 6.82 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.683 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.4 t -92.71 138.88 23.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.628 0.728 . . . . 0.0 111.119 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.683 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.76 149.95 67.6 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.709 2.273 . . . . 0.0 112.309 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.05 -19.24 31.48 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.505 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 265' ' ' TYR . 94.9 t -83.54 107.11 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.398 . . . . 0.0 111.129 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 59.1 p -60.2 -56.04 26.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.167 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -156.34 162.11 40.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.125 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.841 HG12 HG23 ' A' ' 264' ' ' ILE . 76.4 mt -135.14 107.05 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -107.13 163.27 13.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.655 HD11 ' CE ' ' A' ' 230' ' ' MET . 7.9 tp -141.06 141.98 34.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.933 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -100.33 129.7 46.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -100.31 -14.9 18.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -63.69 -38.72 92.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 54.5 p -128.81 -29.46 2.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.091 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.16 58.69 0.78 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.495 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.613 ' OG1' HG22 ' A' ' 224' ' ' VAL . 91.2 m -125.35 122.38 36.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 111.107 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.537 ' CZ ' HD22 ' A' ' 255' ' ' LEU . 11.1 m-85 -86.5 123.99 32.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -110.84 111.89 23.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.876 HG22 HG12 ' A' ' 272' ' ' VAL . 9.5 mt -104.44 141.02 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.407 ' O ' HG13 ' A' ' 250' ' ' VAL . 87.2 m-85 -121.63 131.28 54.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -154.29 143.63 10.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.481 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -58.22 -32.53 68.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 0.0 110.938 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.1 t -134.67 137.07 43.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.877 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.876 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.43 -28.87 2.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.134 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -42.53 84.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.74 -66.89 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.112 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.876 HG12 HG22 ' A' ' 264' ' ' ILE . 0.2 OUTLIER -48.76 -34.84 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 36.2 mttm -64.23 -50.75 66.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -63.32 -39.75 95.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.8 -29.62 62.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.466 ' CZ ' ' OE1' ' A' ' 280' ' ' GLU . 21.2 ttt-85 -60.7 -42.79 97.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.841 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.41 ' HA2' ' CG ' ' A' ' 280' ' ' GLU . . . -51.09 -24.93 9.64 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.491 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -80.36 -25.82 38.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 110.866 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.471 HD22 ' CE1' ' A' ' 262' ' ' PHE . 68.3 mt -102.16 11.39 38.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.466 ' OE1' ' CZ ' ' A' ' 276' ' ' ARG . 8.9 mm-40 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.047 0 CA-C-O 120.802 0.334 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.81 86.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.127 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.557 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 83.4 m-85 -108.02 142.29 38.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -133.06 140.46 47.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -111.55 141.85 44.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.418 ' CD ' ' C ' ' A' ' 222' ' ' GLU . 0.6 OUTLIER -148.94 111.31 4.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.837 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.528 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 34.0 p90 -140.9 151.42 44.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 20.0 t -96.52 134.34 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.123 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 69.0 t -118.61 137.38 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -57.02 130.07 44.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -57.7 -22.53 46.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -83.72 -19.54 35.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 229' ' ' LEU . 30.9 mt -100.42 -18.07 16.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.557 ' CE ' HD11 ' A' ' 255' ' ' LEU . 4.8 mmt -45.02 -66.96 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -40.45 -40.59 2.03 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.511 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 40.9 mt -69.94 -55.99 8.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.834 0.35 . . . . 0.0 110.945 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -52.9 -38.43 61.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.045 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 25.7 mt -77.5 -37.8 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 95.16 -158.5 22.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.471 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 22.1 m -95.77 128.59 42.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 111.189 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 67.4 t60 52.67 46.34 26.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.831 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 53.76 67.95 1.89 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.511 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.8 t -92.8 -61.51 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 110.912 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -50.02 -60.58 2.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 19.2 mt -41.61 -49.06 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -54.53 -51.2 65.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -58.02 -37.63 74.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.94 96.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.444 ' HG3' HD12 ' A' ' 253' ' ' ILE . 5.9 mtp-105 -70.7 -0.91 9.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -104.98 12.88 31.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.654 HG13 ' HD2' ' A' ' 248' ' ' PRO . 84.9 t -95.16 138.63 21.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 111.142 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.654 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.7 Cg_endo -69.77 133.4 25.46 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.683 2.255 . . . . 0.0 112.331 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 96.74 -0.43 61.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 74.5 t -102.17 106.57 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 111.147 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 265' ' ' TYR . 35.9 p -63.0 -58.25 7.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -151.47 157.59 42.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.629 HG12 HG23 ' A' ' 264' ' ' ILE . 66.0 mt -130.37 114.17 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.148 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -118.38 149.12 41.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.557 HD11 ' CE ' ' A' ' 230' ' ' MET . 8.9 tp -127.56 147.7 50.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.944 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.532 ' H ' HD12 ' A' ' 255' ' ' LEU . 0.8 OUTLIER -112.84 118.92 36.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -84.74 -27.82 26.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -49.72 -40.5 40.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 62.0 p -125.25 -27.76 3.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.139 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 97.68 39.01 4.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 35.1 m -103.97 130.28 51.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 0.0 111.146 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.823 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.9 m-85 -93.58 116.6 29.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 53.5 mtt-85 -104.28 119.23 38.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.707 HG22 HG12 ' A' ' 272' ' ' VAL . 10.9 mt -115.49 143.32 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 251' ' ' THR . 88.9 m-85 -122.9 117.16 24.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.61 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -141.07 151.35 22.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.506 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -69.74 -26.51 64.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.2 p -132.71 132.79 42.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.21 -29.89 2.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.103 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.31 -35.71 81.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -69.79 -53.96 15.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.08 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.707 HG12 HG22 ' A' ' 264' ' ' ILE . 0.4 OUTLIER -63.11 -29.54 47.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -72.22 -51.32 21.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -55.53 -48.94 73.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.97 -34.36 76.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.528 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 45.9 ttt180 -53.88 -47.06 71.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -46.44 -26.12 2.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -79.53 -33.71 41.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.905 0.383 . . . . 0.0 110.884 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.823 HD22 ' CE1' ' A' ' 262' ' ' PHE . 92.9 mt -85.27 -17.23 37.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.765 0.317 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -66.83 -36.29 82.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.074 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.536 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 88.2 m-85 -112.56 141.01 46.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.912 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -140.89 138.73 34.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.853 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -113.93 138.62 50.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -139.12 121.36 15.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 12.9 p90 -142.33 143.14 32.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.94 119.73 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.31 134.73 50.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 229' ' ' LEU . 46.9 mtm180 -54.26 120.9 7.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -38.15 -28.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 226' ' ' ARG . 15.9 t0 -72.42 -44.36 62.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 226' ' ' ARG . 86.4 mt -74.14 -26.15 60.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.842 ' CE ' HD11 ' A' ' 255' ' ' LEU . 30.3 mtp -49.22 -58.91 4.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -36.47 -56.62 1.22 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.464 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 50.4 mt -67.78 -52.17 40.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -46.24 -34.59 4.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.087 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 56.4 mt -85.94 -32.44 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.128 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 93.78 -150.57 19.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.485 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 85.2 m -111.34 112.67 24.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 111.129 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 73.73 35.03 0.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.82 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 63.05 62.8 5.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 27.6 t -92.21 -53.62 4.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.835 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 7.1 m120 -58.01 -50.53 73.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 52.7 mt -52.06 -45.74 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.124 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -53.95 -67.31 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -42.79 -43.45 3.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.82 81.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.423 ' CG ' HD12 ' A' ' 253' ' ' ILE . 54.7 mtp180 -69.8 -21.69 63.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -76.33 -5.01 45.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.671 HG13 ' HD2' ' A' ' 248' ' ' PRO . 84.0 t -77.78 138.65 62.06 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.63 0.729 . . . . 0.0 111.104 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.671 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.0 Cg_endo -69.77 143.31 50.4 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.662 2.241 . . . . 0.0 112.388 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 91.41 -19.92 44.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.0 t -80.49 106.05 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.921 0.391 . . . . 0.0 111.129 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.459 ' CG2' ' HB2' ' A' ' 217' ' ' ALA . 32.6 p -60.09 -58.76 7.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.159 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -154.46 159.13 40.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.499 HG12 HG23 ' A' ' 264' ' ' ILE . 50.9 mt -132.57 103.85 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.158 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -104.05 155.63 18.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.842 HD11 ' CE ' ' A' ' 230' ' ' MET . 8.5 tp -140.17 157.11 46.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.649 ' H ' HD12 ' A' ' 255' ' ' LEU . 6.4 t0 -116.93 134.5 54.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -100.88 -16.97 17.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.37 -34.37 28.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.83 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 59.7 p -114.77 -21.76 10.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.186 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 74.02 53.03 7.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.516 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.8 m -122.4 129.47 52.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.319 . . . . 0.0 111.142 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.785 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.9 m-85 -93.11 121.85 34.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.871 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.7 mtm-85 -113.02 114.17 26.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.834 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.734 HG22 HG12 ' A' ' 272' ' ' VAL . 5.2 mt -107.1 138.59 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.112 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 251' ' ' THR . 93.7 m-85 -122.82 117.47 25.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.564 ' O ' ' HB1' ' A' ' 217' ' ' ALA . . . -139.88 144.81 15.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -58.06 -33.4 69.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.899 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.2 t -134.57 137.29 43.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.878 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -45.2 -26.8 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.061 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.25 -44.83 94.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.47 -65.09 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.139 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.734 HG12 HG22 ' A' ' 264' ' ' ILE . 0.9 OUTLIER -48.46 -31.1 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -71.54 -54.14 11.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -58.17 -35.5 71.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -76.46 -37.34 57.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -54.8 -36.61 65.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -58.65 -12.22 13.16 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -94.61 -28.08 15.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 110.891 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.785 HD22 ' CE1' ' A' ' 262' ' ' PHE . 82.2 mt -92.95 -2.68 55.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 179.904 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.777 0.322 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -73.23 -41.22 63.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.614 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 66.1 m-85 -107.98 132.29 53.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -126.17 145.72 50.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -119.22 137.65 53.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -143.53 111.96 6.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.448 ' CE2' ' HG3' ' A' ' 276' ' ' ARG . 30.2 p90 -141.21 150.08 42.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.869 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.412 HG22 ' OG1' ' A' ' 261' ' ' THR . 47.7 t -96.47 132.25 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.5 t -113.77 137.43 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.098 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -53.54 122.06 9.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -49.7 -20.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -86.16 -38.49 17.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 34.6 mt -79.8 -25.24 40.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.525 ' CE ' HD11 ' A' ' 255' ' ' LEU . 25.7 mtp -45.98 -58.84 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.87 -52.24 3.25 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.463 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 26.1 mt -67.8 -50.71 55.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.838 0.352 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.426 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -47.51 -45.78 26.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 52.8 mt -69.68 -40.7 79.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 101.84 -143.87 16.16 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.489 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.56 ' O ' HG23 ' A' ' 236' ' ' THR . 8.8 t -115.29 114.26 24.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.774 0.321 . . . . 0.0 111.13 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 69.19 39.25 1.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 60.11 59.54 10.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 2.5 t -89.29 -60.11 2.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.907 0.384 . . . . 0.0 110.858 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 3.7 m120 -50.6 -56.89 9.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 48.9 mt -44.94 -51.35 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -56.24 -44.43 79.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -60.73 -35.38 76.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.549 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -64.48 -53.63 45.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.483 ' N ' HD12 ' A' ' 253' ' ' ILE . 9.6 ptt180 -60.84 -30.29 70.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -64.81 -6.66 8.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.663 HG13 ' HD2' ' A' ' 248' ' ' PRO . 85.7 t -77.15 138.7 64.69 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.614 0.721 . . . . 0.0 111.136 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.663 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.9 Cg_endo -69.75 128.55 16.2 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.686 2.257 . . . . 0.0 112.368 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 104.12 -12.27 52.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.9 t -87.1 102.2 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 111.137 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 53.0 p -57.1 -48.96 77.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.168 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -162.35 166.86 24.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.096 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.6 HG12 HG23 ' A' ' 264' ' ' ILE . 58.6 mt -139.05 113.11 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.121 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -111.94 152.58 27.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.525 HD11 ' CE ' ' A' ' 230' ' ' MET . 8.3 tp -129.19 110.72 12.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.91 99.4 6.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -73.75 -30.92 63.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.882 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -42.81 -39.52 2.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 3.0 p -127.06 -28.53 2.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.126 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 101.89 40.39 2.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.512 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.412 ' OG1' HG22 ' A' ' 224' ' ' VAL . 93.8 m -110.15 116.79 32.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.846 0.355 . . . . 0.0 111.13 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.489 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.8 m-85 -79.87 118.36 21.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -108.37 113.73 27.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.992 HD11 HD12 ' A' ' 279' ' ' LEU . 40.7 mt -107.25 139.79 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -117.9 121.92 41.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.917 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -144.79 140.45 9.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.504 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -61.99 -33.11 73.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.851 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 271' ' ' ALA . 23.8 p -127.37 123.83 37.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.872 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.614 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -38.5 -33.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.081 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -57.7 -46.05 84.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.834 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 268' ' ' SER . . . -61.27 -68.15 0.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.071 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.917 HG13 ' HA3' ' A' ' 266' ' ' GLY . 3.5 m -47.86 -34.21 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -66.6 -52.23 47.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 39.8 tttt -54.5 -49.04 71.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.549 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -67.43 -38.16 84.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.113 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.448 ' HG3' ' CE2' ' A' ' 223' ' ' PHE . 24.9 ttp85 -47.1 -44.47 21.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -49.27 -35.32 19.99 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -69.43 -42.7 74.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.992 HD12 HD11 ' A' ' 264' ' ' ILE . 81.1 mt -75.05 -27.03 59.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.983 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.916 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.737 0.303 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.84 76.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.103 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.714 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 70.5 m-85 -122.08 125.46 46.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -122.76 138.62 54.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -115.08 146.16 41.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.458 ' HG3' ' CG2' ' A' ' 261' ' ' THR . 19.5 tt0 -149.28 124.6 10.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 4.8 p90 -141.42 146.0 36.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.403 HG22 ' OG1' ' A' ' 261' ' ' THR . 13.0 t -97.83 110.48 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 31.5 t -95.66 146.03 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.453 ' HB2' HD12 ' A' ' 229' ' ' LEU . 12.4 mmm-85 -61.6 148.59 41.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.14 -22.58 66.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -94.47 -12.91 26.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 226' ' ' ARG . 91.5 mt -98.36 -8.93 26.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.554 ' CE ' HD11 ' A' ' 255' ' ' LEU . 2.9 mmt -56.38 -68.63 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -34.74 -57.09 0.78 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.466 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 62.7 mt -61.99 -51.16 69.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.922 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.75 -22.61 47.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.15 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.651 HG22 ' HA2' ' A' ' 238' ' ' GLY . 37.8 mt -100.44 -10.75 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.14 -157.68 53.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.529 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 238' ' ' GLY . 15.2 t -89.33 147.4 24.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.125 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.436 ' C ' ' O ' ' A' ' 236' ' ' THR . 96.1 m-70 35.37 33.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.651 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 65.13 48.91 65.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.476 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 236' ' ' THR . 3.0 t -77.25 -48.84 16.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 110.837 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -53.54 -54.71 33.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.492 ' HA ' HD21 ' A' ' 279' ' ' LEU . 55.7 mt -48.57 -45.46 14.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -55.03 -62.0 1.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 247' ' ' VAL . 80.4 mt-30 -43.75 -49.03 8.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.935 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.42 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -59.19 -43.9 92.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -73.43 -18.07 61.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -90.64 15.24 11.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.665 HG13 ' HD2' ' A' ' 248' ' ' PRO . 98.0 t -93.95 138.38 22.71 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.616 0.722 . . . . 0.0 111.142 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.665 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.5 Cg_endo -69.7 128.89 16.73 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.702 2.268 . . . . 0.0 112.397 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.72 -7.88 50.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.537 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 84.0 t -96.75 103.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 111.137 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 68.3 p -54.11 -57.41 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.149 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.07 174.62 14.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.128 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.642 HG12 HG23 ' A' ' 264' ' ' ILE . 79.1 mt -143.19 108.54 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -105.43 155.34 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.554 HD11 ' CE ' ' A' ' 230' ' ' MET . 9.8 tp -141.01 133.43 28.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.7 120.49 40.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.809 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -85.36 -26.96 26.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.76 -40.03 27.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 35.0 p -127.16 -27.97 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 98.45 54.99 1.12 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.477 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.458 ' CG2' ' HG3' ' A' ' 222' ' ' GLU . 3.5 m -116.3 123.93 48.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.341 . . . . 0.0 111.154 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.538 ' CE1' HD22 ' A' ' 255' ' ' LEU . 11.0 m-85 -92.52 112.74 24.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.883 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 38.4 mtp85 -103.21 120.37 40.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.642 HG23 HG12 ' A' ' 253' ' ' ILE . 7.4 mt -110.89 136.93 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.182 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -116.88 119.59 35.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.625 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -141.51 146.62 17.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.468 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -68.22 -28.28 67.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 p -130.21 130.8 45.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.714 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -43.82 -30.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.072 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.21 -40.79 98.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.47 -65.9 0.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.093 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.625 HG13 ' HA3' ' A' ' 266' ' ' GLY . 0.3 OUTLIER -47.92 -41.25 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -67.13 -47.0 72.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.936 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -59.85 -39.21 84.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.42 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -75.57 -30.35 59.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.139 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -62.84 -39.92 95.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -54.64 -13.38 4.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.514 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -93.91 -26.06 17.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.492 HD21 ' HA ' ' A' ' 241' ' ' ILE . 83.0 mt -94.85 6.2 49.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.803 0.335 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -70.94 -29.17 65.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.069 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.932 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 86.6 m-85 -123.37 114.5 20.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -118.03 145.6 44.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -114.33 133.22 55.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.465 ' C ' ' CD ' ' A' ' 222' ' ' GLU . 0.3 OUTLIER -135.87 117.04 14.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.527 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 12.0 p90 -142.57 151.77 41.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.851 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 18.4 t -102.26 121.99 53.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.082 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 93.2 t -109.24 144.98 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.532 ' HB2' HD12 ' A' ' 229' ' ' LEU . 70.8 mtt180 -60.9 122.06 13.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -40.48 -32.37 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.95 -43.08 56.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.532 HD12 ' HB2' ' A' ' 226' ' ' ARG . 80.2 mt -71.23 -25.39 62.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.834 ' CE ' HD11 ' A' ' 255' ' ' LEU . 26.5 mtp -47.22 -64.46 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -36.32 -51.69 1.31 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.48 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 63.1 mt -67.03 -44.6 79.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 110.947 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -55.56 -37.9 68.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.554 HG23 HG13 ' A' ' 241' ' ' ILE . 41.8 mt -83.7 -27.61 7.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.147 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 90.18 -153.94 23.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.524 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 91.2 m -108.66 117.13 33.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.8 0.333 . . . . 0.0 111.182 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 9.1 t60 72.93 30.64 1.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.857 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 65.31 56.76 13.82 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.522 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 30.8 t -86.49 -58.15 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 0.0 110.856 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 4.6 m120 -51.17 -59.39 4.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.906 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.554 HG13 HG23 ' A' ' 234' ' ' ILE . 44.3 mt -42.83 -48.34 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -54.93 -55.36 31.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -48.74 -54.76 13.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.43 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -52.62 -40.6 62.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.075 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -71.31 -19.45 62.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -85.09 15.75 3.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.65 HG13 ' HD2' ' A' ' 248' ' ' PRO . 95.6 t -98.6 138.05 20.71 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.634 0.731 . . . . 0.0 111.092 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.65 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.3 Cg_endo -69.73 133.07 24.74 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.698 2.265 . . . . 0.0 112.391 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 101.41 -17.65 55.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.521 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 275' ' ' ALA . 58.7 t -87.31 101.78 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.851 0.358 . . . . 0.0 111.164 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 66.7 p -56.28 -47.91 77.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -163.76 170.88 16.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.081 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 264' ' ' ILE . 86.8 mt -140.1 116.22 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.101 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -113.65 160.45 18.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.834 HD11 ' CE ' ' A' ' 230' ' ' MET . 4.1 tp -142.13 144.0 33.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -104.61 126.64 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.828 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -97.25 -19.17 18.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -58.6 -44.28 89.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 67.6 p -124.1 -31.01 3.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.173 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.67 57.35 0.7 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 90.7 m -122.65 119.17 29.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 111.189 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.584 ' CD1' HD13 ' A' ' 279' ' ' LEU . 12.4 m-85 -85.7 130.97 34.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -119.49 119.2 33.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.747 HG22 HG12 ' A' ' 272' ' ' VAL . 6.2 mt -109.47 139.94 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.148 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -120.0 115.53 23.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.476 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -140.16 138.05 8.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.453 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -56.86 -29.48 62.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.861 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.1 t -134.91 138.95 44.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.932 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.78 -30.19 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.071 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -59.56 -40.68 88.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.402 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -68.09 -67.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.747 HG12 HG22 ' A' ' 264' ' ' ILE . 0.3 OUTLIER -47.32 -38.46 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -64.03 -54.59 31.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -39.82 78.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.906 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.43 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -71.18 -35.75 71.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.054 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.41 ' HB2' HD12 ' A' ' 264' ' ' ILE . 50.1 ttt180 -59.17 -35.59 73.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -60.05 -8.87 9.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.493 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -98.72 -24.65 14.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 110.911 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.584 HD13 ' CD1' ' A' ' 262' ' ' PHE . 82.4 mt -99.28 1.94 45.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.887 179.921 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.835 0.35 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -65.42 -38.55 90.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.714 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 77.7 m-85 -109.01 130.86 55.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -127.68 141.32 51.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -113.62 142.82 45.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.44 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 0.1 OUTLIER -147.13 105.55 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 15.5 p90 -130.12 156.38 44.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 62.1 t -106.91 126.69 62.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.081 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.0 t -110.0 143.29 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.088 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.607 ' HB2' HD12 ' A' ' 229' ' ' LEU . 16.5 mmt180 -55.69 123.08 12.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -45.5 -25.08 0.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.26 -39.29 17.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.607 HD12 ' HB2' ' A' ' 226' ' ' ARG . 45.3 mt -71.81 -30.23 65.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 24.1 mtp -39.7 -57.94 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -41.55 -49.02 4.87 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.502 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 30.0 mt -70.67 -58.02 4.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 110.905 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -42.26 -42.75 3.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.064 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.429 HG23 HG13 ' A' ' 241' ' ' ILE . 22.9 mt -74.81 -36.08 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.121 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 99.51 -158.09 19.86 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 22.0 m -105.19 113.27 26.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.806 0.336 . . . . 0.0 111.137 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 74.4 31.34 1.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.858 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 64.11 61.52 6.01 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.461 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 29.3 t -90.96 -55.17 3.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.901 0.381 . . . . 0.0 110.851 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -55.84 -47.94 76.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.496 HG12 HD21 ' A' ' 279' ' ' LEU . 26.5 mt -54.55 -47.74 71.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -57.23 -46.72 82.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -60.25 -54.51 44.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.587 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -48.8 -40.1 27.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.082 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.4 ' CA ' HD12 ' A' ' 253' ' ' ILE . 18.4 ttt85 -72.87 -22.33 60.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -86.65 21.72 2.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.642 HG13 ' HD2' ' A' ' 248' ' ' PRO . 86.3 t -100.89 138.07 19.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.619 0.724 . . . . 0.0 111.104 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.642 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.77 127.26 14.33 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.711 2.274 . . . . 0.0 112.359 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 104.1 -4.53 45.1 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.538 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 82.9 t -100.89 104.96 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 0.0 111.141 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 69.9 p -59.19 -54.03 51.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.02 166.41 33.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.107 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.712 HG12 HG23 ' A' ' 264' ' ' ILE . 77.0 mt -137.57 105.94 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.163 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -110.79 148.59 32.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.719 HD12 ' H ' ' A' ' 256' ' ' ASP . 8.0 tp -128.15 154.57 45.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.929 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.719 ' H ' HD12 ' A' ' 255' ' ' LEU . 14.7 m-20 -112.07 130.15 55.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -100.13 -14.74 18.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.21 -45.18 95.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.9 p -126.0 -28.65 3.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.131 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.58 61.62 0.66 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.481 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.44 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 91.9 m -124.67 122.21 36.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 0.0 111.124 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.795 ' CE1' HD22 ' A' ' 279' ' ' LEU . 13.6 m-85 -89.2 113.14 24.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -102.2 110.63 22.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.807 HG22 HG12 ' A' ' 272' ' ' VAL . 7.2 mt -104.59 144.78 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -123.0 124.11 42.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.489 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -149.46 136.3 5.71 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.533 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -56.58 -29.73 62.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.833 0.349 . . . . 0.0 110.866 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 13.2 p -129.08 135.23 48.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.714 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -49.29 -28.83 5.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.141 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.62 -36.86 84.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.854 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.424 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -66.6 -59.82 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.075 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.807 HG12 HG22 ' A' ' 264' ' ' ILE . 0.3 OUTLIER -58.85 -29.98 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -68.07 -50.45 55.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -58.21 -48.01 81.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.587 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -65.09 -33.61 76.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.43 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 74.1 ttt180 -53.89 -50.12 67.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -44.14 -27.73 1.17 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.495 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -80.54 -39.07 28.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.924 0.392 . . . . 0.0 110.953 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.795 HD22 ' CE1' ' A' ' 262' ' ' PHE . 30.7 mt -88.08 -2.54 58.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.863 179.948 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.784 0.326 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -58.56 -43.75 89.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.125 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.636 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 83.5 m-85 -110.05 143.66 39.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -137.06 143.79 42.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -115.01 134.26 55.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.891 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.1 108.09 5.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.789 ' O ' HG23 ' A' ' 261' ' ' THR . 32.0 p90 -139.31 163.37 32.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.592 HG22 ' OG1' ' A' ' 261' ' ' THR . 60.6 t -108.65 132.34 56.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.15 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 79.2 t -113.39 142.62 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 -55.16 125.04 18.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -53.76 -18.16 2.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.54 -38.53 17.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 51.4 mt -80.24 -27.54 38.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.46 ' CE ' HD11 ' A' ' 255' ' ' LEU . 22.4 mtp -40.23 -59.26 1.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.849 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -41.21 -54.13 3.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.467 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.04 -54.75 33.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.882 0.372 . . . . 0.0 110.936 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -45.92 -44.11 14.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.105 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 11.0 mt -71.6 -38.5 67.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 94.84 -134.25 11.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.454 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 237' ' ' HIS . 60.2 m -113.01 138.66 49.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.833 0.349 . . . . 0.0 111.141 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 236' ' ' THR . 5.5 m-70 35.91 48.8 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 59.29 57.73 18.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.493 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.7 t -84.57 -68.14 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.877 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 4.7 m120 -41.64 -62.32 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 60.2 mt -39.9 -52.52 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -54.76 -48.93 72.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.944 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.452 ' OE1' ' N ' ' A' ' 243' ' ' GLN . 0.3 OUTLIER -60.97 -30.83 70.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 247' ' ' VAL . . . -68.54 -53.39 23.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -57.72 -23.91 54.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -72.51 1.89 7.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.669 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.4 t -82.67 138.9 43.75 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.654 0.74 . . . . 0.0 111.105 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.669 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.4 Cg_endo -69.75 133.28 25.22 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.728 2.286 . . . . 0.0 112.316 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 96.83 -3.45 62.68 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.511 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 70.6 t -96.59 113.46 31.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 111.095 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 20.6 p -70.87 -57.83 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -148.41 168.24 23.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.074 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.564 HG12 HG23 ' A' ' 264' ' ' ILE . 65.6 mt -143.84 109.17 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.126 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -113.13 154.45 26.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.46 HD11 ' CE ' ' A' ' 230' ' ' MET . 8.0 tp -131.47 138.78 49.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.953 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.415 ' N ' HD12 ' A' ' 255' ' ' LEU . 6.6 m-20 -104.51 113.28 26.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -82.38 -33.19 28.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.849 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -45.46 -35.68 3.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 63.6 p -128.07 -31.33 2.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 99.15 47.05 1.93 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.49 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 223' ' ' PHE . 97.7 m -115.17 128.84 56.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 111.132 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.557 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.6 m-85 -91.12 123.0 34.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -111.78 114.67 27.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.932 HG22 HG12 ' A' ' 272' ' ' VAL . 19.2 mt -109.1 139.84 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -120.25 117.05 26.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.607 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -139.67 151.88 22.24 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.506 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 25.1 mt-10 -67.74 -31.52 71.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 110.917 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.3 p -129.84 134.99 47.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.636 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -46.46 -32.42 3.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.099 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -62.06 -41.84 98.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.73 -65.54 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.085 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.932 HG12 HG22 ' A' ' 264' ' ' ILE . 0.3 OUTLIER -51.22 -34.57 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.153 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -65.59 -53.05 47.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -53.63 -48.25 69.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.36 -35.25 77.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.113 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.54 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 56.5 ttt180 -51.92 -42.81 63.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -49.46 -33.83 18.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.97 -43.81 67.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.381 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.887 HD12 HD11 ' A' ' 264' ' ' ILE . 69.8 mt -72.79 -28.94 62.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.904 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.777 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.796 0.332 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -51.84 -33.56 36.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.123 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.819 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 43.4 m-85 -119.02 122.77 42.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -121.28 152.19 39.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.822 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -129.87 153.11 48.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -157.49 117.53 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.401 ' CE2' ' HG3' ' A' ' 276' ' ' ARG . 27.9 p90 -142.79 144.96 32.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.3 t -91.73 129.19 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 55.3 t -109.83 139.03 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.12 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -53.82 131.08 39.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.17 -11.69 6.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -96.82 -21.29 17.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.827 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 74.4 mt -97.58 -9.03 27.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.412 ' CE ' HD11 ' A' ' 255' ' ' LEU . 5.4 mmt -49.97 -66.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -40.27 -51.41 3.62 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.503 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 68.1 mt -59.42 -63.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -45.97 -39.53 9.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 45.6 mt -75.74 -30.38 21.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 88.85 -147.35 19.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.483 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 237' ' ' HIS . 9.6 t -101.58 140.69 35.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.765 0.317 . . . . 0.0 111.185 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 236' ' ' THR . 14.4 p80 34.63 49.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 56.46 66.27 2.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.486 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.7 t -93.74 -61.24 1.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 110.86 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -48.42 -63.46 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 45.4 mt -39.59 -52.75 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -50.68 -45.5 58.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -61.98 -50.24 72.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.934 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.537 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -56.7 -35.59 68.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.09 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -75.99 -18.37 59.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -89.29 12.86 14.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.623 HG13 ' HD2' ' A' ' 248' ' ' PRO . 93.7 t -91.76 137.4 25.54 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.646 0.736 . . . . 0.0 111.16 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.623 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.0 Cg_endo -69.69 139.69 41.08 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.657 2.238 . . . . 0.0 112.385 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 95.97 -18.99 56.42 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.541 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 86.9 t -81.01 116.79 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 111.104 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 265' ' ' TYR . 37.2 p -71.24 -49.17 46.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.108 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -161.45 169.44 21.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.505 HG12 HG23 ' A' ' 264' ' ' ILE . 90.6 mt -144.6 113.56 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.088 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -114.01 153.51 29.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 256' ' ' ASP . 1.8 tp -135.31 125.52 26.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.889 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.676 ' N ' HD12 ' A' ' 255' ' ' LEU . 1.7 t70 -84.87 107.81 17.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 29.7 mp0 -83.15 -3.93 57.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -91.33 -36.23 13.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 40.1 p -115.36 -17.02 11.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 76.88 51.79 6.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.475 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 96.8 m -124.97 126.62 45.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 111.161 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.825 ' CE1' HD22 ' A' ' 279' ' ' LEU . 11.1 m-85 -88.02 114.16 24.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 27.4 mtt-85 -104.24 117.09 33.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.83 HG22 HG12 ' A' ' 272' ' ' VAL . 10.2 mt -110.02 148.43 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 251' ' ' THR . 60.2 m-85 -131.65 112.43 12.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.777 ' O ' ' HB1' ' A' ' 217' ' ' ALA . . . -133.34 148.81 19.49 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.524 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -67.4 -25.71 66.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.888 0.375 . . . . 0.0 110.9 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 270' ' ' ASP . 6.3 m -141.08 131.26 24.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.833 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.819 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -36.8 -34.11 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.118 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 268' ' ' SER . 2.6 m-20 -57.74 -50.73 72.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.87 -66.98 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.83 HG12 HG22 ' A' ' 264' ' ' ILE . 2.4 m -50.66 -41.7 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -56.28 -52.79 63.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -57.79 -49.23 77.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.537 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -64.56 -31.53 72.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.401 ' HG3' ' CE2' ' A' ' 223' ' ' PHE . 37.8 ttp85 -60.41 -45.99 91.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.06 -22.52 2.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.469 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -85.55 -50.63 7.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 0.0 110.851 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.825 HD22 ' CE1' ' A' ' 262' ' ' PHE . 78.2 mt -68.75 -8.66 45.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.938 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 179.962 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.784 0.326 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -74.84 -43.11 56.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.553 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 96.7 m-85 -114.41 122.72 47.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -118.46 141.79 48.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -119.13 135.97 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.405 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 0.9 OUTLIER -138.05 122.93 18.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 223' ' ' PHE . 1.7 p90 -140.57 151.79 44.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.9 t -104.42 114.03 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 226' ' ' ARG . 19.5 t -97.91 143.6 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.155 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.412 ' O ' HG12 ' A' ' 225' ' ' VAL . 13.9 mmt85 -53.9 172.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -91.42 -17.57 25.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -102.28 -8.89 20.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.451 HD23 HD12 ' A' ' 232' ' ' LEU . 65.7 mt -100.69 -4.08 28.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 2.8 mmt -58.21 -66.8 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -42.85 -39.21 3.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.451 HD12 HD23 ' A' ' 229' ' ' LEU . 68.1 mt -66.34 -59.86 3.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 0.0 110.889 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.422 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -53.76 -49.68 67.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 8.0 mt -65.76 -31.66 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.158 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 92.92 -153.12 21.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.463 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 70.1 p -108.72 118.13 35.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.349 . . . . 0.0 111.169 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 69.25 35.44 2.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.857 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 58.84 61.07 7.79 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.485 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.3 t -92.42 -54.25 3.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.882 0.372 . . . . 0.0 110.876 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 5.5 m120 -52.88 -56.2 17.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.885 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.493 ' HA ' HD21 ' A' ' 279' ' ' LEU . 39.4 mt -46.54 -45.59 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -55.21 -62.53 1.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -45.91 -41.41 11.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.69 -57.21 13.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.418 ' HG3' HD12 ' A' ' 253' ' ' ILE . 80.8 mtt180 -60.3 -11.62 6.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -98.21 14.1 28.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.661 HG13 ' HD2' ' A' ' 248' ' ' PRO . 98.1 t -94.36 138.29 22.48 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.581 0.705 . . . . 0.0 111.153 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.661 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.8 Cg_endo -69.77 128.41 15.97 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.649 2.233 . . . . 0.0 112.355 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.568 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 103.75 -6.26 48.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 78.3 t -98.14 108.55 22.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 0.0 111.122 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 43.5 p -64.89 -46.29 82.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.152 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -162.02 165.79 26.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.065 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 264' ' ' ILE . 58.3 mt -139.37 106.37 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.089 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -109.37 151.98 25.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.733 HD22 ' CZ ' ' A' ' 262' ' ' PHE . 7.8 tp -138.07 151.37 47.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.916 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.511 ' H ' HD12 ' A' ' 255' ' ' LEU . 3.6 t70 -112.89 124.37 52.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -89.49 -19.57 24.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.95 -27.39 39.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.836 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 60.3 p -121.69 -14.15 8.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 66.67 44.08 90.46 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.51 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.405 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 71.1 m -115.25 123.48 48.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 111.137 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.733 ' CZ ' HD22 ' A' ' 255' ' ' LEU . 11.3 m-85 -91.25 113.99 26.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -104.65 115.52 30.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.965 HG22 HG12 ' A' ' 272' ' ' VAL . 55.8 mt -108.32 140.36 27.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.183 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -121.25 122.16 39.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.568 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -143.46 152.73 24.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 22.9 mt-10 -71.77 -34.4 69.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.341 . . . . 0.0 110.858 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 21.5 p -125.76 132.08 52.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.553 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -43.0 -31.28 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.39 -43.7 98.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.568 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -60.3 -64.41 0.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.091 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.965 HG12 HG22 ' A' ' 264' ' ' ILE . 0.5 OUTLIER -52.77 -40.52 35.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.118 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -59.63 -55.81 29.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -58.49 -41.96 86.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.881 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.83 -24.14 61.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 18.3 ttt-85 -68.35 -45.11 73.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.67 -27.64 6.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.477 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -78.58 -36.82 43.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.37 . . . . 0.0 110.868 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.493 HD21 ' HA ' ' A' ' 241' ' ' ILE . 86.0 mt -88.33 -13.75 39.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.931 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 179.95 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.575 ' HB1' ' C ' ' A' ' 266' ' ' GLY . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.818 0.342 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -57.25 -39.54 75.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.04 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -111.6 135.33 52.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -133.32 138.01 46.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -115.34 127.17 55.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.554 ' CD ' ' CG2' ' A' ' 261' ' ' THR . 3.0 tp10 -132.73 119.62 20.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.931 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -140.52 153.16 46.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.47 122.62 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 19.1 t -104.59 146.23 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -53.52 173.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -89.79 -27.54 19.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -90.92 -30.98 16.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 64.2 mt -73.09 -18.74 61.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.434 ' CE ' HD11 ' A' ' 255' ' ' LEU . 2.3 mtt -47.13 -59.03 3.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -46.22 -43.22 13.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.497 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 36.7 mt -68.29 -63.27 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 110.889 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.444 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -45.08 -43.47 9.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.162 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 61.2 mt -73.91 -35.52 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.1 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 89.95 -158.06 26.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.511 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 237' ' ' HIS . 5.4 m -92.12 145.25 24.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.35 . . . . 0.0 111.132 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.43 ' C ' ' O ' ' A' ' 236' ' ' THR . 89.4 m-70 35.2 51.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 50.19 66.93 2.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 17.1 t -92.06 -68.95 0.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.862 0.363 . . . . 0.0 110.849 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.444 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 5.0 m120 -40.33 -67.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 240' ' ' ASN . 45.4 mt -36.5 -54.99 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -55.21 -48.63 73.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -58.45 -52.54 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -50.67 -39.14 50.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -71.91 -25.04 61.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -81.3 11.05 4.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.683 HG13 ' HD2' ' A' ' 248' ' ' PRO . 98.7 t -91.38 138.94 25.26 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.612 0.72 . . . . 0.0 111.128 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.683 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.8 Cg_endo -69.72 137.4 35.47 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.704 2.27 . . . . 0.0 112.34 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 97.93 -21.46 45.97 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.514 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 88.5 t -82.15 115.72 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.918 0.389 . . . . 0.0 111.086 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 265' ' ' TYR . 79.4 p -71.35 -48.39 50.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -158.85 169.43 24.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 264' ' ' ILE . 73.3 mt -145.42 109.72 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -110.97 163.22 14.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.65 HD13 ' CZ ' ' A' ' 262' ' ' PHE . 10.3 tp -140.88 153.98 45.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.607 ' H ' HD12 ' A' ' 255' ' ' LEU . 3.8 m-20 -121.03 119.28 32.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.831 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -86.12 -13.93 45.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -58.29 -52.85 63.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 37.3 p -119.18 -19.36 8.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 95.28 48.28 2.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.514 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.554 ' CG2' ' CD ' ' A' ' 222' ' ' GLU . 20.7 m -110.97 136.79 49.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 111.117 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.65 ' CZ ' HD13 ' A' ' 255' ' ' LEU . 11.6 m-85 -107.39 127.02 53.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ARG . . . . . 0.412 ' HG3' ' CD ' ' A' ' 222' ' ' GLU . 17.4 mtp180 -113.99 115.23 27.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.813 HG22 HG12 ' A' ' 272' ' ' VAL . 34.0 mt -107.18 142.64 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 251' ' ' THR . 79.1 m-85 -124.5 124.02 41.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.61 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -147.73 136.27 5.96 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.461 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 55.3 mt-10 -54.96 -41.75 71.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.87 0.367 . . . . 0.0 110.869 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 271' ' ' ALA . 38.3 m -122.24 136.26 54.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 271' ' ' ALA . . . -43.04 -59.65 1.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.139 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 269' ' ' ALA . 3.1 m-20 -36.51 -30.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 269' ' ' ALA . . . -75.07 -68.94 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.116 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.813 HG12 HG22 ' A' ' 264' ' ' ILE . 0.8 OUTLIER -51.8 -28.71 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.087 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.09 -51.17 22.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -60.35 -33.96 73.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -82.5 -30.69 29.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -58.56 -44.4 89.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.07 -27.39 5.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.504 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -79.04 -54.95 5.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.866 0.365 . . . . 0.0 110.829 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.707 HD12 HD11 ' A' ' 264' ' ' ILE . 67.4 mt -63.48 -22.14 66.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 179.942 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.408 ' HB1' ' C ' ' A' ' 266' ' ' GLY . . . . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.802 0.334 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -48.2 -39.05 19.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.622 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 75.9 m-85 -110.39 146.45 35.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.896 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -145.03 140.33 28.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -113.46 138.26 50.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.433 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 8.6 tt0 -143.0 116.94 9.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 29.6 p90 -142.23 139.22 31.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.02 123.6 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 56.0 t -111.72 136.35 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.551 ' HB2' HD12 ' A' ' 229' ' ' LEU . 23.6 mmt180 -54.05 142.96 23.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -58.5 -25.85 62.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.51 -43.53 22.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.551 HD12 ' HB2' ' A' ' 226' ' ' ARG . 23.6 mt -66.59 -32.02 73.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.517 ' CE ' HD11 ' A' ' 255' ' ' LEU . 3.2 mtt -36.83 -66.81 0.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -34.47 -61.8 0.54 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.496 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 235' ' ' GLY . 60.2 mt -60.11 -65.32 0.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' LEU . . . -37.62 -36.85 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.102 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.464 HG23 HG13 ' A' ' 241' ' ' ILE . 64.7 mt -83.02 -36.2 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 232' ' ' LEU . . . 96.58 -151.2 19.81 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 86.0 m -100.99 136.28 41.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.768 0.318 . . . . 0.0 111.16 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 2.7 m80 43.99 49.49 7.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 52.45 65.74 3.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 3.5 t -92.68 -65.65 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.861 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -43.64 -63.35 0.86 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.572 HG12 HD21 ' A' ' 279' ' ' LEU . 33.7 mt -39.71 -52.11 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.096 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -54.05 -51.17 64.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -54.59 -48.13 72.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -54.69 -48.05 72.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.092 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -65.91 -29.66 70.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -72.17 -1.33 14.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.685 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.2 t -82.39 138.88 44.71 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.657 0.741 . . . . 0.0 111.142 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.685 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.7 Cg_endo -69.76 148.43 65.09 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.671 2.247 . . . . 0.0 112.355 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 89.26 -26.8 8.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 87.6 t -74.4 105.5 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.931 0.396 . . . . 0.0 111.11 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 34.7 p -60.52 -49.41 77.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.25 162.92 33.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.089 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.563 HG12 HG23 ' A' ' 264' ' ' ILE . 24.4 mt -134.05 106.42 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -107.74 155.7 19.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.517 HD11 ' CE ' ' A' ' 230' ' ' MET . 6.1 tp -141.64 150.54 42.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -108.16 141.53 39.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -103.57 -20.15 14.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -76.76 -36.46 57.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.7 p -115.02 -22.76 9.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.154 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 77.58 47.0 9.19 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.449 ' O ' HD12 ' A' ' 255' ' ' LEU . 48.6 m -112.89 135.54 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 111.191 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.533 ' HB2' ' CE2' ' A' ' 223' ' ' PHE . 12.9 m-85 -98.73 115.68 29.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -105.89 114.48 28.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.917 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.965 HG22 HG12 ' A' ' 272' ' ' VAL . 34.5 mt -108.91 132.0 58.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.141 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -111.22 126.4 54.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.644 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -147.24 143.61 11.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.453 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.34 -34.8 74.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.925 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 14.2 m -133.24 131.43 40.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.622 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -40.73 -38.56 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.112 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.49 -43.16 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.873 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.09 -68.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.965 HG12 HG22 ' A' ' 264' ' ' ILE . 1.2 m -49.38 -30.54 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -67.94 -52.46 35.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -56.72 -41.23 77.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.64 -41.77 62.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.081 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -50.34 -39.92 47.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.835 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -53.79 -23.36 21.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.535 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -82.14 -36.84 27.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.362 . . . . 0.0 110.898 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.572 HD21 HG12 ' A' ' 241' ' ' ILE . 69.0 mt -91.08 16.92 8.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 179.883 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.796 0.331 . . . . 0.0 111.064 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.44 -30.71 61.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 1.076 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 58.9 m-85 -117.62 138.36 52.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -139.17 147.71 42.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -121.84 144.88 48.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -147.27 112.21 5.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -136.17 147.62 47.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 37.4 t -101.18 122.95 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.157 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 99.6 t -108.21 136.34 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.46 ' O ' ' N ' ' A' ' 229' ' ' LEU . 37.7 mtt-85 -54.15 122.44 10.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -42.1 -32.04 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -74.94 -37.5 61.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 226' ' ' ARG . 51.5 mt -74.87 -30.01 61.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.462 ' HE3' HD11 ' A' ' 255' ' ' LEU . 4.0 mmt -37.26 -61.51 0.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.0 -53.48 2.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 35.6 mt -67.04 -54.61 19.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.815 0.34 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.443 ' O ' ' ND2' ' A' ' 240' ' ' ASN . . . -43.06 -48.85 6.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.571 HG22 ' HA2' ' A' ' 238' ' ' GLY . 38.8 mt -71.49 -34.6 53.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.095 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 94.21 -145.97 17.93 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.474 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 237' ' ' HIS . 0.0 OUTLIER -99.84 140.26 34.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.86 0.362 . . . . 0.0 111.104 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 236' ' ' THR . 8.1 m170 36.76 42.59 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.571 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 59.72 65.6 3.31 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.493 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 27.2 t -93.54 -59.58 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.82 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 233' ' ' ALA . 2.4 m120 -47.16 -57.86 4.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.904 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.706 HG12 HD21 ' A' ' 279' ' ' LEU . 27.2 mt -45.01 -53.46 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.159 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -46.97 -64.77 0.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -42.36 -45.34 4.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.56 98.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.077 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -72.32 -12.71 61.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.902 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -95.99 8.46 43.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.588 HG13 ' HD2' ' A' ' 248' ' ' PRO . 84.2 t -86.93 136.69 33.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.597 0.713 . . . . 0.0 111.159 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.588 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.1 Cg_endo -69.86 130.06 18.58 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.66 2.24 . . . . 0.0 112.319 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.43 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 102.21 -9.13 56.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.452 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 45.9 t -91.62 99.3 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.886 0.374 . . . . 0.0 111.137 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.7 p -55.34 -49.46 72.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -159.36 170.02 22.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.498 HG12 HG23 ' A' ' 264' ' ' ILE . 56.8 mt -144.2 106.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -101.89 155.42 18.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.705 HD22 ' CE1' ' A' ' 262' ' ' PHE . 2.5 tp -138.76 122.44 17.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.52 ' N ' HD12 ' A' ' 255' ' ' LEU . 19.1 m-20 -93.42 102.32 14.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.49 -33.06 68.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -43.35 -46.72 6.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.857 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 11.1 p -122.75 -9.89 8.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 256' ' ' ASP . . . 79.2 56.61 3.4 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.52 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 25.2 m -117.95 112.84 20.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.849 0.357 . . . . 0.0 111.153 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.705 ' CE1' HD22 ' A' ' 255' ' ' LEU . 9.9 m-85 -85.01 114.25 22.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -106.58 123.32 47.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.984 HG22 HG12 ' A' ' 272' ' ' VAL . 6.3 mt -109.53 146.46 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -128.12 118.5 23.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.675 ' O ' ' HB1' ' A' ' 217' ' ' ALA . . . -142.23 155.73 25.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -71.95 -25.22 61.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.873 0.368 . . . . 0.0 110.874 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 270' ' ' ASP . 2.3 m -141.75 132.23 25.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 1.076 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -40.12 -27.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.096 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 268' ' ' SER . 0.8 OUTLIER -62.13 -46.65 88.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.43 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -61.38 -64.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.115 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.984 HG12 HG22 ' A' ' 264' ' ' ILE . 0.9 OUTLIER -51.29 -35.45 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.111 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 269' ' ' ALA . 19.0 mtpp -63.06 -53.55 51.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -56.81 -39.57 74.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.933 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.37 -41.93 69.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.524 ' HB2' HD12 ' A' ' 264' ' ' ILE . 39.5 ttp180 -59.06 -27.55 65.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -67.84 -6.9 46.66 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.459 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -101.37 -32.52 10.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 0.0 110.891 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.706 HD21 HG12 ' A' ' 241' ' ' ILE . 40.8 mt -86.29 0.94 52.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 179.945 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.803 0.335 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.04 -38.78 68.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.07 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.802 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 39.2 m-85 -111.08 139.38 46.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -135.4 151.84 50.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -132.88 146.29 51.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.462 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 7.3 tm-20 -152.3 116.7 5.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -137.95 153.62 49.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.481 HG22 ' OG1' ' A' ' 261' ' ' THR . 38.6 t -102.06 121.5 53.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.89 140.98 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.137 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.411 ' HB2' HD12 ' A' ' 229' ' ' LEU . 82.3 mtt180 -56.51 127.08 29.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -50.8 -21.86 1.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.64 -42.25 18.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.831 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 226' ' ' ARG . 65.9 mt -77.86 -16.17 58.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.55 ' CE ' HD11 ' A' ' 255' ' ' LEU . 5.3 mmt -45.25 -67.73 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.844 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.13 -58.29 1.97 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.501 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 235' ' ' GLY . 50.5 mt -55.31 -62.88 1.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.806 0.336 . . . . 0.0 110.931 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -42.33 -45.69 4.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.683 HG23 HG13 ' A' ' 241' ' ' ILE . 54.9 mt -73.39 -29.28 27.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.137 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 232' ' ' LEU . . . 93.75 -162.35 25.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.513 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 67.9 p -96.68 123.82 40.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.155 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 60.25 37.66 20.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.43 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 61.54 63.21 5.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.435 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 5.5 t -92.55 -58.29 2.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.907 0.384 . . . . 0.0 110.843 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -50.06 -53.23 28.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.683 HG13 HG23 ' A' ' 234' ' ' ILE . 14.4 mt -49.76 -49.12 20.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -50.31 -63.46 1.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -48.31 -41.59 28.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.39 -52.94 63.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -62.65 -12.12 21.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -96.02 11.8 32.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.683 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.0 t -91.3 138.91 25.39 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.617 0.722 . . . . 0.0 111.127 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.683 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.76 139.4 40.12 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.677 2.251 . . . . 0.0 112.381 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 96.2 -24.19 31.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.454 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 86.0 t -77.88 109.89 12.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 30.0 p -67.47 -49.8 61.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.154 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.14 153.6 22.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.494 HG12 HG23 ' A' ' 264' ' ' ILE . 22.4 mt -128.81 112.38 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -112.35 153.67 26.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.709 HD22 ' CE1' ' A' ' 262' ' ' PHE . 11.1 tp -137.79 109.42 7.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.959 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.44 92.29 3.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.93 -25.43 68.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.874 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -43.8 -49.57 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 2.3 p -116.83 -29.28 6.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.127 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 107.78 43.86 1.28 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.434 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.481 ' OG1' HG22 ' A' ' 224' ' ' VAL . 6.5 m -110.79 133.42 53.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 111.117 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.709 ' CE1' HD22 ' A' ' 255' ' ' LEU . 10.5 m-85 -99.59 113.97 26.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.5 mtt-85 -103.69 113.93 27.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.844 HG22 HG12 ' A' ' 272' ' ' VAL . 9.3 mt -109.25 136.54 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.096 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -120.58 123.57 43.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.569 ' O ' ' HB1' ' A' ' 217' ' ' ALA . . . -142.7 151.13 22.84 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.515 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.95 -27.39 66.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 12.1 m -138.14 132.68 32.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.861 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.802 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -41.24 -35.24 0.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -55.55 -46.88 77.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.507 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -59.05 -67.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.844 HG12 HG22 ' A' ' 264' ' ' ILE . 1.5 m -51.61 -34.22 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -65.05 -49.6 69.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -66.0 -36.34 83.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -75.54 -30.86 59.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -60.37 -47.67 85.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -45.53 -27.8 2.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -78.85 -41.7 29.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.873 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.502 HD22 ' CE1' ' A' ' 262' ' ' PHE . 88.6 mt -80.21 -13.8 58.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.923 179.926 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.798 0.332 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -63.52 -42.6 98.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.1 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.784 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 53.2 m-85 -109.31 143.46 38.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -140.49 137.09 33.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -111.59 143.2 42.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -148.45 112.46 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.914 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.429 ' O ' HG23 ' A' ' 261' ' ' THR . 11.9 p90 -137.77 149.51 46.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.54 HG22 ' OG1' ' A' ' 261' ' ' THR . 20.0 t -95.37 120.98 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.17 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.2 t -103.46 137.14 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -54.94 126.99 26.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -53.95 -22.0 9.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -86.59 -23.66 25.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 37.7 mt -95.33 -12.68 25.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.637 ' CE ' HD11 ' A' ' 255' ' ' LEU . 4.8 mmt -47.1 -60.48 2.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -47.53 -50.83 17.84 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.513 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 49.5 mt -57.56 -55.96 28.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.814 0.34 . . . . 0.0 110.919 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.42 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -52.59 -52.31 55.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.114 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 70.9 mt -61.02 -24.33 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.6 -154.89 34.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.461 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 237' ' ' HIS . 23.9 m -92.93 138.13 31.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 111.153 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 236' ' ' THR . 9.5 m170 37.07 54.46 1.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 50.83 56.73 12.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.484 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 30.2 t -84.96 -60.7 1.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.855 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.42 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 4.4 m120 -49.39 -62.57 1.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 48.2 mt -39.48 -46.44 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.166 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -59.06 -52.92 63.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -54.66 -43.0 72.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.968 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.26 -45.17 95.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.436 ' HA ' HD12 ' A' ' 253' ' ' ILE . 36.0 ttt180 -68.0 -16.38 64.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -91.03 19.82 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.669 HG13 ' HD2' ' A' ' 248' ' ' PRO . 86.4 t -98.28 138.75 20.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.666 0.746 . . . . 0.0 111.125 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.669 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.3 Cg_endo -69.75 131.97 22.38 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.271 . . . . 0.0 112.338 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.12 -22.59 36.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 79.6 t -79.63 108.45 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.373 . . . . 0.0 111.124 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 63.3 p -64.64 -50.91 65.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.09 165.46 36.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.62 HG12 HG23 ' A' ' 264' ' ' ILE . 48.2 mt -139.65 111.95 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -112.87 159.51 18.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.637 HD11 ' CE ' ' A' ' 230' ' ' MET . 15.4 tp -135.83 138.32 42.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -108.69 112.19 24.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -80.15 -35.38 36.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -42.18 -40.58 2.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 78.0 p -124.58 -25.97 3.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 93.68 37.26 5.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.54 ' OG1' HG22 ' A' ' 224' ' ' VAL . 82.4 m -106.81 118.37 36.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 111.169 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.605 ' CE1' HD13 ' A' ' 255' ' ' LEU . 11.1 m-85 -81.15 132.36 35.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -116.57 118.31 32.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.916 HG22 HG12 ' A' ' 272' ' ' VAL . 7.1 mt -112.66 139.44 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -120.9 130.37 53.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.477 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -154.87 146.77 15.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.443 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 32.6 mm-40 -62.35 -33.63 75.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 110.882 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 47.4 m -128.91 132.09 47.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.784 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -44.91 -37.95 4.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.115 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -53.59 -37.76 63.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.853 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -68.01 -65.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.916 HG12 HG22 ' A' ' 264' ' ' ILE . 1.0 OUTLIER -55.15 -29.95 23.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.141 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -66.25 -53.52 35.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.934 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -57.81 -43.65 85.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.56 -32.86 70.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 34.9 ttp85 -55.04 -48.47 73.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -45.92 -32.06 4.45 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.428 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -73.01 -49.24 30.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.841 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.554 HD12 HD11 ' A' ' 264' ' ' ILE . 94.1 mt -71.15 -9.33 57.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.918 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 41.3 t -45.09 153.12 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.394 . . . . 0.0 110.871 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 66.3 m -97.04 152.92 18.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.862 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 154.84 47.19 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.512 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 17.2 t -81.16 164.46 22.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.882 0.372 . . . . 0.0 110.83 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 75.7 m -126.38 -45.79 1.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.849 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 163.45 -159.53 32.14 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.478 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 81.8 p -120.74 125.43 47.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 111.174 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -62.35 -44.95 95.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -116.78 138.02 51.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 23.9 mt -48.17 -58.66 4.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.22 177.66 8.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . -106.76 122.93 47.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.084 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -57.16 -37.31 71.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.077 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 1.084 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 45.0 m-85 -114.55 139.63 49.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.851 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -138.97 137.31 36.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -113.43 127.39 56.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.409 ' CD ' ' O ' ' A' ' 222' ' ' GLU . 4.9 tm-20 -135.21 111.97 10.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.522 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 14.9 p90 -139.87 158.17 44.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.584 HG22 ' OG1' ' A' ' 261' ' ' THR . 42.9 t -103.5 128.5 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 36.4 t -110.2 138.46 37.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 17.0 mtm-85 -56.85 128.49 37.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -55.6 -18.12 7.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -84.98 -31.85 23.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.863 HD13 ' HB2' ' A' ' 281' ' ' PHE . 59.8 mt -90.76 -23.32 20.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 25.3 mtp -45.99 -57.13 4.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.76 -61.81 1.53 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.492 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 60.1 mt -60.89 -43.68 98.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.881 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -52.0 -40.57 61.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.121 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 58.1 mt -78.63 -36.41 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 89.94 -155.16 24.36 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.521 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 237' ' ' HIS . 15.0 m -91.88 142.93 27.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.853 0.359 . . . . 0.0 111.156 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.437 ' C ' ' O ' ' A' ' 236' ' ' THR . 9.5 m170 35.2 48.28 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.48 ' O ' ' NE2' ' A' ' 242' ' ' GLN . . . 55.67 59.19 10.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.463 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.0 t -80.83 -63.54 1.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.846 0.355 . . . . 0.0 110.862 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 4.9 m120 -46.84 -61.02 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 31.7 mt -44.1 -61.45 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.087 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.49 ' OE1' ' N ' ' A' ' 242' ' ' GLN . 0.0 OUTLIER -43.8 -44.58 6.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.926 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -63.92 -52.38 60.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -49.57 -38.75 32.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 17.2 ttt-85 -72.19 -21.96 61.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.84 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -81.22 7.36 11.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.682 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.4 t -91.93 138.94 24.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.628 0.728 . . . . 0.0 111.136 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.682 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.3 Cg_endo -69.72 154.25 68.13 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.264 . . . . 0.0 112.407 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.43 -11.68 43.58 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.472 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 95.8 t -90.03 109.85 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.892 0.377 . . . . 0.0 111.136 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 68.5 p -67.92 -50.97 52.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.132 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -156.56 171.01 21.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.593 HG12 HG23 ' A' ' 264' ' ' ILE . 82.4 mt -143.89 110.77 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -111.21 151.96 27.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 256' ' ' ASP . 10.9 tp -131.0 134.98 47.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.579 ' N ' HD12 ' A' ' 255' ' ' LEU . 1.3 m-20 -105.35 110.4 22.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -78.79 -37.14 41.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -43.07 -40.98 3.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 77.2 p -122.78 -22.67 5.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 256' ' ' ASP . . . 86.99 45.44 5.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.483 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.584 ' OG1' HG22 ' A' ' 224' ' ' VAL . 85.3 m -112.74 119.13 37.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 111.116 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.644 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.8 m-85 -81.76 120.87 25.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -110.47 111.78 23.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.823 HG22 HG12 ' A' ' 272' ' ' VAL . 8.6 mt -105.16 145.11 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -125.74 120.35 30.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.598 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -145.29 144.06 12.61 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.486 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 86.4 mt-10 -59.1 -30.19 67.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 0.0 110.868 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 57.9 m -134.37 136.36 43.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 1.084 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -49.34 -33.85 14.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.079 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.81 -38.23 69.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.78 -67.47 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.073 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.823 HG12 HG22 ' A' ' 264' ' ' ILE . 1.3 m -48.51 -30.34 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.184 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -68.98 -52.72 25.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -57.09 -40.03 76.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -74.06 -37.17 64.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.115 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.522 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 27.0 ttt180 -52.45 -42.12 63.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -51.18 -30.85 25.32 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -74.16 -38.94 63.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.644 HD22 ' CE1' ' A' ' 262' ' ' PHE . 96.3 mt -79.84 -23.51 41.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.965 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -50.04 148.83 3.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.863 ' HB2' HD13 ' A' ' 229' ' ' LEU . 8.3 p90 -68.22 149.53 49.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.841 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.481 ' O ' HD22 ' A' ' 229' ' ' LEU . 60.0 t -128.5 134.54 64.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -63.65 148.64 48.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.96 111.6 0.87 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -109.37 141.83 41.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 48.6 mm -123.39 99.45 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -110.12 112.27 24.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 30.7 m -87.06 144.28 36.16 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 0.0 111.148 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -5.98 17.52 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.656 2.237 . . . . 0.0 112.314 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 86.1 p 40.67 51.59 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.863 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 133.02 81.02 0.18 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.52 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 97.77 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.682 2.255 . . . . 0.0 112.36 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 17.2 m -75.71 118.24 18.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 86.7 p -78.4 -46.33 20.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.855 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.47 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 55.6 m -159.89 176.63 11.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 0.0 110.838 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.4 m -156.83 140.12 15.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.842 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 138.46 -168.36 24.7 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.502 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.7 t -85.96 161.11 19.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 110.848 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 79.1 p -93.77 168.52 10.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.828 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -174.0 140.08 5.31 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.508 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 14.7 t -91.81 134.02 35.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.371 . . . . 0.0 111.096 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -132.18 168.28 18.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -126.9 40.13 3.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.919 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 216' ' ' ALA . 4.5 mm? -77.76 105.88 9.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 215' ' ' LEU . . . -34.81 144.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.483 ' HB1' ' N ' ' A' ' 266' ' ' GLY . . . -85.14 117.56 24.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.101 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.71 -47.73 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.079 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.846 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 61.0 m-85 -103.87 137.02 42.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -136.22 137.43 40.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -114.47 130.25 56.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.441 ' C ' ' CD ' ' A' ' 222' ' ' GLU . 1.8 tm-20 -133.21 118.63 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.418 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 16.0 p90 -141.86 149.1 39.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 40.4 t -98.9 124.43 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 80.4 t -111.44 137.07 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.105 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 28.0 mtp180 -55.63 126.82 27.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -49.44 -22.68 1.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -77.08 -46.57 23.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.761 HD13 ' HB2' ' A' ' 281' ' ' PHE . 53.7 mt -73.02 -31.69 64.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.611 ' HE1' HD11 ' A' ' 255' ' ' LEU . 19.5 mtp -37.08 -64.38 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.899 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -38.17 -48.08 2.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.62 -50.84 32.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.857 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -50.04 -40.47 45.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.101 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.567 HG23 HG13 ' A' ' 241' ' ' ILE . 54.4 mt -78.25 -36.17 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 99.63 -147.93 18.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 236' ' ' THR . 12.0 t -109.06 119.09 38.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 111.127 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 64.26 38.26 8.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.464 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 64.31 59.34 8.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.47 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.4 t -87.67 -69.76 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 3.6 m120 -43.71 -55.39 4.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.658 HG12 HD21 ' A' ' 279' ' ' LEU . 21.7 mt -49.27 -52.11 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -50.24 -53.18 30.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.482 ' NE2' ' N ' ' A' ' 243' ' ' GLN . 0.3 OUTLIER -55.54 -39.62 70.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.955 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.36 94.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.063 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.623 ' HG3' HD12 ' A' ' 253' ' ' ILE . 44.0 mtp180 -69.47 -17.96 63.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -85.75 12.72 8.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.678 HG13 ' HD2' ' A' ' 248' ' ' PRO . 98.9 t -93.16 138.89 22.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 0.0 111.16 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.678 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.2 Cg_endo -69.83 131.68 21.65 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.705 2.27 . . . . 0.0 112.305 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 98.29 -9.42 63.02 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.517 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 74.2 t -88.65 108.05 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 43.8 p -64.92 -53.1 51.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -158.98 161.47 36.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.106 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.623 HD12 ' HG3' ' A' ' 245' ' ' ARG . 38.8 mt -134.09 96.43 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -94.44 157.35 16.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.611 HD11 ' HE1' ' A' ' 230' ' ' MET . 4.0 tp -141.38 129.02 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.941 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -83.81 96.7 8.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.67 3.09 6.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -93.3 -48.19 6.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.1 p -108.28 -22.51 12.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 89.91 52.64 2.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 31.6 m -122.64 122.73 39.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 0.0 111.093 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.462 ' CE1' HD22 ' A' ' 255' ' ' LEU . 18.4 m-85 -89.57 116.85 28.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -109.08 116.0 31.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.768 HG22 HG12 ' A' ' 272' ' ' VAL . 5.9 mt -104.25 146.72 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.139 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -128.88 127.07 41.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.483 ' N ' ' HB1' ' A' ' 217' ' ' ALA . . . -150.19 147.99 18.75 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.508 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.24 -21.72 66.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.917 0.389 . . . . 0.0 110.892 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 2.1 m -145.34 140.22 27.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.858 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.846 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.21 -30.92 3.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.052 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.27 -38.86 81.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.838 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.472 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -68.96 -65.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.083 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.768 HG12 HG22 ' A' ' 264' ' ' ILE . 0.2 OUTLIER -50.4 -38.65 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -60.87 -53.13 61.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.504 ' HB3' HG11 ' A' ' 247' ' ' VAL . 19.4 tttt -56.35 -40.98 75.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.94 -33.34 70.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.146 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.418 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 36.7 ttp180 -59.7 -43.94 93.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.848 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -52.42 -15.57 2.94 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.445 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -92.78 -33.73 14.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 0.0 110.876 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.658 HD21 HG12 ' A' ' 241' ' ' ILE . 88.3 mt -87.08 7.29 28.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -58.34 155.14 12.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.761 ' HB2' HD13 ' A' ' 229' ' ' LEU . 26.8 p90 -84.33 129.67 34.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.41 130.39 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.132 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -64.59 158.6 23.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.42 106.0 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.848 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -88.47 142.23 27.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 5.4 mp -106.75 98.6 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.123 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -89.78 154.02 20.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 24.0 m -74.27 144.35 81.38 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.625 0.726 . . . . 0.0 111.136 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 87.14 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.683 2.256 . . . . 0.0 112.34 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 18.6 m -146.0 120.61 9.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 145.86 147.16 4.54 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.452 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -18.04 37.05 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.662 2.241 . . . . 0.0 112.314 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 77.1 p -44.09 145.3 0.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.882 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 43.8 t -146.75 133.13 19.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.471 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.4 t -111.65 159.3 18.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 0.0 110.833 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 25.5 t -103.7 119.28 38.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.08 106.11 0.19 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.507 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.4 m -146.65 175.16 10.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 0.0 110.845 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 30.5 p -112.11 140.49 46.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.906 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -111.29 53.79 0.57 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.477 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 24.8 p -137.74 155.71 48.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.92 0.39 . . . . 0.0 111.136 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 22.8 mmtm -103.14 142.65 33.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -118.44 -178.44 3.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.874 ' O ' HD22 ' A' ' 215' ' ' LEU . 0.0 OUTLIER -130.5 8.85 5.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -137.76 165.71 25.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -92.39 114.01 26.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -65.56 -41.24 93.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.099 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.631 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 88.3 m-85 -110.96 133.72 53.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.864 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -132.41 132.43 42.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -112.67 151.49 30.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.856 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -152.39 123.99 7.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.449 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 18.5 p90 -142.79 140.68 31.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.592 HG22 ' OG1' ' A' ' 261' ' ' THR . 24.3 t -93.4 122.68 45.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 82.7 t -111.23 137.77 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.137 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.445 ' HB2' HD12 ' A' ' 229' ' ' LEU . 62.0 mtt180 -54.81 127.59 29.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -41.85 -45.27 3.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.848 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -62.78 -37.72 87.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.461 ' CD2' ' HA ' ' A' ' 283' ' ' GLU . 60.6 mt -72.94 -37.84 67.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.888 ' CE ' HD11 ' A' ' 255' ' ' LEU . 27.0 mtp -37.52 -60.62 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -36.13 -61.41 0.8 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 54.0 mt -60.92 -47.07 88.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.938 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -50.17 -41.65 49.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.058 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.407 HG23 HG13 ' A' ' 241' ' ' ILE . 59.4 mt -79.41 -27.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 88.81 -137.63 14.35 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.482 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 4.5 t -112.59 136.63 51.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.804 0.335 . . . . 0.0 111.125 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 27.4 m80 42.13 45.18 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 60.19 65.04 3.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.5 t -91.58 -69.3 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.874 0.369 . . . . 0.0 110.85 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -42.88 -55.26 3.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.407 HG13 HG23 ' A' ' 234' ' ' ILE . 52.4 mt -47.94 -55.45 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.104 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -47.64 -55.8 8.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -50.39 -58.63 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.42 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -45.6 -48.57 14.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -64.59 -24.13 67.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -82.83 17.05 1.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.684 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.5 t -100.44 138.89 20.28 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.616 0.722 . . . . 0.0 111.097 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.684 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.71 137.95 36.82 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.723 2.282 . . . . 0.0 112.358 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 95.67 -12.6 67.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 81.8 t -89.45 104.87 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.898 0.38 . . . . 0.0 111.139 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 71.1 p -60.1 -50.5 73.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.15 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.17 169.84 22.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.07 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.572 HG12 HG23 ' A' ' 264' ' ' ILE . 81.4 mt -141.84 113.96 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.149 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -113.21 160.67 18.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.888 HD11 ' CE ' ' A' ' 230' ' ' MET . 12.1 tp -141.84 108.84 5.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.13 112.89 13.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -80.86 -37.63 29.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -38.96 -42.36 0.85 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 32.0 p -120.34 -21.59 6.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 88.82 51.72 2.97 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.482 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.592 ' OG1' HG22 ' A' ' 224' ' ' VAL . 96.2 m -119.44 136.34 54.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 111.124 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.696 ' CE1' HD22 ' A' ' 279' ' ' LEU . 12.3 m-85 -95.15 125.02 39.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 -114.13 111.05 20.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.572 HG23 HG12 ' A' ' 253' ' ' ILE . 6.7 mt -105.02 135.48 42.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.138 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -116.27 126.55 53.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.541 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -148.42 141.12 8.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.505 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 65.2 mt-10 -59.71 -33.63 71.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 110.856 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.1 m -128.8 136.79 50.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.631 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.32 -29.33 2.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.079 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.04 -39.88 93.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -68.46 -62.62 1.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.541 HG13 ' HA3' ' A' ' 266' ' ' GLY . 0.1 OUTLIER -52.18 -31.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.171 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -70.85 -50.44 35.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.934 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -59.75 -44.59 93.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.42 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -66.64 -35.64 80.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -59.44 -37.57 78.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -56.83 -13.11 7.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.438 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -95.1 -25.49 16.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.883 0.373 . . . . 0.0 110.839 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.696 HD22 ' CE1' ' A' ' 262' ' ' PHE . 76.8 mt -98.74 0.96 45.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -50.88 139.75 16.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.877 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.441 ' CD2' ' O ' ' A' ' 281' ' ' PHE . 30.2 p90 -68.35 118.62 11.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 84.7 t -121.2 127.26 75.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.174 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.461 ' HA ' ' CD2' ' A' ' 229' ' ' LEU . 2.3 pp20? -95.09 154.35 17.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 283' ' ' GLU . 1.3 p30 -36.15 97.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 283' ' ' GLU . 12.8 p90 -84.4 141.53 30.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 47.0 mt -125.2 96.46 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.114 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -114.45 136.86 52.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 16.0 m -115.58 144.42 32.44 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.608 0.718 . . . . 0.0 111.126 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -32.32 18.95 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.271 . . . . 0.0 112.374 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 53.9 m -94.54 89.11 5.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -130.79 -95.07 0.69 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.524 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 293' ' ' SER . 53.8 Cg_endo -69.78 94.51 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.683 2.255 . . . . 0.0 112.337 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 292' ' ' PRO . 1.9 m 37.26 37.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.1 t -84.15 148.4 26.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.839 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.496 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 34.1 p -147.28 108.09 4.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 110.836 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.5 t -72.93 -60.31 2.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -72.64 -150.8 1.27 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.467 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 8.2 t -144.58 175.87 9.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.833 0.349 . . . . 0.0 110.886 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 24.8 p -166.97 172.64 10.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 152.61 77.64 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 75.8 p -136.03 126.49 26.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.845 0.355 . . . . 0.0 111.14 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.6 ptpt -155.02 157.18 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -172.19 161.41 5.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.977 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 78.4 mt -51.5 -45.43 62.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.86 174.39 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.058 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.425 ' HB1' ' N ' ' A' ' 266' ' ' GLY . . . -107.01 114.54 28.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.67 83.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.072 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -104.82 140.78 37.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -130.52 153.38 48.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -132.68 136.72 46.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.83 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.495 ' CG ' ' HG2' ' A' ' 263' ' ' ARG . 3.5 mt-10 -145.74 116.41 7.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.894 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -139.2 147.3 41.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.423 HG22 ' OG1' ' A' ' 261' ' ' THR . 15.2 t -94.81 116.92 37.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.172 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.499 HG13 ' HB3' ' A' ' 281' ' ' PHE . 73.5 t -98.25 147.42 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -58.74 124.97 21.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -53.89 -16.23 1.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.931 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.8 -38.75 15.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.81 HD13 ' HB2' ' A' ' 281' ' ' PHE . 69.9 mt -79.64 -29.03 40.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.417 ' CE ' HD11 ' A' ' 255' ' ' LEU . 19.8 mtp -37.42 -66.62 0.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -38.34 -46.74 2.02 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.51 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 56.8 mt -69.84 -57.05 5.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.761 ' HB2' ' HA ' ' A' ' 281' ' ' PHE . . . -45.06 -38.47 4.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.412 HG23 HG13 ' A' ' 241' ' ' ILE . 71.4 mt -77.27 -35.45 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 92.64 -145.98 17.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.487 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' HIS . 24.9 p -100.56 143.65 30.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 236' ' ' THR . 6.6 m80 34.77 41.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 61.89 61.35 6.81 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.432 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.6 m -86.83 -59.9 2.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.84 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -49.3 -54.68 15.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.412 HG13 HG23 ' A' ' 234' ' ' ILE . 18.2 mt -48.02 -52.85 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -52.29 -44.59 65.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -60.45 -50.88 71.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -53.86 -36.2 62.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.058 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -74.61 -11.94 60.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -93.97 15.11 17.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.676 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.5 t -96.98 138.91 21.29 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.614 0.721 . . . . 0.0 111.126 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.676 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.5 Cg_endo -69.83 144.94 55.21 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.641 2.227 . . . . 0.0 112.323 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 91.37 -19.65 45.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 91.4 t -84.46 112.59 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.957 0.408 . . . . 0.0 111.155 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 217' ' ' ALA . 41.8 p -68.86 -46.78 67.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -162.12 166.09 26.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.098 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.549 HG12 HG23 ' A' ' 264' ' ' ILE . 91.4 mt -140.5 115.65 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.121 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -117.76 154.39 31.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.469 HD12 ' H ' ' A' ' 256' ' ' ASP . 11.5 tp -130.77 147.13 52.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.469 ' H ' HD12 ' A' ' 255' ' ' LEU . 5.7 m-20 -107.85 136.07 48.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -101.34 -18.25 16.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -58.03 -49.17 77.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 63.3 p -123.68 -25.63 4.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.108 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 99.95 54.68 1.03 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.485 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.423 ' OG1' HG22 ' A' ' 224' ' ' VAL . 27.2 m -114.14 121.84 45.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.884 0.373 . . . . 0.0 111.127 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.708 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.9 m-85 -86.29 113.99 22.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ARG . . . . . 0.495 ' HG2' ' CG ' ' A' ' 222' ' ' GLU . 48.6 mtm180 -98.83 114.59 27.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 1.002 HG22 HG12 ' A' ' 272' ' ' VAL . 17.9 mt -111.08 133.07 57.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -113.91 122.95 48.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.634 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -146.12 143.82 12.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.5 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.35 -23.6 67.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 0.0 110.927 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 24.5 m -141.74 131.33 23.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.797 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -42.57 -34.27 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.122 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -55.72 -43.48 76.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.411 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -65.29 -68.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 1.002 HG12 HG22 ' A' ' 264' ' ' ILE . 1.0 OUTLIER -48.1 -31.82 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -67.2 -50.9 59.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -59.42 -40.12 85.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.56 -38.5 65.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -49.28 -46.88 46.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.41 -32.94 10.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.504 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -71.83 -42.03 67.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.871 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.708 HD22 ' CE1' ' A' ' 262' ' ' PHE . 97.1 mt -78.75 -13.27 59.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.92 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -59.97 142.96 52.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.81 ' HB2' HD13 ' A' ' 229' ' ' LEU . 7.4 p90 -67.56 142.17 56.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 89.8 t -121.8 132.23 71.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.146 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -59.56 140.33 56.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -50.07 126.44 14.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -105.12 141.58 36.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 72.9 mt -127.21 103.05 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.168 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -95.22 141.29 29.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.75 144.42 29.9 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.636 0.732 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 290' ' ' SER . 53.2 Cg_endo -69.78 2.83 3.2 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.653 2.235 . . . . 0.0 112.331 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 289' ' ' PRO . 40.1 t -34.58 -56.32 0.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.86 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 170.13 146.53 5.16 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -8.61 24.03 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.66 2.24 . . . . 0.0 112.338 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 2.0 m -60.06 -62.14 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.814 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 23.1 t -58.29 102.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.815 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.474 179.998 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 2.6 m -148.93 153.71 38.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.894 0.378 . . . . 0.0 110.858 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.8 m -123.12 170.33 10.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 134.9 91.38 0.37 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.45 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 11.7 m -132.56 97.35 4.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.904 0.383 . . . . 0.0 110.871 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 97.9 p -108.64 155.95 20.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 149.72 169.81 16.47 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.5 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.422 ' O ' ' NE2' ' A' ' 214' ' ' GLN . 20.2 m -141.13 125.25 17.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 111.158 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.0 tptt -58.9 116.81 4.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.422 ' NE2' ' O ' ' A' ' 212' ' ' THR . 1.6 mp0 -122.21 177.46 5.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 215' ' ' LEU . 4.2 mm? -97.71 58.05 1.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -164.57 -175.74 4.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -120.81 118.09 29.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -60.55 -33.76 73.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.82 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 79.8 m-85 -121.97 134.32 54.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.915 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -136.01 133.3 37.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -112.64 138.57 49.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.458 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 20.4 tt0 -141.6 125.3 16.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.515 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 11.8 p90 -142.4 149.66 39.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.847 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.62 115.5 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.16 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 41.4 t -104.94 136.57 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.109 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.411 ' HB2' HD12 ' A' ' 229' ' ' LEU . 51.5 mtp180 -54.4 133.94 45.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -50.91 -28.8 10.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -74.82 -39.69 61.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.857 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' A' ' 281' ' ' PHE . 53.4 mt -74.01 -27.11 60.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.796 ' CE ' HD11 ' A' ' 255' ' ' LEU . 8.5 mmm -41.5 -55.68 2.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -52.22 -40.24 52.13 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.566 HD22 ' CE2' ' A' ' 285' ' ' PHE . 44.1 mt -71.71 -58.62 3.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -52.02 -37.33 53.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.064 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 37.6 mt -77.03 -33.4 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.145 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 88.9 -150.93 21.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.429 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 236' ' ' THR . 9.9 t -103.03 123.92 47.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 0.0 111.139 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 18.7 m80 55.32 46.41 23.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 56.83 58.32 15.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.509 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.5 t -84.45 -57.67 3.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.361 . . . . 0.0 110.862 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 2.5 m120 -54.37 -57.62 10.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.728 HG12 HD21 ' A' ' 279' ' ' LEU . 70.7 mt -45.22 -49.58 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -51.92 -68.47 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -44.01 -35.3 2.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 241' ' ' ILE . . . -62.78 -51.67 66.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -66.96 -11.85 57.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -86.91 3.36 45.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.68 HG13 ' HD2' ' A' ' 248' ' ' PRO . 97.7 t -89.74 138.85 27.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 111.091 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.68 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.8 144.76 54.83 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.93 -14.75 62.51 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.462 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 93.8 t -88.97 103.1 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 0.0 111.153 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 64.9 p -56.9 -50.85 71.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -161.15 171.41 18.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 264' ' ' ILE . 49.4 mt -143.52 113.17 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.144 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -116.11 156.98 25.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.796 HD11 ' CE ' ' A' ' 230' ' ' MET . 7.8 tp -142.09 147.21 36.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.43 ' H ' HD12 ' A' ' 255' ' ' LEU . 5.2 t0 -103.97 135.57 45.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -100.22 -23.03 14.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -82.58 -22.03 35.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 68.1 p -120.74 -23.23 6.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 71.79 47.31 33.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.458 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 90.2 m -122.62 124.08 42.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.353 . . . . 0.0 111.174 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.677 ' CZ ' HD22 ' A' ' 255' ' ' LEU . 10.7 m-85 -87.14 123.07 31.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -113.39 115.95 28.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.691 HG22 HG12 ' A' ' 272' ' ' VAL . 7.1 mt -108.42 139.26 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.137 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -119.22 121.42 39.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.578 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -144.73 145.12 14.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.518 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 38.0 mt-10 -62.09 -33.34 74.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.891 0.377 . . . . 0.0 110.946 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.8 m -132.93 135.23 45.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.864 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.82 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -46.11 -26.94 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.118 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -60.87 -40.94 94.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.53 -64.36 0.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.137 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.691 HG12 HG22 ' A' ' 264' ' ' ILE . 0.2 OUTLIER -50.07 -31.08 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 269' ' ' ALA . 19.5 mtpp -68.99 -53.18 21.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.874 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -42.99 94.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.84 -33.89 76.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -61.37 -41.43 97.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.879 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.418 ' HA2' ' CG ' ' A' ' 280' ' ' GLU . . . -51.54 -20.02 5.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.478 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -85.32 -39.89 17.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.913 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.728 HD21 HG12 ' A' ' 241' ' ' ILE . 72.3 mt -87.24 6.16 34.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.418 ' CG ' ' HA2' ' A' ' 277' ' ' GLY . 7.6 mm-40 -53.25 149.62 7.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.516 ' HB2' HD13 ' A' ' 229' ' ' LEU . 39.0 p90 -75.28 119.94 20.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.487 ' O ' HD13 ' A' ' 232' ' ' LEU . 73.0 t -119.96 126.91 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.134 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.432 ' HG2' HD21 ' A' ' 229' ' ' LEU . 35.3 mt-10 -82.53 160.02 22.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -38.74 107.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' PHE . . . . . 0.566 ' CE2' HD22 ' A' ' 232' ' ' LEU . 37.7 p90 -99.97 136.92 39.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 286' ' ' ILE . 4.8 mp -119.75 101.4 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -116.95 142.16 47.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.895 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 16.8 m -114.57 145.61 34.21 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.624 0.726 . . . . 0.0 111.149 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 161.0 47.64 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.658 2.239 . . . . 0.0 112.363 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 2.0 t -148.22 133.24 18.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.838 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 84.52 -157.9 33.4 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.458 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.86 -31.76 19.44 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.637 2.225 . . . . 0.0 112.316 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 38.9 t -38.5 150.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 52.2 m -82.29 170.27 15.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.823 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.488 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 89.4 p -149.46 155.92 41.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 0.0 110.824 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 93.6 p -168.87 148.04 4.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.892 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.29 162.75 32.53 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.507 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -124.6 115.89 21.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.917 0.389 . . . . 0.0 110.848 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.5 m -136.1 172.9 12.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -80.88 113.1 3.57 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.47 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 7.7 t -131.79 154.96 48.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 0.0 111.147 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.08 136.05 55.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -131.23 163.76 27.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.956 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.22 -63.0 1.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -148.94 135.22 19.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.058 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -76.64 127.11 32.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.088 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -73.92 -30.12 62.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.09 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.876 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 68.1 m-85 -118.22 137.94 52.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.88 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -144.02 148.68 35.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -117.67 136.23 53.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -132.98 113.36 12.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 15.7 p90 -137.61 141.3 41.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.613 HG22 ' OG1' ' A' ' 261' ' ' THR . 59.2 t -92.62 120.17 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 53.5 t -103.47 136.07 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.456 ' HB2' HD12 ' A' ' 229' ' ' LEU . 2.9 mmp_? -53.38 130.94 36.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -52.78 -16.72 1.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -92.9 -36.34 12.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.456 HD12 ' HB2' ' A' ' 226' ' ' ARG . 88.4 mt -74.38 -23.52 59.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.655 ' CE ' HD11 ' A' ' 255' ' ' LEU . 4.6 mtt -41.14 -65.2 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.895 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -35.44 -56.3 0.96 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.468 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 235' ' ' GLY . 41.6 mt -63.95 -64.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -41.32 -28.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.152 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 60.1 mt -89.95 -34.43 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 232' ' ' LEU . . . 89.94 -149.97 20.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 237' ' ' HIS . 4.9 t -98.9 143.58 29.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 111.192 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.44 ' C ' ' O ' ' A' ' 236' ' ' THR . 27.3 m-70 34.85 45.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.841 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 60.31 60.08 9.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.49 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.4 t -84.43 -61.46 1.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.876 0.37 . . . . 0.0 110.852 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -48.51 -59.84 3.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 30.9 mt -42.62 -53.37 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -50.05 -67.9 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -39.92 -52.8 2.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -50.69 -48.16 58.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -69.28 -13.55 62.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.841 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -86.27 6.82 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.683 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.4 t -92.71 138.88 23.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.628 0.728 . . . . 0.0 111.119 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.683 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.76 149.95 67.6 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.709 2.273 . . . . 0.0 112.309 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.05 -19.24 31.48 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.505 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 265' ' ' TYR . 94.9 t -83.54 107.11 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.398 . . . . 0.0 111.129 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 59.1 p -60.2 -56.04 26.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.167 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -156.34 162.11 40.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.125 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.841 HG12 HG23 ' A' ' 264' ' ' ILE . 76.4 mt -135.14 107.05 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -107.13 163.27 13.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.655 HD11 ' CE ' ' A' ' 230' ' ' MET . 7.9 tp -141.06 141.98 34.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.933 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -100.33 129.7 46.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -100.31 -14.9 18.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -63.69 -38.72 92.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 54.5 p -128.81 -29.46 2.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.091 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.16 58.69 0.78 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.495 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.613 ' OG1' HG22 ' A' ' 224' ' ' VAL . 91.2 m -125.35 122.38 36.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 111.107 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.537 ' CZ ' HD22 ' A' ' 255' ' ' LEU . 11.1 m-85 -86.5 123.99 32.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -110.84 111.89 23.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.876 HG22 HG12 ' A' ' 272' ' ' VAL . 9.5 mt -104.44 141.02 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.407 ' O ' HG13 ' A' ' 250' ' ' VAL . 87.2 m-85 -121.63 131.28 54.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -154.29 143.63 10.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.481 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -58.22 -32.53 68.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 0.0 110.938 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.1 t -134.67 137.07 43.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.877 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.876 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.43 -28.87 2.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.134 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -42.53 84.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.74 -66.89 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.112 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.876 HG12 HG22 ' A' ' 264' ' ' ILE . 0.2 OUTLIER -48.76 -34.84 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 36.2 mttm -64.23 -50.75 66.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -63.32 -39.75 95.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.8 -29.62 62.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.466 ' CZ ' ' OE1' ' A' ' 280' ' ' GLU . 21.2 ttt-85 -60.7 -42.79 97.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.841 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.41 ' HA2' ' CG ' ' A' ' 280' ' ' GLU . . . -51.09 -24.93 9.64 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.491 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -80.36 -25.82 38.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 110.866 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.471 HD22 ' CE1' ' A' ' 262' ' ' PHE . 68.3 mt -102.16 11.39 38.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.466 ' OE1' ' CZ ' ' A' ' 276' ' ' ARG . 8.9 mm-40 -63.61 144.09 57.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.487 ' O ' ' CD1' ' A' ' 281' ' ' PHE . 46.8 p90 -69.86 120.22 15.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 94.1 t -119.89 126.78 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -74.0 166.71 22.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -63.77 122.96 17.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -108.25 119.95 40.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 27.7 mm -122.76 103.28 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -91.7 129.23 37.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.913 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 22.1 m -101.04 144.24 28.17 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.565 0.698 . . . . 0.0 111.123 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 110.61 2.6 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.626 2.218 . . . . 0.0 112.356 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 91.4 p -79.86 -44.3 20.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -78.59 150.9 35.32 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.501 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 138.21 37.37 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.669 2.246 . . . . 0.0 112.337 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 89.6 p -118.57 154.05 33.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 71.5 p -169.22 111.45 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.475 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 3.6 m -126.19 147.36 49.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.883 0.373 . . . . 0.0 110.892 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 89.2 p -132.98 118.99 19.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -109.34 -160.16 18.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.449 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.6 t -126.02 102.43 7.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.877 0.37 . . . . 0.0 110.831 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.3 m -84.09 162.55 20.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 155.73 -70.04 0.28 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 46.4 m -129.99 137.27 50.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.371 . . . . 0.0 111.143 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.48 150.46 8.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -109.57 177.13 4.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 43.5 mt -116.38 90.48 3.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -171.47 133.53 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.069 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -106.76 111.62 24.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.077 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.81 86.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.127 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.557 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 83.4 m-85 -108.02 142.29 38.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -133.06 140.46 47.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -111.55 141.85 44.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.418 ' C ' ' CD ' ' A' ' 222' ' ' GLU . 0.6 OUTLIER -148.94 111.31 4.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.837 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.528 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 34.0 p90 -140.9 151.42 44.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 20.0 t -96.52 134.34 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.123 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.709 HG13 ' HB3' ' A' ' 281' ' ' PHE . 69.0 t -118.61 137.38 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -57.02 130.07 44.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -57.7 -22.53 46.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -83.72 -19.54 35.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.718 HD13 ' HB2' ' A' ' 281' ' ' PHE . 30.9 mt -100.42 -18.07 16.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.557 ' CE ' HD11 ' A' ' 255' ' ' LEU . 4.8 mmt -45.02 -66.96 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -40.45 -40.59 2.03 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.511 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 40.9 mt -69.94 -55.99 8.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.834 0.35 . . . . 0.0 110.945 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.787 ' HB2' ' HA ' ' A' ' 281' ' ' PHE . . . -52.9 -38.43 61.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.045 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 25.7 mt -77.5 -37.8 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 95.16 -158.5 22.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.471 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 22.1 m -95.77 128.59 42.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 111.189 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 67.4 t60 52.67 46.34 26.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.831 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 53.76 67.95 1.89 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.511 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.8 t -92.8 -61.51 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 110.912 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -50.02 -60.58 2.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 19.2 mt -41.61 -49.06 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -54.53 -51.2 65.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -58.02 -37.63 74.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.94 96.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.444 ' HG3' HD12 ' A' ' 253' ' ' ILE . 5.9 mtp-105 -70.7 -0.91 9.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -104.98 12.88 31.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.654 HG13 ' HD2' ' A' ' 248' ' ' PRO . 84.9 t -95.16 138.63 21.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 111.142 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.654 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.7 Cg_endo -69.77 133.4 25.46 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.683 2.255 . . . . 0.0 112.331 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 96.74 -0.43 61.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 74.5 t -102.17 106.57 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 111.147 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 265' ' ' TYR . 35.9 p -63.0 -58.25 7.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -151.47 157.59 42.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.629 HG12 HG23 ' A' ' 264' ' ' ILE . 66.0 mt -130.37 114.17 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.148 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -118.38 149.12 41.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.557 HD11 ' CE ' ' A' ' 230' ' ' MET . 8.9 tp -127.56 147.7 50.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.944 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.532 ' H ' HD12 ' A' ' 255' ' ' LEU . 0.8 OUTLIER -112.84 118.92 36.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -84.74 -27.82 26.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -49.72 -40.5 40.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 62.0 p -125.25 -27.76 3.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.139 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 97.68 39.01 4.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 35.1 m -103.97 130.28 51.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 0.0 111.146 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.823 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.9 m-85 -93.58 116.6 29.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 53.5 mtt-85 -104.28 119.23 38.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.707 HG22 HG12 ' A' ' 272' ' ' VAL . 10.9 mt -115.49 143.32 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 251' ' ' THR . 88.9 m-85 -122.9 117.16 24.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.61 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -141.07 151.35 22.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.506 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -69.74 -26.51 64.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.2 p -132.71 132.79 42.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.21 -29.89 2.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.103 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.31 -35.71 81.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -69.79 -53.96 15.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.08 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.707 HG12 HG22 ' A' ' 264' ' ' ILE . 0.4 OUTLIER -63.11 -29.54 47.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -72.22 -51.32 21.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -55.53 -48.94 73.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.97 -34.36 76.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.528 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 45.9 ttt180 -53.88 -47.06 71.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -46.44 -26.12 2.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -79.53 -33.71 41.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.905 0.383 . . . . 0.0 110.884 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.823 HD22 ' CE1' ' A' ' 262' ' ' PHE . 92.9 mt -85.27 -17.23 37.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -62.78 141.33 58.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.787 ' HA ' ' HB2' ' A' ' 233' ' ' ALA . 8.4 p90 -62.34 144.59 55.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.881 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 62.9 t -127.23 127.69 69.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.114 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 284' ' ' ASP . 22.7 mp0 -54.51 145.83 17.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 283' ' ' GLU . 10.5 t0 -35.63 134.84 0.31 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -81.28 134.79 35.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 39.1 mt -108.12 98.34 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 43.9 tp60 -69.05 141.13 54.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.937 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 32.8 m -94.93 146.71 31.83 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.606 0.717 . . . . 0.0 111.142 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 109.91 2.43 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.673 2.249 . . . . 0.0 112.301 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 72.7 m -48.98 170.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -142.93 146.11 16.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -34.58 14.35 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.7 2.266 . . . . 0.0 112.295 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 96.9 p -54.01 136.21 41.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.832 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 12.0 t -75.05 -42.72 56.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.521 -179.964 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 6.3 t -161.97 144.51 11.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.89 0.376 . . . . 0.0 110.905 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.6 t -87.4 115.08 24.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 113.27 124.06 4.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.461 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.1 m -152.51 137.27 17.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.921 0.391 . . . . 0.0 110.857 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.824 ' O ' HG23 ' A' ' 212' ' ' THR . 3.3 t -51.35 127.88 20.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 210' ' ' SER . . . -34.85 108.67 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.457 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.824 HG23 ' O ' ' A' ' 210' ' ' SER . 34.4 p -123.99 170.02 11.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.171 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -124.24 94.62 4.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.9 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -108.12 131.19 54.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 12.9 tp -127.65 38.56 4.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -158.42 157.45 32.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.103 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . -110.99 132.07 54.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.091 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -66.83 -36.29 82.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.074 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.536 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 88.2 m-85 -112.56 141.01 46.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.912 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -140.89 138.73 34.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.853 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -113.93 138.62 50.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -139.12 121.36 15.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 12.9 p90 -142.33 143.14 32.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.94 119.73 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.31 134.73 50.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 229' ' ' LEU . 46.9 mtm180 -54.26 120.9 7.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -38.15 -28.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 226' ' ' ARG . 15.9 t0 -72.42 -44.36 62.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 281' ' ' PHE . 86.4 mt -74.14 -26.15 60.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.842 ' CE ' HD11 ' A' ' 255' ' ' LEU . 30.3 mtp -49.22 -58.91 4.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -36.47 -56.62 1.22 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.464 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 50.4 mt -67.78 -52.17 40.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -46.24 -34.59 4.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.087 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 56.4 mt -85.94 -32.44 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.128 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 93.78 -150.57 19.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.485 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 85.2 m -111.34 112.67 24.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 111.129 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 73.73 35.03 0.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.82 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 63.05 62.8 5.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 27.6 t -92.21 -53.62 4.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.835 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 7.1 m120 -58.01 -50.53 73.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 52.7 mt -52.06 -45.74 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.124 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -53.95 -67.31 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -42.79 -43.45 3.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.82 81.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.423 ' CG ' HD12 ' A' ' 253' ' ' ILE . 54.7 mtp180 -69.8 -21.69 63.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -76.33 -5.01 45.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.671 HG13 ' HD2' ' A' ' 248' ' ' PRO . 84.0 t -77.78 138.65 62.06 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.63 0.729 . . . . 0.0 111.104 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.671 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.0 Cg_endo -69.77 143.31 50.4 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.662 2.241 . . . . 0.0 112.388 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 91.41 -19.92 44.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.0 t -80.49 106.05 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.921 0.391 . . . . 0.0 111.129 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.459 ' CG2' ' HB2' ' A' ' 217' ' ' ALA . 32.6 p -60.09 -58.76 7.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.159 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -154.46 159.13 40.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.499 HG12 HG23 ' A' ' 264' ' ' ILE . 50.9 mt -132.57 103.85 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.158 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -104.05 155.63 18.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.842 HD11 ' CE ' ' A' ' 230' ' ' MET . 8.5 tp -140.17 157.11 46.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.649 ' H ' HD12 ' A' ' 255' ' ' LEU . 6.4 t0 -116.93 134.5 54.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -100.88 -16.97 17.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.37 -34.37 28.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.83 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 59.7 p -114.77 -21.76 10.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.186 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 74.02 53.03 7.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.516 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.8 m -122.4 129.47 52.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.319 . . . . 0.0 111.142 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.785 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.9 m-85 -93.11 121.85 34.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.871 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.7 mtm-85 -113.02 114.17 26.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.834 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.734 HG22 HG12 ' A' ' 272' ' ' VAL . 5.2 mt -107.1 138.59 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.112 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 251' ' ' THR . 93.7 m-85 -122.82 117.47 25.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.564 ' O ' ' HB1' ' A' ' 217' ' ' ALA . . . -139.88 144.81 15.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -58.06 -33.4 69.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.899 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.2 t -134.57 137.29 43.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.878 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -45.2 -26.8 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.061 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.25 -44.83 94.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.47 -65.09 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.139 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.734 HG12 HG22 ' A' ' 264' ' ' ILE . 0.9 OUTLIER -48.46 -31.1 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -71.54 -54.14 11.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -58.17 -35.5 71.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -76.46 -37.34 57.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -54.8 -36.61 65.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -58.65 -12.22 13.16 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -94.61 -28.08 15.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 110.891 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.785 HD22 ' CE1' ' A' ' 262' ' ' PHE . 82.2 mt -92.95 -2.68 55.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -47.92 153.1 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.634 ' HB2' HD13 ' A' ' 229' ' ' LEU . 53.5 p90 -82.07 135.87 35.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.893 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.463 ' O ' HD22 ' A' ' 229' ' ' LEU . 80.1 t -128.14 133.64 66.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -77.36 162.5 27.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.81 143.54 57.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -81.8 139.59 34.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 52.3 mt -103.0 95.86 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 13.5 tp60 -80.19 105.0 11.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 16.6 m -91.93 144.4 29.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.612 0.72 . . . . 0.0 111.142 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -5.75 16.96 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.689 2.259 . . . . 0.0 112.341 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.3 m -95.51 161.73 13.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -141.93 153.85 24.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.523 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 171.68 14.0 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.716 2.278 . . . . 0.0 112.355 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 73.9 m -143.1 145.56 32.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.804 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 54.7 p -58.28 125.63 24.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.868 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.545 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 35.3 p -137.11 152.2 49.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.918 0.39 . . . . 0.0 110.825 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.0 t -48.63 -61.02 2.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 209' ' ' SER . . . 132.04 -54.35 0.78 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.51 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 208' ' ' GLY . 34.0 t -36.86 145.52 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.879 0.371 . . . . 0.0 110.842 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 80.1 p -134.13 164.89 26.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 99.57 94.19 2.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.505 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 23.3 m -127.57 149.49 50.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 111.126 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -86.82 168.83 13.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -94.12 46.71 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 216' ' ' ALA . 28.2 tp -78.05 157.64 29.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.465 ' N ' ' HG ' ' A' ' 215' ' ' LEU . . . -69.65 159.75 32.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.108 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -111.94 137.12 50.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.099 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -73.23 -41.22 63.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.614 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 66.1 m-85 -107.98 132.29 53.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -126.17 145.72 50.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -119.22 137.65 53.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -143.53 111.96 6.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.448 ' CE2' ' HG3' ' A' ' 276' ' ' ARG . 30.2 p90 -141.21 150.08 42.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.869 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.412 HG22 ' OG1' ' A' ' 261' ' ' THR . 47.7 t -96.47 132.25 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.5 t -113.77 137.43 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.098 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -53.54 122.06 9.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -49.7 -20.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -86.16 -38.49 17.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.775 HD13 ' HB2' ' A' ' 281' ' ' PHE . 34.6 mt -79.8 -25.24 40.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.525 ' CE ' HD11 ' A' ' 255' ' ' LEU . 25.7 mtp -45.98 -58.84 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.87 -52.24 3.25 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.463 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 26.1 mt -67.8 -50.71 55.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.838 0.352 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.426 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -47.51 -45.78 26.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 52.8 mt -69.68 -40.7 79.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 101.84 -143.87 16.16 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.489 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.56 ' O ' HG23 ' A' ' 236' ' ' THR . 8.8 t -115.29 114.26 24.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.774 0.321 . . . . 0.0 111.13 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 69.19 39.25 1.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 60.11 59.54 10.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 2.5 t -89.29 -60.11 2.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.907 0.384 . . . . 0.0 110.858 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 3.7 m120 -50.6 -56.89 9.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 48.9 mt -44.94 -51.35 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -56.24 -44.43 79.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -60.73 -35.38 76.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.549 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -64.48 -53.63 45.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.483 ' N ' HD12 ' A' ' 253' ' ' ILE . 9.6 ptt180 -60.84 -30.29 70.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -64.81 -6.66 8.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.663 HG13 ' HD2' ' A' ' 248' ' ' PRO . 85.7 t -77.15 138.7 64.69 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.614 0.721 . . . . 0.0 111.136 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.663 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.9 Cg_endo -69.75 128.55 16.2 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.686 2.257 . . . . 0.0 112.368 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 104.12 -12.27 52.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.9 t -87.1 102.2 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 111.137 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 53.0 p -57.1 -48.96 77.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.168 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -162.35 166.86 24.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.096 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.6 HG12 HG23 ' A' ' 264' ' ' ILE . 58.6 mt -139.05 113.11 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.121 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -111.94 152.58 27.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.525 HD11 ' CE ' ' A' ' 230' ' ' MET . 8.3 tp -129.19 110.72 12.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.91 99.4 6.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -73.75 -30.92 63.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.882 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -42.81 -39.52 2.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 3.0 p -127.06 -28.53 2.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.126 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 101.89 40.39 2.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.512 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.412 ' OG1' HG22 ' A' ' 224' ' ' VAL . 93.8 m -110.15 116.79 32.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.846 0.355 . . . . 0.0 111.13 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.489 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.8 m-85 -79.87 118.36 21.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -108.37 113.73 27.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.992 HD11 HD12 ' A' ' 279' ' ' LEU . 40.7 mt -107.25 139.79 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -117.9 121.92 41.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.917 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -144.79 140.45 9.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.504 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -61.99 -33.11 73.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.851 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 271' ' ' ALA . 23.8 p -127.37 123.83 37.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.872 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.614 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -38.5 -33.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.081 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -57.7 -46.05 84.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.834 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 268' ' ' SER . . . -61.27 -68.15 0.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.071 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.917 HG13 ' HA3' ' A' ' 266' ' ' GLY . 3.5 m -47.86 -34.21 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -66.6 -52.23 47.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 39.8 tttt -54.5 -49.04 71.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.549 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -67.43 -38.16 84.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.113 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.448 ' HG3' ' CE2' ' A' ' 223' ' ' PHE . 24.9 ttp85 -47.1 -44.47 21.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -49.27 -35.32 19.99 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -69.43 -42.7 74.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.992 HD12 HD11 ' A' ' 264' ' ' ILE . 81.1 mt -75.05 -27.03 59.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.983 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -49.79 148.02 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.775 ' HB2' HD13 ' A' ' 229' ' ' LEU . 9.7 p90 -66.87 144.29 56.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 85.8 t -127.18 131.54 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.153 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 284' ' ' ASP . 5.7 mm-40 -58.14 133.01 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 283' ' ' GLU . 6.9 p-10 -34.93 112.25 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -100.24 125.04 46.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 70.6 mt -104.02 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.087 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -108.31 145.3 34.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 35.6 m -108.51 144.3 29.24 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.588 0.708 . . . . 0.0 111.115 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 93.07 0.52 Allowed 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.7 2.267 . . . . 0.0 112.364 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.9 m -89.03 -62.16 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -162.95 83.38 0.11 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.456 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 140.17 42.03 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.7 2.266 . . . . 0.0 112.362 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 24.3 m -107.99 171.22 7.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.3 t 40.91 41.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.889 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.484 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 53.0 p -121.54 138.11 54.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.918 0.389 . . . . 0.0 110.814 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 59.2 m -69.9 152.91 43.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.888 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -88.07 -103.89 0.94 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.531 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.4 p -94.62 147.9 22.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 110.825 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.4 t -76.05 121.87 23.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -107.69 -85.89 1.79 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.486 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 52.4 p -86.84 134.19 33.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 0.0 111.183 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.5 161.13 9.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.895 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -138.89 142.06 38.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.11 82.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -148.24 135.43 20.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.051 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -103.49 110.69 22.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.84 76.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.103 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.714 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 70.5 m-85 -122.08 125.46 46.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -122.76 138.62 54.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -115.08 146.16 41.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.458 ' HG3' ' CG2' ' A' ' 261' ' ' THR . 19.5 tt0 -149.28 124.6 10.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 4.8 p90 -141.42 146.0 36.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.403 HG22 ' OG1' ' A' ' 261' ' ' THR . 13.0 t -97.83 110.48 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 31.5 t -95.66 146.03 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.453 ' HB2' HD12 ' A' ' 229' ' ' LEU . 12.4 mmm-85 -61.6 148.59 41.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.14 -22.58 66.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -94.47 -12.91 26.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 226' ' ' ARG . 91.5 mt -98.36 -8.93 26.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.554 ' CE ' HD11 ' A' ' 255' ' ' LEU . 2.9 mmt -56.38 -68.63 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -34.74 -57.09 0.78 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.466 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 62.7 mt -61.99 -51.16 69.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.922 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 281' ' ' PHE . . . -57.75 -22.61 47.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.15 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.651 HG22 ' HA2' ' A' ' 238' ' ' GLY . 37.8 mt -100.44 -10.75 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.14 -157.68 53.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.529 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 238' ' ' GLY . 15.2 t -89.33 147.4 24.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.125 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.436 ' C ' ' O ' ' A' ' 236' ' ' THR . 96.1 m-70 35.37 33.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.651 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 65.13 48.91 65.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.476 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 236' ' ' THR . 3.0 t -77.25 -48.84 16.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 110.837 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -53.54 -54.71 33.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.492 ' HA ' HD21 ' A' ' 279' ' ' LEU . 55.7 mt -48.57 -45.46 14.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -55.03 -62.0 1.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 247' ' ' VAL . 80.4 mt-30 -43.75 -49.03 8.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.935 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.42 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -59.19 -43.9 92.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -73.43 -18.07 61.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -90.64 15.24 11.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.665 HG13 ' HD2' ' A' ' 248' ' ' PRO . 98.0 t -93.95 138.38 22.71 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.616 0.722 . . . . 0.0 111.142 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.665 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.5 Cg_endo -69.7 128.89 16.73 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.702 2.268 . . . . 0.0 112.397 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.72 -7.88 50.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.537 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 84.0 t -96.75 103.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 111.137 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 68.3 p -54.11 -57.41 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.149 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.07 174.62 14.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.128 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.642 HG12 HG23 ' A' ' 264' ' ' ILE . 79.1 mt -143.19 108.54 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -105.43 155.34 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.554 HD11 ' CE ' ' A' ' 230' ' ' MET . 9.8 tp -141.01 133.43 28.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.7 120.49 40.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.809 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -85.36 -26.96 26.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.76 -40.03 27.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 35.0 p -127.16 -27.97 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 98.45 54.99 1.12 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.477 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.458 ' CG2' ' HG3' ' A' ' 222' ' ' GLU . 3.5 m -116.3 123.93 48.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.341 . . . . 0.0 111.154 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.538 ' CE1' HD22 ' A' ' 255' ' ' LEU . 11.0 m-85 -92.52 112.74 24.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.883 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 38.4 mtp85 -103.21 120.37 40.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.642 HG23 HG12 ' A' ' 253' ' ' ILE . 7.4 mt -110.89 136.93 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.182 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -116.88 119.59 35.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.625 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -141.51 146.62 17.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.468 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -68.22 -28.28 67.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 p -130.21 130.8 45.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.714 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -43.82 -30.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.072 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.21 -40.79 98.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.47 -65.9 0.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.093 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.625 HG13 ' HA3' ' A' ' 266' ' ' GLY . 0.3 OUTLIER -47.92 -41.25 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -67.13 -47.0 72.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.936 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -59.85 -39.21 84.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.42 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -75.57 -30.35 59.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.139 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -62.84 -39.92 95.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -54.64 -13.38 4.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.514 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -93.91 -26.06 17.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.492 HD21 ' HA ' ' A' ' 241' ' ' ILE . 83.0 mt -94.85 6.2 49.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -56.16 138.12 50.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.495 ' HA ' ' HB2' ' A' ' 233' ' ' ALA . 43.4 p90 -66.3 135.06 53.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 63.8 t -126.09 127.12 70.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -77.15 155.02 32.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.892 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -61.59 112.96 2.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.83 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -107.28 144.99 33.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 286' ' ' ILE . 4.6 mp -95.92 95.68 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.18 107.08 14.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 33.9 m -110.44 146.41 34.25 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.622 0.725 . . . . 0.0 111.12 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 128.05 15.45 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.739 2.293 . . . . 0.0 112.319 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 47.0 t -94.3 93.2 7.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 95.9 150.96 27.69 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 123.81 10.47 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.711 2.274 . . . . 0.0 112.355 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 80.0 p 37.31 43.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.4 p -131.56 -53.3 1.01 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 46.9 t -39.51 150.09 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 110.853 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.7 t -149.87 128.63 12.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.839 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -125.04 89.24 0.39 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.496 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 30.4 m -70.89 114.15 8.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.865 0.364 . . . . 0.0 110.841 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 81.0 p -124.75 175.98 6.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.892 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.52 -137.79 2.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 53.2 p -121.88 129.97 52.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.83 0.348 . . . . 0.0 111.154 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm -90.84 89.23 7.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.897 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -82.42 -179.17 7.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.945 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.711 HD23 ' H ' ' A' ' 215' ' ' LEU . 0.8 OUTLIER -89.34 13.79 12.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.952 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -139.28 171.87 13.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -84.15 114.23 21.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.073 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -70.94 -29.17 65.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.069 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.932 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 86.6 m-85 -123.37 114.5 20.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -118.03 145.6 44.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -114.33 133.22 55.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.465 ' C ' ' CD ' ' A' ' 222' ' ' GLU . 0.3 OUTLIER -135.87 117.04 14.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.527 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 12.0 p90 -142.57 151.77 41.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.851 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 18.4 t -102.26 121.99 53.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.082 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 93.2 t -109.24 144.98 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.532 ' HB2' HD12 ' A' ' 229' ' ' LEU . 70.8 mtt180 -60.9 122.06 13.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -40.48 -32.37 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.95 -43.08 56.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.535 HD13 ' HB2' ' A' ' 281' ' ' PHE . 80.2 mt -71.23 -25.39 62.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.834 ' CE ' HD11 ' A' ' 255' ' ' LEU . 26.5 mtp -47.22 -64.46 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -36.32 -51.69 1.31 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.48 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 63.1 mt -67.03 -44.6 79.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 110.947 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -55.56 -37.9 68.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.554 HG23 HG13 ' A' ' 241' ' ' ILE . 41.8 mt -83.7 -27.61 7.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.147 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 90.18 -153.94 23.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.524 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 91.2 m -108.66 117.13 33.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.8 0.333 . . . . 0.0 111.182 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 9.1 t60 72.93 30.64 1.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.857 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 65.31 56.76 13.82 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.522 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 30.8 t -86.49 -58.15 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 0.0 110.856 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 4.6 m120 -51.17 -59.39 4.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.906 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.554 HG13 HG23 ' A' ' 234' ' ' ILE . 44.3 mt -42.83 -48.34 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -54.93 -55.36 31.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -48.74 -54.76 13.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.43 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -52.62 -40.6 62.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.075 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -71.31 -19.45 62.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -85.09 15.75 3.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.65 HG13 ' HD2' ' A' ' 248' ' ' PRO . 95.6 t -98.6 138.05 20.71 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.634 0.731 . . . . 0.0 111.092 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.65 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.3 Cg_endo -69.73 133.07 24.74 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.698 2.265 . . . . 0.0 112.391 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 101.41 -17.65 55.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.521 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 275' ' ' ALA . 58.7 t -87.31 101.78 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.851 0.358 . . . . 0.0 111.164 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 66.7 p -56.28 -47.91 77.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -163.76 170.88 16.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.081 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 264' ' ' ILE . 86.8 mt -140.1 116.22 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.101 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -113.65 160.45 18.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.834 HD11 ' CE ' ' A' ' 230' ' ' MET . 4.1 tp -142.13 144.0 33.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -104.61 126.64 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.828 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -97.25 -19.17 18.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -58.6 -44.28 89.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 67.6 p -124.1 -31.01 3.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.173 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.67 57.35 0.7 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 90.7 m -122.65 119.17 29.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 111.189 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.584 ' CD1' HD13 ' A' ' 279' ' ' LEU . 12.4 m-85 -85.7 130.97 34.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -119.49 119.2 33.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.747 HG22 HG12 ' A' ' 272' ' ' VAL . 6.2 mt -109.47 139.94 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.148 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -120.0 115.53 23.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.476 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -140.16 138.05 8.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.453 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -56.86 -29.48 62.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.861 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.1 t -134.91 138.95 44.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.932 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.78 -30.19 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.071 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -59.56 -40.68 88.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.402 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -68.09 -67.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.747 HG12 HG22 ' A' ' 264' ' ' ILE . 0.3 OUTLIER -47.32 -38.46 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -64.03 -54.59 31.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -39.82 78.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.906 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.43 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -71.18 -35.75 71.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.054 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.41 ' HB2' HD12 ' A' ' 264' ' ' ILE . 50.1 ttt180 -59.17 -35.59 73.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -60.05 -8.87 9.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.493 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -98.72 -24.65 14.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 110.911 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.584 HD13 ' CD1' ' A' ' 262' ' ' PHE . 82.4 mt -99.28 1.94 45.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -54.53 145.24 19.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.887 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.535 ' HB2' HD13 ' A' ' 229' ' ' LEU . 53.5 p90 -67.52 127.59 33.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 87.5 t -126.55 126.94 69.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.09 164.34 26.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.04 133.08 38.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -70.24 121.45 17.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 85.6 mt -107.12 98.76 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.106 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -115.45 153.29 31.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.6 m -132.31 146.22 60.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.629 0.728 . . . . 0.0 111.116 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 116.25 4.47 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.702 2.268 . . . . 0.0 112.322 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 38.7 m -167.14 154.41 8.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -127.2 171.33 18.76 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.526 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 166.96 25.82 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.702 2.268 . . . . 0.0 112.367 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 19.4 m -65.76 163.45 16.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 29.0 t -98.96 117.67 34.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.878 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.458 -179.926 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 7.8 t -171.0 163.51 7.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.858 0.361 . . . . 0.0 110.834 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 69.4 m -58.27 164.35 2.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.9 147.01 18.37 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 25.0 t -134.26 96.04 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.899 0.381 . . . . 0.0 110.841 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 80.2 p -146.24 150.19 35.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 148.72 -81.64 0.19 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.489 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 26.9 m -117.49 124.84 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 0.0 111.167 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -84.78 172.64 11.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -170.94 159.34 6.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.932 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 215' ' ' LEU . 3.9 pp -84.9 45.44 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -143.34 136.66 28.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.088 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -98.97 113.54 25.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -65.42 -38.55 90.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.714 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 77.7 m-85 -109.01 130.86 55.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -127.68 141.32 51.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -113.62 142.82 45.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.44 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 0.1 OUTLIER -147.13 105.55 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 15.5 p90 -130.12 156.38 44.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 62.1 t -106.91 126.69 62.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.081 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.77 HG13 ' HB3' ' A' ' 281' ' ' PHE . 95.0 t -110.0 143.29 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.088 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.607 ' HB2' HD12 ' A' ' 229' ' ' LEU . 16.5 mmt180 -55.69 123.08 12.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -45.5 -25.08 0.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.26 -39.29 17.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.768 HD13 ' HB2' ' A' ' 281' ' ' PHE . 45.3 mt -71.81 -30.23 65.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 24.1 mtp -39.7 -57.94 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -41.55 -49.02 4.87 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.502 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 30.0 mt -70.67 -58.02 4.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 110.905 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -42.26 -42.75 3.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.064 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.429 HG23 HG13 ' A' ' 241' ' ' ILE . 22.9 mt -74.81 -36.08 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.121 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 99.51 -158.09 19.86 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 22.0 m -105.19 113.27 26.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.806 0.336 . . . . 0.0 111.137 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 74.4 31.34 1.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.858 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 64.11 61.52 6.01 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.461 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 29.3 t -90.96 -55.17 3.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.901 0.381 . . . . 0.0 110.851 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -55.84 -47.94 76.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.496 HG12 HD21 ' A' ' 279' ' ' LEU . 26.5 mt -54.55 -47.74 71.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -57.23 -46.72 82.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -60.25 -54.51 44.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.587 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -48.8 -40.1 27.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.082 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.4 ' CA ' HD12 ' A' ' 253' ' ' ILE . 18.4 ttt85 -72.87 -22.33 60.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -86.65 21.72 2.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.642 HG13 ' HD2' ' A' ' 248' ' ' PRO . 86.3 t -100.89 138.07 19.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.619 0.724 . . . . 0.0 111.104 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.642 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.77 127.26 14.33 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.711 2.274 . . . . 0.0 112.359 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 104.1 -4.53 45.1 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.538 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 82.9 t -100.89 104.96 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 0.0 111.141 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 69.9 p -59.19 -54.03 51.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.02 166.41 33.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.107 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.712 HG12 HG23 ' A' ' 264' ' ' ILE . 77.0 mt -137.57 105.94 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.163 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -110.79 148.59 32.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.719 HD12 ' H ' ' A' ' 256' ' ' ASP . 8.0 tp -128.15 154.57 45.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.929 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.719 ' H ' HD12 ' A' ' 255' ' ' LEU . 14.7 m-20 -112.07 130.15 55.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -100.13 -14.74 18.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.21 -45.18 95.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.9 p -126.0 -28.65 3.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.131 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.58 61.62 0.66 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.481 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.44 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 91.9 m -124.67 122.21 36.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 0.0 111.124 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.795 ' CE1' HD22 ' A' ' 279' ' ' LEU . 13.6 m-85 -89.2 113.14 24.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -102.2 110.63 22.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.807 HG22 HG12 ' A' ' 272' ' ' VAL . 7.2 mt -104.59 144.78 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -123.0 124.11 42.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.489 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -149.46 136.3 5.71 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.533 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -56.58 -29.73 62.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.833 0.349 . . . . 0.0 110.866 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 13.2 p -129.08 135.23 48.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.714 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -49.29 -28.83 5.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.141 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.62 -36.86 84.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.854 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.424 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -66.6 -59.82 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.075 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.807 HG12 HG22 ' A' ' 264' ' ' ILE . 0.3 OUTLIER -58.85 -29.98 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -68.07 -50.45 55.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -58.21 -48.01 81.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.587 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -65.09 -33.61 76.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.43 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 74.1 ttt180 -53.89 -50.12 67.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -44.14 -27.73 1.17 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.495 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -80.54 -39.07 28.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.924 0.392 . . . . 0.0 110.953 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.795 HD22 ' CE1' ' A' ' 262' ' ' PHE . 30.7 mt -88.08 -2.54 58.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -66.35 142.81 57.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.863 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.77 ' HB3' HG13 ' A' ' 225' ' ' VAL . 37.9 p90 -64.85 132.96 50.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.876 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.461 ' O ' HD22 ' A' ' 229' ' ' LEU . 57.3 t -127.12 125.32 66.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.118 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -55.77 160.33 2.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.22 115.42 2.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -105.72 148.18 27.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 30.4 mt -116.32 103.33 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -107.21 151.65 25.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.58 146.28 42.86 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.639 0.733 . . . . 0.0 111.121 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 138.73 38.53 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.731 2.287 . . . . 0.0 112.357 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 7.7 t -82.02 135.98 35.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -64.64 -158.42 0.31 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -31.73 19.92 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.677 2.252 . . . . 0.0 112.38 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 1.5 t -85.38 155.8 21.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.866 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 295' ' ' GLY . 96.5 p -136.87 174.84 10.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.84 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 294' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.486 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 8.6 m -121.18 99.99 6.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 0.0 110.875 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 51.0 p -99.46 159.55 14.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.68 -115.41 0.64 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.474 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 44.6 m 47.57 42.44 14.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.9 0.381 . . . . 0.0 110.883 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.2 m -139.93 144.6 37.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.867 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -72.56 -110.06 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.437 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 23.5 m -128.11 126.71 41.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.826 0.346 . . . . 0.0 111.115 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -152.26 150.55 29.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -112.25 92.96 4.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.974 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 15.3 tp -131.8 147.27 52.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -38.72 145.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.107 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -78.68 116.15 18.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.083 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -58.56 -43.75 89.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.125 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.636 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 83.5 m-85 -110.05 143.66 39.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -137.06 143.79 42.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -115.01 134.26 55.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.891 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.1 108.09 5.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.789 ' O ' HG23 ' A' ' 261' ' ' THR . 32.0 p90 -139.31 163.37 32.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.592 HG22 ' OG1' ' A' ' 261' ' ' THR . 60.6 t -108.65 132.34 56.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.15 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.643 HG13 ' HB3' ' A' ' 281' ' ' PHE . 79.2 t -113.39 142.62 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 -55.16 125.04 18.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -53.76 -18.16 2.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.54 -38.53 17.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 281' ' ' PHE . 51.4 mt -80.24 -27.54 38.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.46 ' CE ' HD11 ' A' ' 255' ' ' LEU . 22.4 mtp -40.23 -59.26 1.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.849 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -41.21 -54.13 3.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.467 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.04 -54.75 33.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.882 0.372 . . . . 0.0 110.936 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -45.92 -44.11 14.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.105 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 11.0 mt -71.6 -38.5 67.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 94.84 -134.25 11.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.454 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 237' ' ' HIS . 60.2 m -113.01 138.66 49.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.833 0.349 . . . . 0.0 111.141 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 236' ' ' THR . 5.5 m-70 35.91 48.8 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 59.29 57.73 18.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.493 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.7 t -84.57 -68.14 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.877 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 4.7 m120 -41.64 -62.32 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 60.2 mt -39.9 -52.52 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -54.76 -48.93 72.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.944 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.452 ' OE1' ' N ' ' A' ' 243' ' ' GLN . 0.3 OUTLIER -60.97 -30.83 70.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 247' ' ' VAL . . . -68.54 -53.39 23.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -57.72 -23.91 54.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -72.51 1.89 7.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.669 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.4 t -82.67 138.9 43.75 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.654 0.74 . . . . 0.0 111.105 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.669 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.4 Cg_endo -69.75 133.28 25.22 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.728 2.286 . . . . 0.0 112.316 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 96.83 -3.45 62.68 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.511 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 70.6 t -96.59 113.46 31.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 111.095 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 20.6 p -70.87 -57.83 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -148.41 168.24 23.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.074 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.564 HG12 HG23 ' A' ' 264' ' ' ILE . 65.6 mt -143.84 109.17 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.126 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -113.13 154.45 26.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.46 HD11 ' CE ' ' A' ' 230' ' ' MET . 8.0 tp -131.47 138.78 49.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.953 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.415 ' N ' HD12 ' A' ' 255' ' ' LEU . 6.6 m-20 -104.51 113.28 26.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -82.38 -33.19 28.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.849 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -45.46 -35.68 3.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 63.6 p -128.07 -31.33 2.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 99.15 47.05 1.93 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.49 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 223' ' ' PHE . 97.7 m -115.17 128.84 56.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 111.132 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.557 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.6 m-85 -91.12 123.0 34.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -111.78 114.67 27.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.932 HG22 HG12 ' A' ' 272' ' ' VAL . 19.2 mt -109.1 139.84 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -120.25 117.05 26.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.607 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -139.67 151.88 22.24 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.506 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 25.1 mt-10 -67.74 -31.52 71.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 110.917 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.3 p -129.84 134.99 47.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.636 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -46.46 -32.42 3.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.099 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -62.06 -41.84 98.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.73 -65.54 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.085 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.932 HG12 HG22 ' A' ' 264' ' ' ILE . 0.3 OUTLIER -51.22 -34.57 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.153 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -65.59 -53.05 47.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -53.63 -48.25 69.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.36 -35.25 77.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.113 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.54 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 56.5 ttt180 -51.92 -42.81 63.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -49.46 -33.83 18.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.97 -43.81 67.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.381 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.887 HD12 HD11 ' A' ' 264' ' ' ILE . 69.8 mt -72.79 -28.94 62.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -49.02 145.76 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.819 ' HB2' HD13 ' A' ' 229' ' ' LEU . 14.8 p90 -66.25 142.91 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 86.4 t -127.51 137.17 58.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.139 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 284' ' ' ASP . 2.9 mp0 -68.85 139.73 55.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 283' ' ' GLU . 6.0 m-20 -35.56 113.27 0.2 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -112.88 122.88 48.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.886 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 286' ' ' ILE . 4.7 mp -109.32 100.95 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -88.49 147.93 24.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 11.9 m -85.37 144.43 40.61 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.641 0.734 . . . . 0.0 111.123 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 176.19 7.13 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.683 2.255 . . . . 0.0 112.306 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 49.7 m -157.33 158.25 35.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -128.74 146.2 16.76 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.491 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 177.9 5.11 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.657 2.238 . . . . 0.0 112.358 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 20.0 t -131.78 114.1 14.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.828 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 30.8 m -40.51 161.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.827 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.506 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 8.7 t 69.61 40.39 1.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.874 0.369 . . . . 0.0 110.899 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 31.3 t -49.73 100.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.832 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -142.03 110.59 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.495 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 30.6 p -79.4 138.65 37.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.87 0.367 . . . . 0.0 110.852 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 82.5 p -166.08 148.66 7.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.876 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -91.68 111.51 4.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.497 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 80.7 p -124.46 151.82 44.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.35 . . . . 0.0 111.138 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -141.33 120.73 13.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -122.12 38.4 4.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 18.0 mt -44.68 -49.27 10.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -89.21 158.75 17.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.777 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . -79.52 115.22 19.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.104 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -51.84 -33.56 36.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.123 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.819 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 43.4 m-85 -119.02 122.77 42.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -121.28 152.19 39.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.822 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -129.87 153.11 48.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -157.49 117.53 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.401 ' CE2' ' HG3' ' A' ' 276' ' ' ARG . 27.9 p90 -142.79 144.96 32.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.3 t -91.73 129.19 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 281' ' ' PHE . 55.3 t -109.83 139.03 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.12 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -53.82 131.08 39.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.17 -11.69 6.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -96.82 -21.29 17.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.827 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.652 HD13 ' HB2' ' A' ' 281' ' ' PHE . 74.4 mt -97.58 -9.03 27.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.412 ' CE ' HD11 ' A' ' 255' ' ' LEU . 5.4 mmt -49.97 -66.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -40.27 -51.41 3.62 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.503 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 68.1 mt -59.42 -63.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.626 ' HB2' ' HA ' ' A' ' 281' ' ' PHE . . . -45.97 -39.53 9.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 45.6 mt -75.74 -30.38 21.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 88.85 -147.35 19.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.483 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 237' ' ' HIS . 9.6 t -101.58 140.69 35.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.765 0.317 . . . . 0.0 111.185 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 236' ' ' THR . 14.4 p80 34.63 49.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 56.46 66.27 2.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.486 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.7 t -93.74 -61.24 1.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 110.86 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -48.42 -63.46 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 45.4 mt -39.59 -52.75 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -50.68 -45.5 58.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -61.98 -50.24 72.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.934 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.537 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -56.7 -35.59 68.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.09 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -75.99 -18.37 59.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -89.29 12.86 14.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.623 HG13 ' HD2' ' A' ' 248' ' ' PRO . 93.7 t -91.76 137.4 25.54 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.646 0.736 . . . . 0.0 111.16 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.623 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.0 Cg_endo -69.69 139.69 41.08 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.657 2.238 . . . . 0.0 112.385 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 95.97 -18.99 56.42 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.541 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 86.9 t -81.01 116.79 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 111.104 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 265' ' ' TYR . 37.2 p -71.24 -49.17 46.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.108 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -161.45 169.44 21.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.505 HG12 HG23 ' A' ' 264' ' ' ILE . 90.6 mt -144.6 113.56 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.088 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -114.01 153.51 29.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 256' ' ' ASP . 1.8 tp -135.31 125.52 26.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.889 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.676 ' N ' HD12 ' A' ' 255' ' ' LEU . 1.7 t70 -84.87 107.81 17.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 29.7 mp0 -83.15 -3.93 57.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -91.33 -36.23 13.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 40.1 p -115.36 -17.02 11.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 76.88 51.79 6.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.475 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 96.8 m -124.97 126.62 45.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 111.161 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.825 ' CE1' HD22 ' A' ' 279' ' ' LEU . 11.1 m-85 -88.02 114.16 24.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 27.4 mtt-85 -104.24 117.09 33.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.83 HG22 HG12 ' A' ' 272' ' ' VAL . 10.2 mt -110.02 148.43 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 251' ' ' THR . 60.2 m-85 -131.65 112.43 12.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.777 ' O ' ' HB1' ' A' ' 217' ' ' ALA . . . -133.34 148.81 19.49 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.524 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -67.4 -25.71 66.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.888 0.375 . . . . 0.0 110.9 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 270' ' ' ASP . 6.3 m -141.08 131.26 24.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.833 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.819 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -36.8 -34.11 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.118 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 268' ' ' SER . 2.6 m-20 -57.74 -50.73 72.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.87 -66.98 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.83 HG12 HG22 ' A' ' 264' ' ' ILE . 2.4 m -50.66 -41.7 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -56.28 -52.79 63.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -57.79 -49.23 77.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.537 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -64.56 -31.53 72.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.401 ' HG3' ' CE2' ' A' ' 223' ' ' PHE . 37.8 ttp85 -60.41 -45.99 91.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.06 -22.52 2.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.469 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -85.55 -50.63 7.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 0.0 110.851 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.825 HD22 ' CE1' ' A' ' 262' ' ' PHE . 78.2 mt -68.75 -8.66 45.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.938 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -64.63 139.75 58.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.652 ' HB2' HD13 ' A' ' 229' ' ' LEU . 8.1 p90 -64.1 142.97 58.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 90.9 t -126.72 134.7 65.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -67.2 152.15 46.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.15 130.44 30.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -107.2 123.82 48.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 85.0 mt -116.85 101.55 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.135 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -121.6 121.77 38.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.932 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.8 m -96.1 144.35 27.67 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 111.138 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -50.54 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.662 2.241 . . . . 0.0 112.355 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 41.1 t -150.99 118.21 5.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -102.03 162.61 17.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.512 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -25.81 28.5 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.705 2.27 . . . . 0.0 112.348 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.6 m -83.73 94.03 8.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.87 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.1 t -96.43 136.3 37.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.486 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 98.4 p -129.12 125.25 36.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.87 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.4 t -142.23 136.83 30.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.75 98.3 1.99 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.475 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 89.1 p -171.09 166.31 7.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 0.0 110.892 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.2 m -63.44 82.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -83.49 129.59 9.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 38.3 p -137.66 148.24 45.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.84 0.352 . . . . 0.0 111.172 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -62.63 165.83 6.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -82.89 163.61 21.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.958 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 73.8 mt -86.41 -58.11 2.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.954 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.94 -178.9 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.129 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -123.58 137.11 54.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.104 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -74.84 -43.11 56.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.553 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 96.7 m-85 -114.41 122.72 47.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -118.46 141.79 48.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -119.13 135.97 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.405 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 0.9 OUTLIER -138.05 122.93 18.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 223' ' ' PHE . 1.7 p90 -140.57 151.79 44.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.9 t -104.42 114.03 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.729 HG22 ' HB3' ' A' ' 281' ' ' PHE . 19.5 t -97.91 143.6 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.155 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.412 ' O ' HG12 ' A' ' 225' ' ' VAL . 13.9 mmt85 -53.9 172.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -91.42 -17.57 25.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -102.28 -8.89 20.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.82 HD22 ' O ' ' A' ' 282' ' ' VAL . 65.7 mt -100.69 -4.08 28.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 2.8 mmt -58.21 -66.8 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -42.85 -39.21 3.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.451 HD12 HD23 ' A' ' 229' ' ' LEU . 68.1 mt -66.34 -59.86 3.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 0.0 110.889 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.422 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -53.76 -49.68 67.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 8.0 mt -65.76 -31.66 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.158 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 92.92 -153.12 21.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.463 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 70.1 p -108.72 118.13 35.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.349 . . . . 0.0 111.169 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 69.25 35.44 2.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.857 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 58.84 61.07 7.79 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.485 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.3 t -92.42 -54.25 3.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.882 0.372 . . . . 0.0 110.876 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 5.5 m120 -52.88 -56.2 17.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.885 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.493 ' HA ' HD21 ' A' ' 279' ' ' LEU . 39.4 mt -46.54 -45.59 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -55.21 -62.53 1.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -45.91 -41.41 11.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.69 -57.21 13.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.418 ' HG3' HD12 ' A' ' 253' ' ' ILE . 80.8 mtt180 -60.3 -11.62 6.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -98.21 14.1 28.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.661 HG13 ' HD2' ' A' ' 248' ' ' PRO . 98.1 t -94.36 138.29 22.48 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.581 0.705 . . . . 0.0 111.153 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.661 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.8 Cg_endo -69.77 128.41 15.97 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.649 2.233 . . . . 0.0 112.355 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.568 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 103.75 -6.26 48.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 78.3 t -98.14 108.55 22.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 0.0 111.122 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 43.5 p -64.89 -46.29 82.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.152 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -162.02 165.79 26.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.065 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 264' ' ' ILE . 58.3 mt -139.37 106.37 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.089 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -109.37 151.98 25.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.733 HD22 ' CZ ' ' A' ' 262' ' ' PHE . 7.8 tp -138.07 151.37 47.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.916 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.511 ' H ' HD12 ' A' ' 255' ' ' LEU . 3.6 t70 -112.89 124.37 52.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -89.49 -19.57 24.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.95 -27.39 39.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.836 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 60.3 p -121.69 -14.15 8.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 66.67 44.08 90.46 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.51 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.405 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 71.1 m -115.25 123.48 48.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 111.137 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.733 ' CZ ' HD22 ' A' ' 255' ' ' LEU . 11.3 m-85 -91.25 113.99 26.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -104.65 115.52 30.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.965 HG22 HG12 ' A' ' 272' ' ' VAL . 55.8 mt -108.32 140.36 27.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.183 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -121.25 122.16 39.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.568 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -143.46 152.73 24.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 22.9 mt-10 -71.77 -34.4 69.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.341 . . . . 0.0 110.858 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 21.5 p -125.76 132.08 52.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.553 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -43.0 -31.28 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.39 -43.7 98.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.568 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -60.3 -64.41 0.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.091 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.965 HG12 HG22 ' A' ' 264' ' ' ILE . 0.5 OUTLIER -52.77 -40.52 35.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.118 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -59.63 -55.81 29.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -58.49 -41.96 86.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.881 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.83 -24.14 61.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 18.3 ttt-85 -68.35 -45.11 73.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.67 -27.64 6.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.477 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -78.58 -36.82 43.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.37 . . . . 0.0 110.868 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.493 HD21 ' HA ' ' A' ' 241' ' ' ILE . 86.0 mt -88.33 -13.75 39.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.931 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -55.15 138.04 45.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.729 ' HB3' HG22 ' A' ' 225' ' ' VAL . 17.0 p90 -63.82 140.81 58.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.82 ' O ' HD22 ' A' ' 229' ' ' LEU . 59.4 t -122.95 133.52 68.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.087 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.92 135.46 54.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.78 161.56 4.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -111.03 145.82 37.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 3.8 mm -114.94 102.13 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -94.03 121.21 35.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.92 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 26.2 m -99.53 144.35 28.14 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.652 0.739 . . . . 0.0 111.108 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 92.83 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.637 2.225 . . . . 0.0 112.35 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 16.1 p -125.78 130.34 51.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.866 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 95.28 -155.12 21.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 150.11 67.78 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.728 2.285 . . . . 0.0 112.351 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 3.1 m -77.82 162.46 26.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.84 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 62.7 p -164.87 132.8 3.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.444 -179.96 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 5.2 t -142.21 157.78 44.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.86 0.362 . . . . 0.0 110.834 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 53.1 p -77.68 169.82 17.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.879 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -103.0 -129.26 6.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.465 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 28.9 t -67.48 130.04 41.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.826 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.8 p -142.65 124.55 15.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.896 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -160.83 97.39 0.16 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.491 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 9.0 t -127.76 151.15 49.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.894 0.378 . . . . 0.0 111.108 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -118.68 157.49 27.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -64.39 96.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 22.1 tp -138.71 146.13 41.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.911 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.06 161.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.575 ' HB1' ' C ' ' A' ' 266' ' ' GLY . . . -102.03 117.59 35.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.102 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -57.25 -39.54 75.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.04 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -111.6 135.33 52.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -133.32 138.01 46.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -115.34 127.17 55.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.554 ' CD ' ' CG2' ' A' ' 261' ' ' THR . 3.0 tp10 -132.73 119.62 20.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.931 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -140.52 153.16 46.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.47 122.62 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.465 HG13 ' HB3' ' A' ' 281' ' ' PHE . 19.1 t -104.59 146.23 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -53.52 173.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -89.79 -27.54 19.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -90.92 -30.98 16.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.824 HD13 ' HB2' ' A' ' 281' ' ' PHE . 64.2 mt -73.09 -18.74 61.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.434 ' CE ' HD11 ' A' ' 255' ' ' LEU . 2.3 mtt -47.13 -59.03 3.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -46.22 -43.22 13.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.497 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 282' ' ' VAL . 36.7 mt -68.29 -63.27 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 110.889 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.757 ' HB2' ' HA ' ' A' ' 281' ' ' PHE . . . -45.08 -43.47 9.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.162 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 61.2 mt -73.91 -35.52 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.1 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 89.95 -158.06 26.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.511 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 237' ' ' HIS . 5.4 m -92.12 145.25 24.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.35 . . . . 0.0 111.132 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.43 ' C ' ' O ' ' A' ' 236' ' ' THR . 89.4 m-70 35.2 51.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 50.19 66.93 2.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 17.1 t -92.06 -68.95 0.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.862 0.363 . . . . 0.0 110.849 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.444 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 5.0 m120 -40.33 -67.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 240' ' ' ASN . 45.4 mt -36.5 -54.99 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -55.21 -48.63 73.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -58.45 -52.54 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -50.67 -39.14 50.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -71.91 -25.04 61.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -81.3 11.05 4.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.683 HG13 ' HD2' ' A' ' 248' ' ' PRO . 98.7 t -91.38 138.94 25.26 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.612 0.72 . . . . 0.0 111.128 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.683 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.8 Cg_endo -69.72 137.4 35.47 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.704 2.27 . . . . 0.0 112.34 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 97.93 -21.46 45.97 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.514 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 88.5 t -82.15 115.72 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.918 0.389 . . . . 0.0 111.086 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 265' ' ' TYR . 79.4 p -71.35 -48.39 50.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -158.85 169.43 24.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 264' ' ' ILE . 73.3 mt -145.42 109.72 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -110.97 163.22 14.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.65 HD13 ' CZ ' ' A' ' 262' ' ' PHE . 10.3 tp -140.88 153.98 45.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.607 ' H ' HD12 ' A' ' 255' ' ' LEU . 3.8 m-20 -121.03 119.28 32.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.831 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -86.12 -13.93 45.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -58.29 -52.85 63.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 37.3 p -119.18 -19.36 8.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 95.28 48.28 2.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.514 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.554 ' CG2' ' CD ' ' A' ' 222' ' ' GLU . 20.7 m -110.97 136.79 49.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 111.117 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.65 ' CZ ' HD13 ' A' ' 255' ' ' LEU . 11.6 m-85 -107.39 127.02 53.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ARG . . . . . 0.412 ' HG3' ' CD ' ' A' ' 222' ' ' GLU . 17.4 mtp180 -113.99 115.23 27.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.813 HG22 HG12 ' A' ' 272' ' ' VAL . 34.0 mt -107.18 142.64 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 251' ' ' THR . 79.1 m-85 -124.5 124.02 41.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.61 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -147.73 136.27 5.96 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.461 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 55.3 mt-10 -54.96 -41.75 71.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.87 0.367 . . . . 0.0 110.869 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 271' ' ' ALA . 38.3 m -122.24 136.26 54.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 271' ' ' ALA . . . -43.04 -59.65 1.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.139 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 269' ' ' ALA . 3.1 m-20 -36.51 -30.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 269' ' ' ALA . . . -75.07 -68.94 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.116 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.813 HG12 HG22 ' A' ' 264' ' ' ILE . 0.8 OUTLIER -51.8 -28.71 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.087 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.09 -51.17 22.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -60.35 -33.96 73.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -82.5 -30.69 29.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -58.56 -44.4 89.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.07 -27.39 5.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.504 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -79.04 -54.95 5.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.866 0.365 . . . . 0.0 110.829 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.707 HD12 HD11 ' A' ' 264' ' ' ILE . 67.4 mt -63.48 -22.14 66.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -58.35 141.5 51.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.824 ' HB2' HD13 ' A' ' 229' ' ' LEU . 10.1 p90 -62.07 152.08 33.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.538 ' O ' HD13 ' A' ' 232' ' ' LEU . 81.6 t -128.14 128.87 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.168 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -51.64 158.67 0.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.925 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.84 76.89 4.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -84.99 127.03 34.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 5.3 mp -108.78 99.09 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.183 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' GLN . . . . . 0.505 ' O ' ' NE2' ' A' ' 287' ' ' GLN . 0.6 OUTLIER -93.7 149.36 21.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.7 m -103.93 142.23 24.16 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.672 0.749 . . . . 0.0 111.108 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 112.32 3.05 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.691 2.26 . . . . 0.0 112.332 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 7.9 t -94.05 150.51 20.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.826 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 61.93 -170.02 11.7 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.52 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -12.79 33.46 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 2.262 . . . . 0.0 112.301 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 74.8 m -86.71 97.04 10.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.8 t -106.35 90.14 3.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.492 -179.973 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 48.0 t -164.2 111.61 1.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.8 m -122.5 173.42 7.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.896 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -120.7 173.81 15.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.437 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 71.1 m -100.05 80.55 2.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.953 0.406 . . . . 0.0 110.851 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.6 t -56.82 156.24 6.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.836 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -90.87 47.19 2.95 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.46 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 8.9 t -124.01 133.23 53.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.869 0.366 . . . . 0.0 111.164 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -134.45 91.62 2.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -132.18 170.13 15.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 15.7 tp -113.08 94.21 4.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -152.43 155.96 38.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.08 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.408 ' HB1' ' C ' ' A' ' 266' ' ' GLY . . . -111.19 110.41 20.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.053 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -48.2 -39.05 19.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.622 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 75.9 m-85 -110.39 146.45 35.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.896 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -145.03 140.33 28.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -113.46 138.26 50.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.433 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 8.6 tt0 -143.0 116.94 9.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 29.6 p90 -142.23 139.22 31.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.02 123.6 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 56.0 t -111.72 136.35 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.551 ' HB2' HD12 ' A' ' 229' ' ' LEU . 23.6 mmt180 -54.05 142.96 23.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -58.5 -25.85 62.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.51 -43.53 22.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.724 HD22 ' O ' ' A' ' 282' ' ' VAL . 23.6 mt -66.59 -32.02 73.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.517 ' CE ' HD11 ' A' ' 255' ' ' LEU . 3.2 mtt -36.83 -66.81 0.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -34.47 -61.8 0.54 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.496 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 235' ' ' GLY . 60.2 mt -60.11 -65.32 0.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' LEU . . . -37.62 -36.85 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.102 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.464 HG23 HG13 ' A' ' 241' ' ' ILE . 64.7 mt -83.02 -36.2 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 232' ' ' LEU . . . 96.58 -151.2 19.81 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 86.0 m -100.99 136.28 41.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.768 0.318 . . . . 0.0 111.16 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 2.7 m80 43.99 49.49 7.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 52.45 65.74 3.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 3.5 t -92.68 -65.65 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.861 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -43.64 -63.35 0.86 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.572 HG12 HD21 ' A' ' 279' ' ' LEU . 33.7 mt -39.71 -52.11 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.096 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -54.05 -51.17 64.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -54.59 -48.13 72.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -54.69 -48.05 72.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.092 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -65.91 -29.66 70.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -72.17 -1.33 14.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.685 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.2 t -82.39 138.88 44.71 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.657 0.741 . . . . 0.0 111.142 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.685 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.7 Cg_endo -69.76 148.43 65.09 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.671 2.247 . . . . 0.0 112.355 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 89.26 -26.8 8.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 87.6 t -74.4 105.5 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.931 0.396 . . . . 0.0 111.11 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 34.7 p -60.52 -49.41 77.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.25 162.92 33.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.089 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.563 HG12 HG23 ' A' ' 264' ' ' ILE . 24.4 mt -134.05 106.42 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -107.74 155.7 19.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.517 HD11 ' CE ' ' A' ' 230' ' ' MET . 6.1 tp -141.64 150.54 42.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -108.16 141.53 39.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -103.57 -20.15 14.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -76.76 -36.46 57.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.7 p -115.02 -22.76 9.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.154 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 77.58 47.0 9.19 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.449 ' O ' HD12 ' A' ' 255' ' ' LEU . 48.6 m -112.89 135.54 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 111.191 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.533 ' HB2' ' CE2' ' A' ' 223' ' ' PHE . 12.9 m-85 -98.73 115.68 29.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -105.89 114.48 28.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.917 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.965 HG22 HG12 ' A' ' 272' ' ' VAL . 34.5 mt -108.91 132.0 58.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.141 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -111.22 126.4 54.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.644 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -147.24 143.61 11.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.453 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.34 -34.8 74.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.925 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 14.2 m -133.24 131.43 40.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.622 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -40.73 -38.56 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.112 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.49 -43.16 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.873 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.09 -68.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.965 HG12 HG22 ' A' ' 264' ' ' ILE . 1.2 m -49.38 -30.54 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -67.94 -52.46 35.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -56.72 -41.23 77.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.64 -41.77 62.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.081 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -50.34 -39.92 47.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.835 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -53.79 -23.36 21.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.535 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -82.14 -36.84 27.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.362 . . . . 0.0 110.898 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.572 HD21 HG12 ' A' ' 241' ' ' ILE . 69.0 mt -91.08 16.92 8.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -64.88 145.44 56.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.414 ' O ' ' CD1' ' A' ' 281' ' ' PHE . 52.0 p90 -72.35 124.77 25.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.724 ' O ' HD22 ' A' ' 229' ' ' LEU . 91.5 t -123.04 127.61 74.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.11 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.461 ' HA ' ' CD2' ' A' ' 229' ' ' LEU . 70.1 mt-10 -58.51 161.78 4.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.02 123.41 25.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -96.49 138.2 34.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 45.8 mt -120.38 104.07 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -100.77 143.11 31.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 30.8 m -125.3 144.34 47.28 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.64 0.734 . . . . 0.0 111.115 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 148.85 65.81 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.667 2.244 . . . . 0.0 112.341 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.4 t -93.5 -55.92 3.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 163.29 -158.2 30.52 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.47 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 86.68 0.58 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.669 2.246 . . . . 0.0 112.342 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 4.4 m -52.85 113.86 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 2.6 m 56.39 52.72 9.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.859 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.445 -179.988 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 3.6 m -132.36 145.55 51.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.881 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 27.8 t -160.93 137.37 8.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.842 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.52 -137.54 3.72 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.541 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.0 t -84.69 106.92 16.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.933 0.397 . . . . 0.0 110.88 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.3 p -82.44 100.87 10.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 60.92 -93.5 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.524 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 52.4 p -85.75 144.79 27.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.922 0.392 . . . . 0.0 111.142 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -48.3 -49.26 34.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -68.82 166.64 17.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.1 pp -138.88 155.68 47.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -109.96 155.76 21.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.075 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . -88.5 112.59 23.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.064 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.44 -30.71 61.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 1.076 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 58.9 m-85 -117.62 138.36 52.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -139.17 147.71 42.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -121.84 144.88 48.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -147.27 112.21 5.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -136.17 147.62 47.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 37.4 t -101.18 122.95 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.157 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 99.6 t -108.21 136.34 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.46 ' O ' ' N ' ' A' ' 229' ' ' LEU . 37.7 mtt-85 -54.15 122.44 10.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -42.1 -32.04 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -74.94 -37.5 61.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.682 HD13 ' HB2' ' A' ' 281' ' ' PHE . 51.5 mt -74.87 -30.01 61.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.462 ' HE3' HD11 ' A' ' 255' ' ' LEU . 4.0 mmt -37.26 -61.51 0.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.0 -53.48 2.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 35.6 mt -67.04 -54.61 19.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.815 0.34 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.443 ' O ' ' ND2' ' A' ' 240' ' ' ASN . . . -43.06 -48.85 6.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.571 HG22 ' HA2' ' A' ' 238' ' ' GLY . 38.8 mt -71.49 -34.6 53.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.095 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 94.21 -145.97 17.93 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.474 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 237' ' ' HIS . 0.0 OUTLIER -99.84 140.26 34.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.86 0.362 . . . . 0.0 111.104 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 236' ' ' THR . 8.1 m170 36.76 42.59 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.571 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 59.72 65.6 3.31 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.493 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 27.2 t -93.54 -59.58 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.82 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 233' ' ' ALA . 2.4 m120 -47.16 -57.86 4.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.904 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.706 HG12 HD21 ' A' ' 279' ' ' LEU . 27.2 mt -45.01 -53.46 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.159 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -46.97 -64.77 0.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -42.36 -45.34 4.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.56 98.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.077 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -72.32 -12.71 61.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.902 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -95.99 8.46 43.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.588 HG13 ' HD2' ' A' ' 248' ' ' PRO . 84.2 t -86.93 136.69 33.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.597 0.713 . . . . 0.0 111.159 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.588 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.1 Cg_endo -69.86 130.06 18.58 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.66 2.24 . . . . 0.0 112.319 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.43 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 102.21 -9.13 56.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.452 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 45.9 t -91.62 99.3 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.886 0.374 . . . . 0.0 111.137 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.7 p -55.34 -49.46 72.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -159.36 170.02 22.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.498 HG12 HG23 ' A' ' 264' ' ' ILE . 56.8 mt -144.2 106.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -101.89 155.42 18.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.705 HD22 ' CE1' ' A' ' 262' ' ' PHE . 2.5 tp -138.76 122.44 17.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.52 ' N ' HD12 ' A' ' 255' ' ' LEU . 19.1 m-20 -93.42 102.32 14.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.49 -33.06 68.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -43.35 -46.72 6.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.857 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 11.1 p -122.75 -9.89 8.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 256' ' ' ASP . . . 79.2 56.61 3.4 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.52 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 25.2 m -117.95 112.84 20.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.849 0.357 . . . . 0.0 111.153 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.705 ' CE1' HD22 ' A' ' 255' ' ' LEU . 9.9 m-85 -85.01 114.25 22.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -106.58 123.32 47.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.984 HG22 HG12 ' A' ' 272' ' ' VAL . 6.3 mt -109.53 146.46 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -128.12 118.5 23.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.675 ' O ' ' HB1' ' A' ' 217' ' ' ALA . . . -142.23 155.73 25.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -71.95 -25.22 61.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.873 0.368 . . . . 0.0 110.874 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 270' ' ' ASP . 2.3 m -141.75 132.23 25.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 1.076 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -40.12 -27.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.096 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 268' ' ' SER . 0.8 OUTLIER -62.13 -46.65 88.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.43 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -61.38 -64.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.115 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.984 HG12 HG22 ' A' ' 264' ' ' ILE . 0.9 OUTLIER -51.29 -35.45 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.111 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 269' ' ' ALA . 19.0 mtpp -63.06 -53.55 51.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -56.81 -39.57 74.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.933 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.37 -41.93 69.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.524 ' HB2' HD12 ' A' ' 264' ' ' ILE . 39.5 ttp180 -59.06 -27.55 65.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -67.84 -6.9 46.66 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.459 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -101.37 -32.52 10.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 0.0 110.891 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.706 HD21 HG12 ' A' ' 241' ' ' ILE . 40.8 mt -86.29 0.94 52.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -47.07 155.31 0.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.682 ' HB2' HD13 ' A' ' 229' ' ' LEU . 41.9 p90 -82.67 127.71 33.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.852 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.469 ' O ' HD22 ' A' ' 229' ' ' LEU . 87.0 t -123.74 131.44 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.152 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.598 ' HG2' HD21 ' A' ' 229' ' ' LEU . 31.6 mt-10 -89.7 162.71 15.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -40.6 103.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -100.85 138.12 38.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 50.6 mt -106.77 98.79 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.85 136.35 34.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.07 146.27 71.09 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.658 0.742 . . . . 0.0 111.116 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 -40.85 4.9 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.648 2.232 . . . . 0.0 112.381 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.2 t -53.13 114.0 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.829 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -115.35 150.68 18.65 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.532 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -11.69 31.4 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.71 2.273 . . . . 0.0 112.339 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 42.0 t -119.06 143.95 46.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.835 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.5 t -108.72 -62.82 1.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.497 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 27.4 t -100.73 159.92 14.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.83 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 93.7 p -94.23 123.97 37.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 124.57 -177.59 16.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.471 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 14.8 p -113.41 134.89 54.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 0.0 110.865 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.5 p -81.17 135.78 35.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.861 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -147.99 164.32 28.89 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.499 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 9.3 t -98.09 138.05 35.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.36 . . . . 0.0 111.15 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -102.74 -55.92 2.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -90.14 132.91 35.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.928 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.1 mp -66.3 -35.73 81.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.08 146.35 54.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . -119.44 116.49 26.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.114 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.04 -38.78 68.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.07 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.802 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 39.2 m-85 -111.08 139.38 46.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -135.4 151.84 50.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -132.88 146.29 51.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.462 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 7.3 tm-20 -152.3 116.7 5.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -137.95 153.62 49.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.481 HG22 ' OG1' ' A' ' 261' ' ' THR . 38.6 t -102.06 121.5 53.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.622 HG22 ' HD2' ' A' ' 281' ' ' PHE . 25.2 t -103.89 140.98 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.137 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.411 ' HB2' HD12 ' A' ' 229' ' ' LEU . 82.3 mtt180 -56.51 127.08 29.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -50.8 -21.86 1.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.64 -42.25 18.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.831 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.467 HD13 ' HB2' ' A' ' 281' ' ' PHE . 65.9 mt -77.86 -16.17 58.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.55 ' CE ' HD11 ' A' ' 255' ' ' LEU . 5.3 mmt -45.25 -67.73 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.844 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.13 -58.29 1.97 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.501 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.472 HD22 ' HE2' ' A' ' 285' ' ' PHE . 50.5 mt -55.31 -62.88 1.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.806 0.336 . . . . 0.0 110.931 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.679 ' HB2' ' HA ' ' A' ' 281' ' ' PHE . . . -42.33 -45.69 4.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.683 HG23 HG13 ' A' ' 241' ' ' ILE . 54.9 mt -73.39 -29.28 27.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.137 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 232' ' ' LEU . . . 93.75 -162.35 25.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.513 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 67.9 p -96.68 123.82 40.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.155 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 60.25 37.66 20.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.43 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 61.54 63.21 5.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.435 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 5.5 t -92.55 -58.29 2.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.907 0.384 . . . . 0.0 110.843 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -50.06 -53.23 28.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.683 HG13 HG23 ' A' ' 234' ' ' ILE . 14.4 mt -49.76 -49.12 20.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -50.31 -63.46 1.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -48.31 -41.59 28.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.39 -52.94 63.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -62.65 -12.12 21.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -96.02 11.8 32.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.683 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.0 t -91.3 138.91 25.39 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.617 0.722 . . . . 0.0 111.127 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.683 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.76 139.4 40.12 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.677 2.251 . . . . 0.0 112.381 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 96.2 -24.19 31.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.454 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 86.0 t -77.88 109.89 12.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 30.0 p -67.47 -49.8 61.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.154 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.14 153.6 22.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.494 HG12 HG23 ' A' ' 264' ' ' ILE . 22.4 mt -128.81 112.38 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -112.35 153.67 26.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.709 HD22 ' CE1' ' A' ' 262' ' ' PHE . 11.1 tp -137.79 109.42 7.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.959 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.44 92.29 3.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.93 -25.43 68.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.874 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -43.8 -49.57 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 2.3 p -116.83 -29.28 6.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.127 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 107.78 43.86 1.28 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.434 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.481 ' OG1' HG22 ' A' ' 224' ' ' VAL . 6.5 m -110.79 133.42 53.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 111.117 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.709 ' CE1' HD22 ' A' ' 255' ' ' LEU . 10.5 m-85 -99.59 113.97 26.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.5 mtt-85 -103.69 113.93 27.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.844 HG22 HG12 ' A' ' 272' ' ' VAL . 9.3 mt -109.25 136.54 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.096 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -120.58 123.57 43.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.569 ' O ' ' HB1' ' A' ' 217' ' ' ALA . . . -142.7 151.13 22.84 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.515 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.95 -27.39 66.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 12.1 m -138.14 132.68 32.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.861 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.802 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -41.24 -35.24 0.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -55.55 -46.88 77.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.507 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -59.05 -67.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.844 HG12 HG22 ' A' ' 264' ' ' ILE . 1.5 m -51.61 -34.22 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -65.05 -49.6 69.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -66.0 -36.34 83.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -75.54 -30.86 59.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -60.37 -47.67 85.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -45.53 -27.8 2.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -78.85 -41.7 29.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.873 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.502 HD22 ' CE1' ' A' ' 262' ' ' PHE . 88.6 mt -80.21 -13.8 58.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -57.11 138.51 54.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.923 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.679 ' HA ' ' HB2' ' A' ' 233' ' ' ALA . 17.5 p90 -65.78 143.99 57.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.917 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 45.6 t -128.23 126.63 66.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.143 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -58.88 166.82 1.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.8 141.55 38.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.848 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' PHE . . . . . 0.472 ' HE2' HD22 ' A' ' 232' ' ' LEU . 53.3 m-85 -88.33 144.22 26.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 63.4 mt -127.68 109.32 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -110.63 119.05 37.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.686 HG23 ' HD2' ' A' ' 289' ' ' PRO . 4.4 p -113.04 138.84 22.41 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.647 0.737 . . . . 0.0 111.168 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.686 ' HD2' HG23 ' A' ' 288' ' ' VAL . 53.6 Cg_endo -69.73 118.71 5.84 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.71 2.273 . . . . 0.0 112.319 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 t -116.2 -56.15 2.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.897 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 151.45 82.14 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.523 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 151.52 69.01 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.647 2.231 . . . . 0.0 112.366 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 4.8 m -109.62 164.51 12.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.82 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 60.6 p -105.32 178.92 4.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.838 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.518 -179.931 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 30.4 t -150.58 106.42 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.875 0.369 . . . . 0.0 110.841 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 60.3 p -160.78 134.8 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.35 152.02 23.88 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.5 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 62.7 m -72.33 166.63 22.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.887 0.375 . . . . 0.0 110.867 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 98.7 p -104.24 129.27 52.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 65.81 -164.9 38.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.488 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 71.2 p -111.09 138.04 48.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 0.0 111.174 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -100.74 113.51 26.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -70.47 82.84 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.961 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 25.2 tp -168.36 116.93 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -45.25 160.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -86.18 132.32 34.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -63.52 -42.6 98.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.1 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.784 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 53.2 m-85 -109.31 143.46 38.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -140.49 137.09 33.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -111.59 143.2 42.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -148.45 112.46 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.914 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.429 ' O ' HG23 ' A' ' 261' ' ' THR . 11.9 p90 -137.77 149.51 46.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.54 HG22 ' OG1' ' A' ' 261' ' ' THR . 20.0 t -95.37 120.98 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.17 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.2 t -103.46 137.14 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -54.94 126.99 26.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -53.95 -22.0 9.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -86.59 -23.66 25.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.753 HD13 ' HB2' ' A' ' 281' ' ' PHE . 37.7 mt -95.33 -12.68 25.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.637 ' CE ' HD11 ' A' ' 255' ' ' LEU . 4.8 mmt -47.1 -60.48 2.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -47.53 -50.83 17.84 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.513 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 49.5 mt -57.56 -55.96 28.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.814 0.34 . . . . 0.0 110.919 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 281' ' ' PHE . . . -52.59 -52.31 55.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.114 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 70.9 mt -61.02 -24.33 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.6 -154.89 34.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.461 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 237' ' ' HIS . 23.9 m -92.93 138.13 31.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 111.153 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 236' ' ' THR . 9.5 m170 37.07 54.46 1.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 50.83 56.73 12.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.484 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 30.2 t -84.96 -60.7 1.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.855 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.42 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 4.4 m120 -49.39 -62.57 1.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 48.2 mt -39.48 -46.44 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.166 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -59.06 -52.92 63.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -54.66 -43.0 72.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.968 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.26 -45.17 95.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.436 ' HA ' HD12 ' A' ' 253' ' ' ILE . 36.0 ttt180 -68.0 -16.38 64.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -91.03 19.82 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.669 HG13 ' HD2' ' A' ' 248' ' ' PRO . 86.4 t -98.28 138.75 20.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.666 0.746 . . . . 0.0 111.125 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.669 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.3 Cg_endo -69.75 131.97 22.38 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.271 . . . . 0.0 112.338 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.12 -22.59 36.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 79.6 t -79.63 108.45 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.373 . . . . 0.0 111.124 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 63.3 p -64.64 -50.91 65.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.09 165.46 36.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.62 HG12 HG23 ' A' ' 264' ' ' ILE . 48.2 mt -139.65 111.95 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -112.87 159.51 18.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.637 HD11 ' CE ' ' A' ' 230' ' ' MET . 15.4 tp -135.83 138.32 42.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -108.69 112.19 24.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -80.15 -35.38 36.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -42.18 -40.58 2.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 78.0 p -124.58 -25.97 3.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 93.68 37.26 5.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.54 ' OG1' HG22 ' A' ' 224' ' ' VAL . 82.4 m -106.81 118.37 36.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 111.169 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.605 ' CE1' HD13 ' A' ' 255' ' ' LEU . 11.1 m-85 -81.15 132.36 35.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -116.57 118.31 32.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.916 HG22 HG12 ' A' ' 272' ' ' VAL . 7.1 mt -112.66 139.44 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -120.9 130.37 53.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.477 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -154.87 146.77 15.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.443 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 32.6 mm-40 -62.35 -33.63 75.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 110.882 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 47.4 m -128.91 132.09 47.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.784 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -44.91 -37.95 4.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.115 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -53.59 -37.76 63.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.853 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -68.01 -65.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.916 HG12 HG22 ' A' ' 264' ' ' ILE . 1.0 OUTLIER -55.15 -29.95 23.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.141 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -66.25 -53.52 35.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.934 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -57.81 -43.65 85.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.56 -32.86 70.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 34.9 ttp85 -55.04 -48.47 73.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -45.92 -32.06 4.45 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.428 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -73.01 -49.24 30.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.841 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.554 HD12 HD11 ' A' ' 264' ' ' ILE . 94.1 mt -71.15 -9.33 57.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -68.12 142.44 55.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.753 ' HB2' HD13 ' A' ' 229' ' ' LEU . 15.5 p90 -63.88 143.49 57.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.24 132.74 69.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.1 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -70.54 133.74 47.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -39.66 138.02 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -110.49 106.37 15.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 49.8 mm -108.61 96.92 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.082 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -121.08 142.56 49.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.666 HG23 ' HD2' ' A' ' 289' ' ' PRO . 5.4 p -89.05 138.63 29.01 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.656 0.741 . . . . 0.0 111.132 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.666 ' HD2' HG23 ' A' ' 288' ' ' VAL . 54.1 Cg_endo -69.72 -44.75 1.92 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.675 2.25 . . . . 0.0 112.388 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 53.2 p 46.49 41.45 9.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -149.31 63.14 0.41 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.477 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 165.11 32.02 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.651 2.234 . . . . 0.0 112.411 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 2.7 m -169.0 121.5 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.7 p -38.5 -32.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.454 -179.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.794 0.331 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -57.16 -37.31 71.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.077 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 1.084 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 45.0 m-85 -114.55 139.63 49.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.851 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -138.97 137.31 36.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -113.43 127.39 56.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.409 ' CD ' ' O ' ' A' ' 222' ' ' GLU . 4.9 tm-20 -135.21 111.97 10.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.522 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 14.9 p90 -139.87 158.17 44.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.584 HG22 ' OG1' ' A' ' 261' ' ' THR . 42.9 t -103.5 128.5 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 36.4 t -110.2 138.46 37.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 17.0 mtm-85 -56.85 128.49 37.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -55.6 -18.12 7.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -84.98 -31.85 23.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 59.8 mt -90.76 -23.32 20.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 25.3 mtp -45.99 -57.13 4.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.76 -61.81 1.53 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.492 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 60.1 mt -60.89 -43.68 98.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.881 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -52.0 -40.57 61.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.121 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 58.1 mt -78.63 -36.41 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 89.94 -155.16 24.36 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.521 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 237' ' ' HIS . 15.0 m -91.88 142.93 27.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.853 0.359 . . . . 0.0 111.156 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.437 ' C ' ' O ' ' A' ' 236' ' ' THR . 9.5 m170 35.2 48.28 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.48 ' O ' ' NE2' ' A' ' 242' ' ' GLN . . . 55.67 59.19 10.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.463 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.0 t -80.83 -63.54 1.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.846 0.355 . . . . 0.0 110.862 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 4.9 m120 -46.84 -61.02 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 31.7 mt -44.1 -61.45 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.087 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' A' ' 242' ' ' GLN . 0.0 OUTLIER -43.8 -44.58 6.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.926 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -63.92 -52.38 60.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -49.57 -38.75 32.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 17.2 ttt-85 -72.19 -21.96 61.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.84 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -81.22 7.36 11.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.682 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.4 t -91.93 138.94 24.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.628 0.728 . . . . 0.0 111.136 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.682 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.3 Cg_endo -69.72 154.25 68.13 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.264 . . . . 0.0 112.407 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.43 -11.68 43.58 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.472 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 95.8 t -90.03 109.85 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.892 0.377 . . . . 0.0 111.136 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 68.5 p -67.92 -50.97 52.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.132 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -156.56 171.01 21.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.593 HG12 HG23 ' A' ' 264' ' ' ILE . 82.4 mt -143.89 110.77 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -111.21 151.96 27.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 256' ' ' ASP . 10.9 tp -131.0 134.98 47.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.579 ' N ' HD12 ' A' ' 255' ' ' LEU . 1.3 m-20 -105.35 110.4 22.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -78.79 -37.14 41.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -43.07 -40.98 3.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 77.2 p -122.78 -22.67 5.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 256' ' ' ASP . . . 86.99 45.44 5.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.483 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.584 ' OG1' HG22 ' A' ' 224' ' ' VAL . 85.3 m -112.74 119.13 37.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 111.116 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.644 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.8 m-85 -81.76 120.87 25.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -110.47 111.78 23.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.823 HG22 HG12 ' A' ' 272' ' ' VAL . 8.6 mt -105.16 145.11 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -125.74 120.35 30.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.598 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -145.29 144.06 12.61 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.486 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 86.4 mt-10 -59.1 -30.19 67.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 0.0 110.868 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 57.9 m -134.37 136.36 43.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 1.084 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -49.34 -33.85 14.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.079 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.81 -38.23 69.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.78 -67.47 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.073 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.823 HG12 HG22 ' A' ' 264' ' ' ILE . 1.3 m -48.51 -30.34 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.184 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -68.98 -52.72 25.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -57.09 -40.03 76.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -74.06 -37.17 64.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.115 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.522 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 27.0 ttt180 -52.45 -42.12 63.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -51.18 -30.85 25.32 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -74.16 -38.94 63.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.644 HD22 ' CE1' ' A' ' 262' ' ' PHE . 96.3 mt -79.84 -23.51 41.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.965 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.483 ' HB1' ' N ' ' A' ' 266' ' ' GLY . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.796 0.331 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.71 -47.73 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.079 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.846 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 61.0 m-85 -103.87 137.02 42.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.425 ' O ' ' CD2' ' A' ' 220' ' ' HIS . 7.7 p-80 -136.22 137.43 40.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -114.47 130.25 56.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.441 ' C ' ' CD ' ' A' ' 222' ' ' GLU . 1.8 tm-20 -133.21 118.63 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.418 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 16.0 p90 -141.86 149.1 39.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 40.4 t -98.9 124.43 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 80.4 t -111.44 137.07 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.105 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 28.0 mtp180 -55.63 126.82 27.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -49.44 -22.68 1.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -77.08 -46.57 23.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 53.7 mt -73.02 -31.69 64.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.611 ' HE1' HD11 ' A' ' 255' ' ' LEU . 19.5 mtp -37.08 -64.38 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.899 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -38.17 -48.08 2.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.62 -50.84 32.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.857 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -50.04 -40.47 45.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.101 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.567 HG23 HG13 ' A' ' 241' ' ' ILE . 54.4 mt -78.25 -36.17 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 99.63 -147.93 18.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 236' ' ' THR . 12.0 t -109.06 119.09 38.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 111.127 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 64.26 38.26 8.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.464 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 64.31 59.34 8.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.47 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.4 t -87.67 -69.76 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 3.6 m120 -43.71 -55.39 4.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.658 HG12 HD21 ' A' ' 279' ' ' LEU . 21.7 mt -49.27 -52.11 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -50.24 -53.18 30.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.482 ' N ' ' NE2' ' A' ' 243' ' ' GLN . 0.3 OUTLIER -55.54 -39.62 70.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.955 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.36 94.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.063 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.623 ' HG3' HD12 ' A' ' 253' ' ' ILE . 44.0 mtp180 -69.47 -17.96 63.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -85.75 12.72 8.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.678 HG13 ' HD2' ' A' ' 248' ' ' PRO . 98.9 t -93.16 138.89 22.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 0.0 111.16 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.678 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.2 Cg_endo -69.83 131.68 21.65 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.705 2.27 . . . . 0.0 112.305 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 98.29 -9.42 63.02 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.517 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 74.2 t -88.65 108.05 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 43.8 p -64.92 -53.1 51.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -158.98 161.47 36.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.106 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.623 HD12 ' HG3' ' A' ' 245' ' ' ARG . 38.8 mt -134.09 96.43 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -94.44 157.35 16.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.611 HD11 ' HE1' ' A' ' 230' ' ' MET . 4.0 tp -141.38 129.02 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.941 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -83.81 96.7 8.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.67 3.09 6.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -93.3 -48.19 6.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.1 p -108.28 -22.51 12.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 89.91 52.64 2.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 31.6 m -122.64 122.73 39.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 0.0 111.093 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.462 ' CE1' HD22 ' A' ' 255' ' ' LEU . 18.4 m-85 -89.57 116.85 28.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -109.08 116.0 31.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.768 HG22 HG12 ' A' ' 272' ' ' VAL . 5.9 mt -104.25 146.72 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.139 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -128.88 127.07 41.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.483 ' N ' ' HB1' ' A' ' 217' ' ' ALA . . . -150.19 147.99 18.75 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.508 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.24 -21.72 66.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.917 0.389 . . . . 0.0 110.892 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 2.1 m -145.34 140.22 27.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.858 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.846 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.21 -30.92 3.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.052 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.27 -38.86 81.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.838 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.472 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -68.96 -65.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.083 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.768 HG12 HG22 ' A' ' 264' ' ' ILE . 0.2 OUTLIER -50.4 -38.65 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -60.87 -53.13 61.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.504 ' HB3' HG11 ' A' ' 247' ' ' VAL . 19.4 tttt -56.35 -40.98 75.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.94 -33.34 70.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.146 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.418 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 36.7 ttp180 -59.7 -43.94 93.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.848 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -52.42 -15.57 2.94 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.445 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -92.78 -33.73 14.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 0.0 110.876 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.658 HD21 HG12 ' A' ' 241' ' ' ILE . 88.3 mt -87.08 7.29 28.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.756 0.312 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -65.56 -41.24 93.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.099 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.631 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 88.3 m-85 -110.96 133.72 53.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.864 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -132.41 132.43 42.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -112.67 151.49 30.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.856 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -152.39 123.99 7.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.449 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 18.5 p90 -142.79 140.68 31.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.592 HG22 ' OG1' ' A' ' 261' ' ' THR . 24.3 t -93.4 122.68 45.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 82.7 t -111.23 137.77 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.137 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.445 ' HB2' HD12 ' A' ' 229' ' ' LEU . 62.0 mtt180 -54.81 127.59 29.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -41.85 -45.27 3.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.848 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -62.78 -37.72 87.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 226' ' ' ARG . 60.6 mt -72.94 -37.84 67.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.888 ' CE ' HD11 ' A' ' 255' ' ' LEU . 27.0 mtp -37.52 -60.62 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -36.13 -61.41 0.8 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 54.0 mt -60.92 -47.07 88.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.938 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -50.17 -41.65 49.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.058 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.407 HG23 HG13 ' A' ' 241' ' ' ILE . 59.4 mt -79.41 -27.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 88.81 -137.63 14.35 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.482 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 4.5 t -112.59 136.63 51.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.804 0.335 . . . . 0.0 111.125 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 27.4 m80 42.13 45.18 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 60.19 65.04 3.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.5 t -91.58 -69.3 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.874 0.369 . . . . 0.0 110.85 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -42.88 -55.26 3.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.407 HG13 HG23 ' A' ' 234' ' ' ILE . 52.4 mt -47.94 -55.45 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.104 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -47.64 -55.8 8.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -50.39 -58.63 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.42 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -45.6 -48.57 14.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -64.59 -24.13 67.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -82.83 17.05 1.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.684 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.5 t -100.44 138.89 20.28 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.616 0.722 . . . . 0.0 111.097 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.684 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.71 137.95 36.82 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.723 2.282 . . . . 0.0 112.358 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 95.67 -12.6 67.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 81.8 t -89.45 104.87 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.898 0.38 . . . . 0.0 111.139 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 71.1 p -60.1 -50.5 73.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.15 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.17 169.84 22.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.07 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.572 HG12 HG23 ' A' ' 264' ' ' ILE . 81.4 mt -141.84 113.96 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.149 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -113.21 160.67 18.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.888 HD11 ' CE ' ' A' ' 230' ' ' MET . 12.1 tp -141.84 108.84 5.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.13 112.89 13.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -80.86 -37.63 29.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -38.96 -42.36 0.85 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 32.0 p -120.34 -21.59 6.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 88.82 51.72 2.97 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.482 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.592 ' OG1' HG22 ' A' ' 224' ' ' VAL . 96.2 m -119.44 136.34 54.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 111.124 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.696 ' CE1' HD22 ' A' ' 279' ' ' LEU . 12.3 m-85 -95.15 125.02 39.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 -114.13 111.05 20.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.572 HG23 HG12 ' A' ' 253' ' ' ILE . 6.7 mt -105.02 135.48 42.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.138 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -116.27 126.55 53.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.541 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -148.42 141.12 8.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.505 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 65.2 mt-10 -59.71 -33.63 71.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 110.856 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.1 m -128.8 136.79 50.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.631 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.32 -29.33 2.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.079 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.04 -39.88 93.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -68.46 -62.62 1.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.541 HG13 ' HA3' ' A' ' 266' ' ' GLY . 0.1 OUTLIER -52.18 -31.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.171 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -70.85 -50.44 35.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.934 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -59.75 -44.59 93.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.42 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -66.64 -35.64 80.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -59.44 -37.57 78.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -56.83 -13.11 7.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.438 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -95.1 -25.49 16.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.883 0.373 . . . . 0.0 110.839 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.696 HD22 ' CE1' ' A' ' 262' ' ' PHE . 76.8 mt -98.74 0.96 45.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.877 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.425 ' HB1' ' N ' ' A' ' 266' ' ' GLY . . . . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.767 0.318 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.67 83.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.072 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -104.82 140.78 37.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -130.52 153.38 48.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -132.68 136.72 46.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.83 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.495 ' CG ' ' HG2' ' A' ' 263' ' ' ARG . 3.5 mt-10 -145.74 116.41 7.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.894 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -139.2 147.3 41.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.423 HG22 ' OG1' ' A' ' 261' ' ' THR . 15.2 t -94.81 116.92 37.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.172 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 73.5 t -98.25 147.42 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -58.74 124.97 21.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -53.89 -16.23 1.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.931 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.8 -38.75 15.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 230' ' ' MET . 69.9 mt -79.64 -29.03 40.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.417 ' CE ' HD11 ' A' ' 255' ' ' LEU . 19.8 mtp -37.42 -66.62 0.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -38.34 -46.74 2.02 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.51 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 56.8 mt -69.84 -57.05 5.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -45.06 -38.47 4.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.412 HG23 HG13 ' A' ' 241' ' ' ILE . 71.4 mt -77.27 -35.45 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 92.64 -145.98 17.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.487 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' HIS . 24.9 p -100.56 143.65 30.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 236' ' ' THR . 6.6 m80 34.77 41.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 61.89 61.35 6.81 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.432 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.6 m -86.83 -59.9 2.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.84 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -49.3 -54.68 15.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.412 HG13 HG23 ' A' ' 234' ' ' ILE . 18.2 mt -48.02 -52.85 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -52.29 -44.59 65.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -60.45 -50.88 71.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -53.86 -36.2 62.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.058 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -74.61 -11.94 60.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -93.97 15.11 17.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.676 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.5 t -96.98 138.91 21.29 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.614 0.721 . . . . 0.0 111.126 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.676 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.5 Cg_endo -69.83 144.94 55.21 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.641 2.227 . . . . 0.0 112.323 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 91.37 -19.65 45.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 91.4 t -84.46 112.59 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.957 0.408 . . . . 0.0 111.155 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 217' ' ' ALA . 41.8 p -68.86 -46.78 67.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -162.12 166.09 26.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.098 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.549 HG12 HG23 ' A' ' 264' ' ' ILE . 91.4 mt -140.5 115.65 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.121 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -117.76 154.39 31.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.469 HD12 ' H ' ' A' ' 256' ' ' ASP . 11.5 tp -130.77 147.13 52.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.469 ' H ' HD12 ' A' ' 255' ' ' LEU . 5.7 m-20 -107.85 136.07 48.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -101.34 -18.25 16.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -58.03 -49.17 77.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 63.3 p -123.68 -25.63 4.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.108 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 99.95 54.68 1.03 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.485 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.423 ' OG1' HG22 ' A' ' 224' ' ' VAL . 27.2 m -114.14 121.84 45.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.884 0.373 . . . . 0.0 111.127 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.708 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.9 m-85 -86.29 113.99 22.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . 0.495 ' HG2' ' CG ' ' A' ' 222' ' ' GLU . 48.6 mtm180 -98.83 114.59 27.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 1.002 HG22 HG12 ' A' ' 272' ' ' VAL . 17.9 mt -111.08 133.07 57.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -113.91 122.95 48.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.634 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -146.12 143.82 12.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.5 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.35 -23.6 67.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 0.0 110.927 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 24.5 m -141.74 131.33 23.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.797 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -42.57 -34.27 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.122 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -55.72 -43.48 76.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.411 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -65.29 -68.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 1.002 HG12 HG22 ' A' ' 264' ' ' ILE . 1.0 OUTLIER -48.1 -31.82 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -67.2 -50.9 59.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -59.42 -40.12 85.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.56 -38.5 65.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -49.28 -46.88 46.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.41 -32.94 10.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.504 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -71.83 -42.03 67.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.871 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.708 HD22 ' CE1' ' A' ' 262' ' ' PHE . 97.1 mt -78.75 -13.27 59.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.92 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.934 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.723 0.297 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -60.55 -33.76 73.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.82 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 79.8 m-85 -121.97 134.32 54.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.915 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.427 ' O ' ' CD2' ' A' ' 220' ' ' HIS . 7.6 p-80 -136.01 133.3 37.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -112.64 138.57 49.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.458 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 20.4 tt0 -141.6 125.3 16.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.515 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 11.8 p90 -142.4 149.66 39.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.847 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.62 115.5 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.16 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 41.4 t -104.94 136.57 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.109 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.411 ' HB2' HD12 ' A' ' 229' ' ' LEU . 51.5 mtp180 -54.4 133.94 45.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -50.91 -28.8 10.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -74.82 -39.69 61.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.857 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 226' ' ' ARG . 53.4 mt -74.01 -27.11 60.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.796 ' CE ' HD11 ' A' ' 255' ' ' LEU . 8.5 mmm -41.5 -55.68 2.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -52.22 -40.24 52.13 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 44.1 mt -71.71 -58.62 3.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -52.02 -37.33 53.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.064 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 37.6 mt -77.03 -33.4 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.145 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 88.9 -150.93 21.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.429 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 236' ' ' THR . 9.9 t -103.03 123.92 47.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 0.0 111.139 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 18.7 m80 55.32 46.41 23.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 56.83 58.32 15.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.509 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.5 t -84.45 -57.67 3.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.361 . . . . 0.0 110.862 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 2.5 m120 -54.37 -57.62 10.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.728 HG12 HD21 ' A' ' 279' ' ' LEU . 70.7 mt -45.22 -49.58 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -51.92 -68.47 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -44.01 -35.3 2.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 241' ' ' ILE . . . -62.78 -51.67 66.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -66.96 -11.85 57.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -86.91 3.36 45.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.68 HG13 ' HD2' ' A' ' 248' ' ' PRO . 97.7 t -89.74 138.85 27.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 111.091 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.68 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.8 144.76 54.83 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.93 -14.75 62.51 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.462 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 93.8 t -88.97 103.1 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 0.0 111.153 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 64.9 p -56.9 -50.85 71.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -161.15 171.41 18.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 264' ' ' ILE . 49.4 mt -143.52 113.17 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.144 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -116.11 156.98 25.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.796 HD11 ' CE ' ' A' ' 230' ' ' MET . 7.8 tp -142.09 147.21 36.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.43 ' H ' HD12 ' A' ' 255' ' ' LEU . 5.2 t0 -103.97 135.57 45.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -100.22 -23.03 14.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -82.58 -22.03 35.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 68.1 p -120.74 -23.23 6.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 71.79 47.31 33.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.458 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 90.2 m -122.62 124.08 42.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.353 . . . . 0.0 111.174 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.677 ' CZ ' HD22 ' A' ' 255' ' ' LEU . 10.7 m-85 -87.14 123.07 31.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -113.39 115.95 28.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.691 HG22 HG12 ' A' ' 272' ' ' VAL . 7.1 mt -108.42 139.26 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.137 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -119.22 121.42 39.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.578 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -144.73 145.12 14.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.518 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 38.0 mt-10 -62.09 -33.34 74.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.891 0.377 . . . . 0.0 110.946 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.8 m -132.93 135.23 45.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.864 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.82 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -46.11 -26.94 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.118 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -60.87 -40.94 94.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.53 -64.36 0.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.137 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.691 HG12 HG22 ' A' ' 264' ' ' ILE . 0.2 OUTLIER -50.07 -31.08 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 269' ' ' ALA . 19.5 mtpp -68.99 -53.18 21.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.874 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -42.99 94.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.84 -33.89 76.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -61.37 -41.43 97.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.879 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.418 ' HA2' ' CG ' ' A' ' 280' ' ' GLU . . . -51.54 -20.02 5.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.478 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -85.32 -39.89 17.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.913 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.728 HD21 HG12 ' A' ' 241' ' ' ILE . 72.3 mt -87.24 6.16 34.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.418 ' CG ' ' HA2' ' A' ' 277' ' ' GLY . 7.6 mm-40 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.817 0.341 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -73.92 -30.12 62.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.09 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.876 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 68.1 m-85 -118.22 137.94 52.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.88 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -144.02 148.68 35.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -117.67 136.23 53.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -132.98 113.36 12.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 15.7 p90 -137.61 141.3 41.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.613 HG22 ' OG1' ' A' ' 261' ' ' THR . 59.2 t -92.62 120.17 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 53.5 t -103.47 136.07 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.456 ' HB2' HD12 ' A' ' 229' ' ' LEU . 2.9 mmp_? -53.38 130.94 36.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -52.78 -16.72 1.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -92.9 -36.34 12.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.456 HD12 ' HB2' ' A' ' 226' ' ' ARG . 88.4 mt -74.38 -23.52 59.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.655 ' CE ' HD11 ' A' ' 255' ' ' LEU . 4.6 mtt -41.14 -65.2 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.895 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -35.44 -56.3 0.96 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.468 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 235' ' ' GLY . 41.6 mt -63.95 -64.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -41.32 -28.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.152 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 60.1 mt -89.95 -34.43 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 232' ' ' LEU . . . 89.94 -149.97 20.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 237' ' ' HIS . 4.9 t -98.9 143.58 29.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 111.192 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.44 ' C ' ' O ' ' A' ' 236' ' ' THR . 27.3 m-70 34.85 45.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.841 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 60.31 60.08 9.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.49 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.4 t -84.43 -61.46 1.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.876 0.37 . . . . 0.0 110.852 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -48.51 -59.84 3.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 30.9 mt -42.62 -53.37 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -50.05 -67.9 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -39.92 -52.8 2.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -50.69 -48.16 58.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -69.28 -13.55 62.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.841 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -86.27 6.82 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.683 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.4 t -92.71 138.88 23.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.628 0.728 . . . . 0.0 111.119 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.683 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.76 149.95 67.6 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.709 2.273 . . . . 0.0 112.309 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.05 -19.24 31.48 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.505 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 265' ' ' TYR . 94.9 t -83.54 107.11 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.398 . . . . 0.0 111.129 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 59.1 p -60.2 -56.04 26.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.167 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -156.34 162.11 40.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.125 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.841 HG12 HG23 ' A' ' 264' ' ' ILE . 76.4 mt -135.14 107.05 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -107.13 163.27 13.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.655 HD11 ' CE ' ' A' ' 230' ' ' MET . 7.9 tp -141.06 141.98 34.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.933 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -100.33 129.7 46.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -100.31 -14.9 18.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -63.69 -38.72 92.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 54.5 p -128.81 -29.46 2.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.091 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.16 58.69 0.78 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.495 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.613 ' OG1' HG22 ' A' ' 224' ' ' VAL . 91.2 m -125.35 122.38 36.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 111.107 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.537 ' CZ ' HD22 ' A' ' 255' ' ' LEU . 11.1 m-85 -86.5 123.99 32.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -110.84 111.89 23.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.876 HG22 HG12 ' A' ' 272' ' ' VAL . 9.5 mt -104.44 141.02 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.407 ' O ' HG13 ' A' ' 250' ' ' VAL . 87.2 m-85 -121.63 131.28 54.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -154.29 143.63 10.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.481 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -58.22 -32.53 68.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 0.0 110.938 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.1 t -134.67 137.07 43.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.877 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.876 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.43 -28.87 2.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.134 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -42.53 84.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.74 -66.89 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.112 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.876 HG12 HG22 ' A' ' 264' ' ' ILE . 0.2 OUTLIER -48.76 -34.84 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 36.2 mttm -64.23 -50.75 66.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -63.32 -39.75 95.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.8 -29.62 62.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.466 ' CZ ' ' OE1' ' A' ' 280' ' ' GLU . 21.2 ttt-85 -60.7 -42.79 97.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.841 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.41 ' HA2' ' CG ' ' A' ' 280' ' ' GLU . . . -51.09 -24.93 9.64 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.491 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -80.36 -25.82 38.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 110.866 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.471 HD22 ' CE1' ' A' ' 262' ' ' PHE . 68.3 mt -102.16 11.39 38.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.466 ' OE1' ' CZ ' ' A' ' 276' ' ' ARG . 8.9 mm-40 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.047 0 CA-C-O 120.802 0.334 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.81 86.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.127 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.557 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 83.4 m-85 -108.02 142.29 38.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -133.06 140.46 47.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -111.55 141.85 44.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.418 ' CD ' ' C ' ' A' ' 222' ' ' GLU . 0.6 OUTLIER -148.94 111.31 4.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.837 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.528 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 34.0 p90 -140.9 151.42 44.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 20.0 t -96.52 134.34 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.123 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 69.0 t -118.61 137.38 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -57.02 130.07 44.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -57.7 -22.53 46.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -83.72 -19.54 35.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 229' ' ' LEU . 30.9 mt -100.42 -18.07 16.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.557 ' CE ' HD11 ' A' ' 255' ' ' LEU . 4.8 mmt -45.02 -66.96 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -40.45 -40.59 2.03 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.511 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 40.9 mt -69.94 -55.99 8.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.834 0.35 . . . . 0.0 110.945 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -52.9 -38.43 61.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.045 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 25.7 mt -77.5 -37.8 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 95.16 -158.5 22.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.471 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 22.1 m -95.77 128.59 42.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 111.189 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 67.4 t60 52.67 46.34 26.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.831 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 53.76 67.95 1.89 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.511 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.8 t -92.8 -61.51 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 110.912 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -50.02 -60.58 2.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 19.2 mt -41.61 -49.06 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -54.53 -51.2 65.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -58.02 -37.63 74.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.94 96.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.444 ' HG3' HD12 ' A' ' 253' ' ' ILE . 5.9 mtp-105 -70.7 -0.91 9.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -104.98 12.88 31.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.654 HG13 ' HD2' ' A' ' 248' ' ' PRO . 84.9 t -95.16 138.63 21.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 111.142 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.654 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.7 Cg_endo -69.77 133.4 25.46 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.683 2.255 . . . . 0.0 112.331 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 96.74 -0.43 61.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 74.5 t -102.17 106.57 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 111.147 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 265' ' ' TYR . 35.9 p -63.0 -58.25 7.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -151.47 157.59 42.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.629 HG12 HG23 ' A' ' 264' ' ' ILE . 66.0 mt -130.37 114.17 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.148 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -118.38 149.12 41.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.557 HD11 ' CE ' ' A' ' 230' ' ' MET . 8.9 tp -127.56 147.7 50.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.944 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.532 ' H ' HD12 ' A' ' 255' ' ' LEU . 0.8 OUTLIER -112.84 118.92 36.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -84.74 -27.82 26.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -49.72 -40.5 40.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 62.0 p -125.25 -27.76 3.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.139 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 97.68 39.01 4.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 35.1 m -103.97 130.28 51.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 0.0 111.146 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.823 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.9 m-85 -93.58 116.6 29.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 53.5 mtt-85 -104.28 119.23 38.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.707 HG22 HG12 ' A' ' 272' ' ' VAL . 10.9 mt -115.49 143.32 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 251' ' ' THR . 88.9 m-85 -122.9 117.16 24.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.61 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -141.07 151.35 22.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.506 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -69.74 -26.51 64.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.2 p -132.71 132.79 42.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.21 -29.89 2.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.103 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.31 -35.71 81.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -69.79 -53.96 15.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.08 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.707 HG12 HG22 ' A' ' 264' ' ' ILE . 0.4 OUTLIER -63.11 -29.54 47.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -72.22 -51.32 21.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -55.53 -48.94 73.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.97 -34.36 76.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.528 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 45.9 ttt180 -53.88 -47.06 71.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -46.44 -26.12 2.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -79.53 -33.71 41.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.905 0.383 . . . . 0.0 110.884 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.823 HD22 ' CE1' ' A' ' 262' ' ' PHE . 92.9 mt -85.27 -17.23 37.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.765 0.317 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -66.83 -36.29 82.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.074 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.536 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 88.2 m-85 -112.56 141.01 46.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.912 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -140.89 138.73 34.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.853 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -113.93 138.62 50.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -139.12 121.36 15.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 12.9 p90 -142.33 143.14 32.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.94 119.73 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.31 134.73 50.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 229' ' ' LEU . 46.9 mtm180 -54.26 120.9 7.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -38.15 -28.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 226' ' ' ARG . 15.9 t0 -72.42 -44.36 62.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 226' ' ' ARG . 86.4 mt -74.14 -26.15 60.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.842 ' CE ' HD11 ' A' ' 255' ' ' LEU . 30.3 mtp -49.22 -58.91 4.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -36.47 -56.62 1.22 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.464 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 50.4 mt -67.78 -52.17 40.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -46.24 -34.59 4.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.087 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 56.4 mt -85.94 -32.44 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.128 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 93.78 -150.57 19.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.485 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 85.2 m -111.34 112.67 24.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 111.129 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 73.73 35.03 0.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.82 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 63.05 62.8 5.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 27.6 t -92.21 -53.62 4.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.835 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 7.1 m120 -58.01 -50.53 73.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 52.7 mt -52.06 -45.74 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.124 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -53.95 -67.31 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -42.79 -43.45 3.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.82 81.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.423 ' CG ' HD12 ' A' ' 253' ' ' ILE . 54.7 mtp180 -69.8 -21.69 63.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -76.33 -5.01 45.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.671 HG13 ' HD2' ' A' ' 248' ' ' PRO . 84.0 t -77.78 138.65 62.06 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.63 0.729 . . . . 0.0 111.104 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.671 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.0 Cg_endo -69.77 143.31 50.4 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.662 2.241 . . . . 0.0 112.388 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 91.41 -19.92 44.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.0 t -80.49 106.05 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.921 0.391 . . . . 0.0 111.129 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.459 ' CG2' ' HB2' ' A' ' 217' ' ' ALA . 32.6 p -60.09 -58.76 7.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.159 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -154.46 159.13 40.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.499 HG12 HG23 ' A' ' 264' ' ' ILE . 50.9 mt -132.57 103.85 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.158 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -104.05 155.63 18.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.842 HD11 ' CE ' ' A' ' 230' ' ' MET . 8.5 tp -140.17 157.11 46.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.649 ' H ' HD12 ' A' ' 255' ' ' LEU . 6.4 t0 -116.93 134.5 54.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -100.88 -16.97 17.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.37 -34.37 28.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.83 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 59.7 p -114.77 -21.76 10.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.186 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 74.02 53.03 7.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.516 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.8 m -122.4 129.47 52.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.319 . . . . 0.0 111.142 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.785 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.9 m-85 -93.11 121.85 34.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.871 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.7 mtm-85 -113.02 114.17 26.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.834 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.734 HG22 HG12 ' A' ' 272' ' ' VAL . 5.2 mt -107.1 138.59 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.112 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 251' ' ' THR . 93.7 m-85 -122.82 117.47 25.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.564 ' O ' ' HB1' ' A' ' 217' ' ' ALA . . . -139.88 144.81 15.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -58.06 -33.4 69.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.899 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.2 t -134.57 137.29 43.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.878 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -45.2 -26.8 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.061 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.25 -44.83 94.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.47 -65.09 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.139 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.734 HG12 HG22 ' A' ' 264' ' ' ILE . 0.9 OUTLIER -48.46 -31.1 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -71.54 -54.14 11.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -58.17 -35.5 71.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -76.46 -37.34 57.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -54.8 -36.61 65.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -58.65 -12.22 13.16 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -94.61 -28.08 15.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 110.891 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.785 HD22 ' CE1' ' A' ' 262' ' ' PHE . 82.2 mt -92.95 -2.68 55.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 179.904 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.777 0.322 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -73.23 -41.22 63.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.614 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 66.1 m-85 -107.98 132.29 53.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -126.17 145.72 50.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -119.22 137.65 53.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -143.53 111.96 6.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.448 ' CE2' ' HG3' ' A' ' 276' ' ' ARG . 30.2 p90 -141.21 150.08 42.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.869 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.412 HG22 ' OG1' ' A' ' 261' ' ' THR . 47.7 t -96.47 132.25 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.5 t -113.77 137.43 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.098 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -53.54 122.06 9.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -49.7 -20.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -86.16 -38.49 17.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 34.6 mt -79.8 -25.24 40.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.525 ' CE ' HD11 ' A' ' 255' ' ' LEU . 25.7 mtp -45.98 -58.84 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.87 -52.24 3.25 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.463 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 26.1 mt -67.8 -50.71 55.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.838 0.352 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.426 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -47.51 -45.78 26.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 52.8 mt -69.68 -40.7 79.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 101.84 -143.87 16.16 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.489 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.56 ' O ' HG23 ' A' ' 236' ' ' THR . 8.8 t -115.29 114.26 24.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.774 0.321 . . . . 0.0 111.13 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 69.19 39.25 1.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 60.11 59.54 10.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 2.5 t -89.29 -60.11 2.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.907 0.384 . . . . 0.0 110.858 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 3.7 m120 -50.6 -56.89 9.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 48.9 mt -44.94 -51.35 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -56.24 -44.43 79.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -60.73 -35.38 76.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.549 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -64.48 -53.63 45.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.483 ' N ' HD12 ' A' ' 253' ' ' ILE . 9.6 ptt180 -60.84 -30.29 70.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -64.81 -6.66 8.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.663 HG13 ' HD2' ' A' ' 248' ' ' PRO . 85.7 t -77.15 138.7 64.69 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.614 0.721 . . . . 0.0 111.136 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.663 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.9 Cg_endo -69.75 128.55 16.2 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.686 2.257 . . . . 0.0 112.368 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 104.12 -12.27 52.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.9 t -87.1 102.2 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 111.137 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 53.0 p -57.1 -48.96 77.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.168 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -162.35 166.86 24.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.096 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.6 HG12 HG23 ' A' ' 264' ' ' ILE . 58.6 mt -139.05 113.11 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.121 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -111.94 152.58 27.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.525 HD11 ' CE ' ' A' ' 230' ' ' MET . 8.3 tp -129.19 110.72 12.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.91 99.4 6.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -73.75 -30.92 63.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.882 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -42.81 -39.52 2.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 3.0 p -127.06 -28.53 2.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.126 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 101.89 40.39 2.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.512 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.412 ' OG1' HG22 ' A' ' 224' ' ' VAL . 93.8 m -110.15 116.79 32.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.846 0.355 . . . . 0.0 111.13 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.489 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.8 m-85 -79.87 118.36 21.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -108.37 113.73 27.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.992 HD11 HD12 ' A' ' 279' ' ' LEU . 40.7 mt -107.25 139.79 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -117.9 121.92 41.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.917 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -144.79 140.45 9.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.504 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -61.99 -33.11 73.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.851 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 271' ' ' ALA . 23.8 p -127.37 123.83 37.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.872 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.614 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -38.5 -33.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.081 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -57.7 -46.05 84.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.834 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 268' ' ' SER . . . -61.27 -68.15 0.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.071 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.917 HG13 ' HA3' ' A' ' 266' ' ' GLY . 3.5 m -47.86 -34.21 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -66.6 -52.23 47.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 39.8 tttt -54.5 -49.04 71.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.549 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -67.43 -38.16 84.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.113 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.448 ' HG3' ' CE2' ' A' ' 223' ' ' PHE . 24.9 ttp85 -47.1 -44.47 21.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -49.27 -35.32 19.99 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -69.43 -42.7 74.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.992 HD12 HD11 ' A' ' 264' ' ' ILE . 81.1 mt -75.05 -27.03 59.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.983 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.916 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.737 0.303 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.84 76.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.103 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.714 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 70.5 m-85 -122.08 125.46 46.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -122.76 138.62 54.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -115.08 146.16 41.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.458 ' HG3' ' CG2' ' A' ' 261' ' ' THR . 19.5 tt0 -149.28 124.6 10.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 4.8 p90 -141.42 146.0 36.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.403 HG22 ' OG1' ' A' ' 261' ' ' THR . 13.0 t -97.83 110.48 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 31.5 t -95.66 146.03 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.453 ' HB2' HD12 ' A' ' 229' ' ' LEU . 12.4 mmm-85 -61.6 148.59 41.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.14 -22.58 66.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -94.47 -12.91 26.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 226' ' ' ARG . 91.5 mt -98.36 -8.93 26.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.554 ' CE ' HD11 ' A' ' 255' ' ' LEU . 2.9 mmt -56.38 -68.63 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -34.74 -57.09 0.78 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.466 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 62.7 mt -61.99 -51.16 69.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.922 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.75 -22.61 47.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.15 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.651 HG22 ' HA2' ' A' ' 238' ' ' GLY . 37.8 mt -100.44 -10.75 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.14 -157.68 53.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.529 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 238' ' ' GLY . 15.2 t -89.33 147.4 24.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.125 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.436 ' C ' ' O ' ' A' ' 236' ' ' THR . 96.1 m-70 35.37 33.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.651 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 65.13 48.91 65.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.476 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 236' ' ' THR . 3.0 t -77.25 -48.84 16.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 110.837 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -53.54 -54.71 33.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.492 ' HA ' HD21 ' A' ' 279' ' ' LEU . 55.7 mt -48.57 -45.46 14.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -55.03 -62.0 1.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 247' ' ' VAL . 80.4 mt-30 -43.75 -49.03 8.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.935 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.42 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -59.19 -43.9 92.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -73.43 -18.07 61.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -90.64 15.24 11.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.665 HG13 ' HD2' ' A' ' 248' ' ' PRO . 98.0 t -93.95 138.38 22.71 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.616 0.722 . . . . 0.0 111.142 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.665 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.5 Cg_endo -69.7 128.89 16.73 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.702 2.268 . . . . 0.0 112.397 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.72 -7.88 50.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.537 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 84.0 t -96.75 103.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 111.137 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 68.3 p -54.11 -57.41 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.149 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.07 174.62 14.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.128 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.642 HG12 HG23 ' A' ' 264' ' ' ILE . 79.1 mt -143.19 108.54 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -105.43 155.34 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.554 HD11 ' CE ' ' A' ' 230' ' ' MET . 9.8 tp -141.01 133.43 28.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.7 120.49 40.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.809 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -85.36 -26.96 26.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.76 -40.03 27.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 35.0 p -127.16 -27.97 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 98.45 54.99 1.12 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.477 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.458 ' CG2' ' HG3' ' A' ' 222' ' ' GLU . 3.5 m -116.3 123.93 48.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.341 . . . . 0.0 111.154 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.538 ' CE1' HD22 ' A' ' 255' ' ' LEU . 11.0 m-85 -92.52 112.74 24.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.883 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 38.4 mtp85 -103.21 120.37 40.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.642 HG23 HG12 ' A' ' 253' ' ' ILE . 7.4 mt -110.89 136.93 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.182 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -116.88 119.59 35.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.625 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -141.51 146.62 17.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.468 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -68.22 -28.28 67.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 p -130.21 130.8 45.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.714 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -43.82 -30.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.072 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.21 -40.79 98.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.47 -65.9 0.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.093 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.625 HG13 ' HA3' ' A' ' 266' ' ' GLY . 0.3 OUTLIER -47.92 -41.25 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -67.13 -47.0 72.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.936 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -59.85 -39.21 84.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.42 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -75.57 -30.35 59.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.139 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -62.84 -39.92 95.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -54.64 -13.38 4.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.514 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -93.91 -26.06 17.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.492 HD21 ' HA ' ' A' ' 241' ' ' ILE . 83.0 mt -94.85 6.2 49.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.803 0.335 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -70.94 -29.17 65.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.069 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.932 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 86.6 m-85 -123.37 114.5 20.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -118.03 145.6 44.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -114.33 133.22 55.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.465 ' C ' ' CD ' ' A' ' 222' ' ' GLU . 0.3 OUTLIER -135.87 117.04 14.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.527 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 12.0 p90 -142.57 151.77 41.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.851 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 18.4 t -102.26 121.99 53.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.082 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 93.2 t -109.24 144.98 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.532 ' HB2' HD12 ' A' ' 229' ' ' LEU . 70.8 mtt180 -60.9 122.06 13.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -40.48 -32.37 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.95 -43.08 56.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.532 HD12 ' HB2' ' A' ' 226' ' ' ARG . 80.2 mt -71.23 -25.39 62.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.834 ' CE ' HD11 ' A' ' 255' ' ' LEU . 26.5 mtp -47.22 -64.46 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -36.32 -51.69 1.31 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.48 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 63.1 mt -67.03 -44.6 79.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 110.947 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -55.56 -37.9 68.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.554 HG23 HG13 ' A' ' 241' ' ' ILE . 41.8 mt -83.7 -27.61 7.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.147 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 90.18 -153.94 23.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.524 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 91.2 m -108.66 117.13 33.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.8 0.333 . . . . 0.0 111.182 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 9.1 t60 72.93 30.64 1.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.857 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 65.31 56.76 13.82 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.522 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 30.8 t -86.49 -58.15 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 0.0 110.856 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 4.6 m120 -51.17 -59.39 4.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.906 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.554 HG13 HG23 ' A' ' 234' ' ' ILE . 44.3 mt -42.83 -48.34 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -54.93 -55.36 31.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -48.74 -54.76 13.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.43 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -52.62 -40.6 62.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.075 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -71.31 -19.45 62.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -85.09 15.75 3.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.65 HG13 ' HD2' ' A' ' 248' ' ' PRO . 95.6 t -98.6 138.05 20.71 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.634 0.731 . . . . 0.0 111.092 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.65 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.3 Cg_endo -69.73 133.07 24.74 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.698 2.265 . . . . 0.0 112.391 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 101.41 -17.65 55.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.521 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 275' ' ' ALA . 58.7 t -87.31 101.78 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.851 0.358 . . . . 0.0 111.164 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 66.7 p -56.28 -47.91 77.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -163.76 170.88 16.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.081 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 264' ' ' ILE . 86.8 mt -140.1 116.22 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.101 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -113.65 160.45 18.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.834 HD11 ' CE ' ' A' ' 230' ' ' MET . 4.1 tp -142.13 144.0 33.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -104.61 126.64 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.828 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -97.25 -19.17 18.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -58.6 -44.28 89.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 67.6 p -124.1 -31.01 3.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.173 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.67 57.35 0.7 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 90.7 m -122.65 119.17 29.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 111.189 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.584 ' CD1' HD13 ' A' ' 279' ' ' LEU . 12.4 m-85 -85.7 130.97 34.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -119.49 119.2 33.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.747 HG22 HG12 ' A' ' 272' ' ' VAL . 6.2 mt -109.47 139.94 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.148 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -120.0 115.53 23.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.476 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -140.16 138.05 8.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.453 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -56.86 -29.48 62.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.861 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.1 t -134.91 138.95 44.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.932 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.78 -30.19 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.071 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -59.56 -40.68 88.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.402 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -68.09 -67.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.747 HG12 HG22 ' A' ' 264' ' ' ILE . 0.3 OUTLIER -47.32 -38.46 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -64.03 -54.59 31.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -39.82 78.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.906 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.43 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -71.18 -35.75 71.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.054 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.41 ' HB2' HD12 ' A' ' 264' ' ' ILE . 50.1 ttt180 -59.17 -35.59 73.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -60.05 -8.87 9.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.493 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -98.72 -24.65 14.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 110.911 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.584 HD13 ' CD1' ' A' ' 262' ' ' PHE . 82.4 mt -99.28 1.94 45.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.887 179.921 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.835 0.35 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -65.42 -38.55 90.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.714 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 77.7 m-85 -109.01 130.86 55.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -127.68 141.32 51.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -113.62 142.82 45.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.44 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 0.1 OUTLIER -147.13 105.55 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 15.5 p90 -130.12 156.38 44.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 62.1 t -106.91 126.69 62.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.081 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.0 t -110.0 143.29 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.088 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.607 ' HB2' HD12 ' A' ' 229' ' ' LEU . 16.5 mmt180 -55.69 123.08 12.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -45.5 -25.08 0.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.26 -39.29 17.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.607 HD12 ' HB2' ' A' ' 226' ' ' ARG . 45.3 mt -71.81 -30.23 65.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 24.1 mtp -39.7 -57.94 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -41.55 -49.02 4.87 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.502 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 30.0 mt -70.67 -58.02 4.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 110.905 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -42.26 -42.75 3.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.064 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.429 HG23 HG13 ' A' ' 241' ' ' ILE . 22.9 mt -74.81 -36.08 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.121 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 99.51 -158.09 19.86 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 22.0 m -105.19 113.27 26.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.806 0.336 . . . . 0.0 111.137 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 74.4 31.34 1.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.858 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 64.11 61.52 6.01 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.461 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 29.3 t -90.96 -55.17 3.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.901 0.381 . . . . 0.0 110.851 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -55.84 -47.94 76.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.496 HG12 HD21 ' A' ' 279' ' ' LEU . 26.5 mt -54.55 -47.74 71.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -57.23 -46.72 82.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -60.25 -54.51 44.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.587 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -48.8 -40.1 27.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.082 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.4 ' CA ' HD12 ' A' ' 253' ' ' ILE . 18.4 ttt85 -72.87 -22.33 60.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -86.65 21.72 2.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.642 HG13 ' HD2' ' A' ' 248' ' ' PRO . 86.3 t -100.89 138.07 19.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.619 0.724 . . . . 0.0 111.104 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.642 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.77 127.26 14.33 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.711 2.274 . . . . 0.0 112.359 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 104.1 -4.53 45.1 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.538 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 82.9 t -100.89 104.96 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 0.0 111.141 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 69.9 p -59.19 -54.03 51.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.02 166.41 33.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.107 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.712 HG12 HG23 ' A' ' 264' ' ' ILE . 77.0 mt -137.57 105.94 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.163 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -110.79 148.59 32.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.719 HD12 ' H ' ' A' ' 256' ' ' ASP . 8.0 tp -128.15 154.57 45.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.929 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.719 ' H ' HD12 ' A' ' 255' ' ' LEU . 14.7 m-20 -112.07 130.15 55.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -100.13 -14.74 18.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.21 -45.18 95.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.9 p -126.0 -28.65 3.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.131 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.58 61.62 0.66 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.481 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.44 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 91.9 m -124.67 122.21 36.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 0.0 111.124 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.795 ' CE1' HD22 ' A' ' 279' ' ' LEU . 13.6 m-85 -89.2 113.14 24.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -102.2 110.63 22.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.807 HG22 HG12 ' A' ' 272' ' ' VAL . 7.2 mt -104.59 144.78 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -123.0 124.11 42.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.489 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -149.46 136.3 5.71 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.533 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -56.58 -29.73 62.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.833 0.349 . . . . 0.0 110.866 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 13.2 p -129.08 135.23 48.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.714 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -49.29 -28.83 5.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.141 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.62 -36.86 84.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.854 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.424 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -66.6 -59.82 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.075 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.807 HG12 HG22 ' A' ' 264' ' ' ILE . 0.3 OUTLIER -58.85 -29.98 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -68.07 -50.45 55.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -58.21 -48.01 81.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.587 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -65.09 -33.61 76.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.43 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 74.1 ttt180 -53.89 -50.12 67.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -44.14 -27.73 1.17 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.495 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -80.54 -39.07 28.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.924 0.392 . . . . 0.0 110.953 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.795 HD22 ' CE1' ' A' ' 262' ' ' PHE . 30.7 mt -88.08 -2.54 58.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.863 179.948 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.784 0.326 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -58.56 -43.75 89.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.125 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.636 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 83.5 m-85 -110.05 143.66 39.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -137.06 143.79 42.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -115.01 134.26 55.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.891 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.1 108.09 5.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.789 ' O ' HG23 ' A' ' 261' ' ' THR . 32.0 p90 -139.31 163.37 32.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.592 HG22 ' OG1' ' A' ' 261' ' ' THR . 60.6 t -108.65 132.34 56.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.15 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 79.2 t -113.39 142.62 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 -55.16 125.04 18.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -53.76 -18.16 2.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.54 -38.53 17.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 51.4 mt -80.24 -27.54 38.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.46 ' CE ' HD11 ' A' ' 255' ' ' LEU . 22.4 mtp -40.23 -59.26 1.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.849 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -41.21 -54.13 3.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.467 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.04 -54.75 33.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.882 0.372 . . . . 0.0 110.936 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -45.92 -44.11 14.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.105 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 11.0 mt -71.6 -38.5 67.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 94.84 -134.25 11.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.454 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 237' ' ' HIS . 60.2 m -113.01 138.66 49.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.833 0.349 . . . . 0.0 111.141 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 236' ' ' THR . 5.5 m-70 35.91 48.8 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 59.29 57.73 18.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.493 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.7 t -84.57 -68.14 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.877 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 4.7 m120 -41.64 -62.32 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 60.2 mt -39.9 -52.52 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -54.76 -48.93 72.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.944 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.452 ' OE1' ' N ' ' A' ' 243' ' ' GLN . 0.3 OUTLIER -60.97 -30.83 70.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 247' ' ' VAL . . . -68.54 -53.39 23.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -57.72 -23.91 54.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -72.51 1.89 7.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.669 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.4 t -82.67 138.9 43.75 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.654 0.74 . . . . 0.0 111.105 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.669 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.4 Cg_endo -69.75 133.28 25.22 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.728 2.286 . . . . 0.0 112.316 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 96.83 -3.45 62.68 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.511 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 70.6 t -96.59 113.46 31.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 111.095 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 20.6 p -70.87 -57.83 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -148.41 168.24 23.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.074 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.564 HG12 HG23 ' A' ' 264' ' ' ILE . 65.6 mt -143.84 109.17 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.126 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -113.13 154.45 26.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.46 HD11 ' CE ' ' A' ' 230' ' ' MET . 8.0 tp -131.47 138.78 49.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.953 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.415 ' N ' HD12 ' A' ' 255' ' ' LEU . 6.6 m-20 -104.51 113.28 26.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -82.38 -33.19 28.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.849 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -45.46 -35.68 3.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 63.6 p -128.07 -31.33 2.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 99.15 47.05 1.93 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.49 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 223' ' ' PHE . 97.7 m -115.17 128.84 56.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 111.132 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.557 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.6 m-85 -91.12 123.0 34.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -111.78 114.67 27.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.932 HG22 HG12 ' A' ' 272' ' ' VAL . 19.2 mt -109.1 139.84 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -120.25 117.05 26.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.607 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -139.67 151.88 22.24 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.506 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 25.1 mt-10 -67.74 -31.52 71.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 110.917 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.3 p -129.84 134.99 47.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.636 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -46.46 -32.42 3.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.099 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -62.06 -41.84 98.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.73 -65.54 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.085 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.932 HG12 HG22 ' A' ' 264' ' ' ILE . 0.3 OUTLIER -51.22 -34.57 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.153 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -65.59 -53.05 47.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -53.63 -48.25 69.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.36 -35.25 77.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.113 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.54 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 56.5 ttt180 -51.92 -42.81 63.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -49.46 -33.83 18.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.97 -43.81 67.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.381 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.887 HD12 HD11 ' A' ' 264' ' ' ILE . 69.8 mt -72.79 -28.94 62.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.904 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.777 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.796 0.332 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -51.84 -33.56 36.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.123 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.819 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 43.4 m-85 -119.02 122.77 42.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -121.28 152.19 39.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.822 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -129.87 153.11 48.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -157.49 117.53 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.401 ' CE2' ' HG3' ' A' ' 276' ' ' ARG . 27.9 p90 -142.79 144.96 32.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.3 t -91.73 129.19 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 55.3 t -109.83 139.03 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.12 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -53.82 131.08 39.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.17 -11.69 6.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -96.82 -21.29 17.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.827 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 74.4 mt -97.58 -9.03 27.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.412 ' CE ' HD11 ' A' ' 255' ' ' LEU . 5.4 mmt -49.97 -66.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -40.27 -51.41 3.62 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.503 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 68.1 mt -59.42 -63.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -45.97 -39.53 9.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 45.6 mt -75.74 -30.38 21.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 88.85 -147.35 19.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.483 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 237' ' ' HIS . 9.6 t -101.58 140.69 35.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.765 0.317 . . . . 0.0 111.185 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 236' ' ' THR . 14.4 p80 34.63 49.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 56.46 66.27 2.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.486 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.7 t -93.74 -61.24 1.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 110.86 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -48.42 -63.46 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 45.4 mt -39.59 -52.75 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -50.68 -45.5 58.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -61.98 -50.24 72.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.934 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.537 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -56.7 -35.59 68.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.09 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -75.99 -18.37 59.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -89.29 12.86 14.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.623 HG13 ' HD2' ' A' ' 248' ' ' PRO . 93.7 t -91.76 137.4 25.54 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.646 0.736 . . . . 0.0 111.16 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.623 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.0 Cg_endo -69.69 139.69 41.08 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.657 2.238 . . . . 0.0 112.385 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 95.97 -18.99 56.42 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.541 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 86.9 t -81.01 116.79 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 111.104 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 265' ' ' TYR . 37.2 p -71.24 -49.17 46.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.108 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -161.45 169.44 21.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.505 HG12 HG23 ' A' ' 264' ' ' ILE . 90.6 mt -144.6 113.56 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.088 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -114.01 153.51 29.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 256' ' ' ASP . 1.8 tp -135.31 125.52 26.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.889 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.676 ' N ' HD12 ' A' ' 255' ' ' LEU . 1.7 t70 -84.87 107.81 17.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 29.7 mp0 -83.15 -3.93 57.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -91.33 -36.23 13.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 40.1 p -115.36 -17.02 11.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 76.88 51.79 6.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.475 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 96.8 m -124.97 126.62 45.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 111.161 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.825 ' CE1' HD22 ' A' ' 279' ' ' LEU . 11.1 m-85 -88.02 114.16 24.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 27.4 mtt-85 -104.24 117.09 33.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.83 HG22 HG12 ' A' ' 272' ' ' VAL . 10.2 mt -110.02 148.43 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 251' ' ' THR . 60.2 m-85 -131.65 112.43 12.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.777 ' O ' ' HB1' ' A' ' 217' ' ' ALA . . . -133.34 148.81 19.49 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.524 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -67.4 -25.71 66.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.888 0.375 . . . . 0.0 110.9 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 270' ' ' ASP . 6.3 m -141.08 131.26 24.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.833 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.819 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -36.8 -34.11 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.118 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 268' ' ' SER . 2.6 m-20 -57.74 -50.73 72.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.87 -66.98 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.83 HG12 HG22 ' A' ' 264' ' ' ILE . 2.4 m -50.66 -41.7 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -56.28 -52.79 63.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -57.79 -49.23 77.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.537 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -64.56 -31.53 72.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.401 ' HG3' ' CE2' ' A' ' 223' ' ' PHE . 37.8 ttp85 -60.41 -45.99 91.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.06 -22.52 2.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.469 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -85.55 -50.63 7.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 0.0 110.851 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.825 HD22 ' CE1' ' A' ' 262' ' ' PHE . 78.2 mt -68.75 -8.66 45.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.938 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 179.962 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.784 0.326 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -74.84 -43.11 56.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.553 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 96.7 m-85 -114.41 122.72 47.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -118.46 141.79 48.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -119.13 135.97 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.405 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 0.9 OUTLIER -138.05 122.93 18.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 223' ' ' PHE . 1.7 p90 -140.57 151.79 44.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.9 t -104.42 114.03 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 226' ' ' ARG . 19.5 t -97.91 143.6 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.155 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.412 ' O ' HG12 ' A' ' 225' ' ' VAL . 13.9 mmt85 -53.9 172.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -91.42 -17.57 25.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -102.28 -8.89 20.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.451 HD23 HD12 ' A' ' 232' ' ' LEU . 65.7 mt -100.69 -4.08 28.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 2.8 mmt -58.21 -66.8 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -42.85 -39.21 3.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.451 HD12 HD23 ' A' ' 229' ' ' LEU . 68.1 mt -66.34 -59.86 3.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 0.0 110.889 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.422 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -53.76 -49.68 67.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 8.0 mt -65.76 -31.66 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.158 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 92.92 -153.12 21.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.463 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 70.1 p -108.72 118.13 35.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.349 . . . . 0.0 111.169 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 69.25 35.44 2.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.857 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 58.84 61.07 7.79 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.485 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.3 t -92.42 -54.25 3.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.882 0.372 . . . . 0.0 110.876 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 5.5 m120 -52.88 -56.2 17.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.885 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.493 ' HA ' HD21 ' A' ' 279' ' ' LEU . 39.4 mt -46.54 -45.59 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -55.21 -62.53 1.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -45.91 -41.41 11.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.69 -57.21 13.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.418 ' HG3' HD12 ' A' ' 253' ' ' ILE . 80.8 mtt180 -60.3 -11.62 6.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -98.21 14.1 28.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.661 HG13 ' HD2' ' A' ' 248' ' ' PRO . 98.1 t -94.36 138.29 22.48 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.581 0.705 . . . . 0.0 111.153 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.661 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.8 Cg_endo -69.77 128.41 15.97 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.649 2.233 . . . . 0.0 112.355 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.568 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 103.75 -6.26 48.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 78.3 t -98.14 108.55 22.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 0.0 111.122 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 43.5 p -64.89 -46.29 82.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.152 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -162.02 165.79 26.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.065 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 264' ' ' ILE . 58.3 mt -139.37 106.37 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.089 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -109.37 151.98 25.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.733 HD22 ' CZ ' ' A' ' 262' ' ' PHE . 7.8 tp -138.07 151.37 47.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.916 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.511 ' H ' HD12 ' A' ' 255' ' ' LEU . 3.6 t70 -112.89 124.37 52.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -89.49 -19.57 24.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.95 -27.39 39.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.836 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 60.3 p -121.69 -14.15 8.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 66.67 44.08 90.46 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.51 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.405 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 71.1 m -115.25 123.48 48.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 111.137 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.733 ' CZ ' HD22 ' A' ' 255' ' ' LEU . 11.3 m-85 -91.25 113.99 26.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -104.65 115.52 30.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.965 HG22 HG12 ' A' ' 272' ' ' VAL . 55.8 mt -108.32 140.36 27.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.183 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -121.25 122.16 39.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.568 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -143.46 152.73 24.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 22.9 mt-10 -71.77 -34.4 69.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.341 . . . . 0.0 110.858 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 21.5 p -125.76 132.08 52.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.553 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -43.0 -31.28 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.39 -43.7 98.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.568 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -60.3 -64.41 0.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.091 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.965 HG12 HG22 ' A' ' 264' ' ' ILE . 0.5 OUTLIER -52.77 -40.52 35.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.118 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -59.63 -55.81 29.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -58.49 -41.96 86.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.881 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.83 -24.14 61.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 18.3 ttt-85 -68.35 -45.11 73.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.67 -27.64 6.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.477 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -78.58 -36.82 43.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.37 . . . . 0.0 110.868 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.493 HD21 ' HA ' ' A' ' 241' ' ' ILE . 86.0 mt -88.33 -13.75 39.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.931 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 179.95 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.575 ' HB1' ' C ' ' A' ' 266' ' ' GLY . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.818 0.342 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -57.25 -39.54 75.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.04 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -111.6 135.33 52.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -133.32 138.01 46.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -115.34 127.17 55.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.554 ' CD ' ' CG2' ' A' ' 261' ' ' THR . 3.0 tp10 -132.73 119.62 20.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.931 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -140.52 153.16 46.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.47 122.62 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 19.1 t -104.59 146.23 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -53.52 173.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -89.79 -27.54 19.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -90.92 -30.98 16.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 64.2 mt -73.09 -18.74 61.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.434 ' CE ' HD11 ' A' ' 255' ' ' LEU . 2.3 mtt -47.13 -59.03 3.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -46.22 -43.22 13.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.497 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 36.7 mt -68.29 -63.27 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 110.889 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.444 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -45.08 -43.47 9.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.162 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 61.2 mt -73.91 -35.52 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.1 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 89.95 -158.06 26.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.511 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 237' ' ' HIS . 5.4 m -92.12 145.25 24.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.35 . . . . 0.0 111.132 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.43 ' C ' ' O ' ' A' ' 236' ' ' THR . 89.4 m-70 35.2 51.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 50.19 66.93 2.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 17.1 t -92.06 -68.95 0.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.862 0.363 . . . . 0.0 110.849 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.444 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 5.0 m120 -40.33 -67.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 240' ' ' ASN . 45.4 mt -36.5 -54.99 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -55.21 -48.63 73.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -58.45 -52.54 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -50.67 -39.14 50.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -71.91 -25.04 61.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -81.3 11.05 4.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.683 HG13 ' HD2' ' A' ' 248' ' ' PRO . 98.7 t -91.38 138.94 25.26 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.612 0.72 . . . . 0.0 111.128 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.683 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.8 Cg_endo -69.72 137.4 35.47 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.704 2.27 . . . . 0.0 112.34 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 97.93 -21.46 45.97 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.514 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 88.5 t -82.15 115.72 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.918 0.389 . . . . 0.0 111.086 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 265' ' ' TYR . 79.4 p -71.35 -48.39 50.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -158.85 169.43 24.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 264' ' ' ILE . 73.3 mt -145.42 109.72 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -110.97 163.22 14.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.65 HD13 ' CZ ' ' A' ' 262' ' ' PHE . 10.3 tp -140.88 153.98 45.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.607 ' H ' HD12 ' A' ' 255' ' ' LEU . 3.8 m-20 -121.03 119.28 32.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.831 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -86.12 -13.93 45.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -58.29 -52.85 63.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 37.3 p -119.18 -19.36 8.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 95.28 48.28 2.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.514 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.554 ' CG2' ' CD ' ' A' ' 222' ' ' GLU . 20.7 m -110.97 136.79 49.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 111.117 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.65 ' CZ ' HD13 ' A' ' 255' ' ' LEU . 11.6 m-85 -107.39 127.02 53.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . 0.412 ' HG3' ' CD ' ' A' ' 222' ' ' GLU . 17.4 mtp180 -113.99 115.23 27.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.813 HG22 HG12 ' A' ' 272' ' ' VAL . 34.0 mt -107.18 142.64 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 251' ' ' THR . 79.1 m-85 -124.5 124.02 41.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.61 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -147.73 136.27 5.96 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.461 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 55.3 mt-10 -54.96 -41.75 71.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.87 0.367 . . . . 0.0 110.869 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 271' ' ' ALA . 38.3 m -122.24 136.26 54.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 271' ' ' ALA . . . -43.04 -59.65 1.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.139 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 269' ' ' ALA . 3.1 m-20 -36.51 -30.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 269' ' ' ALA . . . -75.07 -68.94 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.116 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.813 HG12 HG22 ' A' ' 264' ' ' ILE . 0.8 OUTLIER -51.8 -28.71 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.087 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.09 -51.17 22.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -60.35 -33.96 73.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -82.5 -30.69 29.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -58.56 -44.4 89.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.07 -27.39 5.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.504 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -79.04 -54.95 5.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.866 0.365 . . . . 0.0 110.829 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.707 HD12 HD11 ' A' ' 264' ' ' ILE . 67.4 mt -63.48 -22.14 66.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 179.942 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.408 ' HB1' ' C ' ' A' ' 266' ' ' GLY . . . . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.802 0.334 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -48.2 -39.05 19.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.622 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 75.9 m-85 -110.39 146.45 35.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.896 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -145.03 140.33 28.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -113.46 138.26 50.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.433 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 8.6 tt0 -143.0 116.94 9.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 29.6 p90 -142.23 139.22 31.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.02 123.6 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 56.0 t -111.72 136.35 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.551 ' HB2' HD12 ' A' ' 229' ' ' LEU . 23.6 mmt180 -54.05 142.96 23.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -58.5 -25.85 62.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.51 -43.53 22.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.551 HD12 ' HB2' ' A' ' 226' ' ' ARG . 23.6 mt -66.59 -32.02 73.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.517 ' CE ' HD11 ' A' ' 255' ' ' LEU . 3.2 mtt -36.83 -66.81 0.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -34.47 -61.8 0.54 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.496 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 235' ' ' GLY . 60.2 mt -60.11 -65.32 0.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' LEU . . . -37.62 -36.85 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.102 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.464 HG23 HG13 ' A' ' 241' ' ' ILE . 64.7 mt -83.02 -36.2 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 232' ' ' LEU . . . 96.58 -151.2 19.81 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 86.0 m -100.99 136.28 41.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.768 0.318 . . . . 0.0 111.16 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 2.7 m80 43.99 49.49 7.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 52.45 65.74 3.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 3.5 t -92.68 -65.65 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.861 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -43.64 -63.35 0.86 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.572 HG12 HD21 ' A' ' 279' ' ' LEU . 33.7 mt -39.71 -52.11 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.096 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -54.05 -51.17 64.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -54.59 -48.13 72.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -54.69 -48.05 72.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.092 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -65.91 -29.66 70.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -72.17 -1.33 14.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.685 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.2 t -82.39 138.88 44.71 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.657 0.741 . . . . 0.0 111.142 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.685 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.7 Cg_endo -69.76 148.43 65.09 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.671 2.247 . . . . 0.0 112.355 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 89.26 -26.8 8.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 87.6 t -74.4 105.5 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.931 0.396 . . . . 0.0 111.11 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 34.7 p -60.52 -49.41 77.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.25 162.92 33.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.089 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.563 HG12 HG23 ' A' ' 264' ' ' ILE . 24.4 mt -134.05 106.42 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -107.74 155.7 19.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.517 HD11 ' CE ' ' A' ' 230' ' ' MET . 6.1 tp -141.64 150.54 42.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -108.16 141.53 39.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -103.57 -20.15 14.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -76.76 -36.46 57.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.7 p -115.02 -22.76 9.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.154 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 77.58 47.0 9.19 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.449 ' O ' HD12 ' A' ' 255' ' ' LEU . 48.6 m -112.89 135.54 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 111.191 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.533 ' HB2' ' CE2' ' A' ' 223' ' ' PHE . 12.9 m-85 -98.73 115.68 29.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -105.89 114.48 28.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.917 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.965 HG22 HG12 ' A' ' 272' ' ' VAL . 34.5 mt -108.91 132.0 58.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.141 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -111.22 126.4 54.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.644 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -147.24 143.61 11.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.453 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.34 -34.8 74.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.925 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 14.2 m -133.24 131.43 40.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.622 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -40.73 -38.56 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.112 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.49 -43.16 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.873 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.09 -68.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.965 HG12 HG22 ' A' ' 264' ' ' ILE . 1.2 m -49.38 -30.54 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -67.94 -52.46 35.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -56.72 -41.23 77.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.64 -41.77 62.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.081 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -50.34 -39.92 47.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.835 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -53.79 -23.36 21.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.535 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -82.14 -36.84 27.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.362 . . . . 0.0 110.898 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.572 HD21 HG12 ' A' ' 241' ' ' ILE . 69.0 mt -91.08 16.92 8.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 179.883 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.796 0.331 . . . . 0.0 111.064 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.44 -30.71 61.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 1.076 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 58.9 m-85 -117.62 138.36 52.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -139.17 147.71 42.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -121.84 144.88 48.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -147.27 112.21 5.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -136.17 147.62 47.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 37.4 t -101.18 122.95 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.157 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 99.6 t -108.21 136.34 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.46 ' O ' ' N ' ' A' ' 229' ' ' LEU . 37.7 mtt-85 -54.15 122.44 10.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -42.1 -32.04 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -74.94 -37.5 61.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 226' ' ' ARG . 51.5 mt -74.87 -30.01 61.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.462 ' HE3' HD11 ' A' ' 255' ' ' LEU . 4.0 mmt -37.26 -61.51 0.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.0 -53.48 2.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 35.6 mt -67.04 -54.61 19.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.815 0.34 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.443 ' O ' ' ND2' ' A' ' 240' ' ' ASN . . . -43.06 -48.85 6.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.571 HG22 ' HA2' ' A' ' 238' ' ' GLY . 38.8 mt -71.49 -34.6 53.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.095 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 94.21 -145.97 17.93 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.474 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 237' ' ' HIS . 0.0 OUTLIER -99.84 140.26 34.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.86 0.362 . . . . 0.0 111.104 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 236' ' ' THR . 8.1 m170 36.76 42.59 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.571 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 59.72 65.6 3.31 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.493 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 27.2 t -93.54 -59.58 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.82 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 233' ' ' ALA . 2.4 m120 -47.16 -57.86 4.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.904 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.706 HG12 HD21 ' A' ' 279' ' ' LEU . 27.2 mt -45.01 -53.46 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.159 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -46.97 -64.77 0.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -42.36 -45.34 4.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.56 98.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.077 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -72.32 -12.71 61.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.902 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -95.99 8.46 43.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.588 HG13 ' HD2' ' A' ' 248' ' ' PRO . 84.2 t -86.93 136.69 33.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.597 0.713 . . . . 0.0 111.159 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.588 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.1 Cg_endo -69.86 130.06 18.58 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.66 2.24 . . . . 0.0 112.319 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.43 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 102.21 -9.13 56.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.452 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 45.9 t -91.62 99.3 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.886 0.374 . . . . 0.0 111.137 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.7 p -55.34 -49.46 72.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -159.36 170.02 22.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.498 HG12 HG23 ' A' ' 264' ' ' ILE . 56.8 mt -144.2 106.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -101.89 155.42 18.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.705 HD22 ' CE1' ' A' ' 262' ' ' PHE . 2.5 tp -138.76 122.44 17.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.52 ' N ' HD12 ' A' ' 255' ' ' LEU . 19.1 m-20 -93.42 102.32 14.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.49 -33.06 68.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -43.35 -46.72 6.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.857 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 11.1 p -122.75 -9.89 8.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 256' ' ' ASP . . . 79.2 56.61 3.4 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.52 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 25.2 m -117.95 112.84 20.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.849 0.357 . . . . 0.0 111.153 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.705 ' CE1' HD22 ' A' ' 255' ' ' LEU . 9.9 m-85 -85.01 114.25 22.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -106.58 123.32 47.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.984 HG22 HG12 ' A' ' 272' ' ' VAL . 6.3 mt -109.53 146.46 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -128.12 118.5 23.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.675 ' O ' ' HB1' ' A' ' 217' ' ' ALA . . . -142.23 155.73 25.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -71.95 -25.22 61.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.873 0.368 . . . . 0.0 110.874 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 270' ' ' ASP . 2.3 m -141.75 132.23 25.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 1.076 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -40.12 -27.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.096 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 268' ' ' SER . 0.8 OUTLIER -62.13 -46.65 88.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.43 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -61.38 -64.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.115 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.984 HG12 HG22 ' A' ' 264' ' ' ILE . 0.9 OUTLIER -51.29 -35.45 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.111 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 269' ' ' ALA . 19.0 mtpp -63.06 -53.55 51.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -56.81 -39.57 74.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.933 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.37 -41.93 69.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.524 ' HB2' HD12 ' A' ' 264' ' ' ILE . 39.5 ttp180 -59.06 -27.55 65.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -67.84 -6.9 46.66 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.459 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -101.37 -32.52 10.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 0.0 110.891 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.706 HD21 HG12 ' A' ' 241' ' ' ILE . 40.8 mt -86.29 0.94 52.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 179.945 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.803 0.335 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.04 -38.78 68.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.07 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.802 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 39.2 m-85 -111.08 139.38 46.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -135.4 151.84 50.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -132.88 146.29 51.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.462 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 7.3 tm-20 -152.3 116.7 5.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -137.95 153.62 49.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.481 HG22 ' OG1' ' A' ' 261' ' ' THR . 38.6 t -102.06 121.5 53.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.89 140.98 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.137 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.411 ' HB2' HD12 ' A' ' 229' ' ' LEU . 82.3 mtt180 -56.51 127.08 29.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -50.8 -21.86 1.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.64 -42.25 18.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.831 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 226' ' ' ARG . 65.9 mt -77.86 -16.17 58.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.55 ' CE ' HD11 ' A' ' 255' ' ' LEU . 5.3 mmt -45.25 -67.73 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.844 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.13 -58.29 1.97 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.501 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 235' ' ' GLY . 50.5 mt -55.31 -62.88 1.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.806 0.336 . . . . 0.0 110.931 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -42.33 -45.69 4.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.683 HG23 HG13 ' A' ' 241' ' ' ILE . 54.9 mt -73.39 -29.28 27.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.137 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 232' ' ' LEU . . . 93.75 -162.35 25.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.513 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 67.9 p -96.68 123.82 40.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.155 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 60.25 37.66 20.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.43 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 61.54 63.21 5.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.435 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 5.5 t -92.55 -58.29 2.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.907 0.384 . . . . 0.0 110.843 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -50.06 -53.23 28.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.683 HG13 HG23 ' A' ' 234' ' ' ILE . 14.4 mt -49.76 -49.12 20.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -50.31 -63.46 1.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -48.31 -41.59 28.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.39 -52.94 63.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -62.65 -12.12 21.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -96.02 11.8 32.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.683 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.0 t -91.3 138.91 25.39 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.617 0.722 . . . . 0.0 111.127 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.683 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.76 139.4 40.12 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.677 2.251 . . . . 0.0 112.381 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 96.2 -24.19 31.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.454 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 86.0 t -77.88 109.89 12.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 30.0 p -67.47 -49.8 61.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.154 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.14 153.6 22.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.494 HG12 HG23 ' A' ' 264' ' ' ILE . 22.4 mt -128.81 112.38 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -112.35 153.67 26.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.709 HD22 ' CE1' ' A' ' 262' ' ' PHE . 11.1 tp -137.79 109.42 7.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.959 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.44 92.29 3.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.93 -25.43 68.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.874 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -43.8 -49.57 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 2.3 p -116.83 -29.28 6.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.127 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 107.78 43.86 1.28 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.434 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.481 ' OG1' HG22 ' A' ' 224' ' ' VAL . 6.5 m -110.79 133.42 53.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 111.117 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.709 ' CE1' HD22 ' A' ' 255' ' ' LEU . 10.5 m-85 -99.59 113.97 26.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.5 mtt-85 -103.69 113.93 27.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.844 HG22 HG12 ' A' ' 272' ' ' VAL . 9.3 mt -109.25 136.54 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.096 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -120.58 123.57 43.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.569 ' O ' ' HB1' ' A' ' 217' ' ' ALA . . . -142.7 151.13 22.84 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.515 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.95 -27.39 66.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 12.1 m -138.14 132.68 32.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.861 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.802 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -41.24 -35.24 0.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -55.55 -46.88 77.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.507 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -59.05 -67.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.844 HG12 HG22 ' A' ' 264' ' ' ILE . 1.5 m -51.61 -34.22 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -65.05 -49.6 69.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -66.0 -36.34 83.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -75.54 -30.86 59.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -60.37 -47.67 85.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -45.53 -27.8 2.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -78.85 -41.7 29.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.873 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.502 HD22 ' CE1' ' A' ' 262' ' ' PHE . 88.6 mt -80.21 -13.8 58.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.923 179.926 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.798 0.332 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -63.52 -42.6 98.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.1 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.784 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 53.2 m-85 -109.31 143.46 38.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -140.49 137.09 33.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -111.59 143.2 42.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -148.45 112.46 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.914 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.429 ' O ' HG23 ' A' ' 261' ' ' THR . 11.9 p90 -137.77 149.51 46.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.54 HG22 ' OG1' ' A' ' 261' ' ' THR . 20.0 t -95.37 120.98 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.17 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.2 t -103.46 137.14 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -54.94 126.99 26.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -53.95 -22.0 9.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -86.59 -23.66 25.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 37.7 mt -95.33 -12.68 25.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.637 ' CE ' HD11 ' A' ' 255' ' ' LEU . 4.8 mmt -47.1 -60.48 2.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -47.53 -50.83 17.84 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.513 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 49.5 mt -57.56 -55.96 28.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.814 0.34 . . . . 0.0 110.919 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.42 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -52.59 -52.31 55.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.114 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 70.9 mt -61.02 -24.33 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.6 -154.89 34.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.461 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 237' ' ' HIS . 23.9 m -92.93 138.13 31.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 111.153 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 236' ' ' THR . 9.5 m170 37.07 54.46 1.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 50.83 56.73 12.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.484 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 30.2 t -84.96 -60.7 1.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.855 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.42 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 4.4 m120 -49.39 -62.57 1.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 48.2 mt -39.48 -46.44 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.166 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -59.06 -52.92 63.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -54.66 -43.0 72.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.968 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.26 -45.17 95.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.436 ' HA ' HD12 ' A' ' 253' ' ' ILE . 36.0 ttt180 -68.0 -16.38 64.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -91.03 19.82 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.669 HG13 ' HD2' ' A' ' 248' ' ' PRO . 86.4 t -98.28 138.75 20.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.666 0.746 . . . . 0.0 111.125 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.669 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.3 Cg_endo -69.75 131.97 22.38 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.271 . . . . 0.0 112.338 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.12 -22.59 36.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 79.6 t -79.63 108.45 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.373 . . . . 0.0 111.124 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 63.3 p -64.64 -50.91 65.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.09 165.46 36.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.62 HG12 HG23 ' A' ' 264' ' ' ILE . 48.2 mt -139.65 111.95 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -112.87 159.51 18.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.637 HD11 ' CE ' ' A' ' 230' ' ' MET . 15.4 tp -135.83 138.32 42.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -108.69 112.19 24.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -80.15 -35.38 36.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -42.18 -40.58 2.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 78.0 p -124.58 -25.97 3.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 93.68 37.26 5.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.54 ' OG1' HG22 ' A' ' 224' ' ' VAL . 82.4 m -106.81 118.37 36.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 111.169 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.605 ' CE1' HD13 ' A' ' 255' ' ' LEU . 11.1 m-85 -81.15 132.36 35.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -116.57 118.31 32.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.916 HG22 HG12 ' A' ' 272' ' ' VAL . 7.1 mt -112.66 139.44 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -120.9 130.37 53.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.477 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -154.87 146.77 15.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.443 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 32.6 mm-40 -62.35 -33.63 75.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 110.882 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 47.4 m -128.91 132.09 47.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.784 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -44.91 -37.95 4.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.115 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -53.59 -37.76 63.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.853 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -68.01 -65.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.916 HG12 HG22 ' A' ' 264' ' ' ILE . 1.0 OUTLIER -55.15 -29.95 23.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.141 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -66.25 -53.52 35.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.934 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -57.81 -43.65 85.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.56 -32.86 70.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 34.9 ttp85 -55.04 -48.47 73.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -45.92 -32.06 4.45 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.428 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -73.01 -49.24 30.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.841 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.554 HD12 HD11 ' A' ' 264' ' ' ILE . 94.1 mt -71.15 -9.33 57.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 41.3 t -45.09 153.12 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.394 . . . . 0.0 110.871 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 66.3 m -97.04 152.92 18.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.862 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 154.84 47.19 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.512 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 17.2 t -81.16 164.46 22.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.882 0.372 . . . . 0.0 110.83 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 75.7 m -126.38 -45.79 1.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.849 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 163.45 -159.53 32.14 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.478 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 81.8 p -120.74 125.43 47.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 111.174 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -62.35 -44.95 95.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -116.78 138.02 51.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 23.9 mt -48.17 -58.66 4.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.22 177.66 8.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . -106.76 122.93 47.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.084 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -57.16 -37.31 71.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.077 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 1.084 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 45.0 m-85 -114.55 139.63 49.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.851 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -138.97 137.31 36.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -113.43 127.39 56.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.409 ' CD ' ' O ' ' A' ' 222' ' ' GLU . 4.9 tm-20 -135.21 111.97 10.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.522 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 14.9 p90 -139.87 158.17 44.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.584 HG22 ' OG1' ' A' ' 261' ' ' THR . 42.9 t -103.5 128.5 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 36.4 t -110.2 138.46 37.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 17.0 mtm-85 -56.85 128.49 37.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -55.6 -18.12 7.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -84.98 -31.85 23.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.863 HD13 ' HB2' ' A' ' 281' ' ' PHE . 59.8 mt -90.76 -23.32 20.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 25.3 mtp -45.99 -57.13 4.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.76 -61.81 1.53 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.492 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 60.1 mt -60.89 -43.68 98.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.881 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -52.0 -40.57 61.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.121 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 58.1 mt -78.63 -36.41 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 89.94 -155.16 24.36 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.521 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 237' ' ' HIS . 15.0 m -91.88 142.93 27.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.853 0.359 . . . . 0.0 111.156 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.437 ' C ' ' O ' ' A' ' 236' ' ' THR . 9.5 m170 35.2 48.28 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.48 ' O ' ' NE2' ' A' ' 242' ' ' GLN . . . 55.67 59.19 10.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.463 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.0 t -80.83 -63.54 1.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.846 0.355 . . . . 0.0 110.862 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 4.9 m120 -46.84 -61.02 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 31.7 mt -44.1 -61.45 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.087 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' A' ' 242' ' ' GLN . 0.0 OUTLIER -43.8 -44.58 6.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.926 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -63.92 -52.38 60.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -49.57 -38.75 32.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 17.2 ttt-85 -72.19 -21.96 61.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.84 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -81.22 7.36 11.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.682 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.4 t -91.93 138.94 24.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.628 0.728 . . . . 0.0 111.136 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.682 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.3 Cg_endo -69.72 154.25 68.13 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.264 . . . . 0.0 112.407 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.43 -11.68 43.58 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.472 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 95.8 t -90.03 109.85 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.892 0.377 . . . . 0.0 111.136 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 68.5 p -67.92 -50.97 52.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.132 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -156.56 171.01 21.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.593 HG12 HG23 ' A' ' 264' ' ' ILE . 82.4 mt -143.89 110.77 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -111.21 151.96 27.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 256' ' ' ASP . 10.9 tp -131.0 134.98 47.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.579 ' N ' HD12 ' A' ' 255' ' ' LEU . 1.3 m-20 -105.35 110.4 22.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -78.79 -37.14 41.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -43.07 -40.98 3.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 77.2 p -122.78 -22.67 5.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 256' ' ' ASP . . . 86.99 45.44 5.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.483 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.584 ' OG1' HG22 ' A' ' 224' ' ' VAL . 85.3 m -112.74 119.13 37.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 111.116 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.644 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.8 m-85 -81.76 120.87 25.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -110.47 111.78 23.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.823 HG22 HG12 ' A' ' 272' ' ' VAL . 8.6 mt -105.16 145.11 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -125.74 120.35 30.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.598 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -145.29 144.06 12.61 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.486 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 86.4 mt-10 -59.1 -30.19 67.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 0.0 110.868 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 57.9 m -134.37 136.36 43.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 1.084 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -49.34 -33.85 14.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.079 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.81 -38.23 69.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.78 -67.47 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.073 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.823 HG12 HG22 ' A' ' 264' ' ' ILE . 1.3 m -48.51 -30.34 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.184 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -68.98 -52.72 25.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -57.09 -40.03 76.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -74.06 -37.17 64.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.115 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.522 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 27.0 ttt180 -52.45 -42.12 63.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -51.18 -30.85 25.32 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -74.16 -38.94 63.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.644 HD22 ' CE1' ' A' ' 262' ' ' PHE . 96.3 mt -79.84 -23.51 41.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.965 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -50.04 148.83 3.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.863 ' HB2' HD13 ' A' ' 229' ' ' LEU . 8.3 p90 -68.22 149.53 49.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.841 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.481 ' O ' HD22 ' A' ' 229' ' ' LEU . 60.0 t -128.5 134.54 64.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -63.65 148.64 48.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.96 111.6 0.87 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -109.37 141.83 41.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 48.6 mm -123.39 99.45 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -110.12 112.27 24.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 30.7 m -87.06 144.28 36.16 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 0.0 111.148 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -5.98 17.52 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.656 2.237 . . . . 0.0 112.314 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 86.1 p 40.67 51.59 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.863 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 133.02 81.02 0.18 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.52 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 97.77 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.682 2.255 . . . . 0.0 112.36 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 17.2 m -75.71 118.24 18.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 86.7 p -78.4 -46.33 20.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.855 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.47 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 55.6 m -159.89 176.63 11.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 0.0 110.838 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.4 m -156.83 140.12 15.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.842 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 138.46 -168.36 24.7 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.502 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.7 t -85.96 161.11 19.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 110.848 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 79.1 p -93.77 168.52 10.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.828 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -174.0 140.08 5.31 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.508 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 14.7 t -91.81 134.02 35.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.371 . . . . 0.0 111.096 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -132.18 168.28 18.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -126.9 40.13 3.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.919 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 216' ' ' ALA . 4.5 mm? -77.76 105.88 9.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 215' ' ' LEU . . . -34.81 144.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.483 ' HB1' ' N ' ' A' ' 266' ' ' GLY . . . -85.14 117.56 24.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.101 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.71 -47.73 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.079 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.846 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 61.0 m-85 -103.87 137.02 42.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.425 ' O ' ' CD2' ' A' ' 220' ' ' HIS . 7.7 p-80 -136.22 137.43 40.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -114.47 130.25 56.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.441 ' C ' ' CD ' ' A' ' 222' ' ' GLU . 1.8 tm-20 -133.21 118.63 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.418 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 16.0 p90 -141.86 149.1 39.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 40.4 t -98.9 124.43 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 80.4 t -111.44 137.07 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.105 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 28.0 mtp180 -55.63 126.82 27.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -49.44 -22.68 1.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -77.08 -46.57 23.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.761 HD13 ' HB2' ' A' ' 281' ' ' PHE . 53.7 mt -73.02 -31.69 64.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.611 ' HE1' HD11 ' A' ' 255' ' ' LEU . 19.5 mtp -37.08 -64.38 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.899 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -38.17 -48.08 2.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.62 -50.84 32.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.857 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -50.04 -40.47 45.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.101 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.567 HG23 HG13 ' A' ' 241' ' ' ILE . 54.4 mt -78.25 -36.17 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 99.63 -147.93 18.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 236' ' ' THR . 12.0 t -109.06 119.09 38.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 111.127 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 64.26 38.26 8.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.464 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 64.31 59.34 8.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.47 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.4 t -87.67 -69.76 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 3.6 m120 -43.71 -55.39 4.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.658 HG12 HD21 ' A' ' 279' ' ' LEU . 21.7 mt -49.27 -52.11 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -50.24 -53.18 30.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.482 ' N ' ' NE2' ' A' ' 243' ' ' GLN . 0.3 OUTLIER -55.54 -39.62 70.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.955 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.36 94.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.063 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.623 ' HG3' HD12 ' A' ' 253' ' ' ILE . 44.0 mtp180 -69.47 -17.96 63.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -85.75 12.72 8.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.678 HG13 ' HD2' ' A' ' 248' ' ' PRO . 98.9 t -93.16 138.89 22.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 0.0 111.16 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.678 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.2 Cg_endo -69.83 131.68 21.65 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.705 2.27 . . . . 0.0 112.305 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 98.29 -9.42 63.02 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.517 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 74.2 t -88.65 108.05 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 43.8 p -64.92 -53.1 51.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -158.98 161.47 36.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.106 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.623 HD12 ' HG3' ' A' ' 245' ' ' ARG . 38.8 mt -134.09 96.43 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -94.44 157.35 16.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.611 HD11 ' HE1' ' A' ' 230' ' ' MET . 4.0 tp -141.38 129.02 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.941 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -83.81 96.7 8.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.67 3.09 6.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -93.3 -48.19 6.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.1 p -108.28 -22.51 12.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 89.91 52.64 2.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 31.6 m -122.64 122.73 39.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 0.0 111.093 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.462 ' CE1' HD22 ' A' ' 255' ' ' LEU . 18.4 m-85 -89.57 116.85 28.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -109.08 116.0 31.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.768 HG22 HG12 ' A' ' 272' ' ' VAL . 5.9 mt -104.25 146.72 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.139 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -128.88 127.07 41.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.483 ' N ' ' HB1' ' A' ' 217' ' ' ALA . . . -150.19 147.99 18.75 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.508 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.24 -21.72 66.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.917 0.389 . . . . 0.0 110.892 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 2.1 m -145.34 140.22 27.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.858 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.846 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.21 -30.92 3.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.052 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.27 -38.86 81.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.838 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.472 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -68.96 -65.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.083 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.768 HG12 HG22 ' A' ' 264' ' ' ILE . 0.2 OUTLIER -50.4 -38.65 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -60.87 -53.13 61.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.504 ' HB3' HG11 ' A' ' 247' ' ' VAL . 19.4 tttt -56.35 -40.98 75.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.94 -33.34 70.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.146 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.418 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 36.7 ttp180 -59.7 -43.94 93.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.848 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -52.42 -15.57 2.94 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.445 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -92.78 -33.73 14.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 0.0 110.876 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.658 HD21 HG12 ' A' ' 241' ' ' ILE . 88.3 mt -87.08 7.29 28.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -58.34 155.14 12.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.761 ' HB2' HD13 ' A' ' 229' ' ' LEU . 26.8 p90 -84.33 129.67 34.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.41 130.39 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.132 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -64.59 158.6 23.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.42 106.0 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.848 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -88.47 142.23 27.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 5.4 mp -106.75 98.6 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.123 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -89.78 154.02 20.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 24.0 m -74.27 144.35 81.38 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.625 0.726 . . . . 0.0 111.136 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 87.14 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.683 2.256 . . . . 0.0 112.34 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 18.6 m -146.0 120.61 9.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 145.86 147.16 4.54 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.452 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -18.04 37.05 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.662 2.241 . . . . 0.0 112.314 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 77.1 p -44.09 145.3 0.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.882 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 43.8 t -146.75 133.13 19.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.471 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.4 t -111.65 159.3 18.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 0.0 110.833 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 25.5 t -103.7 119.28 38.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.08 106.11 0.19 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.507 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.4 m -146.65 175.16 10.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 0.0 110.845 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 30.5 p -112.11 140.49 46.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.906 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -111.29 53.79 0.57 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.477 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 24.8 p -137.74 155.71 48.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.92 0.39 . . . . 0.0 111.136 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 22.8 mmtm -103.14 142.65 33.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -118.44 -178.44 3.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.874 HD22 ' O ' ' A' ' 215' ' ' LEU . 0.0 OUTLIER -130.5 8.85 5.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -137.76 165.71 25.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -92.39 114.01 26.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -65.56 -41.24 93.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.099 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.631 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 88.3 m-85 -110.96 133.72 53.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.864 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -132.41 132.43 42.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -112.67 151.49 30.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.856 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -152.39 123.99 7.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.449 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 18.5 p90 -142.79 140.68 31.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.592 HG22 ' OG1' ' A' ' 261' ' ' THR . 24.3 t -93.4 122.68 45.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 82.7 t -111.23 137.77 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.137 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.445 ' HB2' HD12 ' A' ' 229' ' ' LEU . 62.0 mtt180 -54.81 127.59 29.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -41.85 -45.27 3.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.848 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -62.78 -37.72 87.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.461 ' CD2' ' HA ' ' A' ' 283' ' ' GLU . 60.6 mt -72.94 -37.84 67.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.888 ' CE ' HD11 ' A' ' 255' ' ' LEU . 27.0 mtp -37.52 -60.62 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -36.13 -61.41 0.8 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 54.0 mt -60.92 -47.07 88.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.938 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -50.17 -41.65 49.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.058 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.407 HG23 HG13 ' A' ' 241' ' ' ILE . 59.4 mt -79.41 -27.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 88.81 -137.63 14.35 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.482 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 4.5 t -112.59 136.63 51.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.804 0.335 . . . . 0.0 111.125 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 27.4 m80 42.13 45.18 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 60.19 65.04 3.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.5 t -91.58 -69.3 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.874 0.369 . . . . 0.0 110.85 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -42.88 -55.26 3.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.407 HG13 HG23 ' A' ' 234' ' ' ILE . 52.4 mt -47.94 -55.45 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.104 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -47.64 -55.8 8.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -50.39 -58.63 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.42 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -45.6 -48.57 14.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -64.59 -24.13 67.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -82.83 17.05 1.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.684 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.5 t -100.44 138.89 20.28 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.616 0.722 . . . . 0.0 111.097 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.684 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.71 137.95 36.82 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.723 2.282 . . . . 0.0 112.358 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 95.67 -12.6 67.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 81.8 t -89.45 104.87 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.898 0.38 . . . . 0.0 111.139 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 71.1 p -60.1 -50.5 73.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.15 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.17 169.84 22.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.07 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.572 HG12 HG23 ' A' ' 264' ' ' ILE . 81.4 mt -141.84 113.96 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.149 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -113.21 160.67 18.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.888 HD11 ' CE ' ' A' ' 230' ' ' MET . 12.1 tp -141.84 108.84 5.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.13 112.89 13.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -80.86 -37.63 29.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -38.96 -42.36 0.85 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 32.0 p -120.34 -21.59 6.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 88.82 51.72 2.97 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.482 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.592 ' OG1' HG22 ' A' ' 224' ' ' VAL . 96.2 m -119.44 136.34 54.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 111.124 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.696 ' CE1' HD22 ' A' ' 279' ' ' LEU . 12.3 m-85 -95.15 125.02 39.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 -114.13 111.05 20.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.572 HG23 HG12 ' A' ' 253' ' ' ILE . 6.7 mt -105.02 135.48 42.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.138 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -116.27 126.55 53.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.541 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -148.42 141.12 8.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.505 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 65.2 mt-10 -59.71 -33.63 71.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 110.856 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.1 m -128.8 136.79 50.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.631 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.32 -29.33 2.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.079 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.04 -39.88 93.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -68.46 -62.62 1.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.541 HG13 ' HA3' ' A' ' 266' ' ' GLY . 0.1 OUTLIER -52.18 -31.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.171 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -70.85 -50.44 35.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.934 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -59.75 -44.59 93.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.42 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -66.64 -35.64 80.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -59.44 -37.57 78.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -56.83 -13.11 7.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.438 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -95.1 -25.49 16.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.883 0.373 . . . . 0.0 110.839 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.696 HD22 ' CE1' ' A' ' 262' ' ' PHE . 76.8 mt -98.74 0.96 45.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -50.88 139.75 16.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.877 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.441 ' O ' ' CD2' ' A' ' 281' ' ' PHE . 30.2 p90 -68.35 118.62 11.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 84.7 t -121.2 127.26 75.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.174 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.461 ' HA ' ' CD2' ' A' ' 229' ' ' LEU . 2.3 pp20? -95.09 154.35 17.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 283' ' ' GLU . 1.3 p30 -36.15 97.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 283' ' ' GLU . 12.8 p90 -84.4 141.53 30.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 47.0 mt -125.2 96.46 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.114 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -114.45 136.86 52.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 16.0 m -115.58 144.42 32.44 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.608 0.718 . . . . 0.0 111.126 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -32.32 18.95 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.271 . . . . 0.0 112.374 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 53.9 m -94.54 89.11 5.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -130.79 -95.07 0.69 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.524 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 293' ' ' SER . 53.8 Cg_endo -69.78 94.51 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.683 2.255 . . . . 0.0 112.337 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 292' ' ' PRO . 1.9 m 37.26 37.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.1 t -84.15 148.4 26.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.839 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.496 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 34.1 p -147.28 108.09 4.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 110.836 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.5 t -72.93 -60.31 2.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -72.64 -150.8 1.27 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.467 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 8.2 t -144.58 175.87 9.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.833 0.349 . . . . 0.0 110.886 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 24.8 p -166.97 172.64 10.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 152.61 77.64 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 75.8 p -136.03 126.49 26.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.845 0.355 . . . . 0.0 111.14 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.6 ptpt -155.02 157.18 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -172.19 161.41 5.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.977 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 78.4 mt -51.5 -45.43 62.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.86 174.39 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.058 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.425 ' HB1' ' N ' ' A' ' 266' ' ' GLY . . . -107.01 114.54 28.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.67 83.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.072 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -104.82 140.78 37.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -130.52 153.38 48.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -132.68 136.72 46.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.83 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.495 ' CG ' ' HG2' ' A' ' 263' ' ' ARG . 3.5 mt-10 -145.74 116.41 7.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.894 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -139.2 147.3 41.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.423 HG22 ' OG1' ' A' ' 261' ' ' THR . 15.2 t -94.81 116.92 37.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.172 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.499 HG13 ' HB3' ' A' ' 281' ' ' PHE . 73.5 t -98.25 147.42 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -58.74 124.97 21.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -53.89 -16.23 1.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.931 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.8 -38.75 15.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.81 HD13 ' HB2' ' A' ' 281' ' ' PHE . 69.9 mt -79.64 -29.03 40.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.417 ' CE ' HD11 ' A' ' 255' ' ' LEU . 19.8 mtp -37.42 -66.62 0.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -38.34 -46.74 2.02 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.51 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 56.8 mt -69.84 -57.05 5.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.761 ' HB2' ' HA ' ' A' ' 281' ' ' PHE . . . -45.06 -38.47 4.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.412 HG23 HG13 ' A' ' 241' ' ' ILE . 71.4 mt -77.27 -35.45 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 92.64 -145.98 17.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.487 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' HIS . 24.9 p -100.56 143.65 30.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 236' ' ' THR . 6.6 m80 34.77 41.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 61.89 61.35 6.81 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.432 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.6 m -86.83 -59.9 2.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.84 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -49.3 -54.68 15.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.412 HG13 HG23 ' A' ' 234' ' ' ILE . 18.2 mt -48.02 -52.85 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -52.29 -44.59 65.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -60.45 -50.88 71.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -53.86 -36.2 62.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.058 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -74.61 -11.94 60.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -93.97 15.11 17.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.676 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.5 t -96.98 138.91 21.29 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.614 0.721 . . . . 0.0 111.126 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.676 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.5 Cg_endo -69.83 144.94 55.21 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.641 2.227 . . . . 0.0 112.323 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 91.37 -19.65 45.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 91.4 t -84.46 112.59 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.957 0.408 . . . . 0.0 111.155 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 217' ' ' ALA . 41.8 p -68.86 -46.78 67.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -162.12 166.09 26.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.098 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.549 HG12 HG23 ' A' ' 264' ' ' ILE . 91.4 mt -140.5 115.65 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.121 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -117.76 154.39 31.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.469 HD12 ' H ' ' A' ' 256' ' ' ASP . 11.5 tp -130.77 147.13 52.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.469 ' H ' HD12 ' A' ' 255' ' ' LEU . 5.7 m-20 -107.85 136.07 48.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -101.34 -18.25 16.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -58.03 -49.17 77.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 63.3 p -123.68 -25.63 4.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.108 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 99.95 54.68 1.03 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.485 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.423 ' OG1' HG22 ' A' ' 224' ' ' VAL . 27.2 m -114.14 121.84 45.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.884 0.373 . . . . 0.0 111.127 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.708 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.9 m-85 -86.29 113.99 22.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . 0.495 ' HG2' ' CG ' ' A' ' 222' ' ' GLU . 48.6 mtm180 -98.83 114.59 27.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 1.002 HG22 HG12 ' A' ' 272' ' ' VAL . 17.9 mt -111.08 133.07 57.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -113.91 122.95 48.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.634 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -146.12 143.82 12.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.5 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.35 -23.6 67.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 0.0 110.927 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 24.5 m -141.74 131.33 23.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.797 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -42.57 -34.27 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.122 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -55.72 -43.48 76.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.411 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -65.29 -68.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 1.002 HG12 HG22 ' A' ' 264' ' ' ILE . 1.0 OUTLIER -48.1 -31.82 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -67.2 -50.9 59.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -59.42 -40.12 85.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.56 -38.5 65.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -49.28 -46.88 46.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.41 -32.94 10.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.504 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -71.83 -42.03 67.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.871 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.708 HD22 ' CE1' ' A' ' 262' ' ' PHE . 97.1 mt -78.75 -13.27 59.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.92 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -59.97 142.96 52.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.81 ' HB2' HD13 ' A' ' 229' ' ' LEU . 7.4 p90 -67.56 142.17 56.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 89.8 t -121.8 132.23 71.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.146 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -59.56 140.33 56.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -50.07 126.44 14.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -105.12 141.58 36.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 72.9 mt -127.21 103.05 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.168 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -95.22 141.29 29.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.75 144.42 29.9 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.636 0.732 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 290' ' ' SER . 53.2 Cg_endo -69.78 2.83 3.2 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.653 2.235 . . . . 0.0 112.331 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 289' ' ' PRO . 40.1 t -34.58 -56.32 0.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.86 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 170.13 146.53 5.16 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -8.61 24.03 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.66 2.24 . . . . 0.0 112.338 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 2.0 m -60.06 -62.14 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.814 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 23.1 t -58.29 102.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.815 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.474 179.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 2.6 m -148.93 153.71 38.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.894 0.378 . . . . 0.0 110.858 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.8 m -123.12 170.33 10.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 134.9 91.38 0.37 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.45 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 11.7 m -132.56 97.35 4.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.904 0.383 . . . . 0.0 110.871 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 97.9 p -108.64 155.95 20.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 149.72 169.81 16.47 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.5 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.422 ' O ' ' NE2' ' A' ' 214' ' ' GLN . 20.2 m -141.13 125.25 17.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 111.158 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.0 tptt -58.9 116.81 4.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.422 ' NE2' ' O ' ' A' ' 212' ' ' THR . 1.6 mp0 -122.21 177.46 5.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 215' ' ' LEU . 4.2 mm? -97.71 58.05 1.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -164.57 -175.74 4.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -120.81 118.09 29.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -60.55 -33.76 73.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.82 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 79.8 m-85 -121.97 134.32 54.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.915 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.427 ' O ' ' CD2' ' A' ' 220' ' ' HIS . 7.6 p-80 -136.01 133.3 37.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -112.64 138.57 49.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.458 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 20.4 tt0 -141.6 125.3 16.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.515 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 11.8 p90 -142.4 149.66 39.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.847 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.62 115.5 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.16 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 41.4 t -104.94 136.57 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.109 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.411 ' HB2' HD12 ' A' ' 229' ' ' LEU . 51.5 mtp180 -54.4 133.94 45.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -50.91 -28.8 10.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -74.82 -39.69 61.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.857 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' A' ' 281' ' ' PHE . 53.4 mt -74.01 -27.11 60.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.796 ' CE ' HD11 ' A' ' 255' ' ' LEU . 8.5 mmm -41.5 -55.68 2.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -52.22 -40.24 52.13 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.566 HD22 ' CE2' ' A' ' 285' ' ' PHE . 44.1 mt -71.71 -58.62 3.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -52.02 -37.33 53.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.064 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 37.6 mt -77.03 -33.4 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.145 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 88.9 -150.93 21.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.429 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 236' ' ' THR . 9.9 t -103.03 123.92 47.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 0.0 111.139 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 18.7 m80 55.32 46.41 23.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 56.83 58.32 15.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.509 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.5 t -84.45 -57.67 3.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.361 . . . . 0.0 110.862 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 2.5 m120 -54.37 -57.62 10.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.728 HG12 HD21 ' A' ' 279' ' ' LEU . 70.7 mt -45.22 -49.58 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -51.92 -68.47 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -44.01 -35.3 2.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 241' ' ' ILE . . . -62.78 -51.67 66.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -66.96 -11.85 57.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -86.91 3.36 45.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.68 HG13 ' HD2' ' A' ' 248' ' ' PRO . 97.7 t -89.74 138.85 27.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 111.091 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.68 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.8 144.76 54.83 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.93 -14.75 62.51 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.462 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 93.8 t -88.97 103.1 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 0.0 111.153 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 64.9 p -56.9 -50.85 71.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -161.15 171.41 18.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 264' ' ' ILE . 49.4 mt -143.52 113.17 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.144 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -116.11 156.98 25.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.796 HD11 ' CE ' ' A' ' 230' ' ' MET . 7.8 tp -142.09 147.21 36.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.43 ' H ' HD12 ' A' ' 255' ' ' LEU . 5.2 t0 -103.97 135.57 45.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -100.22 -23.03 14.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -82.58 -22.03 35.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 68.1 p -120.74 -23.23 6.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 71.79 47.31 33.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.458 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 90.2 m -122.62 124.08 42.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.353 . . . . 0.0 111.174 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.677 ' CZ ' HD22 ' A' ' 255' ' ' LEU . 10.7 m-85 -87.14 123.07 31.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -113.39 115.95 28.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.691 HG22 HG12 ' A' ' 272' ' ' VAL . 7.1 mt -108.42 139.26 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.137 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -119.22 121.42 39.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.578 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -144.73 145.12 14.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.518 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 38.0 mt-10 -62.09 -33.34 74.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.891 0.377 . . . . 0.0 110.946 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.8 m -132.93 135.23 45.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.864 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.82 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -46.11 -26.94 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.118 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -60.87 -40.94 94.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.53 -64.36 0.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.137 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.691 HG12 HG22 ' A' ' 264' ' ' ILE . 0.2 OUTLIER -50.07 -31.08 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 269' ' ' ALA . 19.5 mtpp -68.99 -53.18 21.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.874 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -42.99 94.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.84 -33.89 76.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -61.37 -41.43 97.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.879 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.418 ' HA2' ' CG ' ' A' ' 280' ' ' GLU . . . -51.54 -20.02 5.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.478 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -85.32 -39.89 17.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.913 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.728 HD21 HG12 ' A' ' 241' ' ' ILE . 72.3 mt -87.24 6.16 34.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.418 ' CG ' ' HA2' ' A' ' 277' ' ' GLY . 7.6 mm-40 -53.25 149.62 7.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.516 ' HB2' HD13 ' A' ' 229' ' ' LEU . 39.0 p90 -75.28 119.94 20.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.487 ' O ' HD13 ' A' ' 232' ' ' LEU . 73.0 t -119.96 126.91 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.134 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.432 ' HG2' HD21 ' A' ' 229' ' ' LEU . 35.3 mt-10 -82.53 160.02 22.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -38.74 107.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . 0.566 ' CE2' HD22 ' A' ' 232' ' ' LEU . 37.7 p90 -99.97 136.92 39.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 286' ' ' ILE . 4.8 mp -119.75 101.4 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -116.95 142.16 47.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.895 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 16.8 m -114.57 145.61 34.21 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.624 0.726 . . . . 0.0 111.149 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 161.0 47.64 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.658 2.239 . . . . 0.0 112.363 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 2.0 t -148.22 133.24 18.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.838 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 84.52 -157.9 33.4 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.458 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.86 -31.76 19.44 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.637 2.225 . . . . 0.0 112.316 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 38.9 t -38.5 150.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 52.2 m -82.29 170.27 15.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.823 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.488 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 89.4 p -149.46 155.92 41.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 0.0 110.824 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 93.6 p -168.87 148.04 4.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.892 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.29 162.75 32.53 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.507 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -124.6 115.89 21.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.917 0.389 . . . . 0.0 110.848 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.5 m -136.1 172.9 12.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -80.88 113.1 3.57 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.47 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 7.7 t -131.79 154.96 48.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 0.0 111.147 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.08 136.05 55.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -131.23 163.76 27.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.956 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.22 -63.0 1.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -148.94 135.22 19.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.058 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -76.64 127.11 32.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.088 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -73.92 -30.12 62.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.09 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.876 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 68.1 m-85 -118.22 137.94 52.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.88 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -144.02 148.68 35.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -117.67 136.23 53.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -132.98 113.36 12.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 15.7 p90 -137.61 141.3 41.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.613 HG22 ' OG1' ' A' ' 261' ' ' THR . 59.2 t -92.62 120.17 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 53.5 t -103.47 136.07 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.456 ' HB2' HD12 ' A' ' 229' ' ' LEU . 2.9 mmp_? -53.38 130.94 36.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -52.78 -16.72 1.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -92.9 -36.34 12.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.456 HD12 ' HB2' ' A' ' 226' ' ' ARG . 88.4 mt -74.38 -23.52 59.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.655 ' CE ' HD11 ' A' ' 255' ' ' LEU . 4.6 mtt -41.14 -65.2 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.895 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -35.44 -56.3 0.96 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.468 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 235' ' ' GLY . 41.6 mt -63.95 -64.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -41.32 -28.8 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.152 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 60.1 mt -89.95 -34.43 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 232' ' ' LEU . . . 89.94 -149.97 20.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 237' ' ' HIS . 4.9 t -98.9 143.58 29.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 111.192 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.44 ' C ' ' O ' ' A' ' 236' ' ' THR . 27.3 m-70 34.85 45.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.841 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 60.31 60.08 9.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.49 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.4 t -84.43 -61.46 1.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.876 0.37 . . . . 0.0 110.852 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -48.51 -59.84 3.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 30.9 mt -42.62 -53.37 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -50.05 -67.9 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -39.92 -52.8 2.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -50.69 -48.16 58.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -69.28 -13.55 62.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.841 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -86.27 6.82 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.683 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.4 t -92.71 138.88 23.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.628 0.728 . . . . 0.0 111.119 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.683 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.76 149.95 67.6 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.709 2.273 . . . . 0.0 112.309 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.05 -19.24 31.48 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.505 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 265' ' ' TYR . 94.9 t -83.54 107.11 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.398 . . . . 0.0 111.129 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 59.1 p -60.2 -56.04 26.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.167 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -156.34 162.11 40.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.125 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.841 HG12 HG23 ' A' ' 264' ' ' ILE . 76.4 mt -135.14 107.05 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -107.13 163.27 13.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.655 HD11 ' CE ' ' A' ' 230' ' ' MET . 7.9 tp -141.06 141.98 34.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.933 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -100.33 129.7 46.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -100.31 -14.9 18.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -63.69 -38.72 92.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 54.5 p -128.81 -29.46 2.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.091 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.16 58.69 0.78 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.495 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.613 ' OG1' HG22 ' A' ' 224' ' ' VAL . 91.2 m -125.35 122.38 36.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 111.107 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.537 ' CZ ' HD22 ' A' ' 255' ' ' LEU . 11.1 m-85 -86.5 123.99 32.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -110.84 111.89 23.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.876 HG22 HG12 ' A' ' 272' ' ' VAL . 9.5 mt -104.44 141.02 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.407 ' O ' HG13 ' A' ' 250' ' ' VAL . 87.2 m-85 -121.63 131.28 54.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -154.29 143.63 10.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.481 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -58.22 -32.53 68.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 0.0 110.938 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.1 t -134.67 137.07 43.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.877 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.876 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.43 -28.87 2.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.134 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -42.53 84.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.74 -66.89 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.112 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.876 HG12 HG22 ' A' ' 264' ' ' ILE . 0.2 OUTLIER -48.76 -34.84 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 36.2 mttm -64.23 -50.75 66.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -63.32 -39.75 95.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.8 -29.62 62.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.466 ' CZ ' ' OE1' ' A' ' 280' ' ' GLU . 21.2 ttt-85 -60.7 -42.79 97.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.841 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.41 ' HA2' ' CG ' ' A' ' 280' ' ' GLU . . . -51.09 -24.93 9.64 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.491 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -80.36 -25.82 38.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 110.866 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.471 HD22 ' CE1' ' A' ' 262' ' ' PHE . 68.3 mt -102.16 11.39 38.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.466 ' OE1' ' CZ ' ' A' ' 276' ' ' ARG . 8.9 mm-40 -63.61 144.09 57.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.487 ' CD1' ' O ' ' A' ' 281' ' ' PHE . 46.8 p90 -69.86 120.22 15.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 94.1 t -119.89 126.78 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -74.0 166.71 22.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -63.77 122.96 17.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -108.25 119.95 40.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 27.7 mm -122.76 103.28 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -91.7 129.23 37.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.913 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 22.1 m -101.04 144.24 28.17 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.565 0.698 . . . . 0.0 111.123 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 110.61 2.6 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.626 2.218 . . . . 0.0 112.356 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 91.4 p -79.86 -44.3 20.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -78.59 150.9 35.32 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.501 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 138.21 37.37 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.669 2.246 . . . . 0.0 112.337 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 89.6 p -118.57 154.05 33.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 71.5 p -169.22 111.45 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.475 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 3.6 m -126.19 147.36 49.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.883 0.373 . . . . 0.0 110.892 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 89.2 p -132.98 118.99 19.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -109.34 -160.16 18.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.449 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.6 t -126.02 102.43 7.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.877 0.37 . . . . 0.0 110.831 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.3 m -84.09 162.55 20.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 155.73 -70.04 0.28 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 46.4 m -129.99 137.27 50.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.371 . . . . 0.0 111.143 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.48 150.46 8.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -109.57 177.13 4.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 43.5 mt -116.38 90.48 3.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -171.47 133.53 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.069 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -106.76 111.62 24.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.077 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.81 86.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.127 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.557 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 83.4 m-85 -108.02 142.29 38.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -133.06 140.46 47.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -111.55 141.85 44.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.418 ' C ' ' CD ' ' A' ' 222' ' ' GLU . 0.6 OUTLIER -148.94 111.31 4.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.837 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.528 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 34.0 p90 -140.9 151.42 44.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 20.0 t -96.52 134.34 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.123 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.709 HG13 ' HB3' ' A' ' 281' ' ' PHE . 69.0 t -118.61 137.38 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -57.02 130.07 44.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -57.7 -22.53 46.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -83.72 -19.54 35.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.718 HD13 ' HB2' ' A' ' 281' ' ' PHE . 30.9 mt -100.42 -18.07 16.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.557 ' CE ' HD11 ' A' ' 255' ' ' LEU . 4.8 mmt -45.02 -66.96 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -40.45 -40.59 2.03 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.511 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 40.9 mt -69.94 -55.99 8.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.834 0.35 . . . . 0.0 110.945 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.787 ' HB2' ' HA ' ' A' ' 281' ' ' PHE . . . -52.9 -38.43 61.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.045 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 25.7 mt -77.5 -37.8 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 95.16 -158.5 22.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.471 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 22.1 m -95.77 128.59 42.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 111.189 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 67.4 t60 52.67 46.34 26.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.831 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 53.76 67.95 1.89 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.511 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.8 t -92.8 -61.51 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 110.912 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -50.02 -60.58 2.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 19.2 mt -41.61 -49.06 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -54.53 -51.2 65.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -58.02 -37.63 74.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.94 96.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.444 ' HG3' HD12 ' A' ' 253' ' ' ILE . 5.9 mtp-105 -70.7 -0.91 9.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -104.98 12.88 31.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.654 HG13 ' HD2' ' A' ' 248' ' ' PRO . 84.9 t -95.16 138.63 21.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 111.142 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.654 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.7 Cg_endo -69.77 133.4 25.46 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.683 2.255 . . . . 0.0 112.331 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 96.74 -0.43 61.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 74.5 t -102.17 106.57 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 111.147 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 265' ' ' TYR . 35.9 p -63.0 -58.25 7.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -151.47 157.59 42.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.629 HG12 HG23 ' A' ' 264' ' ' ILE . 66.0 mt -130.37 114.17 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.148 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -118.38 149.12 41.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.557 HD11 ' CE ' ' A' ' 230' ' ' MET . 8.9 tp -127.56 147.7 50.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.944 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.532 ' H ' HD12 ' A' ' 255' ' ' LEU . 0.8 OUTLIER -112.84 118.92 36.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -84.74 -27.82 26.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -49.72 -40.5 40.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 62.0 p -125.25 -27.76 3.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.139 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 97.68 39.01 4.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 35.1 m -103.97 130.28 51.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 0.0 111.146 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.823 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.9 m-85 -93.58 116.6 29.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 53.5 mtt-85 -104.28 119.23 38.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.707 HG22 HG12 ' A' ' 272' ' ' VAL . 10.9 mt -115.49 143.32 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 251' ' ' THR . 88.9 m-85 -122.9 117.16 24.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.61 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -141.07 151.35 22.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.506 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -69.74 -26.51 64.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.2 p -132.71 132.79 42.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.21 -29.89 2.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.103 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.31 -35.71 81.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -69.79 -53.96 15.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.08 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.707 HG12 HG22 ' A' ' 264' ' ' ILE . 0.4 OUTLIER -63.11 -29.54 47.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -72.22 -51.32 21.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -55.53 -48.94 73.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.97 -34.36 76.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.528 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 45.9 ttt180 -53.88 -47.06 71.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -46.44 -26.12 2.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -79.53 -33.71 41.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.905 0.383 . . . . 0.0 110.884 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.823 HD22 ' CE1' ' A' ' 262' ' ' PHE . 92.9 mt -85.27 -17.23 37.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -62.78 141.33 58.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.787 ' HA ' ' HB2' ' A' ' 233' ' ' ALA . 8.4 p90 -62.34 144.59 55.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.881 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 62.9 t -127.23 127.69 69.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.114 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 284' ' ' ASP . 22.7 mp0 -54.51 145.83 17.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 283' ' ' GLU . 10.5 t0 -35.63 134.84 0.31 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -81.28 134.79 35.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 39.1 mt -108.12 98.34 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 43.9 tp60 -69.05 141.13 54.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.937 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 32.8 m -94.93 146.71 31.83 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.606 0.717 . . . . 0.0 111.142 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 109.91 2.43 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.673 2.249 . . . . 0.0 112.301 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 72.7 m -48.98 170.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -142.93 146.11 16.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -34.58 14.35 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.7 2.266 . . . . 0.0 112.295 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 96.9 p -54.01 136.21 41.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.832 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 12.0 t -75.05 -42.72 56.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.521 -179.964 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 6.3 t -161.97 144.51 11.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.89 0.376 . . . . 0.0 110.905 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.6 t -87.4 115.08 24.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 113.27 124.06 4.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.461 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.1 m -152.51 137.27 17.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.921 0.391 . . . . 0.0 110.857 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.824 ' O ' HG23 ' A' ' 212' ' ' THR . 3.3 t -51.35 127.88 20.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 210' ' ' SER . . . -34.85 108.67 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.457 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.824 HG23 ' O ' ' A' ' 210' ' ' SER . 34.4 p -123.99 170.02 11.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.171 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -124.24 94.62 4.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.9 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -108.12 131.19 54.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 12.9 tp -127.65 38.56 4.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -158.42 157.45 32.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.103 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . -110.99 132.07 54.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.091 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -66.83 -36.29 82.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.074 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.536 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 88.2 m-85 -112.56 141.01 46.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.912 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -140.89 138.73 34.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.853 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -113.93 138.62 50.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -139.12 121.36 15.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 12.9 p90 -142.33 143.14 32.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.94 119.73 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.31 134.73 50.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 229' ' ' LEU . 46.9 mtm180 -54.26 120.9 7.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -38.15 -28.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 226' ' ' ARG . 15.9 t0 -72.42 -44.36 62.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 281' ' ' PHE . 86.4 mt -74.14 -26.15 60.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.842 ' CE ' HD11 ' A' ' 255' ' ' LEU . 30.3 mtp -49.22 -58.91 4.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -36.47 -56.62 1.22 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.464 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 50.4 mt -67.78 -52.17 40.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -46.24 -34.59 4.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.087 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 56.4 mt -85.94 -32.44 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.128 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 93.78 -150.57 19.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.485 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 85.2 m -111.34 112.67 24.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 111.129 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 73.73 35.03 0.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.82 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 63.05 62.8 5.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 27.6 t -92.21 -53.62 4.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.835 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 7.1 m120 -58.01 -50.53 73.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 52.7 mt -52.06 -45.74 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.124 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -53.95 -67.31 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -42.79 -43.45 3.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.82 81.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.423 ' CG ' HD12 ' A' ' 253' ' ' ILE . 54.7 mtp180 -69.8 -21.69 63.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -76.33 -5.01 45.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.671 HG13 ' HD2' ' A' ' 248' ' ' PRO . 84.0 t -77.78 138.65 62.06 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.63 0.729 . . . . 0.0 111.104 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.671 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.0 Cg_endo -69.77 143.31 50.4 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.662 2.241 . . . . 0.0 112.388 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 91.41 -19.92 44.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.0 t -80.49 106.05 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.921 0.391 . . . . 0.0 111.129 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.459 ' CG2' ' HB2' ' A' ' 217' ' ' ALA . 32.6 p -60.09 -58.76 7.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.159 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -154.46 159.13 40.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.499 HG12 HG23 ' A' ' 264' ' ' ILE . 50.9 mt -132.57 103.85 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.158 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -104.05 155.63 18.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.842 HD11 ' CE ' ' A' ' 230' ' ' MET . 8.5 tp -140.17 157.11 46.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.649 ' H ' HD12 ' A' ' 255' ' ' LEU . 6.4 t0 -116.93 134.5 54.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -100.88 -16.97 17.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.37 -34.37 28.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.83 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 59.7 p -114.77 -21.76 10.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.186 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 74.02 53.03 7.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.516 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.8 m -122.4 129.47 52.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.319 . . . . 0.0 111.142 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.785 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.9 m-85 -93.11 121.85 34.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.871 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.7 mtm-85 -113.02 114.17 26.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.834 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.734 HG22 HG12 ' A' ' 272' ' ' VAL . 5.2 mt -107.1 138.59 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.112 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 251' ' ' THR . 93.7 m-85 -122.82 117.47 25.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.564 ' O ' ' HB1' ' A' ' 217' ' ' ALA . . . -139.88 144.81 15.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -58.06 -33.4 69.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.899 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.2 t -134.57 137.29 43.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.878 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -45.2 -26.8 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.061 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.25 -44.83 94.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.47 -65.09 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.139 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.734 HG12 HG22 ' A' ' 264' ' ' ILE . 0.9 OUTLIER -48.46 -31.1 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -71.54 -54.14 11.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -58.17 -35.5 71.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -76.46 -37.34 57.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -54.8 -36.61 65.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -58.65 -12.22 13.16 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -94.61 -28.08 15.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 110.891 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.785 HD22 ' CE1' ' A' ' 262' ' ' PHE . 82.2 mt -92.95 -2.68 55.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -47.92 153.1 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.634 ' HB2' HD13 ' A' ' 229' ' ' LEU . 53.5 p90 -82.07 135.87 35.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.893 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.463 ' O ' HD22 ' A' ' 229' ' ' LEU . 80.1 t -128.14 133.64 66.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -77.36 162.5 27.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.81 143.54 57.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -81.8 139.59 34.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 52.3 mt -103.0 95.86 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 13.5 tp60 -80.19 105.0 11.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 16.6 m -91.93 144.4 29.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.612 0.72 . . . . 0.0 111.142 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -5.75 16.96 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.689 2.259 . . . . 0.0 112.341 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.3 m -95.51 161.73 13.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -141.93 153.85 24.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.523 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 171.68 14.0 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.716 2.278 . . . . 0.0 112.355 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 73.9 m -143.1 145.56 32.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.804 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 54.7 p -58.28 125.63 24.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.868 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.545 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 35.3 p -137.11 152.2 49.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.918 0.39 . . . . 0.0 110.825 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.0 t -48.63 -61.02 2.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 209' ' ' SER . . . 132.04 -54.35 0.78 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.51 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 208' ' ' GLY . 34.0 t -36.86 145.52 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.879 0.371 . . . . 0.0 110.842 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 80.1 p -134.13 164.89 26.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 99.57 94.19 2.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.505 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 23.3 m -127.57 149.49 50.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 111.126 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -86.82 168.83 13.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -94.12 46.71 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 216' ' ' ALA . 28.2 tp -78.05 157.64 29.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.465 ' N ' ' HG ' ' A' ' 215' ' ' LEU . . . -69.65 159.75 32.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.108 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -111.94 137.12 50.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.099 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -73.23 -41.22 63.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.614 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 66.1 m-85 -107.98 132.29 53.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -126.17 145.72 50.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -119.22 137.65 53.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -143.53 111.96 6.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.448 ' CE2' ' HG3' ' A' ' 276' ' ' ARG . 30.2 p90 -141.21 150.08 42.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.869 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.412 HG22 ' OG1' ' A' ' 261' ' ' THR . 47.7 t -96.47 132.25 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.5 t -113.77 137.43 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.098 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -53.54 122.06 9.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -49.7 -20.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -86.16 -38.49 17.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.775 HD13 ' HB2' ' A' ' 281' ' ' PHE . 34.6 mt -79.8 -25.24 40.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.525 ' CE ' HD11 ' A' ' 255' ' ' LEU . 25.7 mtp -45.98 -58.84 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.87 -52.24 3.25 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.463 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 26.1 mt -67.8 -50.71 55.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.838 0.352 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.426 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -47.51 -45.78 26.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 52.8 mt -69.68 -40.7 79.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 101.84 -143.87 16.16 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.489 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.56 ' O ' HG23 ' A' ' 236' ' ' THR . 8.8 t -115.29 114.26 24.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.774 0.321 . . . . 0.0 111.13 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 69.19 39.25 1.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 60.11 59.54 10.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 2.5 t -89.29 -60.11 2.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.907 0.384 . . . . 0.0 110.858 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 3.7 m120 -50.6 -56.89 9.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 48.9 mt -44.94 -51.35 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -56.24 -44.43 79.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -60.73 -35.38 76.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.549 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -64.48 -53.63 45.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.483 ' N ' HD12 ' A' ' 253' ' ' ILE . 9.6 ptt180 -60.84 -30.29 70.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -64.81 -6.66 8.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.663 HG13 ' HD2' ' A' ' 248' ' ' PRO . 85.7 t -77.15 138.7 64.69 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.614 0.721 . . . . 0.0 111.136 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.663 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.9 Cg_endo -69.75 128.55 16.2 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.686 2.257 . . . . 0.0 112.368 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 104.12 -12.27 52.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.9 t -87.1 102.2 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 111.137 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 53.0 p -57.1 -48.96 77.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.168 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -162.35 166.86 24.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.096 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.6 HG12 HG23 ' A' ' 264' ' ' ILE . 58.6 mt -139.05 113.11 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.121 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -111.94 152.58 27.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.525 HD11 ' CE ' ' A' ' 230' ' ' MET . 8.3 tp -129.19 110.72 12.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.91 99.4 6.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -73.75 -30.92 63.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.882 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -42.81 -39.52 2.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 3.0 p -127.06 -28.53 2.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.126 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 101.89 40.39 2.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.512 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.412 ' OG1' HG22 ' A' ' 224' ' ' VAL . 93.8 m -110.15 116.79 32.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.846 0.355 . . . . 0.0 111.13 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.489 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.8 m-85 -79.87 118.36 21.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -108.37 113.73 27.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.992 HD11 HD12 ' A' ' 279' ' ' LEU . 40.7 mt -107.25 139.79 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -117.9 121.92 41.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.917 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -144.79 140.45 9.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.504 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -61.99 -33.11 73.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.851 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 271' ' ' ALA . 23.8 p -127.37 123.83 37.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.872 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.614 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -38.5 -33.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.081 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -57.7 -46.05 84.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.834 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 268' ' ' SER . . . -61.27 -68.15 0.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.071 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.917 HG13 ' HA3' ' A' ' 266' ' ' GLY . 3.5 m -47.86 -34.21 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -66.6 -52.23 47.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 39.8 tttt -54.5 -49.04 71.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.549 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -67.43 -38.16 84.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.113 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.448 ' HG3' ' CE2' ' A' ' 223' ' ' PHE . 24.9 ttp85 -47.1 -44.47 21.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -49.27 -35.32 19.99 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -69.43 -42.7 74.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.992 HD12 HD11 ' A' ' 264' ' ' ILE . 81.1 mt -75.05 -27.03 59.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.983 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -49.79 148.02 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.775 ' HB2' HD13 ' A' ' 229' ' ' LEU . 9.7 p90 -66.87 144.29 56.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 85.8 t -127.18 131.54 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.153 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 284' ' ' ASP . 5.7 mm-40 -58.14 133.01 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 283' ' ' GLU . 6.9 p-10 -34.93 112.25 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -100.24 125.04 46.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 70.6 mt -104.02 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.087 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -108.31 145.3 34.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 35.6 m -108.51 144.3 29.24 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.588 0.708 . . . . 0.0 111.115 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 93.07 0.52 Allowed 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.7 2.267 . . . . 0.0 112.364 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.9 m -89.03 -62.16 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -162.95 83.38 0.11 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.456 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 140.17 42.03 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.7 2.266 . . . . 0.0 112.362 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 24.3 m -107.99 171.22 7.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.3 t 40.91 41.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.889 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.484 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 53.0 p -121.54 138.11 54.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.918 0.389 . . . . 0.0 110.814 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 59.2 m -69.9 152.91 43.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.888 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -88.07 -103.89 0.94 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.531 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.4 p -94.62 147.9 22.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 110.825 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.4 t -76.05 121.87 23.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -107.69 -85.89 1.79 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.486 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 52.4 p -86.84 134.19 33.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 0.0 111.183 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.5 161.13 9.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.895 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -138.89 142.06 38.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.11 82.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -148.24 135.43 20.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.051 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -103.49 110.69 22.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.84 76.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.103 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.714 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 70.5 m-85 -122.08 125.46 46.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -122.76 138.62 54.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -115.08 146.16 41.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.458 ' HG3' ' CG2' ' A' ' 261' ' ' THR . 19.5 tt0 -149.28 124.6 10.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 4.8 p90 -141.42 146.0 36.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.403 HG22 ' OG1' ' A' ' 261' ' ' THR . 13.0 t -97.83 110.48 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 31.5 t -95.66 146.03 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.453 ' HB2' HD12 ' A' ' 229' ' ' LEU . 12.4 mmm-85 -61.6 148.59 41.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.14 -22.58 66.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -94.47 -12.91 26.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 226' ' ' ARG . 91.5 mt -98.36 -8.93 26.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.554 ' CE ' HD11 ' A' ' 255' ' ' LEU . 2.9 mmt -56.38 -68.63 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -34.74 -57.09 0.78 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.466 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 62.7 mt -61.99 -51.16 69.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.922 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 281' ' ' PHE . . . -57.75 -22.61 47.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.15 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.651 HG22 ' HA2' ' A' ' 238' ' ' GLY . 37.8 mt -100.44 -10.75 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.14 -157.68 53.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.529 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 238' ' ' GLY . 15.2 t -89.33 147.4 24.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.125 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.436 ' C ' ' O ' ' A' ' 236' ' ' THR . 96.1 m-70 35.37 33.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.651 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 65.13 48.91 65.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.476 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 236' ' ' THR . 3.0 t -77.25 -48.84 16.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 110.837 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -53.54 -54.71 33.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.492 ' HA ' HD21 ' A' ' 279' ' ' LEU . 55.7 mt -48.57 -45.46 14.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -55.03 -62.0 1.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 247' ' ' VAL . 80.4 mt-30 -43.75 -49.03 8.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.935 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.42 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -59.19 -43.9 92.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -73.43 -18.07 61.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -90.64 15.24 11.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.665 HG13 ' HD2' ' A' ' 248' ' ' PRO . 98.0 t -93.95 138.38 22.71 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.616 0.722 . . . . 0.0 111.142 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.665 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.5 Cg_endo -69.7 128.89 16.73 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.702 2.268 . . . . 0.0 112.397 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.72 -7.88 50.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.537 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 84.0 t -96.75 103.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 111.137 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 68.3 p -54.11 -57.41 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.149 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.07 174.62 14.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.128 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.642 HG12 HG23 ' A' ' 264' ' ' ILE . 79.1 mt -143.19 108.54 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -105.43 155.34 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.554 HD11 ' CE ' ' A' ' 230' ' ' MET . 9.8 tp -141.01 133.43 28.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.7 120.49 40.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.809 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -85.36 -26.96 26.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.76 -40.03 27.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 35.0 p -127.16 -27.97 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 98.45 54.99 1.12 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.477 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.458 ' CG2' ' HG3' ' A' ' 222' ' ' GLU . 3.5 m -116.3 123.93 48.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.341 . . . . 0.0 111.154 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.538 ' CE1' HD22 ' A' ' 255' ' ' LEU . 11.0 m-85 -92.52 112.74 24.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.883 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 38.4 mtp85 -103.21 120.37 40.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.642 HG23 HG12 ' A' ' 253' ' ' ILE . 7.4 mt -110.89 136.93 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.182 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -116.88 119.59 35.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.625 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -141.51 146.62 17.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.468 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -68.22 -28.28 67.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 p -130.21 130.8 45.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.714 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -43.82 -30.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.072 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.21 -40.79 98.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.47 -65.9 0.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.093 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.625 HG13 ' HA3' ' A' ' 266' ' ' GLY . 0.3 OUTLIER -47.92 -41.25 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -67.13 -47.0 72.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.936 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -59.85 -39.21 84.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.42 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -75.57 -30.35 59.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.139 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -62.84 -39.92 95.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -54.64 -13.38 4.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.514 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -93.91 -26.06 17.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.492 HD21 ' HA ' ' A' ' 241' ' ' ILE . 83.0 mt -94.85 6.2 49.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -56.16 138.12 50.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.495 ' HA ' ' HB2' ' A' ' 233' ' ' ALA . 43.4 p90 -66.3 135.06 53.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 63.8 t -126.09 127.12 70.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -77.15 155.02 32.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.892 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -61.59 112.96 2.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.83 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -107.28 144.99 33.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 286' ' ' ILE . 4.6 mp -95.92 95.68 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.18 107.08 14.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 33.9 m -110.44 146.41 34.25 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.622 0.725 . . . . 0.0 111.12 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 128.05 15.45 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.739 2.293 . . . . 0.0 112.319 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 47.0 t -94.3 93.2 7.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 95.9 150.96 27.69 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 123.81 10.47 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.711 2.274 . . . . 0.0 112.355 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 80.0 p 37.31 43.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.4 p -131.56 -53.3 1.01 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 46.9 t -39.51 150.09 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 110.853 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.7 t -149.87 128.63 12.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.839 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -125.04 89.24 0.39 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.496 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 30.4 m -70.89 114.15 8.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.865 0.364 . . . . 0.0 110.841 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 81.0 p -124.75 175.98 6.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.892 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.52 -137.79 2.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 53.2 p -121.88 129.97 52.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.83 0.348 . . . . 0.0 111.154 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm -90.84 89.23 7.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.897 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -82.42 -179.17 7.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.945 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.711 HD23 ' H ' ' A' ' 215' ' ' LEU . 0.8 OUTLIER -89.34 13.79 12.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.952 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -139.28 171.87 13.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -84.15 114.23 21.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.073 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -70.94 -29.17 65.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.069 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.932 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 86.6 m-85 -123.37 114.5 20.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -118.03 145.6 44.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -114.33 133.22 55.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.465 ' C ' ' CD ' ' A' ' 222' ' ' GLU . 0.3 OUTLIER -135.87 117.04 14.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.527 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 12.0 p90 -142.57 151.77 41.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.851 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 18.4 t -102.26 121.99 53.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.082 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 93.2 t -109.24 144.98 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.532 ' HB2' HD12 ' A' ' 229' ' ' LEU . 70.8 mtt180 -60.9 122.06 13.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -40.48 -32.37 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.95 -43.08 56.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.535 HD13 ' HB2' ' A' ' 281' ' ' PHE . 80.2 mt -71.23 -25.39 62.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.834 ' CE ' HD11 ' A' ' 255' ' ' LEU . 26.5 mtp -47.22 -64.46 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -36.32 -51.69 1.31 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.48 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 63.1 mt -67.03 -44.6 79.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 110.947 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 240' ' ' ASN . . . -55.56 -37.9 68.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.554 HG23 HG13 ' A' ' 241' ' ' ILE . 41.8 mt -83.7 -27.61 7.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.147 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 90.18 -153.94 23.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.524 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 91.2 m -108.66 117.13 33.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.8 0.333 . . . . 0.0 111.182 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 9.1 t60 72.93 30.64 1.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.857 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 65.31 56.76 13.82 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.522 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 30.8 t -86.49 -58.15 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 0.0 110.856 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 233' ' ' ALA . 4.6 m120 -51.17 -59.39 4.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.906 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.554 HG13 HG23 ' A' ' 234' ' ' ILE . 44.3 mt -42.83 -48.34 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -54.93 -55.36 31.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -48.74 -54.76 13.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.43 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -52.62 -40.6 62.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.075 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -71.31 -19.45 62.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -85.09 15.75 3.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.65 HG13 ' HD2' ' A' ' 248' ' ' PRO . 95.6 t -98.6 138.05 20.71 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.634 0.731 . . . . 0.0 111.092 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.65 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.3 Cg_endo -69.73 133.07 24.74 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.698 2.265 . . . . 0.0 112.391 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 101.41 -17.65 55.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.521 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 275' ' ' ALA . 58.7 t -87.31 101.78 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.851 0.358 . . . . 0.0 111.164 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 66.7 p -56.28 -47.91 77.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -163.76 170.88 16.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.081 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 264' ' ' ILE . 86.8 mt -140.1 116.22 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.101 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -113.65 160.45 18.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.834 HD11 ' CE ' ' A' ' 230' ' ' MET . 4.1 tp -142.13 144.0 33.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -104.61 126.64 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.828 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -97.25 -19.17 18.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -58.6 -44.28 89.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 67.6 p -124.1 -31.01 3.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.173 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.67 57.35 0.7 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 90.7 m -122.65 119.17 29.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 111.189 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.584 ' CD1' HD13 ' A' ' 279' ' ' LEU . 12.4 m-85 -85.7 130.97 34.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -119.49 119.2 33.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.747 HG22 HG12 ' A' ' 272' ' ' VAL . 6.2 mt -109.47 139.94 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.148 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -120.0 115.53 23.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.476 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -140.16 138.05 8.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.453 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -56.86 -29.48 62.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.861 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.1 t -134.91 138.95 44.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.932 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -47.78 -30.19 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.071 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -59.56 -40.68 88.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.402 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -68.09 -67.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.747 HG12 HG22 ' A' ' 264' ' ' ILE . 0.3 OUTLIER -47.32 -38.46 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -64.03 -54.59 31.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -39.82 78.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.906 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.43 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -71.18 -35.75 71.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.054 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.41 ' HB2' HD12 ' A' ' 264' ' ' ILE . 50.1 ttt180 -59.17 -35.59 73.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -60.05 -8.87 9.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.493 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -98.72 -24.65 14.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 110.911 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.584 HD13 ' CD1' ' A' ' 262' ' ' PHE . 82.4 mt -99.28 1.94 45.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -54.53 145.24 19.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.887 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.535 ' HB2' HD13 ' A' ' 229' ' ' LEU . 53.5 p90 -67.52 127.59 33.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 87.5 t -126.55 126.94 69.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.09 164.34 26.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.04 133.08 38.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -70.24 121.45 17.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 85.6 mt -107.12 98.76 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.106 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -115.45 153.29 31.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.6 m -132.31 146.22 60.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.629 0.728 . . . . 0.0 111.116 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 116.25 4.47 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.702 2.268 . . . . 0.0 112.322 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 38.7 m -167.14 154.41 8.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -127.2 171.33 18.76 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.526 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 166.96 25.82 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.702 2.268 . . . . 0.0 112.367 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 19.4 m -65.76 163.45 16.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 29.0 t -98.96 117.67 34.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.878 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.458 -179.926 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 7.8 t -171.0 163.51 7.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.858 0.361 . . . . 0.0 110.834 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 69.4 m -58.27 164.35 2.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.9 147.01 18.37 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 25.0 t -134.26 96.04 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.899 0.381 . . . . 0.0 110.841 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 80.2 p -146.24 150.19 35.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 148.72 -81.64 0.19 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.489 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 26.9 m -117.49 124.84 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 0.0 111.167 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -84.78 172.64 11.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -170.94 159.34 6.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.932 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.794 ' O ' HD12 ' A' ' 215' ' ' LEU . 3.9 pp -84.9 45.44 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -143.34 136.66 28.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.088 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -98.97 113.54 25.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -65.42 -38.55 90.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.714 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 77.7 m-85 -109.01 130.86 55.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -127.68 141.32 51.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -113.62 142.82 45.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.44 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 0.1 OUTLIER -147.13 105.55 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 276' ' ' ARG . 15.5 p90 -130.12 156.38 44.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 62.1 t -106.91 126.69 62.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.081 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.77 HG13 ' HB3' ' A' ' 281' ' ' PHE . 95.0 t -110.0 143.29 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.088 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.607 ' HB2' HD12 ' A' ' 229' ' ' LEU . 16.5 mmt180 -55.69 123.08 12.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -45.5 -25.08 0.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.26 -39.29 17.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.768 HD13 ' HB2' ' A' ' 281' ' ' PHE . 45.3 mt -71.81 -30.23 65.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 24.1 mtp -39.7 -57.94 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -41.55 -49.02 4.87 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.502 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 30.0 mt -70.67 -58.02 4.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 110.905 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -42.26 -42.75 3.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.064 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.429 HG23 HG13 ' A' ' 241' ' ' ILE . 22.9 mt -74.81 -36.08 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.121 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 99.51 -158.09 19.86 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 22.0 m -105.19 113.27 26.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.806 0.336 . . . . 0.0 111.137 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 74.4 31.34 1.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.858 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 64.11 61.52 6.01 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.461 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 29.3 t -90.96 -55.17 3.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.901 0.381 . . . . 0.0 110.851 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -55.84 -47.94 76.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.496 HG12 HD21 ' A' ' 279' ' ' LEU . 26.5 mt -54.55 -47.74 71.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -57.23 -46.72 82.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -60.25 -54.51 44.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.587 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -48.8 -40.1 27.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.082 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.4 ' CA ' HD12 ' A' ' 253' ' ' ILE . 18.4 ttt85 -72.87 -22.33 60.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -86.65 21.72 2.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.642 HG13 ' HD2' ' A' ' 248' ' ' PRO . 86.3 t -100.89 138.07 19.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.619 0.724 . . . . 0.0 111.104 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.642 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.77 127.26 14.33 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.711 2.274 . . . . 0.0 112.359 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 104.1 -4.53 45.1 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.538 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 82.9 t -100.89 104.96 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 0.0 111.141 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 69.9 p -59.19 -54.03 51.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.02 166.41 33.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.107 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.712 HG12 HG23 ' A' ' 264' ' ' ILE . 77.0 mt -137.57 105.94 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.163 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -110.79 148.59 32.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.719 HD12 ' H ' ' A' ' 256' ' ' ASP . 8.0 tp -128.15 154.57 45.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.929 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.719 ' H ' HD12 ' A' ' 255' ' ' LEU . 14.7 m-20 -112.07 130.15 55.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -100.13 -14.74 18.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.21 -45.18 95.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.9 p -126.0 -28.65 3.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.131 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.58 61.62 0.66 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.481 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.44 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 91.9 m -124.67 122.21 36.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 0.0 111.124 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.795 ' CE1' HD22 ' A' ' 279' ' ' LEU . 13.6 m-85 -89.2 113.14 24.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -102.2 110.63 22.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.807 HG22 HG12 ' A' ' 272' ' ' VAL . 7.2 mt -104.59 144.78 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -123.0 124.11 42.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.489 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -149.46 136.3 5.71 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.533 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -56.58 -29.73 62.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.833 0.349 . . . . 0.0 110.866 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 13.2 p -129.08 135.23 48.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.714 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -49.29 -28.83 5.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.141 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.62 -36.86 84.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.854 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.424 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -66.6 -59.82 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.075 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.807 HG12 HG22 ' A' ' 264' ' ' ILE . 0.3 OUTLIER -58.85 -29.98 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -68.07 -50.45 55.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -58.21 -48.01 81.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.587 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -65.09 -33.61 76.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.43 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 74.1 ttt180 -53.89 -50.12 67.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -44.14 -27.73 1.17 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.495 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -80.54 -39.07 28.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.924 0.392 . . . . 0.0 110.953 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.795 HD22 ' CE1' ' A' ' 262' ' ' PHE . 30.7 mt -88.08 -2.54 58.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -66.35 142.81 57.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.863 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.77 ' HB3' HG13 ' A' ' 225' ' ' VAL . 37.9 p90 -64.85 132.96 50.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.876 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.461 ' O ' HD22 ' A' ' 229' ' ' LEU . 57.3 t -127.12 125.32 66.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.118 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -55.77 160.33 2.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.22 115.42 2.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -105.72 148.18 27.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 30.4 mt -116.32 103.33 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -107.21 151.65 25.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.58 146.28 42.86 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.639 0.733 . . . . 0.0 111.121 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 138.73 38.53 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.731 2.287 . . . . 0.0 112.357 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 7.7 t -82.02 135.98 35.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -64.64 -158.42 0.31 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -31.73 19.92 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.677 2.252 . . . . 0.0 112.38 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 1.5 t -85.38 155.8 21.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.866 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 295' ' ' GLY . 96.5 p -136.87 174.84 10.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.84 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 294' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.486 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 8.6 m -121.18 99.99 6.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 0.0 110.875 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 51.0 p -99.46 159.55 14.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.68 -115.41 0.64 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.474 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 44.6 m 47.57 42.44 14.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.9 0.381 . . . . 0.0 110.883 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.2 m -139.93 144.6 37.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.867 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -72.56 -110.06 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.437 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 23.5 m -128.11 126.71 41.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.826 0.346 . . . . 0.0 111.115 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -152.26 150.55 29.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -112.25 92.96 4.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.974 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 15.3 tp -131.8 147.27 52.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -38.72 145.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.107 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -78.68 116.15 18.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.083 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -58.56 -43.75 89.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.125 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.636 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 83.5 m-85 -110.05 143.66 39.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -137.06 143.79 42.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -115.01 134.26 55.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.891 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.1 108.09 5.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.789 ' O ' HG23 ' A' ' 261' ' ' THR . 32.0 p90 -139.31 163.37 32.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.592 HG22 ' OG1' ' A' ' 261' ' ' THR . 60.6 t -108.65 132.34 56.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.15 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.643 HG13 ' HB3' ' A' ' 281' ' ' PHE . 79.2 t -113.39 142.62 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 -55.16 125.04 18.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -53.76 -18.16 2.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.54 -38.53 17.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 281' ' ' PHE . 51.4 mt -80.24 -27.54 38.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.46 ' CE ' HD11 ' A' ' 255' ' ' LEU . 22.4 mtp -40.23 -59.26 1.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.849 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -41.21 -54.13 3.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.467 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.04 -54.75 33.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.882 0.372 . . . . 0.0 110.936 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -45.92 -44.11 14.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.105 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 11.0 mt -71.6 -38.5 67.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 94.84 -134.25 11.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.454 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 237' ' ' HIS . 60.2 m -113.01 138.66 49.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.833 0.349 . . . . 0.0 111.141 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 236' ' ' THR . 5.5 m-70 35.91 48.8 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 59.29 57.73 18.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.493 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.7 t -84.57 -68.14 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.877 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 4.7 m120 -41.64 -62.32 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 60.2 mt -39.9 -52.52 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -54.76 -48.93 72.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.944 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.452 ' OE1' ' N ' ' A' ' 243' ' ' GLN . 0.3 OUTLIER -60.97 -30.83 70.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 247' ' ' VAL . . . -68.54 -53.39 23.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -57.72 -23.91 54.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -72.51 1.89 7.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.669 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.4 t -82.67 138.9 43.75 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.654 0.74 . . . . 0.0 111.105 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.669 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.4 Cg_endo -69.75 133.28 25.22 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.728 2.286 . . . . 0.0 112.316 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 96.83 -3.45 62.68 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.511 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 70.6 t -96.59 113.46 31.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 111.095 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 20.6 p -70.87 -57.83 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -148.41 168.24 23.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.074 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.564 HG12 HG23 ' A' ' 264' ' ' ILE . 65.6 mt -143.84 109.17 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.126 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -113.13 154.45 26.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.46 HD11 ' CE ' ' A' ' 230' ' ' MET . 8.0 tp -131.47 138.78 49.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.953 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.415 ' N ' HD12 ' A' ' 255' ' ' LEU . 6.6 m-20 -104.51 113.28 26.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -82.38 -33.19 28.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.849 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -45.46 -35.68 3.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 63.6 p -128.07 -31.33 2.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 99.15 47.05 1.93 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.49 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 223' ' ' PHE . 97.7 m -115.17 128.84 56.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 111.132 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.557 ' CE1' HD22 ' A' ' 279' ' ' LEU . 10.6 m-85 -91.12 123.0 34.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -111.78 114.67 27.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.932 HG22 HG12 ' A' ' 272' ' ' VAL . 19.2 mt -109.1 139.84 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -120.25 117.05 26.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.607 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -139.67 151.88 22.24 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.506 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 25.1 mt-10 -67.74 -31.52 71.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 110.917 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.3 p -129.84 134.99 47.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.636 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -46.46 -32.42 3.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.099 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -62.06 -41.84 98.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.73 -65.54 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.085 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.932 HG12 HG22 ' A' ' 264' ' ' ILE . 0.3 OUTLIER -51.22 -34.57 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.153 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -65.59 -53.05 47.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -53.63 -48.25 69.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.36 -35.25 77.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.113 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.54 ' HG3' ' CE1' ' A' ' 223' ' ' PHE . 56.5 ttt180 -51.92 -42.81 63.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -49.46 -33.83 18.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.97 -43.81 67.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.381 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.887 HD12 HD11 ' A' ' 264' ' ' ILE . 69.8 mt -72.79 -28.94 62.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -49.02 145.76 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.819 ' HB2' HD13 ' A' ' 229' ' ' LEU . 14.8 p90 -66.25 142.91 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 86.4 t -127.51 137.17 58.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.139 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 284' ' ' ASP . 2.9 mp0 -68.85 139.73 55.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 283' ' ' GLU . 6.0 m-20 -35.56 113.27 0.2 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -112.88 122.88 48.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.886 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 286' ' ' ILE . 4.7 mp -109.32 100.95 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -88.49 147.93 24.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 11.9 m -85.37 144.43 40.61 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.641 0.734 . . . . 0.0 111.123 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 176.19 7.13 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.683 2.255 . . . . 0.0 112.306 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 49.7 m -157.33 158.25 35.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -128.74 146.2 16.76 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.491 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 177.9 5.11 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.657 2.238 . . . . 0.0 112.358 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 20.0 t -131.78 114.1 14.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.828 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 30.8 m -40.51 161.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.827 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.506 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 8.7 t 69.61 40.39 1.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.874 0.369 . . . . 0.0 110.899 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 31.3 t -49.73 100.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.832 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -142.03 110.59 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.495 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 30.6 p -79.4 138.65 37.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.87 0.367 . . . . 0.0 110.852 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 82.5 p -166.08 148.66 7.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.876 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -91.68 111.51 4.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.497 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 80.7 p -124.46 151.82 44.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.35 . . . . 0.0 111.138 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -141.33 120.73 13.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -122.12 38.4 4.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 18.0 mt -44.68 -49.27 10.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -89.21 158.75 17.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.777 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . -79.52 115.22 19.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.104 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -51.84 -33.56 36.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.123 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.819 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 43.4 m-85 -119.02 122.77 42.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -121.28 152.19 39.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.822 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -129.87 153.11 48.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -157.49 117.53 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.401 ' CE2' ' HG3' ' A' ' 276' ' ' ARG . 27.9 p90 -142.79 144.96 32.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.3 t -91.73 129.19 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 281' ' ' PHE . 55.3 t -109.83 139.03 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.12 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -53.82 131.08 39.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.17 -11.69 6.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -96.82 -21.29 17.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.827 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.652 HD13 ' HB2' ' A' ' 281' ' ' PHE . 74.4 mt -97.58 -9.03 27.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.412 ' CE ' HD11 ' A' ' 255' ' ' LEU . 5.4 mmt -49.97 -66.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -40.27 -51.41 3.62 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.503 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 68.1 mt -59.42 -63.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.626 ' HB2' ' HA ' ' A' ' 281' ' ' PHE . . . -45.97 -39.53 9.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 45.6 mt -75.74 -30.38 21.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 88.85 -147.35 19.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.483 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 237' ' ' HIS . 9.6 t -101.58 140.69 35.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.765 0.317 . . . . 0.0 111.185 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 236' ' ' THR . 14.4 p80 34.63 49.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 56.46 66.27 2.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.486 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.7 t -93.74 -61.24 1.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 110.86 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -48.42 -63.46 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 45.4 mt -39.59 -52.75 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -50.68 -45.5 58.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -61.98 -50.24 72.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.934 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.537 ' HB1' ' HB1' ' A' ' 275' ' ' ALA . . . -56.7 -35.59 68.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.09 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -75.99 -18.37 59.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -89.29 12.86 14.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.623 HG13 ' HD2' ' A' ' 248' ' ' PRO . 93.7 t -91.76 137.4 25.54 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.646 0.736 . . . . 0.0 111.16 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.623 ' HD2' HG13 ' A' ' 247' ' ' VAL . 54.0 Cg_endo -69.69 139.69 41.08 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.657 2.238 . . . . 0.0 112.385 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 95.97 -18.99 56.42 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.541 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 86.9 t -81.01 116.79 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 111.104 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 265' ' ' TYR . 37.2 p -71.24 -49.17 46.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.108 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -161.45 169.44 21.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.505 HG12 HG23 ' A' ' 264' ' ' ILE . 90.6 mt -144.6 113.56 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.088 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -114.01 153.51 29.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 256' ' ' ASP . 1.8 tp -135.31 125.52 26.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.889 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.676 ' N ' HD12 ' A' ' 255' ' ' LEU . 1.7 t70 -84.87 107.81 17.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 29.7 mp0 -83.15 -3.93 57.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -91.33 -36.23 13.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 40.1 p -115.36 -17.02 11.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 76.88 51.79 6.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.475 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 96.8 m -124.97 126.62 45.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 111.161 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.825 ' CE1' HD22 ' A' ' 279' ' ' LEU . 11.1 m-85 -88.02 114.16 24.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 27.4 mtt-85 -104.24 117.09 33.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.83 HG22 HG12 ' A' ' 272' ' ' VAL . 10.2 mt -110.02 148.43 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 251' ' ' THR . 60.2 m-85 -131.65 112.43 12.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.777 ' O ' ' HB1' ' A' ' 217' ' ' ALA . . . -133.34 148.81 19.49 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.524 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -67.4 -25.71 66.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.888 0.375 . . . . 0.0 110.9 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 270' ' ' ASP . 6.3 m -141.08 131.26 24.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.833 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.819 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -36.8 -34.11 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.118 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 268' ' ' SER . 2.6 m-20 -57.74 -50.73 72.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -55.87 -66.98 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.83 HG12 HG22 ' A' ' 264' ' ' ILE . 2.4 m -50.66 -41.7 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -56.28 -52.79 63.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -57.79 -49.23 77.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.537 ' HB1' ' HB1' ' A' ' 244' ' ' ALA . . . -64.56 -31.53 72.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.401 ' HG3' ' CE2' ' A' ' 223' ' ' PHE . 37.8 ttp85 -60.41 -45.99 91.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.06 -22.52 2.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.469 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -85.55 -50.63 7.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 0.0 110.851 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.825 HD22 ' CE1' ' A' ' 262' ' ' PHE . 78.2 mt -68.75 -8.66 45.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.938 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -64.63 139.75 58.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.652 ' HB2' HD13 ' A' ' 229' ' ' LEU . 8.1 p90 -64.1 142.97 58.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 90.9 t -126.72 134.7 65.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -67.2 152.15 46.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.15 130.44 30.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -107.2 123.82 48.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 85.0 mt -116.85 101.55 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.135 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -121.6 121.77 38.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.932 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.8 m -96.1 144.35 27.67 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 111.138 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -50.54 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.662 2.241 . . . . 0.0 112.355 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 41.1 t -150.99 118.21 5.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -102.03 162.61 17.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.512 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -25.81 28.5 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.705 2.27 . . . . 0.0 112.348 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.6 m -83.73 94.03 8.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.87 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.1 t -96.43 136.3 37.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.486 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 98.4 p -129.12 125.25 36.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.87 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.4 t -142.23 136.83 30.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.75 98.3 1.99 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.475 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 89.1 p -171.09 166.31 7.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 0.0 110.892 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.2 m -63.44 82.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -83.49 129.59 9.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 38.3 p -137.66 148.24 45.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.84 0.352 . . . . 0.0 111.172 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -62.63 165.83 6.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -82.89 163.61 21.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.958 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 73.8 mt -86.41 -58.11 2.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.954 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.94 -178.9 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.129 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -123.58 137.11 54.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.104 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -74.84 -43.11 56.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.553 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 96.7 m-85 -114.41 122.72 47.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -118.46 141.79 48.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -119.13 135.97 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.405 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 0.9 OUTLIER -138.05 122.93 18.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 223' ' ' PHE . 1.7 p90 -140.57 151.79 44.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.9 t -104.42 114.03 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.729 HG22 ' HB3' ' A' ' 281' ' ' PHE . 19.5 t -97.91 143.6 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.155 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.412 ' O ' HG12 ' A' ' 225' ' ' VAL . 13.9 mmt85 -53.9 172.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -91.42 -17.57 25.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -102.28 -8.89 20.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.82 HD22 ' O ' ' A' ' 282' ' ' VAL . 65.7 mt -100.69 -4.08 28.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 2.8 mmt -58.21 -66.8 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -42.85 -39.21 3.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.451 HD12 HD23 ' A' ' 229' ' ' LEU . 68.1 mt -66.34 -59.86 3.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 0.0 110.889 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.422 ' O ' ' CG ' ' A' ' 240' ' ' ASN . . . -53.76 -49.68 67.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 8.0 mt -65.76 -31.66 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.158 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 92.92 -153.12 21.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.463 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 70.1 p -108.72 118.13 35.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.349 . . . . 0.0 111.169 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 69.25 35.44 2.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.857 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 58.84 61.07 7.79 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.485 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.3 t -92.42 -54.25 3.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.882 0.372 . . . . 0.0 110.876 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 5.5 m120 -52.88 -56.2 17.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.885 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.493 ' HA ' HD21 ' A' ' 279' ' ' LEU . 39.4 mt -46.54 -45.59 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -55.21 -62.53 1.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -45.91 -41.41 11.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.69 -57.21 13.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.418 ' HG3' HD12 ' A' ' 253' ' ' ILE . 80.8 mtt180 -60.3 -11.62 6.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -98.21 14.1 28.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.661 HG13 ' HD2' ' A' ' 248' ' ' PRO . 98.1 t -94.36 138.29 22.48 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.581 0.705 . . . . 0.0 111.153 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.661 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.8 Cg_endo -69.77 128.41 15.97 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.649 2.233 . . . . 0.0 112.355 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.568 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 103.75 -6.26 48.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 78.3 t -98.14 108.55 22.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 0.0 111.122 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 43.5 p -64.89 -46.29 82.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.152 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -162.02 165.79 26.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.065 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 264' ' ' ILE . 58.3 mt -139.37 106.37 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.089 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -109.37 151.98 25.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.733 HD22 ' CZ ' ' A' ' 262' ' ' PHE . 7.8 tp -138.07 151.37 47.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.916 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.511 ' H ' HD12 ' A' ' 255' ' ' LEU . 3.6 t70 -112.89 124.37 52.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -89.49 -19.57 24.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.95 -27.39 39.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.836 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 60.3 p -121.69 -14.15 8.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 66.67 44.08 90.46 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.51 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.405 ' CG2' ' HG2' ' A' ' 222' ' ' GLU . 71.1 m -115.25 123.48 48.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 111.137 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.733 ' CZ ' HD22 ' A' ' 255' ' ' LEU . 11.3 m-85 -91.25 113.99 26.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -104.65 115.52 30.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.965 HG22 HG12 ' A' ' 272' ' ' VAL . 55.8 mt -108.32 140.36 27.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.183 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -121.25 122.16 39.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.568 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -143.46 152.73 24.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 22.9 mt-10 -71.77 -34.4 69.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.341 . . . . 0.0 110.858 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 21.5 p -125.76 132.08 52.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.553 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -43.0 -31.28 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.39 -43.7 98.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.568 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -60.3 -64.41 0.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.091 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.965 HG12 HG22 ' A' ' 264' ' ' ILE . 0.5 OUTLIER -52.77 -40.52 35.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.118 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -59.63 -55.81 29.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -58.49 -41.96 86.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.881 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.83 -24.14 61.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 18.3 ttt-85 -68.35 -45.11 73.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.67 -27.64 6.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.477 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -78.58 -36.82 43.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.37 . . . . 0.0 110.868 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.493 HD21 ' HA ' ' A' ' 241' ' ' ILE . 86.0 mt -88.33 -13.75 39.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.931 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -55.15 138.04 45.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.729 ' HB3' HG22 ' A' ' 225' ' ' VAL . 17.0 p90 -63.82 140.81 58.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.82 ' O ' HD22 ' A' ' 229' ' ' LEU . 59.4 t -122.95 133.52 68.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.087 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.92 135.46 54.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.78 161.56 4.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -111.03 145.82 37.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 3.8 mm -114.94 102.13 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -94.03 121.21 35.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.92 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 26.2 m -99.53 144.35 28.14 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.652 0.739 . . . . 0.0 111.108 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 92.83 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.637 2.225 . . . . 0.0 112.35 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 16.1 p -125.78 130.34 51.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.866 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 95.28 -155.12 21.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 150.11 67.78 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.728 2.285 . . . . 0.0 112.351 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 3.1 m -77.82 162.46 26.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.84 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 62.7 p -164.87 132.8 3.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.444 -179.96 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 5.2 t -142.21 157.78 44.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.86 0.362 . . . . 0.0 110.834 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 53.1 p -77.68 169.82 17.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.879 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -103.0 -129.26 6.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.465 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 28.9 t -67.48 130.04 41.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.826 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.8 p -142.65 124.55 15.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.896 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -160.83 97.39 0.16 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.491 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 9.0 t -127.76 151.15 49.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.894 0.378 . . . . 0.0 111.108 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -118.68 157.49 27.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -64.39 96.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 22.1 tp -138.71 146.13 41.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.911 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.06 161.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.575 ' HB1' ' C ' ' A' ' 266' ' ' GLY . . . -102.03 117.59 35.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.102 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -57.25 -39.54 75.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.04 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -111.6 135.33 52.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -133.32 138.01 46.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -115.34 127.17 55.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.554 ' CD ' ' CG2' ' A' ' 261' ' ' THR . 3.0 tp10 -132.73 119.62 20.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.931 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -140.52 153.16 46.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.47 122.62 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.465 HG22 ' HD2' ' A' ' 281' ' ' PHE . 19.1 t -104.59 146.23 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -53.52 173.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -89.79 -27.54 19.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -90.92 -30.98 16.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.824 HD13 ' HB2' ' A' ' 281' ' ' PHE . 64.2 mt -73.09 -18.74 61.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.434 ' CE ' HD11 ' A' ' 255' ' ' LEU . 2.3 mtt -47.13 -59.03 3.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -46.22 -43.22 13.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.497 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 282' ' ' VAL . 36.7 mt -68.29 -63.27 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 110.889 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.757 ' HB2' ' HA ' ' A' ' 281' ' ' PHE . . . -45.08 -43.47 9.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.162 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 61.2 mt -73.91 -35.52 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.1 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 89.95 -158.06 26.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.511 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 237' ' ' HIS . 5.4 m -92.12 145.25 24.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.35 . . . . 0.0 111.132 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.43 ' C ' ' O ' ' A' ' 236' ' ' THR . 89.4 m-70 35.2 51.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 50.19 66.93 2.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 17.1 t -92.06 -68.95 0.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.862 0.363 . . . . 0.0 110.849 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.444 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 5.0 m120 -40.33 -67.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 240' ' ' ASN . 45.4 mt -36.5 -54.99 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -55.21 -48.63 73.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -58.45 -52.54 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -50.67 -39.14 50.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -71.91 -25.04 61.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -81.3 11.05 4.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.683 HG13 ' HD2' ' A' ' 248' ' ' PRO . 98.7 t -91.38 138.94 25.26 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.612 0.72 . . . . 0.0 111.128 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.683 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.8 Cg_endo -69.72 137.4 35.47 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.704 2.27 . . . . 0.0 112.34 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 97.93 -21.46 45.97 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.514 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 88.5 t -82.15 115.72 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.918 0.389 . . . . 0.0 111.086 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 265' ' ' TYR . 79.4 p -71.35 -48.39 50.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -158.85 169.43 24.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 264' ' ' ILE . 73.3 mt -145.42 109.72 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -110.97 163.22 14.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.65 HD13 ' CZ ' ' A' ' 262' ' ' PHE . 10.3 tp -140.88 153.98 45.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.607 ' H ' HD12 ' A' ' 255' ' ' LEU . 3.8 m-20 -121.03 119.28 32.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.831 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -86.12 -13.93 45.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -58.29 -52.85 63.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 37.3 p -119.18 -19.36 8.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 95.28 48.28 2.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.514 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.554 ' CG2' ' CD ' ' A' ' 222' ' ' GLU . 20.7 m -110.97 136.79 49.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 111.117 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.65 ' CZ ' HD13 ' A' ' 255' ' ' LEU . 11.6 m-85 -107.39 127.02 53.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . 0.412 ' HG3' ' CD ' ' A' ' 222' ' ' GLU . 17.4 mtp180 -113.99 115.23 27.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.813 HG22 HG12 ' A' ' 272' ' ' VAL . 34.0 mt -107.18 142.64 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 251' ' ' THR . 79.1 m-85 -124.5 124.02 41.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.61 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -147.73 136.27 5.96 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.461 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 55.3 mt-10 -54.96 -41.75 71.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.87 0.367 . . . . 0.0 110.869 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 271' ' ' ALA . 38.3 m -122.24 136.26 54.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 271' ' ' ALA . . . -43.04 -59.65 1.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.139 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 269' ' ' ALA . 3.1 m-20 -36.51 -30.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 269' ' ' ALA . . . -75.07 -68.94 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.116 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.813 HG12 HG22 ' A' ' 264' ' ' ILE . 0.8 OUTLIER -51.8 -28.71 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.087 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.09 -51.17 22.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -60.35 -33.96 73.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -82.5 -30.69 29.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -58.56 -44.4 89.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -48.07 -27.39 5.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.504 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -79.04 -54.95 5.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.866 0.365 . . . . 0.0 110.829 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.707 HD12 HD11 ' A' ' 264' ' ' ILE . 67.4 mt -63.48 -22.14 66.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -58.35 141.5 51.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.824 ' HB2' HD13 ' A' ' 229' ' ' LEU . 10.1 p90 -62.07 152.08 33.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.538 ' O ' HD13 ' A' ' 232' ' ' LEU . 81.6 t -128.14 128.87 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.168 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -51.64 158.67 0.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.925 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.84 76.89 4.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -84.99 127.03 34.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 5.3 mp -108.78 99.09 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.183 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.7 149.36 21.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.7 m -103.93 142.23 24.16 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.672 0.749 . . . . 0.0 111.108 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 112.32 3.05 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.691 2.26 . . . . 0.0 112.332 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 7.9 t -94.05 150.51 20.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.826 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 61.93 -170.02 11.7 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.52 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -12.79 33.46 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 2.262 . . . . 0.0 112.301 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 74.8 m -86.71 97.04 10.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.8 t -106.35 90.14 3.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.492 -179.973 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 48.0 t -164.2 111.61 1.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.8 m -122.5 173.42 7.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.896 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -120.7 173.81 15.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.437 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 71.1 m -100.05 80.55 2.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.953 0.406 . . . . 0.0 110.851 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.6 t -56.82 156.24 6.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.836 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -90.87 47.19 2.95 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.46 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 8.9 t -124.01 133.23 53.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.869 0.366 . . . . 0.0 111.164 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -134.45 91.62 2.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -132.18 170.13 15.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 15.7 tp -113.08 94.21 4.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -152.43 155.96 38.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.08 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.408 ' HB1' ' C ' ' A' ' 266' ' ' GLY . . . -111.19 110.41 20.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.053 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -48.2 -39.05 19.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.622 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 75.9 m-85 -110.39 146.45 35.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.896 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -145.03 140.33 28.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -113.46 138.26 50.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.433 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 8.6 tt0 -143.0 116.94 9.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' A' ' 262' ' ' PHE . 29.6 p90 -142.23 139.22 31.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.02 123.6 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 56.0 t -111.72 136.35 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.551 ' HB2' HD12 ' A' ' 229' ' ' LEU . 23.6 mmt180 -54.05 142.96 23.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -58.5 -25.85 62.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.51 -43.53 22.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.724 HD22 ' O ' ' A' ' 282' ' ' VAL . 23.6 mt -66.59 -32.02 73.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.517 ' CE ' HD11 ' A' ' 255' ' ' LEU . 3.2 mtt -36.83 -66.81 0.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 230' ' ' MET . . . -34.47 -61.8 0.54 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.496 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 235' ' ' GLY . 60.2 mt -60.11 -65.32 0.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' LEU . . . -37.62 -36.85 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.102 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.464 HG23 HG13 ' A' ' 241' ' ' ILE . 64.7 mt -83.02 -36.2 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 232' ' ' LEU . . . 96.58 -151.2 19.81 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 86.0 m -100.99 136.28 41.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.768 0.318 . . . . 0.0 111.16 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 2.7 m80 43.99 49.49 7.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 52.45 65.74 3.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 3.5 t -92.68 -65.65 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.861 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -43.64 -63.35 0.86 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.572 HG12 HD21 ' A' ' 279' ' ' LEU . 33.7 mt -39.71 -52.11 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.096 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -54.05 -51.17 64.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -54.59 -48.13 72.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -54.69 -48.05 72.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.092 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -65.91 -29.66 70.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -72.17 -1.33 14.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.685 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.2 t -82.39 138.88 44.71 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.657 0.741 . . . . 0.0 111.142 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.685 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.7 Cg_endo -69.76 148.43 65.09 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.671 2.247 . . . . 0.0 112.355 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 89.26 -26.8 8.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 87.6 t -74.4 105.5 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.931 0.396 . . . . 0.0 111.11 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 34.7 p -60.52 -49.41 77.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.25 162.92 33.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.089 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.563 HG12 HG23 ' A' ' 264' ' ' ILE . 24.4 mt -134.05 106.42 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -107.74 155.7 19.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.517 HD11 ' CE ' ' A' ' 230' ' ' MET . 6.1 tp -141.64 150.54 42.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -108.16 141.53 39.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -103.57 -20.15 14.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -76.76 -36.46 57.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.7 p -115.02 -22.76 9.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.154 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 77.58 47.0 9.19 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.449 ' O ' HD12 ' A' ' 255' ' ' LEU . 48.6 m -112.89 135.54 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 111.191 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.533 ' HB2' ' CE2' ' A' ' 223' ' ' PHE . 12.9 m-85 -98.73 115.68 29.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -105.89 114.48 28.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.917 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.965 HG22 HG12 ' A' ' 272' ' ' VAL . 34.5 mt -108.91 132.0 58.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.141 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -111.22 126.4 54.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.644 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -147.24 143.61 11.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.453 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.34 -34.8 74.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.925 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 14.2 m -133.24 131.43 40.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.622 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -40.73 -38.56 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.112 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.49 -43.16 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.873 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.09 -68.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.965 HG12 HG22 ' A' ' 264' ' ' ILE . 1.2 m -49.38 -30.54 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -67.94 -52.46 35.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -56.72 -41.23 77.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.64 -41.77 62.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.081 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -50.34 -39.92 47.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.835 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -53.79 -23.36 21.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.535 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -82.14 -36.84 27.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.362 . . . . 0.0 110.898 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.572 HD21 HG12 ' A' ' 241' ' ' ILE . 69.0 mt -91.08 16.92 8.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -64.88 145.44 56.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 281' ' ' PHE . 52.0 p90 -72.35 124.77 25.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.724 ' O ' HD22 ' A' ' 229' ' ' LEU . 91.5 t -123.04 127.61 74.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.11 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.461 ' HA ' ' CD2' ' A' ' 229' ' ' LEU . 70.1 mt-10 -58.51 161.78 4.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.02 123.41 25.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -96.49 138.2 34.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 45.8 mt -120.38 104.07 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -100.77 143.11 31.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 30.8 m -125.3 144.34 47.28 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.64 0.734 . . . . 0.0 111.115 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 148.85 65.81 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.667 2.244 . . . . 0.0 112.341 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.4 t -93.5 -55.92 3.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 163.29 -158.2 30.52 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.47 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 86.68 0.58 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.669 2.246 . . . . 0.0 112.342 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 4.4 m -52.85 113.86 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 2.6 m 56.39 52.72 9.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.859 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.445 -179.988 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 3.6 m -132.36 145.55 51.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.881 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 27.8 t -160.93 137.37 8.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.842 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.52 -137.54 3.72 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.541 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.0 t -84.69 106.92 16.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.933 0.397 . . . . 0.0 110.88 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.3 p -82.44 100.87 10.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 60.92 -93.5 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.524 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 52.4 p -85.75 144.79 27.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.922 0.392 . . . . 0.0 111.142 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -48.3 -49.26 34.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -68.82 166.64 17.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.1 pp -138.88 155.68 47.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -109.96 155.76 21.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.075 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . -88.5 112.59 23.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.064 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.44 -30.71 61.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 1.076 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 58.9 m-85 -117.62 138.36 52.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -139.17 147.71 42.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -121.84 144.88 48.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -147.27 112.21 5.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -136.17 147.62 47.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 37.4 t -101.18 122.95 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.157 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 99.6 t -108.21 136.34 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.46 ' O ' ' N ' ' A' ' 229' ' ' LEU . 37.7 mtt-85 -54.15 122.44 10.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -42.1 -32.04 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -74.94 -37.5 61.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.682 HD13 ' HB2' ' A' ' 281' ' ' PHE . 51.5 mt -74.87 -30.01 61.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.462 ' HE3' HD11 ' A' ' 255' ' ' LEU . 4.0 mmt -37.26 -61.51 0.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.0 -53.48 2.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 35.6 mt -67.04 -54.61 19.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.815 0.34 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.443 ' O ' ' ND2' ' A' ' 240' ' ' ASN . . . -43.06 -48.85 6.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.571 HG22 ' HA2' ' A' ' 238' ' ' GLY . 38.8 mt -71.49 -34.6 53.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.095 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 94.21 -145.97 17.93 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.474 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 237' ' ' HIS . 0.0 OUTLIER -99.84 140.26 34.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.86 0.362 . . . . 0.0 111.104 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 236' ' ' THR . 8.1 m170 36.76 42.59 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.571 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 59.72 65.6 3.31 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.493 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 27.2 t -93.54 -59.58 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.82 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 233' ' ' ALA . 2.4 m120 -47.16 -57.86 4.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.904 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.706 HG12 HD21 ' A' ' 279' ' ' LEU . 27.2 mt -45.01 -53.46 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.159 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -46.97 -64.77 0.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -42.36 -45.34 4.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.56 98.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.077 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -72.32 -12.71 61.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.902 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -95.99 8.46 43.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.588 HG13 ' HD2' ' A' ' 248' ' ' PRO . 84.2 t -86.93 136.69 33.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.597 0.713 . . . . 0.0 111.159 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.588 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.1 Cg_endo -69.86 130.06 18.58 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.66 2.24 . . . . 0.0 112.319 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.43 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 102.21 -9.13 56.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.452 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 45.9 t -91.62 99.3 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.886 0.374 . . . . 0.0 111.137 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.7 p -55.34 -49.46 72.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -159.36 170.02 22.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.498 HG12 HG23 ' A' ' 264' ' ' ILE . 56.8 mt -144.2 106.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -101.89 155.42 18.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.705 HD22 ' CE1' ' A' ' 262' ' ' PHE . 2.5 tp -138.76 122.44 17.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.52 ' N ' HD12 ' A' ' 255' ' ' LEU . 19.1 m-20 -93.42 102.32 14.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.49 -33.06 68.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -43.35 -46.72 6.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.857 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 11.1 p -122.75 -9.89 8.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 256' ' ' ASP . . . 79.2 56.61 3.4 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.52 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 25.2 m -117.95 112.84 20.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.849 0.357 . . . . 0.0 111.153 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.705 ' CE1' HD22 ' A' ' 255' ' ' LEU . 9.9 m-85 -85.01 114.25 22.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -106.58 123.32 47.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.984 HG22 HG12 ' A' ' 272' ' ' VAL . 6.3 mt -109.53 146.46 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -128.12 118.5 23.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.675 ' O ' ' HB1' ' A' ' 217' ' ' ALA . . . -142.23 155.73 25.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -71.95 -25.22 61.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.873 0.368 . . . . 0.0 110.874 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 270' ' ' ASP . 2.3 m -141.75 132.23 25.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 1.076 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -40.12 -27.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.096 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 268' ' ' SER . 0.8 OUTLIER -62.13 -46.65 88.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.43 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -61.38 -64.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.115 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.984 HG12 HG22 ' A' ' 264' ' ' ILE . 0.9 OUTLIER -51.29 -35.45 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.111 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 269' ' ' ALA . 19.0 mtpp -63.06 -53.55 51.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -56.81 -39.57 74.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.933 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.37 -41.93 69.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.524 ' HB2' HD12 ' A' ' 264' ' ' ILE . 39.5 ttp180 -59.06 -27.55 65.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -67.84 -6.9 46.66 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.459 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -101.37 -32.52 10.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 0.0 110.891 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.706 HD21 HG12 ' A' ' 241' ' ' ILE . 40.8 mt -86.29 0.94 52.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -47.07 155.31 0.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.682 ' HB2' HD13 ' A' ' 229' ' ' LEU . 41.9 p90 -82.67 127.71 33.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.852 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.469 ' O ' HD22 ' A' ' 229' ' ' LEU . 87.0 t -123.74 131.44 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.152 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.598 ' HG2' HD21 ' A' ' 229' ' ' LEU . 31.6 mt-10 -89.7 162.71 15.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -40.6 103.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -100.85 138.12 38.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 50.6 mt -106.77 98.79 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.85 136.35 34.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.07 146.27 71.09 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.658 0.742 . . . . 0.0 111.116 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 -40.85 4.9 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.648 2.232 . . . . 0.0 112.381 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.2 t -53.13 114.0 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.829 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -115.35 150.68 18.65 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.532 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -11.69 31.4 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.71 2.273 . . . . 0.0 112.339 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 42.0 t -119.06 143.95 46.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.835 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.5 t -108.72 -62.82 1.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.497 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 27.4 t -100.73 159.92 14.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.83 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 93.7 p -94.23 123.97 37.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 124.57 -177.59 16.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.471 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 14.8 p -113.41 134.89 54.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 0.0 110.865 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.5 p -81.17 135.78 35.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.861 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -147.99 164.32 28.89 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.499 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 9.3 t -98.09 138.05 35.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.36 . . . . 0.0 111.15 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -102.74 -55.92 2.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -90.14 132.91 35.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.928 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.1 mp -66.3 -35.73 81.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.08 146.35 54.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' A' ' 266' ' ' GLY . . . -119.44 116.49 26.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.114 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.04 -38.78 68.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.07 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.802 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 39.2 m-85 -111.08 139.38 46.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -135.4 151.84 50.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -132.88 146.29 51.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.462 ' HG2' ' CG2' ' A' ' 261' ' ' THR . 7.3 tm-20 -152.3 116.7 5.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -137.95 153.62 49.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.481 HG22 ' OG1' ' A' ' 261' ' ' THR . 38.6 t -102.06 121.5 53.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.622 HG22 ' HD2' ' A' ' 281' ' ' PHE . 25.2 t -103.89 140.98 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.137 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.411 ' HB2' HD12 ' A' ' 229' ' ' LEU . 82.3 mtt180 -56.51 127.08 29.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -50.8 -21.86 1.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.64 -42.25 18.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.831 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.467 HD13 ' HB2' ' A' ' 281' ' ' PHE . 65.9 mt -77.86 -16.17 58.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.55 ' CE ' HD11 ' A' ' 255' ' ' LEU . 5.3 mmt -45.25 -67.73 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.844 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -39.13 -58.29 1.97 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.501 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.472 HD22 ' HE2' ' A' ' 285' ' ' PHE . 50.5 mt -55.31 -62.88 1.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.806 0.336 . . . . 0.0 110.931 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.679 ' HB2' ' HA ' ' A' ' 281' ' ' PHE . . . -42.33 -45.69 4.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.683 HG23 HG13 ' A' ' 241' ' ' ILE . 54.9 mt -73.39 -29.28 27.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.137 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 232' ' ' LEU . . . 93.75 -162.35 25.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.513 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 67.9 p -96.68 123.82 40.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.155 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 60.25 37.66 20.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.43 ' HA2' HG22 ' A' ' 234' ' ' ILE . . . 61.54 63.21 5.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.435 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 5.5 t -92.55 -58.29 2.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.907 0.384 . . . . 0.0 110.843 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -50.06 -53.23 28.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.683 HG13 HG23 ' A' ' 234' ' ' ILE . 14.4 mt -49.76 -49.12 20.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -50.31 -63.46 1.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -48.31 -41.59 28.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.39 -52.94 63.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -62.65 -12.12 21.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -96.02 11.8 32.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.683 HG13 ' HD2' ' A' ' 248' ' ' PRO . 99.0 t -91.3 138.91 25.39 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.617 0.722 . . . . 0.0 111.127 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.683 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.6 Cg_endo -69.76 139.4 40.12 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.677 2.251 . . . . 0.0 112.381 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 271' ' ' ALA . . . 96.2 -24.19 31.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.454 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 86.0 t -77.88 109.89 12.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 30.0 p -67.47 -49.8 61.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.154 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.14 153.6 22.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.494 HG12 HG23 ' A' ' 264' ' ' ILE . 22.4 mt -128.81 112.38 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -112.35 153.67 26.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.709 HD22 ' CE1' ' A' ' 262' ' ' PHE . 11.1 tp -137.79 109.42 7.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.959 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.44 92.29 3.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.93 -25.43 68.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.874 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -43.8 -49.57 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 2.3 p -116.83 -29.28 6.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.127 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 107.78 43.86 1.28 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.434 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.481 ' OG1' HG22 ' A' ' 224' ' ' VAL . 6.5 m -110.79 133.42 53.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 111.117 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.709 ' CE1' HD22 ' A' ' 255' ' ' LEU . 10.5 m-85 -99.59 113.97 26.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.5 mtt-85 -103.69 113.93 27.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.844 HG22 HG12 ' A' ' 272' ' ' VAL . 9.3 mt -109.25 136.54 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.096 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -120.58 123.57 43.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.569 ' O ' ' HB1' ' A' ' 217' ' ' ALA . . . -142.7 151.13 22.84 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.515 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.95 -27.39 66.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 12.1 m -138.14 132.68 32.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.861 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.802 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -41.24 -35.24 0.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -55.55 -46.88 77.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.507 ' HB2' ' HA3' ' A' ' 249' ' ' GLY . . . -59.05 -67.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.844 HG12 HG22 ' A' ' 264' ' ' ILE . 1.5 m -51.61 -34.22 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -65.05 -49.6 69.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -66.0 -36.34 83.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -75.54 -30.86 59.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -60.37 -47.67 85.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -45.53 -27.8 2.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -78.85 -41.7 29.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.873 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.502 HD22 ' CE1' ' A' ' 262' ' ' PHE . 88.6 mt -80.21 -13.8 58.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -57.11 138.51 54.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.923 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.679 ' HA ' ' HB2' ' A' ' 233' ' ' ALA . 17.5 p90 -65.78 143.99 57.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.917 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 45.6 t -128.23 126.63 66.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.143 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -58.88 166.82 1.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.8 141.55 38.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.848 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . 0.472 ' HE2' HD22 ' A' ' 232' ' ' LEU . 53.3 m-85 -88.33 144.22 26.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 63.4 mt -127.68 109.32 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -110.63 119.05 37.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.686 HG23 ' HD2' ' A' ' 289' ' ' PRO . 4.4 p -113.04 138.84 22.41 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.647 0.737 . . . . 0.0 111.168 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.686 ' HD2' HG23 ' A' ' 288' ' ' VAL . 53.6 Cg_endo -69.73 118.71 5.84 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.71 2.273 . . . . 0.0 112.319 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 t -116.2 -56.15 2.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.897 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 151.45 82.14 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.523 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 151.52 69.01 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.647 2.231 . . . . 0.0 112.366 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 4.8 m -109.62 164.51 12.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.82 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 60.6 p -105.32 178.92 4.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.838 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.518 -179.931 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 30.4 t -150.58 106.42 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.875 0.369 . . . . 0.0 110.841 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 60.3 p -160.78 134.8 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.35 152.02 23.88 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.5 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 62.7 m -72.33 166.63 22.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.887 0.375 . . . . 0.0 110.867 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 98.7 p -104.24 129.27 52.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 65.81 -164.9 38.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.488 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 71.2 p -111.09 138.04 48.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 0.0 111.174 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -100.74 113.51 26.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -70.47 82.84 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.961 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 25.2 tp -168.36 116.93 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -45.25 160.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -86.18 132.32 34.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 267' ' ' GLU . . . -63.52 -42.6 98.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.1 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.784 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 53.2 m-85 -109.31 143.46 38.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -140.49 137.09 33.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -111.59 143.2 42.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -148.45 112.46 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.914 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.429 ' O ' HG23 ' A' ' 261' ' ' THR . 11.9 p90 -137.77 149.51 46.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.54 HG22 ' OG1' ' A' ' 261' ' ' THR . 20.0 t -95.37 120.98 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.17 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.2 t -103.46 137.14 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -54.94 126.99 26.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -53.95 -22.0 9.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -86.59 -23.66 25.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.753 HD13 ' HB2' ' A' ' 281' ' ' PHE . 37.7 mt -95.33 -12.68 25.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.637 ' CE ' HD11 ' A' ' 255' ' ' LEU . 4.8 mmt -47.1 -60.48 2.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -47.53 -50.83 17.84 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.513 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 49.5 mt -57.56 -55.96 28.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.814 0.34 . . . . 0.0 110.919 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 281' ' ' PHE . . . -52.59 -52.31 55.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.114 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 70.9 mt -61.02 -24.33 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.6 -154.89 34.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.461 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 237' ' ' HIS . 23.9 m -92.93 138.13 31.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 111.153 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 236' ' ' THR . 9.5 m170 37.07 54.46 1.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 50.83 56.73 12.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.484 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 30.2 t -84.96 -60.7 1.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.855 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.42 ' CG ' ' O ' ' A' ' 233' ' ' ALA . 4.4 m120 -49.39 -62.57 1.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 48.2 mt -39.48 -46.44 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.166 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -59.06 -52.92 63.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -54.66 -43.0 72.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.968 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.26 -45.17 95.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.436 ' HA ' HD12 ' A' ' 253' ' ' ILE . 36.0 ttt180 -68.0 -16.38 64.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -91.03 19.82 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.669 HG13 ' HD2' ' A' ' 248' ' ' PRO . 86.4 t -98.28 138.75 20.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.666 0.746 . . . . 0.0 111.125 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.669 ' HD2' HG13 ' A' ' 247' ' ' VAL . 53.3 Cg_endo -69.75 131.97 22.38 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.271 . . . . 0.0 112.338 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.12 -22.59 36.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 79.6 t -79.63 108.45 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.373 . . . . 0.0 111.124 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 63.3 p -64.64 -50.91 65.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.09 165.46 36.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.62 HG12 HG23 ' A' ' 264' ' ' ILE . 48.2 mt -139.65 111.95 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -112.87 159.51 18.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.637 HD11 ' CE ' ' A' ' 230' ' ' MET . 15.4 tp -135.83 138.32 42.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -108.69 112.19 24.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -80.15 -35.38 36.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -42.18 -40.58 2.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 78.0 p -124.58 -25.97 3.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 93.68 37.26 5.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.54 ' OG1' HG22 ' A' ' 224' ' ' VAL . 82.4 m -106.81 118.37 36.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 111.169 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.605 ' CE1' HD13 ' A' ' 255' ' ' LEU . 11.1 m-85 -81.15 132.36 35.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -116.57 118.31 32.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.916 HG22 HG12 ' A' ' 272' ' ' VAL . 7.1 mt -112.66 139.44 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -120.9 130.37 53.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.477 ' HA3' HG13 ' A' ' 272' ' ' VAL . . . -154.87 146.77 15.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.443 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 32.6 mm-40 -62.35 -33.63 75.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 110.882 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 47.4 m -128.91 132.09 47.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.784 ' HB2' ' CD2' ' A' ' 219' ' ' PHE . . . -44.91 -37.95 4.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.115 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -53.59 -37.76 63.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.853 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -68.01 -65.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.916 HG12 HG22 ' A' ' 264' ' ' ILE . 1.0 OUTLIER -55.15 -29.95 23.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.141 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -66.25 -53.52 35.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.934 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -57.81 -43.65 85.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.56 -32.86 70.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 34.9 ttp85 -55.04 -48.47 73.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -45.92 -32.06 4.45 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.428 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -73.01 -49.24 30.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.841 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.554 HD12 HD11 ' A' ' 264' ' ' ILE . 94.1 mt -71.15 -9.33 57.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -68.12 142.44 55.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.753 ' HB2' HD13 ' A' ' 229' ' ' LEU . 15.5 p90 -63.88 143.49 57.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.24 132.74 69.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.1 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -70.54 133.74 47.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -39.66 138.02 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -110.49 106.37 15.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 49.8 mm -108.61 96.92 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.082 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -121.08 142.56 49.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.666 HG23 ' HD2' ' A' ' 289' ' ' PRO . 5.4 p -89.05 138.63 29.01 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.656 0.741 . . . . 0.0 111.132 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.666 ' HD2' HG23 ' A' ' 288' ' ' VAL . 54.1 Cg_endo -69.72 -44.75 1.92 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.675 2.25 . . . . 0.0 112.388 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 53.2 p 46.49 41.45 9.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -149.31 63.14 0.41 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.477 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 165.11 32.02 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.651 2.234 . . . . 0.0 112.411 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 2.7 m -169.0 121.5 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.7 p -38.5 -32.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.454 -179.996 . . . . . . . . 0 0 . 1 stop_ save_